{
  "general_data": {
    "settings": {
      "pathway_id": "hsa04010",
      "pathway_source": "kegg",
      "protein_selection_option": 2,
      "ptm_selection_option": 2,
      "ptm_max_display": 4,
      "show_background_image": true,
      "display_types": [
        "prot_box"
      ],
      "show_groups": true,
      "show_multi_protein_indicator": true,
      "show_arrows": true,
      "show_text_boxes": false,
      "debug_mode": false,
      "negative_color": [
        2,
        81,
        150
      ],
      "positive_color": [
        253,
        179,
        56
      ],
      "max_negative": -2.0,
      "max_positive": 2.0,
      "prot_label_font": "Arial",
      "prot_label_size": 9,
      "ptm_label_font": "Arial",
      "ptm_label_color": [
        0,
        0,
        0
      ],
      "ptm_label_size": 6,
      "ptm_circle_radius": 5,
      "ptm_circle_spacing": 4,
      "prot_outline_width": 1.0,
      "ptm_outline_width": 1.0,
      "protein_tooltip_columns": [
        "T: Function [CC]",
        "T: Absorption",
        "T: Active site"
      ],
      "protein_file_path": "c:\\Users\\clayt\\Desktop\\MapKinase\\sample_input_files\\mapk_prot_examplefile.csv"
    },
    "data": {
      "protein": {
        "file_path": "c:\\Users\\clayt\\Desktop\\MapKinase\\sample_input_files\\mapk_prot_examplefile.csv",
        "uniprot_column": "Uniprot_ID",
        "kegg_column": "KEGG_Gene_ID",
        "gene_column": "Gene_Org",
        "main_columns": [
          "C: 0hr - 1hr",
          "C: 0hr - 4hr",
          "C: 0hr - 12hr",
          "C: 0hr - 24hr",
          "C: 0hr - 72hr"
        ],
        "tooltip_columns": [
          "T: Function [CC]",
          "T: Absorption",
          "T: Active site"
        ]
      },
      "ptm": [
        {
          "type": "Phosphorylation",
          "file_path": "c:\\Users\\clayt\\Desktop\\MapKinase\\sample_input_files\\mapk_phos_examplefile.csv",
          "uniprot_column": "Uniprot ID",
          "site_column": "Site Position",
          "shape": "Circle",
          "main_columns": [
            [
              "C: 0hr - 1hr",
              "C: 0hr - 1hr"
            ],
            [
              "C: 0hr - 4hr",
              "C: 0hr - 4hr"
            ],
            [
              "C: 0hr - 12hr",
              "C: 0hr - 12hr"
            ],
            [
              "C: 0hr - 24hr",
              "C: 0hr - 24hr"
            ],
            [
              "C: 0hr - 72hr",
              "C: 0hr - 72hr"
            ]
          ],
          "modulation_column": "PSP: regulatory_site",
          "tooltip_columns": [
            "T: sequence",
            "PSP: DOMAIN",
            "PSP: ON_FUNCTION",
            "PSP: ON_PROCESS",
            "PSP: ON_PROT_INTERACT",
            "PSP: ON_OTHER_INTERACT",
            "PSP: NOTES",
            "PSP: in_vivo_kinases",
            "PSP: in_vitro_kinases"
          ],
          "ptm_symbol_list": [
            {
              "symbol_label_1_dict": {
                "symbol": "\u2191",
                "symbol_font": "Segoe UI Symbol",
                "symbol_size": 8,
                "symbol_color": [
                  0,
                  0,
                  0
                ],
                "symbol_x_offset": -0.1,
                "symbol_y_offset": -0.5,
                "statement_type": "if_or_statement",
                "header_to_search": "PSP: ON_FUNCTION",
                "search_text_1": "activity, induced",
                "search_text_2": "enzymatic activity, induced",
                "search_text_3": "",
                "search_text_4": ""
              }
            },
            {
              "symbol_label_2_dict": {
                "symbol": "x",
                "symbol_font": "Arial",
                "symbol_size": 8,
                "symbol_color": [
                  0,
                  0,
                  0
                ],
                "symbol_x_offset": -0.3,
                "symbol_y_offset": 0,
                "statement_type": "if_or_statement",
                "header_to_search": "PSP: ON_FUNCTION",
                "search_text_1": "activity, inhibited",
                "search_text_2": "enzymatic activity, inhibited",
                "search_text_3": "",
                "search_text_4": ""
              }
            },
            {
              "symbol_label_3_dict": {
                "symbol": "+",
                "symbol_font": "Arial",
                "symbol_size": 9,
                "symbol_color": [
                  0,
                  0,
                  0
                ],
                "symbol_x_offset": -0.1,
                "symbol_y_offset": 0,
                "statement_type": "if_or_and_or_statement",
                "header_to_search": "PSP: ON_FUNCTION",
                "search_text_1": "activity, inhibited",
                "search_text_2": "enzymatic activity, inhibited",
                "search_text_3": "activity, induced",
                "search_text_4": "enzymatic activity, induced"
              }
            },
            {
              "symbol_label_4_dict": {
                "symbol": "+",
                "symbol_font": "Arial",
                "symbol_size": 9,
                "symbol_color": [
                  0,
                  0,
                  0
                ],
                "symbol_x_offset": -0.1,
                "symbol_y_offset": 0,
                "statement_type": "if_and_notlabeled_statement",
                "header_to_search": "PSP: regulatory_site",
                "search_text_1": "+",
                "search_text_2": "",
                "search_text_3": "",
                "search_text_4": ""
              }
            }
          ]
        }
      ]
    }
  },
  "protein_data": {
    "unknown_20": {
      "label": "RASGRF1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_21": {
      "label": "DUSP10",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P51452": {
      "label": "DUS3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines (PubMed:10224087, PubMed:11863439). Specifically dephosphorylates and inactivates ERK1 and ERK2 (PubMed:10224087, PubMed:11863439). {ECO:0000269|PubMed:10224087, ECO:0000269|PubMed:11863439}.\",\"ACT_SITE 124; /note=\"Phosphocysteine intermediate\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00160\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines (PubMed:10224087, PubMed:11863439). Specifically dephosphorylates and inactivates ERK1 and ERK2 (PubMed:10224087, PubMed:11863439). {ECO:0000269|PubMed:10224087, ECO:0000269|PubMed:11863439}.\nT: Active site: ACT_SITE 124; /note=\"Phosphocysteine intermediate\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00160\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines (PubMed:10224087, PubMed:11863439). Specifically dephosphorylates and inactivates ERK1 and ERK2 (PubMed:10224087, PubMed:11863439). {ECO:0000269|PubMed:10224087, ECO:0000269|PubMed:11863439}.<br/><strong>T: Active site:</strong> ACT_SITE 124; /note=&quot;Phosphocysteine intermediate&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00160&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        219,
        162
      ],
      "fold_change_1": 0.929231,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        209,
        134
      ],
      "fold_change_2": 1.20965,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        229,
        188
      ],
      "fold_change_3": 0.66388,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        231,
        194
      ],
      "fold_change_4": 0.607413,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        217,
        155
      ],
      "fold_change_5": 0.999224,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O75688": {
      "label": "PPM1B",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Enzyme with a broad specificity. Dephosphorylates CDK2 and CDK6 in vitro. Dephosphorylates PRKAA1 and PRKAA2. Inhibits TBK1-mediated antiviral signaling by dephosphorylating it at 'Ser-172'. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:18930133, ECO:0000269|PubMed:22750291}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Enzyme with a broad specificity. Dephosphorylates CDK2 and CDK6 in vitro. Dephosphorylates PRKAA1 and PRKAA2. Inhibits TBK1-mediated antiviral signaling by dephosphorylating it at 'Ser-172'. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:18930133, ECO:0000269|PubMed:22750291}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Enzyme with a broad specificity. Dephosphorylates CDK2 and CDK6 in vitro. Dephosphorylates PRKAA1 and PRKAA2. Inhibits TBK1-mediated antiviral signaling by dephosphorylating it at &#x27;Ser-172&#x27;. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:18930133, ECO:0000269|PubMed:22750291}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        235,
        204
      ],
      "fold_change_1": 0.507573,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        231,
        193
      ],
      "fold_change_2": 0.615545,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        243,
        225
      ],
      "fold_change_3": 0.300697,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        247,
        234
      ],
      "fold_change_4": 0.210307,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        232,
        195
      ],
      "fold_change_5": 0.601621,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_24": {
      "label": "FASLG",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_29": {
      "label": "MAP4K4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9UP65": {
      "label": "PA24C",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Calcium-independent phospholipase, lysophospholipase and O-acyltransferase involved in phospholipid remodeling with implications in endoplasmic reticulum membrane homeostasis and lipid droplet biogenesis (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Preferentially hydrolyzes the ester bond of the fatty acyl group attached at the sn-2 position of phospholipids with choline and ethanolamine head groups, producing lysophospholipids that are used in deacylation-reacylation cycles (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Transfers the sn-1 fatty acyl from one lysophospholipid molecule to the sn-2 position of another lysophospholipid to form diacyl, alkylacyl and alkenylacyl glycerophospholipids. Cleaves ester bonds but not alkyl or alkenyl ether bonds at sn-1 position of lysophospholipids (PubMed:15944408, PubMed:19501189). Catalyzes sn-2 fatty acyl transfer from phospholipids to the sn-2 position of 1-O-alkyl or 1-O-alkenyl lysophospholipids with lower efficiency (PubMed:15944408, PubMed:19501189). In response to dietary fatty acids, may play a role in the formation of nascent lipid droplets from the endoplasmic reticulum likely by regulating the phospholipid composition of these organelles (PubMed:28336330). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:15944408, ECO:0000269|PubMed:19501189, ECO:0000269|PubMed:28336330, ECO:0000269|PubMed:9705332}.; FUNCTION: (Microbial infection) May play a role in replication and assembly of human hepatitis C virus (HCV) (PubMed:23015700, PubMed:28336330). In response to HCV infection, promotes remodeling of host endoplasmic reticulum membranes to form organelle-like structures called membranous web, where HCV replication occur (PubMed:23015700). Can further mediate translocation of replication complexes to lipid droplets to enable virion assembly (PubMed:23015700, PubMed:28336330). {ECO:0000269|PubMed:23015700, ECO:0000269|PubMed:28336330}.; FUNCTION: (Microbial infection) May facilitate human T-lymphotropic virus type 1 (HTLV-1) infection by promoting leukotriene B4 (LTB4) biosynthesis. LTB4 acts as a chemoattractant for HTLV-1-infected CD4-positive T cells and favors cell to cell viral transmission. {ECO:0000269|PubMed:28639618}.\",\"ACT_SITE 82; /note=\"Nucleophile\"; /evidence=\"ECO:0000305|PubMed:10085124\"; ACT_SITE 385; /note=\"Proton acceptor\"; /evidence=\"ECO:0000305|PubMed:10085124\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Calcium-independent phospholipase, lysophospholipase and O-acyltransferase involved in phospholipid remodeling with implications in endoplasmic reticulum membrane homeostasis and lipid droplet biogenesis (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Preferentially hydrolyzes the ester bond of the fatty acyl group attached at the sn-2 position of phospholipids with choline and ethanolamine head groups, producing lysophospholipids that are used in deacylation-reacylation cycles (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Transfers the sn-1 fatty acyl from one lysophospholipid molecule to the sn-2 position of another lysophospholipid to form diacyl, alkylacyl and alkenylacyl glycerophospholipids. Cleaves ester bonds but not alkyl or alkenyl ether bonds at sn-1 position of lysophospholipids (PubMed:15944408, PubMed:19501189). Catalyzes sn-2 fatty acyl transfer from phospholipids to the sn-2 position of 1-O-alkyl or 1-O-alkenyl lysophospholipids with lower efficiency (PubMed:15944408, PubMed:19501189). In response to dietary fatty acids, may play a role in the formation of nascent lipid droplets from the endoplasmic reticulum likely by regulating the phospholipid composition of these organelles (PubMed:28336330). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:15944408, ECO:0000269|PubMed:19501189, ECO:0000269|PubMed:28336330, ECO:0000269|PubMed:9705332}.; FUNCTION: (Microbial infection) May play a role in replication and assembly of human hepatitis C virus (HCV) (PubMed:23015700, PubMed:28336330). In response to HCV infection, promotes remodeling of host endoplasmic reticulum membranes to form organelle-like structures called membranous web, where HCV replication occur (PubMed:23015700). Can further mediate translocation of replication complexes to lipid droplets to enable virion assembly (PubMed:23015700, PubMed:28336330). {ECO:0000269|PubMed:23015700, ECO:0000269|PubMed:28336330}.; FUNCTION: (Microbial infection) May facilitate human T-lymphotropic virus type 1 (HTLV-1) infection by promoting leukotriene B4 (LTB4) biosynthesis. LTB4 acts as a chemoattractant for HTLV-1-infected CD4-positive T cells and favors cell to cell viral transmission. {ECO:0000269|PubMed:28639618}.\nT: Active site: ACT_SITE 82; /note=\"Nucleophile\"; /evidence=\"ECO:0000305|PubMed:10085124\"; ACT_SITE 385; /note=\"Proton acceptor\"; /evidence=\"ECO:0000305|PubMed:10085124\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Calcium-independent phospholipase, lysophospholipase and O-acyltransferase involved in phospholipid remodeling with implications in endoplasmic reticulum membrane homeostasis and lipid droplet biogenesis (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Preferentially hydrolyzes the ester bond of the fatty acyl group attached at the sn-2 position of phospholipids with choline and ethanolamine head groups, producing lysophospholipids that are used in deacylation-reacylation cycles (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Transfers the sn-1 fatty acyl from one lysophospholipid molecule to the sn-2 position of another lysophospholipid to form diacyl, alkylacyl and alkenylacyl glycerophospholipids. Cleaves ester bonds but not alkyl or alkenyl ether bonds at sn-1 position of lysophospholipids (PubMed:15944408, PubMed:19501189). Catalyzes sn-2 fatty acyl transfer from phospholipids to the sn-2 position of 1-O-alkyl or 1-O-alkenyl lysophospholipids with lower efficiency (PubMed:15944408, PubMed:19501189). In response to dietary fatty acids, may play a role in the formation of nascent lipid droplets from the endoplasmic reticulum likely by regulating the phospholipid composition of these organelles (PubMed:28336330). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:15944408, ECO:0000269|PubMed:19501189, ECO:0000269|PubMed:28336330, ECO:0000269|PubMed:9705332}.; FUNCTION: (Microbial infection) May play a role in replication and assembly of human hepatitis C virus (HCV) (PubMed:23015700, PubMed:28336330). In response to HCV infection, promotes remodeling of host endoplasmic reticulum membranes to form organelle-like structures called membranous web, where HCV replication occur (PubMed:23015700). Can further mediate translocation of replication complexes to lipid droplets to enable virion assembly (PubMed:23015700, PubMed:28336330). {ECO:0000269|PubMed:23015700, ECO:0000269|PubMed:28336330}.; FUNCTION: (Microbial infection) May facilitate human T-lymphotropic virus type 1 (HTLV-1) infection by promoting leukotriene B4 (LTB4) biosynthesis. LTB4 acts as a chemoattractant for HTLV-1-infected CD4-positive T cells and favors cell to cell viral transmission. {ECO:0000269|PubMed:28639618}.<br/><strong>T: Active site:</strong> ACT_SITE 82; /note=&quot;Nucleophile&quot;; /evidence=&quot;ECO:0000305|PubMed:10085124&quot;; ACT_SITE 385; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000305|PubMed:10085124&quot;",
      "PTMs": {
        "Q9UP65_337": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9UP65",
          "fc_color_1": [
            2,
            81,
            150
          ],
          "label": "337",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.KGS#LSNLMDFVK.K",
          "tooltip_html": "<strong>T: sequence:</strong> R.KGS#LSNLMDFVK.K",
          "fold_change_1": -2.91745,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            2,
            81,
            150
          ],
          "fold_change_2": -3.21871,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            214,
            227,
            238
          ],
          "fold_change_3": -0.316293,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            219,
            230,
            240
          ],
          "fold_change_4": -0.277147,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            209,
            223,
            235
          ],
          "fold_change_5": -0.362246,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 836.2,
          "shape_y": 231.5,
          "label_x": 831.2,
          "label_y": 236.5,
          "label_centering": "right",
          "symbol_x": 836.2,
          "symbol_y": 231.5
        }
      },
      "fc_color_1": [
        212,
        225,
        237
      ],
      "fold_change_1": -0.336811,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        245,
        229
      ],
      "fold_change_2": 0.258849,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        243,
        226
      ],
      "fold_change_3": 0.289868,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        249,
        241
      ],
      "fold_change_4": 0.133976,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        253,
        250
      ],
      "fold_change_5": 0.0450616,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P16949": {
      "label": "STMN1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). {ECO:0000250}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). {ECO:0000250}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). {ECO:0000250}.",
      "PTMs": {
        "P16949_16": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P16949",
          "fc_color_1": [
            254,
            222,
            169
          ],
          "label": "16",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_2",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "x",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.RAS#GQAFELILS#PR.S\nPSP: DOMAIN: Stathmin\nPSP: ON_FUNCTION: molecular association, regulation; activity, inhibited; phosphorylation\nPSP: ON_PROCESS: cell cycle regulation; apoptosis, altered; carcinogenesis, inhibited; cell growth, inhibited; apoptosis, induced; cell motility, inhibited; signaling pathway regulation; cytoskeletal reorganization\nPSP: ON_PROT_INTERACT: TUBA1A(DISRUPTS); TUBA4A(DISRUPTS); TUBB(DISRUPTS)\nPSP: in_vivo_kinases: CAMK2A; PAK1; RSK2\nPSP: in_vitro_kinases: CAMK4; PKACA; PKACA; CAMK2B; PAK1; RSK2",
          "tooltip_html": "<strong>T: sequence:</strong> K.RAS#GQAFELILS#PR.S<br/><strong>PSP: DOMAIN:</strong> Stathmin<br/><strong>PSP: ON_FUNCTION:</strong> molecular association, regulation; activity, inhibited; phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; apoptosis, altered; carcinogenesis, inhibited; cell growth, inhibited; apoptosis, induced; cell motility, inhibited; signaling pathway regulation; cytoskeletal reorganization<br/><strong>PSP: ON_PROT_INTERACT:</strong> TUBA1A(DISRUPTS); TUBA4A(DISRUPTS); TUBB(DISRUPTS)<br/><strong>PSP: in_vivo_kinases:</strong> CAMK2A; PAK1; RSK2<br/><strong>PSP: in_vitro_kinases:</strong> CAMK4; PKACA; PKACA; CAMK2B; PAK1; RSK2",
          "fold_change_1": 0.859173,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            208,
            132
          ],
          "fold_change_2": 1.23069,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            241,
            245,
            249
          ],
          "fold_change_3": -0.103495,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            242,
            246,
            249
          ],
          "fold_change_4": -0.0969518,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            239,
            244,
            248
          ],
          "fold_change_5": -0.121806,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "W1",
          "shape_x": 823.0,
          "shape_y": 189.11,
          "label_x": 818.0,
          "label_y": 187.11,
          "label_centering": "right",
          "symbol_x": 822.7,
          "symbol_y": 189.11
        },
        "P16949_63": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P16949",
          "fc_color_1": [
            201,
            217,
            232
          ],
          "label": "63",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_2",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "x",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.S#HEAEVLK.Q\nPSP: DOMAIN: Stathmin\nPSP: ON_FUNCTION: protein degradation; molecular association, regulation; intracellular localization; activity, inhibited; phosphorylation\nPSP: ON_PROCESS: cell cycle regulation; apoptosis, altered; carcinogenesis, inhibited; cell growth, inhibited; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; autophagy, induced; cell growth, induced; cytoskeletal reorganization\nPSP: ON_PROT_INTERACT: TUBA1A(DISRUPTS); TUBA4A(DISRUPTS); SQSTM1(INDUCES); TUBB(DISRUPTS)\nPSP: in_vivo_kinases: PKG1\nPSP: in_vitro_kinases: PKACA; PKACA",
          "tooltip_html": "<strong>T: sequence:</strong> K.S#HEAEVLK.Q<br/><strong>PSP: DOMAIN:</strong> Stathmin<br/><strong>PSP: ON_FUNCTION:</strong> protein degradation; molecular association, regulation; intracellular localization; activity, inhibited; phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; apoptosis, altered; carcinogenesis, inhibited; cell growth, inhibited; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; autophagy, induced; cell growth, induced; cytoskeletal reorganization<br/><strong>PSP: ON_PROT_INTERACT:</strong> TUBA1A(DISRUPTS); TUBA4A(DISRUPTS); SQSTM1(INDUCES); TUBB(DISRUPTS)<br/><strong>PSP: in_vivo_kinases:</strong> PKG1<br/><strong>PSP: in_vitro_kinases:</strong> PKACA; PKACA",
          "fold_change_1": -0.426435,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            203,
            119
          ],
          "fold_change_2": 1.36114,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            252,
            247
          ],
          "fold_change_3": 0.0718087,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            212,
            225,
            237
          ],
          "fold_change_4": -0.338053,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            240,
            244,
            248
          ],
          "fold_change_5": -0.11675,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "E1",
          "shape_x": 877.0,
          "shape_y": 189.11,
          "label_x": 882.0,
          "label_y": 187.11,
          "label_centering": "left",
          "symbol_x": 876.7,
          "symbol_y": 189.11
        },
        "P16949_25": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P16949",
          "fc_color_1": [
            254,
            251,
            246
          ],
          "label": "25",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_2",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "x",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.RAS#GQAFELILS#PR.S\nPSP: DOMAIN: Stathmin\nPSP: ON_FUNCTION: protein stabilization; molecular association, regulation; activity, inhibited; phosphorylation\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, inhibited; cell growth, inhibited; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; cell growth, induced; cytoskeletal reorganization\nPSP: ON_PROT_INTERACT: TUBA1A(DISRUPTS); TUBB(DISRUPTS); GRP78(INDUCES)\nPSP: NOTES: Stathmin hyperphosphorylation leads to microtubule stability.\nPSP: in_vivo_kinases: CDK1; P38D; PKCB\nPSP: in_vitro_kinases: ERK1; CDK1; CDK2; P38D",
          "tooltip_html": "<strong>T: sequence:</strong> K.RAS#GQAFELILS#PR.S<br/><strong>PSP: DOMAIN:</strong> Stathmin<br/><strong>PSP: ON_FUNCTION:</strong> protein stabilization; molecular association, regulation; activity, inhibited; phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, inhibited; cell growth, inhibited; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; cell growth, induced; cytoskeletal reorganization<br/><strong>PSP: ON_PROT_INTERACT:</strong> TUBA1A(DISRUPTS); TUBB(DISRUPTS); GRP78(INDUCES)<br/><strong>PSP: NOTES:</strong> Stathmin hyperphosphorylation leads to microtubule stability.<br/><strong>PSP: in_vivo_kinases:</strong> CDK1; P38D; PKCB<br/><strong>PSP: in_vitro_kinases:</strong> ERK1; CDK1; CDK2; P38D",
          "fold_change_1": 0.0812715,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            236,
            205
          ],
          "fold_change_2": 0.495916,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            218,
            229,
            239
          ],
          "fold_change_3": -0.288685,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            237,
            243,
            247
          ],
          "fold_change_4": -0.135167,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            251,
            246
          ],
          "fold_change_5": 0.0898412,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "W2",
          "shape_x": 823.0,
          "shape_y": 200.72,
          "label_x": 818.0,
          "label_y": 202.72,
          "label_centering": "right",
          "symbol_x": 822.7,
          "symbol_y": 200.72
        },
        "P16949_38": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P16949",
          "fc_color_1": [
            254,
            252,
            248
          ],
          "label": "38",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_2",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "x",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.ESVPEFPLS#PPK.K\nPSP: DOMAIN: Stathmin\nPSP: ON_FUNCTION: protein degradation; protein stabilization; molecular association, regulation; activity, inhibited; phosphorylation\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, inhibited; cell growth, inhibited; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; cytoskeletal reorganization; cell growth, altered\nPSP: ON_PROT_INTERACT: TUBA1A(DISRUPTS); TUBB(DISRUPTS); GRP78(INDUCES)\nPSP: NOTES: Stathmin hyperphosphorylation leads to microtubule stability.\nPSP: in_vivo_kinases: KIS; CDK1; PAK1; P38D; PKCB\nPSP: in_vitro_kinases: ERK1; CDK1; KIS; CDK2; P38D",
          "tooltip_html": "<strong>T: sequence:</strong> K.ESVPEFPLS#PPK.K<br/><strong>PSP: DOMAIN:</strong> Stathmin<br/><strong>PSP: ON_FUNCTION:</strong> protein degradation; protein stabilization; molecular association, regulation; activity, inhibited; phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, inhibited; cell growth, inhibited; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; cytoskeletal reorganization; cell growth, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> TUBA1A(DISRUPTS); TUBB(DISRUPTS); GRP78(INDUCES)<br/><strong>PSP: NOTES:</strong> Stathmin hyperphosphorylation leads to microtubule stability.<br/><strong>PSP: in_vivo_kinases:</strong> KIS; CDK1; PAK1; P38D; PKCB<br/><strong>PSP: in_vitro_kinases:</strong> ERK1; CDK1; KIS; CDK2; P38D",
          "fold_change_1": 0.0635286,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            205,
            125
          ],
          "fold_change_2": 1.30055,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            253,
            251
          ],
          "fold_change_3": 0.0380934,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            248,
            237
          ],
          "fold_change_4": 0.17794,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            243,
            224
          ],
          "fold_change_5": 0.309004,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "E2",
          "shape_x": 877.0,
          "shape_y": 200.72,
          "label_x": 882.0,
          "label_y": 202.72,
          "label_centering": "left",
          "symbol_x": 876.7,
          "symbol_y": 200.72
        }
      },
      "fc_color_1": [
        254,
        223,
        172
      ],
      "fold_change_1": 0.829292,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        223,
        172
      ],
      "fold_change_2": 0.830517,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        227
      ],
      "fold_change_3": 0.280146,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        239,
        215
      ],
      "fold_change_4": 0.39988,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        225,
        176
      ],
      "fold_change_5": 0.786048,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_32": {
      "label": "MAPT",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P19838": {
      "label": "NFKB1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105. {ECO:0000269|PubMed:15485931, ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:2203531, ECO:0000269|PubMed:2234062, ECO:0000269|PubMed:7830764}.; FUNCTION: [Nuclear factor NF-kappa-B p105 subunit]: P105 is the precursor of the active p50 subunit (Nuclear factor NF-kappa-B p50 subunit) of the nuclear factor NF-kappa-B (PubMed:1423592). Acts as a cytoplasmic retention of attached NF-kappa-B proteins by p105 (PubMed:1423592). {ECO:0000269|PubMed:1423592}.; FUNCTION: [Nuclear factor NF-kappa-B p50 subunit]: Constitutes the active form, which associates with RELA/p65 to form the NF-kappa-B p65-p50 complex to form a transcription factor (PubMed:1740106, PubMed:7830764). Together with RELA/p65, binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions (PubMed:1740106, PubMed:7830764). {ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:7830764}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105. {ECO:0000269|PubMed:15485931, ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:2203531, ECO:0000269|PubMed:2234062, ECO:0000269|PubMed:7830764}.; FUNCTION: [Nuclear factor NF-kappa-B p105 subunit]: P105 is the precursor of the active p50 subunit (Nuclear factor NF-kappa-B p50 subunit) of the nuclear factor NF-kappa-B (PubMed:1423592). Acts as a cytoplasmic retention of attached NF-kappa-B proteins by p105 (PubMed:1423592). {ECO:0000269|PubMed:1423592}.; FUNCTION: [Nuclear factor NF-kappa-B p50 subunit]: Constitutes the active form, which associates with RELA/p65 to form the NF-kappa-B p65-p50 complex to form a transcription factor (PubMed:1740106, PubMed:7830764). Together with RELA/p65, binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions (PubMed:1740106, PubMed:7830764). {ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:7830764}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5&#x27;-GGRNNYYCC-3&#x27;, located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105. {ECO:0000269|PubMed:15485931, ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:2203531, ECO:0000269|PubMed:2234062, ECO:0000269|PubMed:7830764}.; FUNCTION: [Nuclear factor NF-kappa-B p105 subunit]: P105 is the precursor of the active p50 subunit (Nuclear factor NF-kappa-B p50 subunit) of the nuclear factor NF-kappa-B (PubMed:1423592). Acts as a cytoplasmic retention of attached NF-kappa-B proteins by p105 (PubMed:1423592). {ECO:0000269|PubMed:1423592}.; FUNCTION: [Nuclear factor NF-kappa-B p50 subunit]: Constitutes the active form, which associates with RELA/p65 to form the NF-kappa-B p65-p50 complex to form a transcription factor (PubMed:1740106, PubMed:7830764). Together with RELA/p65, binds to the kappa-B consensus sequence 5&#x27;-GGRNNYYCC-3&#x27;, located in the enhancer region of genes involved in immune response and acute phase reactions (PubMed:1740106, PubMed:7830764). {ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:7830764}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        227,
        182
      ],
      "fold_change_1": 0.731747,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        230,
        190
      ],
      "fold_change_2": 0.652706,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        246,
        231
      ],
      "fold_change_3": 0.235033,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        242,
        221
      ],
      "fold_change_4": 0.337331,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        233,
        199
      ],
      "fold_change_5": 0.561817,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q00653": {
      "label": "NFKB2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. {ECO:0000269|PubMed:7925301}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. {ECO:0000269|PubMed:7925301}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5&#x27;-GGRNNYYCC-3&#x27;, located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. {ECO:0000269|PubMed:7925301}.",
      "PTMs": {},
      "fc_color_1": [
        246,
        249,
        251
      ],
      "fold_change_1": -0.0653937,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        252,
        249
      ],
      "fold_change_2": 0.0599768,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        254,
        254
      ],
      "fold_change_3": 0.00802159,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        226,
        235,
        243
      ],
      "fold_change_4": -0.221614,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        213,
        226,
        237
      ],
      "fold_change_5": -0.325186,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q01201": {
      "label": "RELB",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer in a CRY1/CRY2 independent manner. Increased repression of the heterodimer is seen in the presence of NFKB2/p52. Is required for both T and B lymphocyte maturation and function (PubMed:26385063). {ECO:0000269|PubMed:1732739, ECO:0000269|PubMed:22565310, ECO:0000269|PubMed:26385063, ECO:0000269|PubMed:7925301, ECO:0000269|PubMed:8441398}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer in a CRY1/CRY2 independent manner. Increased repression of the heterodimer is seen in the presence of NFKB2/p52. Is required for both T and B lymphocyte maturation and function (PubMed:26385063). {ECO:0000269|PubMed:1732739, ECO:0000269|PubMed:22565310, ECO:0000269|PubMed:26385063, ECO:0000269|PubMed:7925301, ECO:0000269|PubMed:8441398}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer in a CRY1/CRY2 independent manner. Increased repression of the heterodimer is seen in the presence of NFKB2/p52. Is required for both T and B lymphocyte maturation and function (PubMed:26385063). {ECO:0000269|PubMed:1732739, ECO:0000269|PubMed:22565310, ECO:0000269|PubMed:26385063, ECO:0000269|PubMed:7925301, ECO:0000269|PubMed:8441398}.",
      "PTMs": {
        "Q01201_573": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q01201",
          "fc_color_1": [
            254,
            217,
            156
          ],
          "label": "573",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.EAAFGGGLLS#PGPEAT.-\nPSP: in_vitro_kinases: GSK3B",
          "tooltip_html": "<strong>T: sequence:</strong> R.EAAFGGGLLS#PGPEAT.-<br/><strong>PSP: in_vitro_kinases:</strong> GSK3B",
          "fold_change_1": 0.9911,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            148,
            181,
            210
          ],
          "fold_change_2": -0.844541,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            152,
            184,
            212
          ],
          "fold_change_3": -0.812557,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            253,
            254,
            254
          ],
          "fold_change_4": -0.0091763,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            237,
            209
          ],
          "fold_change_5": 0.458434,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 900.2,
          "shape_y": 118.5,
          "label_x": 895.2,
          "label_y": 113.5,
          "label_centering": "right",
          "symbol_x": 900.2,
          "symbol_y": 118.5
        }
      },
      "fc_color_1": [
        226,
        235,
        243
      ],
      "fold_change_1": -0.223145,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        249,
        251,
        252
      ],
      "fold_change_2": -0.0397289,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        226,
        235,
        243
      ],
      "fold_change_3": -0.226757,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        178,
        202,
        223
      ],
      "fold_change_4": -0.602448,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        175,
        200,
        221
      ],
      "fold_change_5": -0.631319,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O15111": {
      "label": "IKKA",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues (PubMed:18626576, PubMed:35952808, PubMed:9244310, PubMed:9252186, PubMed:9346484). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11) (PubMed:21765415). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes (PubMed:20501937). In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Also participates in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities (PubMed:17434128). Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP (PubMed:12789342). Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor (PubMed:15084260). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates AMBRA1 following mitophagy induction, promoting AMBRA1 interaction with ATG8 family proteins and its mitophagic activity (PubMed:30217973). {ECO:0000250|UniProtKB:Q60680, ECO:0000269|PubMed:12789342, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17434128, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20501937, ECO:0000269|PubMed:21765415, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:35952808, ECO:0000269|PubMed:9244310, ECO:0000269|PubMed:9252186, ECO:0000269|PubMed:9346484, ECO:0000303|PubMed:18626576}.\",\"ACT_SITE 144; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues (PubMed:18626576, PubMed:35952808, PubMed:9244310, PubMed:9252186, PubMed:9346484). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11) (PubMed:21765415). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes (PubMed:20501937). In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Also participates in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities (PubMed:17434128). Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP (PubMed:12789342). Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor (PubMed:15084260). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates AMBRA1 following mitophagy induction, promoting AMBRA1 interaction with ATG8 family proteins and its mitophagic activity (PubMed:30217973). {ECO:0000250|UniProtKB:Q60680, ECO:0000269|PubMed:12789342, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17434128, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20501937, ECO:0000269|PubMed:21765415, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:35952808, ECO:0000269|PubMed:9244310, ECO:0000269|PubMed:9252186, ECO:0000269|PubMed:9346484, ECO:0000303|PubMed:18626576}.\nT: Active site: ACT_SITE 144; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues (PubMed:18626576, PubMed:35952808, PubMed:9244310, PubMed:9252186, PubMed:9346484). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:18626576, PubMed:9244310, PubMed:9252186, PubMed:9346484). Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11) (PubMed:21765415). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes (PubMed:20501937). In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Also participates in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities (PubMed:17434128). Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at &#x27;Ser-10&#x27; that are subsequently acetylated at &#x27;Lys-14&#x27; by CREBBP (PubMed:12789342). Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor (PubMed:15084260). Phosphorylates RIPK1 at &#x27;Ser-25&#x27; which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates AMBRA1 following mitophagy induction, promoting AMBRA1 interaction with ATG8 family proteins and its mitophagic activity (PubMed:30217973). {ECO:0000250|UniProtKB:Q60680, ECO:0000269|PubMed:12789342, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17434128, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20501937, ECO:0000269|PubMed:21765415, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:35952808, ECO:0000269|PubMed:9244310, ECO:0000269|PubMed:9252186, ECO:0000269|PubMed:9346484, ECO:0000303|PubMed:18626576}.<br/><strong>T: Active site:</strong> ACT_SITE 144; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        248,
        236
      ],
      "fold_change_1": 0.182258,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        249,
        239
      ],
      "fold_change_2": 0.151583,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        252,
        248
      ],
      "fold_change_3": 0.0626185,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        250,
        243
      ],
      "fold_change_4": 0.117767,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        254,
        254
      ],
      "fold_change_5": -0.00649714,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O14920": {
      "label": "IKKB",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:30337470, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation (PubMed:9346484). Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE (PubMed:11297557, PubMed:14673179, PubMed:20410276, PubMed:21138416). IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs (PubMed:11297557, PubMed:20410276, PubMed:21138416). Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor (PubMed:15084260). Also phosphorylates other substrates including NAA10, NCOA3, BCL10 and IRS1 (PubMed:17213322, PubMed:19716809). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates the C-terminus of IRF5, stimulating IRF5 homodimerization and translocation into the nucleus (PubMed:25326418). Following bacterial lipopolysaccharide (LPS)-induced TLR4 endocytosis, phosphorylates STAT1 at 'Thr-749' which restricts interferon signaling and anti-inflammatory responses and promotes innate inflammatory responses (PubMed:38621137). IKBKB-mediated phosphorylation of STAT1 at 'Thr-749' promotes binding of STAT1 to the ARID5A promoter, resulting in transcriptional activation of ARID5A and subsequent ARID5A-mediated stabilization of IL6 (PubMed:32209697). It also promotes binding of STAT1 to the IL12B promoter and activation of IL12B transcription (PubMed:32209697). {ECO:0000250|UniProtKB:O88351, ECO:0000269|PubMed:11297557, ECO:0000269|PubMed:14673179, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17213322, ECO:0000269|PubMed:19716809, ECO:0000269|PubMed:20410276, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20797629, ECO:0000269|PubMed:21138416, ECO:0000269|PubMed:25326418, ECO:0000269|PubMed:30337470, ECO:0000269|PubMed:32209697, ECO:0000269|PubMed:38621137, ECO:0000269|PubMed:9346484}.\",\"ACT_SITE 145; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:30337470, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation (PubMed:9346484). Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE (PubMed:11297557, PubMed:14673179, PubMed:20410276, PubMed:21138416). IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs (PubMed:11297557, PubMed:20410276, PubMed:21138416). Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor (PubMed:15084260). Also phosphorylates other substrates including NAA10, NCOA3, BCL10 and IRS1 (PubMed:17213322, PubMed:19716809). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates the C-terminus of IRF5, stimulating IRF5 homodimerization and translocation into the nucleus (PubMed:25326418). Following bacterial lipopolysaccharide (LPS)-induced TLR4 endocytosis, phosphorylates STAT1 at 'Thr-749' which restricts interferon signaling and anti-inflammatory responses and promotes innate inflammatory responses (PubMed:38621137). IKBKB-mediated phosphorylation of STAT1 at 'Thr-749' promotes binding of STAT1 to the ARID5A promoter, resulting in transcriptional activation of ARID5A and subsequent ARID5A-mediated stabilization of IL6 (PubMed:32209697). It also promotes binding of STAT1 to the IL12B promoter and activation of IL12B transcription (PubMed:32209697). {ECO:0000250|UniProtKB:O88351, ECO:0000269|PubMed:11297557, ECO:0000269|PubMed:14673179, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17213322, ECO:0000269|PubMed:19716809, ECO:0000269|PubMed:20410276, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20797629, ECO:0000269|PubMed:21138416, ECO:0000269|PubMed:25326418, ECO:0000269|PubMed:30337470, ECO:0000269|PubMed:32209697, ECO:0000269|PubMed:38621137, ECO:0000269|PubMed:9346484}.\nT: Active site: ACT_SITE 145; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:30337470, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation (PubMed:9346484). Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE (PubMed:11297557, PubMed:14673179, PubMed:20410276, PubMed:21138416). IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs (PubMed:11297557, PubMed:20410276, PubMed:21138416). Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor (PubMed:15084260). Also phosphorylates other substrates including NAA10, NCOA3, BCL10 and IRS1 (PubMed:17213322, PubMed:19716809). Phosphorylates RIPK1 at &#x27;Ser-25&#x27; which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates the C-terminus of IRF5, stimulating IRF5 homodimerization and translocation into the nucleus (PubMed:25326418). Following bacterial lipopolysaccharide (LPS)-induced TLR4 endocytosis, phosphorylates STAT1 at &#x27;Thr-749&#x27; which restricts interferon signaling and anti-inflammatory responses and promotes innate inflammatory responses (PubMed:38621137). IKBKB-mediated phosphorylation of STAT1 at &#x27;Thr-749&#x27; promotes binding of STAT1 to the ARID5A promoter, resulting in transcriptional activation of ARID5A and subsequent ARID5A-mediated stabilization of IL6 (PubMed:32209697). It also promotes binding of STAT1 to the IL12B promoter and activation of IL12B transcription (PubMed:32209697). {ECO:0000250|UniProtKB:O88351, ECO:0000269|PubMed:11297557, ECO:0000269|PubMed:14673179, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17213322, ECO:0000269|PubMed:19716809, ECO:0000269|PubMed:20410276, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20797629, ECO:0000269|PubMed:21138416, ECO:0000269|PubMed:25326418, ECO:0000269|PubMed:30337470, ECO:0000269|PubMed:32209697, ECO:0000269|PubMed:38621137, ECO:0000269|PubMed:9346484}.<br/><strong>T: Active site:</strong> ACT_SITE 145; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        228,
        184
      ],
      "fold_change_1": 0.704039,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        222,
        168
      ],
      "fold_change_2": 0.868101,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        240,
        217
      ],
      "fold_change_3": 0.379105,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        252,
        253,
        253
      ],
      "fold_change_4": -0.0193608,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        239,
        214
      ],
      "fold_change_5": 0.407118,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9Y6K9": {
      "label": "NEMO",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor (PubMed:14695475, PubMed:20724660, PubMed:21518757, PubMed:9751060). Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308, PubMed:33567255). Can recognize and bind both 'Lys-63'-linked and linear polyubiquitin upon cell stimulation, with a much higher affinity for linear polyubiquitin (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308). Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3 (PubMed:19854139). Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination (PubMed:20724660). {ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:16547522, ECO:0000269|PubMed:18287044, ECO:0000269|PubMed:19033441, ECO:0000269|PubMed:19185524, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20724660, ECO:0000269|PubMed:21518757, ECO:0000269|PubMed:21606507, ECO:0000269|PubMed:27777308, ECO:0000269|PubMed:33567255, ECO:0000269|PubMed:9751060}.; FUNCTION: (Microbial infection) Also considered to be a mediator for HTLV-1 Tax oncoprotein activation of NF-kappa-B. {ECO:0000269|PubMed:10364167, ECO:0000269|PubMed:11064457}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor (PubMed:14695475, PubMed:20724660, PubMed:21518757, PubMed:9751060). Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308, PubMed:33567255). Can recognize and bind both 'Lys-63'-linked and linear polyubiquitin upon cell stimulation, with a much higher affinity for linear polyubiquitin (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308). Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3 (PubMed:19854139). Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination (PubMed:20724660). {ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:16547522, ECO:0000269|PubMed:18287044, ECO:0000269|PubMed:19033441, ECO:0000269|PubMed:19185524, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20724660, ECO:0000269|PubMed:21518757, ECO:0000269|PubMed:21606507, ECO:0000269|PubMed:27777308, ECO:0000269|PubMed:33567255, ECO:0000269|PubMed:9751060}.; FUNCTION: (Microbial infection) Also considered to be a mediator for HTLV-1 Tax oncoprotein activation of NF-kappa-B. {ECO:0000269|PubMed:10364167, ECO:0000269|PubMed:11064457}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor (PubMed:14695475, PubMed:20724660, PubMed:21518757, PubMed:9751060). Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308, PubMed:33567255). Can recognize and bind both &#x27;Lys-63&#x27;-linked and linear polyubiquitin upon cell stimulation, with a much higher affinity for linear polyubiquitin (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308). Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3 (PubMed:19854139). Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires &#x27;Lys-27&#x27;-linked polyubiquitination (PubMed:20724660). {ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:16547522, ECO:0000269|PubMed:18287044, ECO:0000269|PubMed:19033441, ECO:0000269|PubMed:19185524, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20724660, ECO:0000269|PubMed:21518757, ECO:0000269|PubMed:21606507, ECO:0000269|PubMed:27777308, ECO:0000269|PubMed:33567255, ECO:0000269|PubMed:9751060}.; FUNCTION: (Microbial infection) Also considered to be a mediator for HTLV-1 Tax oncoprotein activation of NF-kappa-B. {ECO:0000269|PubMed:10364167, ECO:0000269|PubMed:11064457}.",
      "PTMs": {},
      "fc_color_1": [
        247,
        249,
        251
      ],
      "fold_change_1": -0.061868,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        200,
        112
      ],
      "fold_change_2": 1.43319,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        205,
        221,
        234
      ],
      "fold_change_3": -0.390553,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        253,
        254,
        254
      ],
      "fold_change_4": -0.00866103,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        251,
        244
      ],
      "fold_change_5": 0.102608,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_35": {
      "label": "MAP3K14",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P28482": {
      "label": "MK01",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1 and FXR1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity). Phosphorylates phosphoglycerate kinase PGK1 under hypoxic conditions to promote its targeting to the mitochondrion and suppress the formation of acetyl-coenzyme A from pyruvate (PubMed:26942675). {ECO:0000250|UniProtKB:P63086, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:10637505, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12792650, ECO:0000269|PubMed:12794087, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15184391, ECO:0000269|PubMed:15241487, ECO:0000269|PubMed:15616583, ECO:0000269|PubMed:15664191, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19879846, ECO:0000269|PubMed:22033920, ECO:0000269|PubMed:26942675, ECO:0000269|PubMed:32721402, ECO:0000269|PubMed:7588608, ECO:0000269|PubMed:8622688, ECO:0000269|PubMed:9480836, ECO:0000269|PubMed:9596579, ECO:0000269|PubMed:9649500, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:16393692, ECO:0000303|PubMed:19565474, ECO:0000303|PubMed:21779493}.; FUNCTION: Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity. {ECO:0000269|PubMed:19879846}.\",\"ACT_SITE 149; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1 and FXR1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity). Phosphorylates phosphoglycerate kinase PGK1 under hypoxic conditions to promote its targeting to the mitochondrion and suppress the formation of acetyl-coenzyme A from pyruvate (PubMed:26942675). {ECO:0000250|UniProtKB:P63086, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:10637505, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12792650, ECO:0000269|PubMed:12794087, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15184391, ECO:0000269|PubMed:15241487, ECO:0000269|PubMed:15616583, ECO:0000269|PubMed:15664191, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19879846, ECO:0000269|PubMed:22033920, ECO:0000269|PubMed:26942675, ECO:0000269|PubMed:32721402, ECO:0000269|PubMed:7588608, ECO:0000269|PubMed:8622688, ECO:0000269|PubMed:9480836, ECO:0000269|PubMed:9596579, ECO:0000269|PubMed:9649500, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:16393692, ECO:0000303|PubMed:19565474, ECO:0000303|PubMed:21779493}.; FUNCTION: Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity. {ECO:0000269|PubMed:19879846}.\nT: Active site: ACT_SITE 149; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1 and FXR1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity). Phosphorylates phosphoglycerate kinase PGK1 under hypoxic conditions to promote its targeting to the mitochondrion and suppress the formation of acetyl-coenzyme A from pyruvate (PubMed:26942675). {ECO:0000250|UniProtKB:P63086, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:10637505, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12792650, ECO:0000269|PubMed:12794087, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15184391, ECO:0000269|PubMed:15241487, ECO:0000269|PubMed:15616583, ECO:0000269|PubMed:15664191, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19879846, ECO:0000269|PubMed:22033920, ECO:0000269|PubMed:26942675, ECO:0000269|PubMed:32721402, ECO:0000269|PubMed:7588608, ECO:0000269|PubMed:8622688, ECO:0000269|PubMed:9480836, ECO:0000269|PubMed:9596579, ECO:0000269|PubMed:9649500, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:16393692, ECO:0000303|PubMed:19565474, ECO:0000303|PubMed:21779493}.; FUNCTION: Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity. {ECO:0000269|PubMed:19879846}.<br/><strong>T: Active site:</strong> ACT_SITE 149; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "P28482_185": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P28482",
          "fc_color_1": [
            165,
            193,
            217
          ],
          "label": "185",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.VADPDHDHTGFLT#EYVATR.W\nPSP: DOMAIN: Pkinase\nPSP: ON_FUNCTION: activity, induced; protein degradation; molecular association, regulation; intracellular localization; protein conformation; phosphorylation; enzymatic activity, induced\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, induced; apoptosis, altered; cell motility, induced; transcription, induced; signaling pathway regulation; cell growth, induced; cell differentiation, induced; cell motility, altered; cytoskeletal reorganization; transcription, inhibited; cell growth, altered\nPSP: ON_PROT_INTERACT: G-beta 1(INDUCES); TACE(INDUCES); leupaxin(NOT_REPORTED); GSK3B(INDUCES); p90RSK(INDUCES); KSR(INDUCES); NFkB-p100(DISRUPTS)\nPSP: in_vivo_kinases: EGFR; MEK1\nPSP: in_vitro_kinases: MEK1",
          "tooltip_html": "<strong>T: sequence:</strong> R.VADPDHDHTGFLT#EYVATR.W<br/><strong>PSP: DOMAIN:</strong> Pkinase<br/><strong>PSP: ON_FUNCTION:</strong> activity, induced; protein degradation; molecular association, regulation; intracellular localization; protein conformation; phosphorylation; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, induced; apoptosis, altered; cell motility, induced; transcription, induced; signaling pathway regulation; cell growth, induced; cell differentiation, induced; cell motility, altered; cytoskeletal reorganization; transcription, inhibited; cell growth, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> G-beta 1(INDUCES); TACE(INDUCES); leupaxin(NOT_REPORTED); GSK3B(INDUCES); p90RSK(INDUCES); KSR(INDUCES); NFkB-p100(DISRUPTS)<br/><strong>PSP: in_vivo_kinases:</strong> EGFR; MEK1<br/><strong>PSP: in_vitro_kinases:</strong> MEK1",
          "fold_change_1": -0.706371,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            103,
            150,
            192
          ],
          "fold_change_2": -1.19823,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            45,
            111,
            168
          ],
          "fold_change_3": -1.65325,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            50,
            114,
            170
          ],
          "fold_change_4": -1.61691,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            150,
            183,
            211
          ],
          "fold_change_5": -0.823626,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 749.2,
          "shape_y": 298.5,
          "label_x": 744.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 749.1,
          "symbol_y": 298.0
        },
        "P28482_187": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P28482",
          "fc_color_1": [
            254,
            254,
            254
          ],
          "label": "187",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.VADPDHDHTGFLTEY#VATR.W\nPSP: DOMAIN: Pkinase\nPSP: ON_FUNCTION: activity, induced; protein degradation; molecular association, regulation; intracellular localization; protein conformation; phosphorylation; enzymatic activity, induced\nPSP: ON_PROCESS: cell differentiation, inhibited; cell cycle regulation; carcinogenesis, induced; apoptosis, altered; cell motility, induced; transcription, induced; transcription, altered; signaling pathway regulation; cell growth, induced; cell differentiation, induced; cell motility, altered; cytoskeletal reorganization; transcription, inhibited; cell growth, altered\nPSP: ON_PROT_INTERACT: G-beta 1(INDUCES); leupaxin(NOT_REPORTED); GSK3B(INDUCES); p90RSK(INDUCES); KSR(INDUCES); NFkB-p100(DISRUPTS); ERK2(INDUCES); TACE(INDUCES)\nPSP: in_vivo_kinases: EGFR; JAK2; MEK1\nPSP: in_vitro_kinases: MEK1; Ret",
          "tooltip_html": "<strong>T: sequence:</strong> R.VADPDHDHTGFLTEY#VATR.W<br/><strong>PSP: DOMAIN:</strong> Pkinase<br/><strong>PSP: ON_FUNCTION:</strong> activity, induced; protein degradation; molecular association, regulation; intracellular localization; protein conformation; phosphorylation; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> cell differentiation, inhibited; cell cycle regulation; carcinogenesis, induced; apoptosis, altered; cell motility, induced; transcription, induced; transcription, altered; signaling pathway regulation; cell growth, induced; cell differentiation, induced; cell motility, altered; cytoskeletal reorganization; transcription, inhibited; cell growth, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> G-beta 1(INDUCES); leupaxin(NOT_REPORTED); GSK3B(INDUCES); p90RSK(INDUCES); KSR(INDUCES); NFkB-p100(DISRUPTS); ERK2(INDUCES); TACE(INDUCES)<br/><strong>PSP: in_vivo_kinases:</strong> EGFR; JAK2; MEK1<br/><strong>PSP: in_vitro_kinases:</strong> MEK1; Ret",
          "fold_change_1": -0.00521857,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            133,
            171,
            204
          ],
          "fold_change_2": -0.959413,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            77,
            132,
            181
          ],
          "fold_change_3": -1.40521,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            151,
            183,
            212
          ],
          "fold_change_4": -0.818531,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            168,
            195,
            219
          ],
          "fold_change_5": -0.683186,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N2",
          "shape_x": 763.0,
          "shape_y": 298.5,
          "label_x": 763.0,
          "label_y": 290.5,
          "label_centering": "center",
          "symbol_x": 762.9,
          "symbol_y": 298.0
        }
      },
      "fc_color_1": [
        254,
        226,
        179
      ],
      "fold_change_1": 0.754572,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        217,
        156
      ],
      "fold_change_2": 0.990733,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        226
      ],
      "fold_change_3": 0.282075,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        238,
        212
      ],
      "fold_change_4": 0.431563,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        234,
        201
      ],
      "fold_change_5": 0.536434,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P27361": {
      "label": "MK03",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:34497368). MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DEPTOR, FRS2 or GRB10) (PubMed:35216969). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. {ECO:0000269|PubMed:10393181, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:34497368, ECO:0000269|PubMed:35216969, ECO:0000269|PubMed:8325880, ECO:0000269|PubMed:9155018, ECO:0000269|PubMed:9480836}.\",\"ACT_SITE 166; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:34497368). MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DEPTOR, FRS2 or GRB10) (PubMed:35216969). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. {ECO:0000269|PubMed:10393181, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:34497368, ECO:0000269|PubMed:35216969, ECO:0000269|PubMed:8325880, ECO:0000269|PubMed:9155018, ECO:0000269|PubMed:9480836}.\nT: Active site: ACT_SITE 166; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:34497368). MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DEPTOR, FRS2 or GRB10) (PubMed:35216969). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. {ECO:0000269|PubMed:10393181, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:34497368, ECO:0000269|PubMed:35216969, ECO:0000269|PubMed:8325880, ECO:0000269|PubMed:9155018, ECO:0000269|PubMed:9480836}.<br/><strong>T: Active site:</strong> ACT_SITE 166; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "P27361_204": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P27361",
          "fc_color_1": [
            184,
            206,
            225
          ],
          "label": "204",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.IADPEHDHTGFLTEY#VATR.W\nPSP: DOMAIN: Pkinase\nPSP: ON_FUNCTION: activity, induced; protein degradation; molecular association, regulation; intracellular localization; protein conformation; phosphorylation; enzymatic activity, induced\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, induced; apoptosis, altered; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; cell growth, induced; cell motility, altered; transcription, inhibited; cell growth, altered; cell differentiation, inhibited; carcinogenesis, inhibited; cell growth, inhibited; transcription, induced; transcription, altered; autophagy, induced; cell differentiation, induced; apoptosis, inhibited; autophagy, inhibited; cytoskeletal reorganization\nPSP: ON_PROT_INTERACT: TACE(INDUCES); ERK2(INDUCES); leupaxin(NOT_REPORTED); GSK3B(INDUCES); KSR(INDUCES)\nPSP: in_vivo_kinases: EGFR; JAK2; MEK1; MEK2\nPSP: in_vitro_kinases: ERK1; Lck; MEK1; MEK2; MEK1; Ret",
          "tooltip_html": "<strong>T: sequence:</strong> R.IADPEHDHTGFLTEY#VATR.W<br/><strong>PSP: DOMAIN:</strong> Pkinase<br/><strong>PSP: ON_FUNCTION:</strong> activity, induced; protein degradation; molecular association, regulation; intracellular localization; protein conformation; phosphorylation; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, induced; apoptosis, altered; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; cell growth, induced; cell motility, altered; transcription, inhibited; cell growth, altered; cell differentiation, inhibited; carcinogenesis, inhibited; cell growth, inhibited; transcription, induced; transcription, altered; autophagy, induced; cell differentiation, induced; apoptosis, inhibited; autophagy, inhibited; cytoskeletal reorganization<br/><strong>PSP: ON_PROT_INTERACT:</strong> TACE(INDUCES); ERK2(INDUCES); leupaxin(NOT_REPORTED); GSK3B(INDUCES); KSR(INDUCES)<br/><strong>PSP: in_vivo_kinases:</strong> EGFR; JAK2; MEK1; MEK2<br/><strong>PSP: in_vitro_kinases:</strong> ERK1; Lck; MEK1; MEK2; MEK1; Ret",
          "fold_change_1": -0.555034,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            198,
            216,
            231
          ],
          "fold_change_2": -0.44379,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            147,
            181,
            210
          ],
          "fold_change_3": -0.846386,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            147,
            180,
            210
          ],
          "fold_change_4": -0.853389,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            250,
            251,
            252
          ],
          "fold_change_5": -0.0394386,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 749.2,
          "shape_y": 298.5,
          "label_x": 744.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 749.1,
          "symbol_y": 298.0
        },
        "P27361_202": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P27361",
          "fc_color_1": [
            254,
            251,
            244
          ],
          "label": "202",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.IADPEHDHTGFLT#EYVATR.W\nPSP: DOMAIN: Pkinase\nPSP: ON_FUNCTION: activity, induced; protein degradation; molecular association, regulation; intracellular localization; protein conformation; phosphorylation; enzymatic activity, induced\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, induced; apoptosis, altered; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; cell growth, induced; cell motility, altered; transcription, inhibited; cell growth, altered; cell differentiation, inhibited; carcinogenesis, inhibited; cell growth, inhibited; transcription, induced; transcription, altered; autophagy, induced; cell differentiation, induced; apoptosis, inhibited; autophagy, inhibited; cytoskeletal reorganization\nPSP: ON_PROT_INTERACT: TACE(INDUCES); leupaxin(NOT_REPORTED); GSK3B(INDUCES); KSR(INDUCES)\nPSP: in_vivo_kinases: EGFR; MEK1; MEK2\nPSP: in_vitro_kinases: MEK1; MEK2; MEK1",
          "tooltip_html": "<strong>T: sequence:</strong> R.IADPEHDHTGFLT#EYVATR.W<br/><strong>PSP: DOMAIN:</strong> Pkinase<br/><strong>PSP: ON_FUNCTION:</strong> activity, induced; protein degradation; molecular association, regulation; intracellular localization; protein conformation; phosphorylation; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, induced; apoptosis, altered; apoptosis, induced; cell motility, induced; cell motility, inhibited; signaling pathway regulation; cell growth, induced; cell motility, altered; transcription, inhibited; cell growth, altered; cell differentiation, inhibited; carcinogenesis, inhibited; cell growth, inhibited; transcription, induced; transcription, altered; autophagy, induced; cell differentiation, induced; apoptosis, inhibited; autophagy, inhibited; cytoskeletal reorganization<br/><strong>PSP: ON_PROT_INTERACT:</strong> TACE(INDUCES); leupaxin(NOT_REPORTED); GSK3B(INDUCES); KSR(INDUCES)<br/><strong>PSP: in_vivo_kinases:</strong> EGFR; MEK1; MEK2<br/><strong>PSP: in_vitro_kinases:</strong> MEK1; MEK2; MEK1",
          "fold_change_1": 0.104591,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            206,
            221,
            234
          ],
          "fold_change_2": -0.385722,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            92,
            143,
            187
          ],
          "fold_change_3": -1.28281,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            154,
            185,
            213
          ],
          "fold_change_4": -0.797842,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            167,
            194,
            218
          ],
          "fold_change_5": -0.69104,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N2",
          "shape_x": 763.0,
          "shape_y": 298.5,
          "label_x": 763.0,
          "label_y": 290.5,
          "label_centering": "center",
          "symbol_x": 762.9,
          "symbol_y": 298.0
        }
      },
      "fc_color_1": [
        254,
        236,
        205
      ],
      "fold_change_1": 0.495086,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        231,
        194
      ],
      "fold_change_2": 0.612213,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        226
      ],
      "fold_change_3": 0.288503,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        243,
        225
      ],
      "fold_change_4": 0.297925,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        238,
        211
      ],
      "fold_change_5": 0.442207,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9UHA4": {
      "label": "LTOR3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids (PubMed:20381137, PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator plays a dual role for the small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD): it (1) acts as a guanine nucleotide exchange factor (GEF), activating the small GTPases Rag and (2) mediates recruitment of Rag GTPases to the lysosome membrane (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Adapter protein that enhances the efficiency of the MAP kinase cascade facilitating the activation of MAPK2 (By similarity). {ECO:0000250|UniProtKB:O88653, ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:22980980, ECO:0000269|PubMed:28935770, ECO:0000269|PubMed:29107538, ECO:0000269|PubMed:29123114, ECO:0000269|PubMed:29158492, ECO:0000269|PubMed:30181260}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids (PubMed:20381137, PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator plays a dual role for the small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD): it (1) acts as a guanine nucleotide exchange factor (GEF), activating the small GTPases Rag and (2) mediates recruitment of Rag GTPases to the lysosome membrane (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Adapter protein that enhances the efficiency of the MAP kinase cascade facilitating the activation of MAPK2 (By similarity). {ECO:0000250|UniProtKB:O88653, ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:22980980, ECO:0000269|PubMed:28935770, ECO:0000269|PubMed:29107538, ECO:0000269|PubMed:29123114, ECO:0000269|PubMed:29158492, ECO:0000269|PubMed:30181260}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids (PubMed:20381137, PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator plays a dual role for the small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD): it (1) acts as a guanine nucleotide exchange factor (GEF), activating the small GTPases Rag and (2) mediates recruitment of Rag GTPases to the lysosome membrane (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Adapter protein that enhances the efficiency of the MAP kinase cascade facilitating the activation of MAPK2 (By similarity). {ECO:0000250|UniProtKB:O88653, ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:22980980, ECO:0000269|PubMed:28935770, ECO:0000269|PubMed:29107538, ECO:0000269|PubMed:29123114, ECO:0000269|PubMed:29158492, ECO:0000269|PubMed:30181260}.",
      "PTMs": {},
      "fc_color_1": [
        253,
        195,
        98
      ],
      "fold_change_1": 1.57373,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        228,
        185
      ],
      "fold_change_2": 0.694031,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        253,
        213,
        145
      ],
      "fold_change_3": 1.09791,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        224,
        175
      ],
      "fold_change_4": 0.801356,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        224,
        175
      ],
      "fold_change_5": 0.797281,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P36507": {
      "label": "MP2K2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.\",\"ACT_SITE 194; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.\nT: Active site: ACT_SITE 194; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.<br/><strong>T: Active site:</strong> ACT_SITE 194; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "P36507_394": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P36507",
          "fc_color_1": [
            254,
            245,
            230
          ],
          "label": "394",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.LNQPGT#PTR.T\nPSP: ON_FUNCTION: phosphorylation; enzymatic activity, induced\nPSP: NOTES: induces ERK1/2 phosphorylation",
          "tooltip_html": "<strong>T: sequence:</strong> R.LNQPGT#PTR.T<br/><strong>PSP: ON_FUNCTION:</strong> phosphorylation; enzymatic activity, induced<br/><strong>PSP: NOTES:</strong> induces ERK1/2 phosphorylation",
          "fold_change_1": 0.245843,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            234,
            201
          ],
          "fold_change_2": 0.535082,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            252,
            248
          ],
          "fold_change_3": 0.062835,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            242,
            223
          ],
          "fold_change_4": 0.318021,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            242,
            221
          ],
          "fold_change_5": 0.338508,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 662.2,
          "shape_y": 334.5,
          "label_x": 657.2,
          "label_y": 339.5,
          "label_centering": "right",
          "symbol_x": 662.1,
          "symbol_y": 334.0
        },
        "P36507_23": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P36507",
          "fc_color_1": [
            206,
            221,
            235
          ],
          "label": "23",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.RKPVLPALTINPTIAEGPS#PTSEGASEANLVDLQK.K",
          "tooltip_html": "<strong>T: sequence:</strong> R.RKPVLPALTINPTIAEGPS#PTSEGASEANLVDLQK.K",
          "fold_change_1": -0.380895,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            236,
            242,
            247
          ],
          "fold_change_2": -0.147166,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            197,
            215,
            231
          ],
          "fold_change_3": -0.452162,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            240,
            244,
            248
          ],
          "fold_change_4": -0.115099,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            144,
            179,
            209
          ],
          "fold_change_5": -0.872079,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S2",
          "shape_x": 676.0,
          "shape_y": 334.5,
          "label_x": 676.0,
          "label_y": 344.5,
          "label_centering": "center",
          "symbol_x": 676.0,
          "symbol_y": 334.5
        },
        "P36507_295": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P36507",
          "fc_color_1": [
            230,
            237,
            244
          ],
          "label": "295",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.ELEAIFGRPVVDGEEGEPHSIS#PR.P",
          "tooltip_html": "<strong>T: sequence:</strong> K.ELEAIFGRPVVDGEEGEPHSIS#PR.P",
          "fold_change_1": -0.197396,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            244,
            227
          ],
          "fold_change_2": 0.275793,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            234,
            200
          ],
          "fold_change_3": 0.548553,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            238,
            212
          ],
          "fold_change_4": 0.426862,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            235,
            205
          ],
          "fold_change_5": 0.50083,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S3",
          "shape_x": 689.8,
          "shape_y": 334.5,
          "label_x": 694.8,
          "label_y": 339.5,
          "label_centering": "left",
          "symbol_x": 689.8,
          "symbol_y": 334.5
        }
      },
      "fc_color_1": [
        254,
        226,
        180
      ],
      "fold_change_1": 0.745711,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        216,
        155
      ],
      "fold_change_2": 1.00078,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        227
      ],
      "fold_change_3": 0.271544,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        250,
        243
      ],
      "fold_change_4": 0.111984,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        233,
        199
      ],
      "fold_change_5": 0.561263,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q02750": {
      "label": "MP2K1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. {ECO:0000269|PubMed:14737111, ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:29433126}.\",\"ACT_SITE 190; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. {ECO:0000269|PubMed:14737111, ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:29433126}.\nT: Active site: ACT_SITE 190; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. {ECO:0000269|PubMed:14737111, ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:29433126}.<br/><strong>T: Active site:</strong> ACT_SITE 190; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        227,
        182
      ],
      "fold_change_1": 0.725701,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        217,
        156
      ],
      "fold_change_2": 0.99,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        236,
        206
      ],
      "fold_change_3": 0.491508,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        241,
        218
      ],
      "fold_change_4": 0.368067,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        223,
        173
      ],
      "fold_change_5": 0.823135,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P04049": {
      "label": "RAF1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}.\",\"ACT_SITE 468; /note=\"Proton acceptor\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}.\nT: Active site: ACT_SITE 468; /note=\"Proton acceptor\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at &#x27;Ser-75&#x27;. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}.<br/><strong>T: Active site:</strong> ACT_SITE 468; /note=&quot;Proton acceptor&quot;",
      "PTMs": {
        "P04049_621": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P04049",
          "fc_color_1": [
            244,
            247,
            250
          ],
          "label": "621",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_3",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: R.SAS#EPSLHR.A\nPSP: ON_FUNCTION: molecular association, regulation; enzymatic activity, inhibited; protein conformation; phosphorylation; enzymatic activity, induced\nPSP: ON_PROCESS: cell growth, altered\nPSP: ON_PROT_INTERACT: 14-3-3 beta(INDUCES); 14-3-3 zeta(INDUCES)\nPSP: in_vivo_kinases: RAF1; PKACA\nPSP: in_vitro_kinases: AMPKA1; RAF1; PKACA; PKACA",
          "tooltip_html": "<strong>T: sequence:</strong> R.SAS#EPSLHR.A<br/><strong>PSP: ON_FUNCTION:</strong> molecular association, regulation; enzymatic activity, inhibited; protein conformation; phosphorylation; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> cell growth, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> 14-3-3 beta(INDUCES); 14-3-3 zeta(INDUCES)<br/><strong>PSP: in_vivo_kinases:</strong> RAF1; PKACA<br/><strong>PSP: in_vitro_kinases:</strong> AMPKA1; RAF1; PKACA; PKACA",
          "fold_change_1": -0.0857251,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            183,
            205,
            225
          ],
          "fold_change_2": -0.566973,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            232,
            195
          ],
          "fold_change_3": 0.59909,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            247,
            235
          ],
          "fold_change_4": 0.196691,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            241,
            245,
            249
          ],
          "fold_change_5": -0.109256,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 567.2,
          "shape_y": 348.5,
          "label_x": 562.2,
          "label_y": 353.5,
          "label_centering": "right",
          "symbol_x": 567.1,
          "symbol_y": 348.5
        },
        "P04049_258": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P04049",
          "fc_color_1": [
            162,
            191,
            216
          ],
          "label": "258",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.ST#STPNVHMVSTTLPVDSR.M",
          "tooltip_html": "<strong>T: sequence:</strong> R.ST#STPNVHMVSTTLPVDSR.M",
          "fold_change_1": -0.731937,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            118,
            161,
            198
          ],
          "fold_change_2": -1.07761,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            147,
            181,
            210
          ],
          "fold_change_3": -0.84741,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            181,
            204,
            224
          ],
          "fold_change_4": -0.581873,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            163,
            191,
            216
          ],
          "fold_change_5": -0.726592,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S2",
          "shape_x": 581.0,
          "shape_y": 348.5,
          "label_x": 581.0,
          "label_y": 358.5,
          "label_centering": "center",
          "symbol_x": 581.0,
          "symbol_y": 348.5
        }
      },
      "fc_color_1": [
        254,
        219,
        162
      ],
      "fold_change_1": 0.925608,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        206,
        126
      ],
      "fold_change_2": 1.28787,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        230,
        190
      ],
      "fold_change_3": 0.651601,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        237,
        210
      ],
      "fold_change_4": 0.451467,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        225,
        177
      ],
      "fold_change_5": 0.774675,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_41": {
      "label": "BRAF",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P20936": {
      "label": "RASA1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Stimulates the GTPase of normal but not oncogenic Ras p21; this stimulation may be further increased in the presence of NCK1. {ECO:0000269|PubMed:11389730, ECO:0000269|PubMed:8360177}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Stimulates the GTPase of normal but not oncogenic Ras p21; this stimulation may be further increased in the presence of NCK1. {ECO:0000269|PubMed:11389730, ECO:0000269|PubMed:8360177}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Stimulates the GTPase of normal but not oncogenic Ras p21; this stimulation may be further increased in the presence of NCK1. {ECO:0000269|PubMed:11389730, ECO:0000269|PubMed:8360177}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        253,
        251
      ],
      "fold_change_1": 0.0345204,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        232,
        195
      ],
      "fold_change_2": 0.59808,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        242,
        246,
        249
      ],
      "fold_change_3": -0.0989721,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        222,
        169
      ],
      "fold_change_4": 0.860494,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        212,
        225,
        237
      ],
      "fold_change_5": -0.339277,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P21359": {
      "label": "NF1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity. {ECO:0000269|PubMed:2121371, ECO:0000269|PubMed:8417346}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity. {ECO:0000269|PubMed:2121371, ECO:0000269|PubMed:8417346}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity. {ECO:0000269|PubMed:2121371, ECO:0000269|PubMed:8417346}.",
      "PTMs": {
        "P21359_2829": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            253,
            210,
            138
          ],
          "label": "2829",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.SAGS#FK.R",
          "tooltip_html": "<strong>T: sequence:</strong> R.SAGS#FK.R",
          "fold_change_1": 1.17461,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            213,
            147
          ],
          "fold_change_2": 1.08103,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            227,
            182
          ],
          "fold_change_3": 0.726832,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            243,
            225
          ],
          "fold_change_4": 0.295832,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            219,
            162
          ],
          "fold_change_5": 0.925099,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 407.2,
          "shape_y": 337.5,
          "label_x": 402.2,
          "label_y": 332.5,
          "label_centering": "right",
          "symbol_x": 407.2,
          "symbol_y": 337.5
        },
        "P21359_2565": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            160,
            190,
            215
          ],
          "label": "2565",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.RQEMESGITT#PPK.M",
          "tooltip_html": "<strong>T: sequence:</strong> K.RQEMESGITT#PPK.M",
          "fold_change_1": -0.745761,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            118,
            160,
            198
          ],
          "fold_change_2": -1.08136,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            165,
            193,
            217
          ],
          "fold_change_3": -0.709945,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            231,
            239,
            245
          ],
          "fold_change_4": -0.182885,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            170,
            196,
            219
          ],
          "fold_change_5": -0.669763,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 434.8,
          "shape_y": 337.5,
          "label_x": 439.8,
          "label_y": 332.5,
          "label_centering": "left",
          "symbol_x": 434.8,
          "symbol_y": 337.5
        },
        "P21359_2521": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            163,
            191,
            216
          ],
          "label": "2521",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.S#MSLDMGQPSQANTK.K",
          "tooltip_html": "<strong>T: sequence:</strong> K.S#MSLDMGQPSQANTK.K",
          "fold_change_1": -0.725069,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            212,
            225,
            237
          ],
          "fold_change_2": -0.338957,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            253,
            250
          ],
          "fold_change_3": 0.0481446,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            225,
            178
          ],
          "fold_change_4": 0.772531,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            241,
            218
          ],
          "fold_change_5": 0.362239,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "E1",
          "shape_x": 448.0,
          "shape_y": 347.11,
          "label_x": 453.0,
          "label_y": 345.11,
          "label_centering": "left",
          "symbol_x": 448.0,
          "symbol_y": 347.11
        },
        "P21359_2597": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            168,
            195,
            218
          ],
          "label": "2597",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.KVS#VSESNVLLDEEVLTDPK.I",
          "tooltip_html": "<strong>T: sequence:</strong> R.KVS#VSESNVLLDEEVLTDPK.I",
          "fold_change_1": -0.685781,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            242,
            246,
            249
          ],
          "fold_change_2": -0.0983858,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            218,
            229,
            239
          ],
          "fold_change_3": -0.287706,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            233,
            240,
            246
          ],
          "fold_change_4": -0.168356,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            227,
            236,
            243
          ],
          "fold_change_5": -0.214372,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "W1",
          "shape_x": 394.0,
          "shape_y": 347.11,
          "label_x": 389.0,
          "label_y": 345.11,
          "label_centering": "right",
          "symbol_x": 394.0,
          "symbol_y": 347.11
        },
        "P21359_653": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            186,
            207,
            226
          ],
          "label": "653",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.T#PGASLR.K",
          "tooltip_html": "<strong>T: sequence:</strong> R.T#PGASLR.K",
          "fold_change_1": -0.542444,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            163,
            192,
            217
          ],
          "fold_change_2": -0.722131,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            192,
            211,
            228
          ],
          "fold_change_3": -0.496998,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            138,
            174,
            206
          ],
          "fold_change_4": -0.921714,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            132,
            170,
            203
          ],
          "fold_change_5": -0.971801,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": ""
        },
        "P21359_2496": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            188,
            208,
            227
          ],
          "label": "2496",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.ETQPWSS#PK.G",
          "tooltip_html": "<strong>T: sequence:</strong> K.ETQPWSS#PK.G",
          "fold_change_1": -0.52887,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            242,
            246,
            249
          ],
          "fold_change_2": -0.100735,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            197,
            215,
            231
          ],
          "fold_change_3": -0.456794,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            152,
            184,
            212
          ],
          "fold_change_4": -0.808188,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            242,
            221
          ],
          "fold_change_5": 0.338443,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": ""
        },
        "P21359_2543": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            219,
            230,
            240
          ],
          "label": "2543",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.S#FDHLISDTK.A",
          "tooltip_html": "<strong>T: sequence:</strong> K.S#FDHLISDTK.A",
          "fold_change_1": -0.283499,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            252,
            247
          ],
          "fold_change_2": 0.0716446,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            238,
            210
          ],
          "fold_change_3": 0.44279,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            238,
            211
          ],
          "fold_change_4": 0.436499,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            253,
            249
          ],
          "fold_change_5": 0.0520096,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": ""
        },
        "P21359_2515": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            254,
            246,
            233
          ],
          "label": "2515",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.GSEGYLAATYPTVGQTS#PR.A",
          "tooltip_html": "<strong>T: sequence:</strong> K.GSEGYLAATYPTVGQTS#PR.A",
          "fold_change_1": 0.21559,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            227,
            181
          ],
          "fold_change_2": 0.734264,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            252,
            248
          ],
          "fold_change_3": 0.0658686,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            240,
            245,
            249
          ],
          "fold_change_4": -0.112267,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            238,
            212
          ],
          "fold_change_5": 0.430117,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": ""
        },
        "P21359_2817": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P21359",
          "fc_color_1": [
            242,
            246,
            249
          ],
          "label": "2817",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.HGS#ASQVQK.Q",
          "tooltip_html": "<strong>T: sequence:</strong> R.HGS#ASQVQK.Q",
          "fold_change_1": -0.0965852,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            237,
            208
          ],
          "fold_change_2": 0.468505,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            239,
            213
          ],
          "fold_change_3": 0.415809,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            253,
            254,
            254
          ],
          "fold_change_4": -0.00893656,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            236,
            242,
            247
          ],
          "fold_change_5": -0.147079,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": ""
        }
      },
      "fc_color_1": [
        254,
        225,
        177
      ],
      "fold_change_1": 0.781381,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        234,
        200
      ],
      "fold_change_2": 0.545874,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        246,
        233
      ],
      "fold_change_3": 0.220949,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        249,
        241
      ],
      "fold_change_4": 0.136138,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        242,
        222
      ],
      "fold_change_5": 0.326714,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P17252": {
      "label": "KPCA",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at 'Ser-52' facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P20444, ECO:0000269|PubMed:10848585, ECO:0000269|PubMed:11909826, ECO:0000269|PubMed:12724315, ECO:0000269|PubMed:12832403, ECO:0000269|PubMed:15016832, ECO:0000269|PubMed:15504744, ECO:0000269|PubMed:15526160, ECO:0000269|PubMed:18056764, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:21576361, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:28028151, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9738012, ECO:0000269|PubMed:9830023, ECO:0000269|PubMed:9873035, ECO:0000269|PubMed:9927633}.\",\"ACT_SITE 463; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at 'Ser-52' facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P20444, ECO:0000269|PubMed:10848585, ECO:0000269|PubMed:11909826, ECO:0000269|PubMed:12724315, ECO:0000269|PubMed:12832403, ECO:0000269|PubMed:15016832, ECO:0000269|PubMed:15504744, ECO:0000269|PubMed:15526160, ECO:0000269|PubMed:18056764, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:21576361, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:28028151, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9738012, ECO:0000269|PubMed:9830023, ECO:0000269|PubMed:9873035, ECO:0000269|PubMed:9927633}.\nT: Active site: ACT_SITE 463; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at &#x27;Ser-52&#x27; facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P20444, ECO:0000269|PubMed:10848585, ECO:0000269|PubMed:11909826, ECO:0000269|PubMed:12724315, ECO:0000269|PubMed:12832403, ECO:0000269|PubMed:15016832, ECO:0000269|PubMed:15504744, ECO:0000269|PubMed:15526160, ECO:0000269|PubMed:18056764, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:21576361, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:28028151, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9738012, ECO:0000269|PubMed:9830023, ECO:0000269|PubMed:9873035, ECO:0000269|PubMed:9927633}.<br/><strong>T: Active site:</strong> ACT_SITE 463; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "P17252_226": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P17252",
          "fc_color_1": [
            178,
            202,
            223
          ],
          "label": "226",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.STLNPQWNES#FTFK.L\nPSP: DOMAIN: C2\nPSP: ON_FUNCTION: molecular association, regulation; enzymatic activity, induced\nPSP: ON_PROT_INTERACT: RhoGDI beta(INDUCES)\nPSP: in_vitro_kinases: MST2",
          "tooltip_html": "<strong>T: sequence:</strong> R.STLNPQWNES#FTFK.L<br/><strong>PSP: DOMAIN:</strong> C2<br/><strong>PSP: ON_FUNCTION:</strong> molecular association, regulation; enzymatic activity, induced<br/><strong>PSP: ON_PROT_INTERACT:</strong> RhoGDI beta(INDUCES)<br/><strong>PSP: in_vitro_kinases:</strong> MST2",
          "fold_change_1": -0.605848,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            167,
            194,
            218
          ],
          "fold_change_2": -0.69434,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            182,
            205,
            224
          ],
          "fold_change_3": -0.574647,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            204,
            220,
            234
          ],
          "fold_change_4": -0.396235,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            191,
            211,
            228
          ],
          "fold_change_5": -0.498666,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 473.2,
          "shape_y": 244.5,
          "label_x": 468.2,
          "label_y": 239.5,
          "label_centering": "right",
          "symbol_x": 473.09999999999997,
          "symbol_y": 244.0
        },
        "P17252_497": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P17252",
          "fc_color_1": [
            165,
            193,
            217
          ],
          "label": "497",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.T#FCGTPDYIAPEIIAYQPYGK.S",
          "tooltip_html": "<strong>T: sequence:</strong> R.T#FCGTPDYIAPEIIAYQPYGK.S",
          "fold_change_1": -0.70558,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            209,
            223,
            236
          ],
          "fold_change_2": -0.360054,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            245,
            229
          ],
          "fold_change_3": 0.255402,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            218,
            230,
            240
          ],
          "fold_change_4": -0.285414,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            246,
            248,
            251
          ],
          "fold_change_5": -0.0695908,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N2",
          "shape_x": 487.0,
          "shape_y": 244.5,
          "label_x": 487.0,
          "label_y": 236.5,
          "label_centering": "center",
          "symbol_x": 487.0,
          "symbol_y": 244.5
        },
        "P17252_319": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P17252",
          "fc_color_1": [
            254,
            236,
            206
          ],
          "label": "319",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.VIS#PSEDR.K",
          "tooltip_html": "<strong>T: sequence:</strong> K.VIS#PSEDR.K",
          "fold_change_1": 0.490436,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            234,
            201
          ],
          "fold_change_2": 0.538551,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            227,
            184
          ],
          "fold_change_3": 0.710765,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            248,
            237
          ],
          "fold_change_4": 0.173499,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            235,
            204
          ],
          "fold_change_5": 0.504846,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 500.8,
          "shape_y": 244.5,
          "label_x": 505.8,
          "label_y": 239.5,
          "label_centering": "left",
          "symbol_x": 500.8,
          "symbol_y": 244.5
        }
      },
      "fc_color_1": [
        254,
        237,
        208
      ],
      "fold_change_1": 0.471489,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        232,
        194
      ],
      "fold_change_2": 0.604985,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        246,
        233
      ],
      "fold_change_3": 0.218731,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        239,
        213
      ],
      "fold_change_4": 0.416153,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        245,
        230
      ],
      "fold_change_5": 0.245466,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P61224": {
      "label": "RAP1B",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function. {ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21840392}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function. {ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21840392}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function. {ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21840392}.",
      "PTMs": {
        "P61224_39": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P61224",
          "fc_color_1": [
            211,
            225,
            237
          ],
          "label": "39",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.YDPTIEDS#YRK.Q",
          "tooltip_html": "<strong>T: sequence:</strong> K.YDPTIEDS#YRK.Q",
          "fold_change_1": -0.339951,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            218,
            229,
            239
          ],
          "fold_change_2": -0.288909,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            246,
            232
          ],
          "fold_change_3": 0.223289,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            254,
            253
          ],
          "fold_change_4": 0.0135055,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            248,
            238
          ],
          "fold_change_5": 0.163759,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 514.2,
          "shape_y": 206.5,
          "label_x": 509.20000000000005,
          "label_y": 201.5,
          "label_centering": "right",
          "symbol_x": 514.2,
          "symbol_y": 206.5
        }
      },
      "fc_color_1": [
        202,
        218,
        233
      ],
      "fold_change_1": -0.418501,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        188,
        209,
        227
      ],
      "fold_change_2": -0.521814,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        180,
        203,
        223
      ],
      "fold_change_3": -0.59125,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        203,
        219,
        233
      ],
      "fold_change_4": -0.408879,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        151,
        183,
        212
      ],
      "fold_change_5": -0.817404,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P17612": {
      "label": "KAPCA",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Required for phosphorylation of GLI transcription factors which inhibits them and prevents transcriptional activation of Hedgehog signaling pathway target genes (By similarity). GLI transcription factor phosphorylation is inhibited by interaction of PRKACA with SMO which sequesters PRKACA at the cell membrane (By similarity). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis most probably through the regulation of OFD1 in ciliogenesis (PubMed:33934390). Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984, ECO:0000269|PubMed:31112131, ECO:0000269|PubMed:33934390}.; FUNCTION: [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.\",\"ACT_SITE 167; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Required for phosphorylation of GLI transcription factors which inhibits them and prevents transcriptional activation of Hedgehog signaling pathway target genes (By similarity). GLI transcription factor phosphorylation is inhibited by interaction of PRKACA with SMO which sequesters PRKACA at the cell membrane (By similarity). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis most probably through the regulation of OFD1 in ciliogenesis (PubMed:33934390). Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984, ECO:0000269|PubMed:31112131, ECO:0000269|PubMed:33934390}.; FUNCTION: [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.\nT: Active site: ACT_SITE 167; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Required for phosphorylation of GLI transcription factors which inhibits them and prevents transcriptional activation of Hedgehog signaling pathway target genes (By similarity). GLI transcription factor phosphorylation is inhibited by interaction of PRKACA with SMO which sequesters PRKACA at the cell membrane (By similarity). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis most probably through the regulation of OFD1 in ciliogenesis (PubMed:33934390). Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984, ECO:0000269|PubMed:31112131, ECO:0000269|PubMed:33934390}.; FUNCTION: [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.<br/><strong>T: Active site:</strong> ACT_SITE 167; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "P17612_339": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P17612",
          "fc_color_1": [
            220,
            231,
            240
          ],
          "label": "339",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.GPGDTSNFDDYEEEEIRVS#INEK.C\nPSP: ON_FUNCTION: protein stabilization; protein processing; protein conformation; phosphorylation; enzymatic activity, induced\nPSP: NOTES: optimal enzymatic activity; solublity of C-sub unit, phosphorylation of T198 site\nPSP: in_vivo_kinases: PKACA\nPSP: in_vitro_kinases: PKACA",
          "tooltip_html": "<strong>T: sequence:</strong> K.GPGDTSNFDDYEEEEIRVS#INEK.C<br/><strong>PSP: ON_FUNCTION:</strong> protein stabilization; protein processing; protein conformation; phosphorylation; enzymatic activity, induced<br/><strong>PSP: NOTES:</strong> optimal enzymatic activity; solublity of C-sub unit, phosphorylation of T198 site<br/><strong>PSP: in_vivo_kinases:</strong> PKACA<br/><strong>PSP: in_vitro_kinases:</strong> PKACA",
          "fold_change_1": -0.271653,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            193,
            212,
            229
          ],
          "fold_change_2": -0.488454,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            198,
            216,
            231
          ],
          "fold_change_3": -0.447726,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            217,
            229,
            239
          ],
          "fold_change_4": -0.296214,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            203,
            219,
            233
          ],
          "fold_change_5": -0.410259,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 514.2,
          "shape_y": 157.5,
          "label_x": 509.20000000000005,
          "label_y": 152.5,
          "label_centering": "right",
          "symbol_x": 514.1,
          "symbol_y": 157.0
        }
      },
      "fc_color_1": [
        254,
        231,
        194
      ],
      "fold_change_1": 0.60551,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        235,
        202
      ],
      "fold_change_2": 0.52344,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        246,
        233
      ],
      "fold_change_3": 0.213018,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        248,
        239
      ],
      "fold_change_4": 0.15793,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        247,
        235
      ],
      "fold_change_5": 0.191993,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P22694": {
      "label": "KAPCB",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.\",\"ACT_SITE 167; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.\nT: Active site: ACT_SITE 167; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed:12420224, PubMed:21423175, PubMed:31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed:12420224, PubMed:21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:12420224, PubMed:21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed:21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21880142, ECO:0000269|PubMed:31112131}.<br/><strong>T: Active site:</strong> ACT_SITE 167; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "P22694_339": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P22694",
          "fc_color_1": [
            199,
            216,
            232
          ],
          "label": "339",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.GSGDTSNFDDYEEEDIRVS#ITEK.C",
          "tooltip_html": "<strong>T: sequence:</strong> R.GSGDTSNFDDYEEEDIRVS#ITEK.C",
          "fold_change_1": -0.437681,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            236,
            242,
            247
          ],
          "fold_change_2": -0.144903,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            241,
            245,
            249
          ],
          "fold_change_3": -0.108668,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            236,
            241,
            247
          ],
          "fold_change_4": -0.14977,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            252,
            253,
            254
          ],
          "fold_change_5": -0.0189465,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 514.2,
          "shape_y": 157.5,
          "label_x": 509.20000000000005,
          "label_y": 152.5,
          "label_centering": "right",
          "symbol_x": 514.2,
          "symbol_y": 157.5
        }
      },
      "fc_color_1": [
        254,
        232,
        196
      ],
      "fold_change_1": 0.591298,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        235,
        203
      ],
      "fold_change_2": 0.514249,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        250,
        243
      ],
      "fold_change_3": 0.11813,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        253,
        250
      ],
      "fold_change_4": 0.0432723,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        246,
        231
      ],
      "fold_change_5": 0.233871,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9Y4G8": {
      "label": "RPGF2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Functions as a guanine nucleotide exchange factor (GEF), which activates Rap and Ras family of small GTPases by exchanging bound GDP for free GTP in a cAMP-dependent manner. Serves as a link between cell surface receptors and Rap/Ras GTPases in intracellular signaling cascades. Also acts as an effector for Rap1 by direct association with Rap1-GTP thereby leading to the amplification of Rap1-mediated signaling. Shows weak activity on HRAS. It is controversial whether RAPGEF2 binds cAMP and cGMP (PubMed:23800469, PubMed:10801446) or not (PubMed:10548487, PubMed:10608844, PubMed:11359771). Its binding to ligand-activated beta-1 adrenergic receptor ADRB1 leads to the Ras activation through the G(s)-alpha signaling pathway. Involved in the cAMP-induced Ras and Erk1/2 signaling pathway that leads to sustained inhibition of long term melanogenesis by reducing dendrite extension and melanin synthesis. Also provides inhibitory signals for cell proliferation of melanoma cells and promotes their apoptosis in a cAMP-independent nanner. Regulates cAMP-induced neuritogenesis by mediating the Rap1/B-Raf/ERK signaling through a pathway that is independent on both PKA and RAPGEF3/RAPGEF4. Involved in neuron migration and in the formation of the major forebrain fiber connections forming the corpus callosum, the anterior commissure and the hippocampal commissure during brain development. Involved in neuronal growth factor (NGF)-induced sustained activation of Rap1 at late endosomes and in brain-derived neurotrophic factor (BDNF)-induced axon outgrowth of hippocampal neurons. Plays a role in the regulation of embryonic blood vessel formation and in the establishment of basal junction integrity and endothelial barrier function. May be involved in the regulation of the vascular endothelial growth factor receptor KDR and cadherin CDH5 expression at allantois endothelial cell-cell junctions. {ECO:0000269|PubMed:10548487, ECO:0000269|PubMed:10608844, ECO:0000269|PubMed:10608883, ECO:0000269|PubMed:10801446, ECO:0000269|PubMed:10934204, ECO:0000269|PubMed:11359771, ECO:0000269|PubMed:12391161, ECO:0000269|PubMed:16272156, ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:21840392, ECO:0000269|PubMed:23800469}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Functions as a guanine nucleotide exchange factor (GEF), which activates Rap and Ras family of small GTPases by exchanging bound GDP for free GTP in a cAMP-dependent manner. Serves as a link between cell surface receptors and Rap/Ras GTPases in intracellular signaling cascades. Also acts as an effector for Rap1 by direct association with Rap1-GTP thereby leading to the amplification of Rap1-mediated signaling. Shows weak activity on HRAS. It is controversial whether RAPGEF2 binds cAMP and cGMP (PubMed:23800469, PubMed:10801446) or not (PubMed:10548487, PubMed:10608844, PubMed:11359771). Its binding to ligand-activated beta-1 adrenergic receptor ADRB1 leads to the Ras activation through the G(s)-alpha signaling pathway. Involved in the cAMP-induced Ras and Erk1/2 signaling pathway that leads to sustained inhibition of long term melanogenesis by reducing dendrite extension and melanin synthesis. Also provides inhibitory signals for cell proliferation of melanoma cells and promotes their apoptosis in a cAMP-independent nanner. Regulates cAMP-induced neuritogenesis by mediating the Rap1/B-Raf/ERK signaling through a pathway that is independent on both PKA and RAPGEF3/RAPGEF4. Involved in neuron migration and in the formation of the major forebrain fiber connections forming the corpus callosum, the anterior commissure and the hippocampal commissure during brain development. Involved in neuronal growth factor (NGF)-induced sustained activation of Rap1 at late endosomes and in brain-derived neurotrophic factor (BDNF)-induced axon outgrowth of hippocampal neurons. Plays a role in the regulation of embryonic blood vessel formation and in the establishment of basal junction integrity and endothelial barrier function. May be involved in the regulation of the vascular endothelial growth factor receptor KDR and cadherin CDH5 expression at allantois endothelial cell-cell junctions. {ECO:0000269|PubMed:10548487, ECO:0000269|PubMed:10608844, ECO:0000269|PubMed:10608883, ECO:0000269|PubMed:10801446, ECO:0000269|PubMed:10934204, ECO:0000269|PubMed:11359771, ECO:0000269|PubMed:12391161, ECO:0000269|PubMed:16272156, ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:21840392, ECO:0000269|PubMed:23800469}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Functions as a guanine nucleotide exchange factor (GEF), which activates Rap and Ras family of small GTPases by exchanging bound GDP for free GTP in a cAMP-dependent manner. Serves as a link between cell surface receptors and Rap/Ras GTPases in intracellular signaling cascades. Also acts as an effector for Rap1 by direct association with Rap1-GTP thereby leading to the amplification of Rap1-mediated signaling. Shows weak activity on HRAS. It is controversial whether RAPGEF2 binds cAMP and cGMP (PubMed:23800469, PubMed:10801446) or not (PubMed:10548487, PubMed:10608844, PubMed:11359771). Its binding to ligand-activated beta-1 adrenergic receptor ADRB1 leads to the Ras activation through the G(s)-alpha signaling pathway. Involved in the cAMP-induced Ras and Erk1/2 signaling pathway that leads to sustained inhibition of long term melanogenesis by reducing dendrite extension and melanin synthesis. Also provides inhibitory signals for cell proliferation of melanoma cells and promotes their apoptosis in a cAMP-independent nanner. Regulates cAMP-induced neuritogenesis by mediating the Rap1/B-Raf/ERK signaling through a pathway that is independent on both PKA and RAPGEF3/RAPGEF4. Involved in neuron migration and in the formation of the major forebrain fiber connections forming the corpus callosum, the anterior commissure and the hippocampal commissure during brain development. Involved in neuronal growth factor (NGF)-induced sustained activation of Rap1 at late endosomes and in brain-derived neurotrophic factor (BDNF)-induced axon outgrowth of hippocampal neurons. Plays a role in the regulation of embryonic blood vessel formation and in the establishment of basal junction integrity and endothelial barrier function. May be involved in the regulation of the vascular endothelial growth factor receptor KDR and cadherin CDH5 expression at allantois endothelial cell-cell junctions. {ECO:0000269|PubMed:10548487, ECO:0000269|PubMed:10608844, ECO:0000269|PubMed:10608883, ECO:0000269|PubMed:10801446, ECO:0000269|PubMed:10934204, ECO:0000269|PubMed:11359771, ECO:0000269|PubMed:12391161, ECO:0000269|PubMed:16272156, ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:21840392, ECO:0000269|PubMed:23800469}.",
      "PTMs": {
        "Q9Y4G8_1080": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9Y4G8",
          "fc_color_1": [
            250,
            252,
            253
          ],
          "label": "1080",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.DLPPFGINS#PQALK.K",
          "tooltip_html": "<strong>T: sequence:</strong> K.DLPPFGINS#PQALK.K",
          "fold_change_1": -0.0341307,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            99,
            148,
            190
          ],
          "fold_change_2": -1.22786,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            233,
            198
          ],
          "fold_change_3": 0.56815,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            249,
            240
          ],
          "fold_change_4": 0.147912,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            236,
            242,
            247
          ],
          "fold_change_5": -0.143868,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 433.2,
          "shape_y": 216.5,
          "label_x": 428.2,
          "label_y": 211.5,
          "label_centering": "right",
          "symbol_x": 433.2,
          "symbol_y": 216.5
        }
      },
      "fc_color_1": [
        254,
        232,
        195
      ],
      "fold_change_1": 0.59423,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        201,
        114
      ],
      "fold_change_2": 1.4116,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        229,
        237,
        244
      ],
      "fold_change_3": -0.204439,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        243,
        224
      ],
      "fold_change_4": 0.310541,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        245,
        230
      ],
      "fold_change_5": 0.244595,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q15283": {
      "label": "RASA2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4).\"",
      "tooltip": "T: Function [CC]: FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4).",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4).",
      "PTMs": {},
      "fc_color_1": [
        254,
        242,
        221
      ],
      "fold_change_1": 0.338269,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        247,
        234
      ],
      "fold_change_2": 0.204854,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        254,
        253
      ],
      "fold_change_3": 0.0148988,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        233,
        240,
        245
      ],
      "fold_change_4": -0.172038,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        254,
        253
      ],
      "fold_change_5": 0.0200634,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P62070": {
      "label": "RRAS2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: GTP-binding protein with GTPase activity, involved in the regulation of MAPK signaling pathway and thereby controlling multiple cellular processes (PubMed:31130282, PubMed:31130285, PubMed:39809765). Regulates craniofacial development (PubMed:31130282, PubMed:31130285). {ECO:0000269|PubMed:31130282, ECO:0000269|PubMed:31130285, ECO:0000269|PubMed:39809765}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: GTP-binding protein with GTPase activity, involved in the regulation of MAPK signaling pathway and thereby controlling multiple cellular processes (PubMed:31130282, PubMed:31130285, PubMed:39809765). Regulates craniofacial development (PubMed:31130282, PubMed:31130285). {ECO:0000269|PubMed:31130282, ECO:0000269|PubMed:31130285, ECO:0000269|PubMed:39809765}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: GTP-binding protein with GTPase activity, involved in the regulation of MAPK signaling pathway and thereby controlling multiple cellular processes (PubMed:31130282, PubMed:31130285, PubMed:39809765). Regulates craniofacial development (PubMed:31130282, PubMed:31130285). {ECO:0000269|PubMed:31130282, ECO:0000269|PubMed:31130285, ECO:0000269|PubMed:39809765}.",
      "PTMs": {
        "P62070_186": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P62070",
          "fc_color_1": [
            220,
            231,
            240
          ],
          "label": "186",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: R.KFQEQECPPS#PEPTR.K\nPSP: ON_PROCESS: carcinogenesis, induced\nPSP: in_vivo_kinases: ERK1; ERK2\nPSP: in_vitro_kinases: ERK1",
          "tooltip_html": "<strong>T: sequence:</strong> R.KFQEQECPPS#PEPTR.K<br/><strong>PSP: ON_PROCESS:</strong> carcinogenesis, induced<br/><strong>PSP: in_vivo_kinases:</strong> ERK1; ERK2<br/><strong>PSP: in_vitro_kinases:</strong> ERK1",
          "fold_change_1": -0.270923,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            232,
            239,
            245
          ],
          "fold_change_2": -0.180203,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            238,
            243,
            248
          ],
          "fold_change_3": -0.127927,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            250,
            243
          ],
          "fold_change_4": 0.118971,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            238,
            243,
            247
          ],
          "fold_change_5": -0.133863,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 394.2,
          "shape_y": 298.5,
          "label_x": 389.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 394.09999999999997,
          "symbol_y": 298.5
        }
      },
      "fc_color_1": [
        254,
        254,
        252
      ],
      "fold_change_1": 0.0230751,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        250,
        242
      ],
      "fold_change_2": 0.129732,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        247,
        235
      ],
      "fold_change_3": 0.200112,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        241,
        218
      ],
      "fold_change_4": 0.367025,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        248,
        238
      ],
      "fold_change_5": 0.162085,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O14807": {
      "label": "RASM",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Signal transducer in the Ras-MAPK signaling pathway that regulates cell proliferation and survival (PubMed:16630891, PubMed:28289718, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The formation of the SMP complex only occurs when MRAS is GTP-bound (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670, PubMed:39809765). MRAS has low intrinsic GTPase activity and may require additional factors for activation (PubMed:39809765). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). {ECO:0000269|PubMed:16630891, ECO:0000269|PubMed:28289718, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35830882, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:36175670, ECO:0000269|PubMed:39809765}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Signal transducer in the Ras-MAPK signaling pathway that regulates cell proliferation and survival (PubMed:16630891, PubMed:28289718, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The formation of the SMP complex only occurs when MRAS is GTP-bound (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670, PubMed:39809765). MRAS has low intrinsic GTPase activity and may require additional factors for activation (PubMed:39809765). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). {ECO:0000269|PubMed:16630891, ECO:0000269|PubMed:28289718, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35830882, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:36175670, ECO:0000269|PubMed:39809765}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Signal transducer in the Ras-MAPK signaling pathway that regulates cell proliferation and survival (PubMed:16630891, PubMed:28289718, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The formation of the SMP complex only occurs when MRAS is GTP-bound (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670, PubMed:39809765). MRAS has low intrinsic GTPase activity and may require additional factors for activation (PubMed:39809765). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at &#x27;Ser-259&#x27; of RAF1 kinase, &#x27;Ser-365&#x27; of BRAF kinase and &#x27;Ser-214&#x27; of ARAF kinase, stimulating their kinase activities (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). {ECO:0000269|PubMed:16630891, ECO:0000269|PubMed:28289718, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35830882, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:36175670, ECO:0000269|PubMed:39809765}.",
      "PTMs": {},
      "fc_color_1": [
        205,
        221,
        234
      ],
      "fold_change_1": -0.38936,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        232,
        239,
        245
      ],
      "fold_change_2": -0.17849,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        249,
        241
      ],
      "fold_change_3": 0.139378,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        218,
        229,
        239
      ],
      "fold_change_4": -0.287543,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        193,
        212,
        229
      ],
      "fold_change_5": -0.487609,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P01112": {
      "label": "RASH",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Involved in the activation of Ras protein signal transduction (PubMed:22821884). Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed:12740440, PubMed:14500341, PubMed:9020151). {ECO:0000269|PubMed:12740440, ECO:0000269|PubMed:14500341, ECO:0000269|PubMed:22821884, ECO:0000269|PubMed:9020151}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Involved in the activation of Ras protein signal transduction (PubMed:22821884). Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed:12740440, PubMed:14500341, PubMed:9020151). {ECO:0000269|PubMed:12740440, ECO:0000269|PubMed:14500341, ECO:0000269|PubMed:22821884, ECO:0000269|PubMed:9020151}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Involved in the activation of Ras protein signal transduction (PubMed:22821884). Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed:12740440, PubMed:14500341, PubMed:9020151). {ECO:0000269|PubMed:12740440, ECO:0000269|PubMed:14500341, ECO:0000269|PubMed:22821884, ECO:0000269|PubMed:9020151}.",
      "PTMs": {},
      "fc_color_1": [
        234,
        241,
        246
      ],
      "fold_change_1": -0.160388,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        233,
        240,
        246
      ],
      "fold_change_2": -0.170495,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        243,
        247,
        250
      ],
      "fold_change_3": -0.0883162,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        251,
        252,
        253
      ],
      "fold_change_4": -0.0247827,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        234,
        240,
        246
      ],
      "fold_change_5": -0.161638,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P01111": {
      "label": "RASN",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. {ECO:0000269|PubMed:30712867}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. {ECO:0000269|PubMed:30712867}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. {ECO:0000269|PubMed:30712867}.",
      "PTMs": {},
      "fc_color_1": [
        252,
        253,
        254
      ],
      "fold_change_1": -0.0164187,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        241,
        245,
        249
      ],
      "fold_change_2": -0.105388,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        210,
        224,
        236
      ],
      "fold_change_3": -0.351618,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        254,
        254
      ],
      "fold_change_4": -0.00227427,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        254,
        254
      ],
      "fold_change_5": -0.00558162,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P10301": {
      "label": "RRAS",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: GTP-binding protein with GTPase activity, likely involved in the regulation of MAPK signaling pathway and thereby controlling multiple cellular processes (PubMed:39809765). Regulates the organization of the actin cytoskeleton (PubMed:16537651, PubMed:18270267). With OSPBL3, modulates integrin beta-1 (ITGB1) activity (PubMed:18270267). {ECO:0000269|PubMed:16537651, ECO:0000269|PubMed:18270267, ECO:0000269|PubMed:39809765}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: GTP-binding protein with GTPase activity, likely involved in the regulation of MAPK signaling pathway and thereby controlling multiple cellular processes (PubMed:39809765). Regulates the organization of the actin cytoskeleton (PubMed:16537651, PubMed:18270267). With OSPBL3, modulates integrin beta-1 (ITGB1) activity (PubMed:18270267). {ECO:0000269|PubMed:16537651, ECO:0000269|PubMed:18270267, ECO:0000269|PubMed:39809765}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: GTP-binding protein with GTPase activity, likely involved in the regulation of MAPK signaling pathway and thereby controlling multiple cellular processes (PubMed:39809765). Regulates the organization of the actin cytoskeleton (PubMed:16537651, PubMed:18270267). With OSPBL3, modulates integrin beta-1 (ITGB1) activity (PubMed:18270267). {ECO:0000269|PubMed:16537651, ECO:0000269|PubMed:18270267, ECO:0000269|PubMed:39809765}.",
      "PTMs": {},
      "fc_color_1": [
        239,
        244,
        248
      ],
      "fold_change_1": -0.121998,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        252,
        249
      ],
      "fold_change_2": 0.0570984,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        245,
        228
      ],
      "fold_change_3": 0.261672,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        243,
        225
      ],
      "fold_change_4": 0.297055,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        251,
        246
      ],
      "fold_change_5": 0.0871353,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_50": {
      "label": "RASGRP1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q07889": {
      "label": "SOS1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Promotes the exchange of Ras-bound GDP by GTP (PubMed:8493579). Probably by promoting Ras activation, regulates phosphorylation of MAP kinase MAPK3/ERK1 in response to EGF (PubMed:17339331). Catalytic component of a trimeric complex that participates in transduction of signals from Ras to Rac by promoting the Rac-specific guanine nucleotide exchange factor (GEF) activity (By similarity). {ECO:0000250|UniProtKB:Q62245, ECO:0000269|PubMed:17339331, ECO:0000269|PubMed:8493579}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Promotes the exchange of Ras-bound GDP by GTP (PubMed:8493579). Probably by promoting Ras activation, regulates phosphorylation of MAP kinase MAPK3/ERK1 in response to EGF (PubMed:17339331). Catalytic component of a trimeric complex that participates in transduction of signals from Ras to Rac by promoting the Rac-specific guanine nucleotide exchange factor (GEF) activity (By similarity). {ECO:0000250|UniProtKB:Q62245, ECO:0000269|PubMed:17339331, ECO:0000269|PubMed:8493579}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Promotes the exchange of Ras-bound GDP by GTP (PubMed:8493579). Probably by promoting Ras activation, regulates phosphorylation of MAP kinase MAPK3/ERK1 in response to EGF (PubMed:17339331). Catalytic component of a trimeric complex that participates in transduction of signals from Ras to Rac by promoting the Rac-specific guanine nucleotide exchange factor (GEF) activity (By similarity). {ECO:0000250|UniProtKB:Q62245, ECO:0000269|PubMed:17339331, ECO:0000269|PubMed:8493579}.",
      "PTMs": {
        "Q07889_1275": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q07889",
          "fc_color_1": [
            148,
            181,
            210
          ],
          "label": "1275",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.HLPS#PPLTQEVDLHSIAGPPVPPR.Q",
          "tooltip_html": "<strong>T: sequence:</strong> R.HLPS#PPLTQEVDLHSIAGPPVPPR.Q",
          "fold_change_1": -0.842225,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            66,
            125,
            176
          ],
          "fold_change_2": -1.49094,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            188,
            209,
            227
          ],
          "fold_change_3": -0.523865,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            222,
            232,
            241
          ],
          "fold_change_4": -0.259962,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            121,
            163,
            199
          ],
          "fold_change_5": -1.05256,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 332.2,
          "shape_y": 298.5,
          "label_x": 327.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 332.2,
          "symbol_y": 298.5
        }
      },
      "fc_color_1": [
        254,
        243,
        225
      ],
      "fold_change_1": 0.297666,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        229,
        189
      ],
      "fold_change_2": 0.662979,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        248,
        238
      ],
      "fold_change_3": 0.168716,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        250,
        242
      ],
      "fold_change_4": 0.12926,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        235,
        205
      ],
      "fold_change_5": 0.500405,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q03113": {
      "label": "GNA12",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems (PubMed:12515866, PubMed:15240885, PubMed:15525651, PubMed:16705036, PubMed:16787920, PubMed:17565996, PubMed:22609986, PubMed:23762476, PubMed:27084452). Activates effector molecule RhoA by binding and activating RhoGEFs (ARHGEF12/LARG) (PubMed:12515866, PubMed:15240885, PubMed:16202387). GNA12-dependent Rho signaling subsequently regulates transcription factor AP-1 (activating protein-1) (By similarity). GNA12-dependent Rho signaling also regulates protein phosphatese 2A activation causing dephosphorylation of its target proteins (PubMed:15525651, PubMed:17565996). Promotes tumor cell invasion and metastasis by activating RhoA/ROCK signaling pathway and up-regulating pro-inflammatory cytokine production (PubMed:16705036, PubMed:16787920, PubMed:23762476, PubMed:27084452). Inhibits CDH1-mediated cell adhesion in process independent from Rho activation (PubMed:11976333, PubMed:16787920). Together with NAPA promotes CDH5 localization to plasma membrane (PubMed:15980433). May play a role in the control of cell migration through the TOR signaling cascade (PubMed:22609986). {ECO:0000250|UniProtKB:P27600, ECO:0000269|PubMed:11976333, ECO:0000269|PubMed:12515866, ECO:0000269|PubMed:15240885, ECO:0000269|PubMed:15525651, ECO:0000269|PubMed:15980433, ECO:0000269|PubMed:16705036, ECO:0000269|PubMed:16787920, ECO:0000269|PubMed:17565996, ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:23762476, ECO:0000269|PubMed:27084452}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems (PubMed:12515866, PubMed:15240885, PubMed:15525651, PubMed:16705036, PubMed:16787920, PubMed:17565996, PubMed:22609986, PubMed:23762476, PubMed:27084452). Activates effector molecule RhoA by binding and activating RhoGEFs (ARHGEF12/LARG) (PubMed:12515866, PubMed:15240885, PubMed:16202387). GNA12-dependent Rho signaling subsequently regulates transcription factor AP-1 (activating protein-1) (By similarity). GNA12-dependent Rho signaling also regulates protein phosphatese 2A activation causing dephosphorylation of its target proteins (PubMed:15525651, PubMed:17565996). Promotes tumor cell invasion and metastasis by activating RhoA/ROCK signaling pathway and up-regulating pro-inflammatory cytokine production (PubMed:16705036, PubMed:16787920, PubMed:23762476, PubMed:27084452). Inhibits CDH1-mediated cell adhesion in process independent from Rho activation (PubMed:11976333, PubMed:16787920). Together with NAPA promotes CDH5 localization to plasma membrane (PubMed:15980433). May play a role in the control of cell migration through the TOR signaling cascade (PubMed:22609986). {ECO:0000250|UniProtKB:P27600, ECO:0000269|PubMed:11976333, ECO:0000269|PubMed:12515866, ECO:0000269|PubMed:15240885, ECO:0000269|PubMed:15525651, ECO:0000269|PubMed:15980433, ECO:0000269|PubMed:16705036, ECO:0000269|PubMed:16787920, ECO:0000269|PubMed:17565996, ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:23762476, ECO:0000269|PubMed:27084452}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems (PubMed:12515866, PubMed:15240885, PubMed:15525651, PubMed:16705036, PubMed:16787920, PubMed:17565996, PubMed:22609986, PubMed:23762476, PubMed:27084452). Activates effector molecule RhoA by binding and activating RhoGEFs (ARHGEF12/LARG) (PubMed:12515866, PubMed:15240885, PubMed:16202387). GNA12-dependent Rho signaling subsequently regulates transcription factor AP-1 (activating protein-1) (By similarity). GNA12-dependent Rho signaling also regulates protein phosphatese 2A activation causing dephosphorylation of its target proteins (PubMed:15525651, PubMed:17565996). Promotes tumor cell invasion and metastasis by activating RhoA/ROCK signaling pathway and up-regulating pro-inflammatory cytokine production (PubMed:16705036, PubMed:16787920, PubMed:23762476, PubMed:27084452). Inhibits CDH1-mediated cell adhesion in process independent from Rho activation (PubMed:11976333, PubMed:16787920). Together with NAPA promotes CDH5 localization to plasma membrane (PubMed:15980433). May play a role in the control of cell migration through the TOR signaling cascade (PubMed:22609986). {ECO:0000250|UniProtKB:P27600, ECO:0000269|PubMed:11976333, ECO:0000269|PubMed:12515866, ECO:0000269|PubMed:15240885, ECO:0000269|PubMed:15525651, ECO:0000269|PubMed:15980433, ECO:0000269|PubMed:16705036, ECO:0000269|PubMed:16787920, ECO:0000269|PubMed:17565996, ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:23762476, ECO:0000269|PubMed:27084452}.",
      "PTMs": {},
      "fc_color_1": [
        240,
        244,
        248
      ],
      "fold_change_1": -0.117244,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        245,
        248,
        251
      ],
      "fold_change_2": -0.0726466,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        226
      ],
      "fold_change_3": 0.284716,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        249
      ],
      "fold_change_4": 0.0542333,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        239,
        244,
        248
      ],
      "fold_change_5": -0.123692,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9UBI6": {
      "label": "GBG12",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.",
      "PTMs": {},
      "fc_color_1": [
        192,
        211,
        228
      ],
      "fold_change_1": -0.497546,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        254,
        252
      ],
      "fold_change_2": 0.0232425,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        244,
        248,
        250
      ],
      "fold_change_3": -0.0799081,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        242,
        222
      ],
      "fold_change_4": 0.331188,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        209,
        223,
        236
      ],
      "fold_change_5": -0.361866,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P62993": {
      "label": "GRB2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Non-enzymatic adapter protein that plays a pivotal role in precisely regulated signaling cascades from cell surface receptors to cellular responses, including signaling transduction and gene expression (PubMed:11726515, PubMed:37626338). Thus, participates in many biological processes including regulation of innate and adaptive immunity, autophagy, DNA repair or necroptosis (PubMed:35831301, PubMed:37626338, PubMed:38182563). Controls signaling complexes at the T-cell antigen receptor to facilitate the activation, differentiation, and function of T-cells (PubMed:36864087, PubMed:9489702). Mechanistically, engagement of the TCR leads to phosphorylation of the adapter protein LAT, which serves as docking site for GRB2 (PubMed:9489702). In turn, GRB2 establishes a a connection with SOS1 that acts as a guanine nucleotide exchange factor and serves as a critical regulator of KRAS/RAF1 leading to MAPKs translocation to the nucleus and activation (PubMed:12171928, PubMed:25870599). Functions also a role in B-cell activation by amplifying Ca(2+) mobilization and activation of the ERK MAP kinase pathway upon recruitment to the phosphorylated B-cell antigen receptor (BCR) (PubMed:25413232, PubMed:29523808). Plays a role in switching between autophagy and programmed necrosis upstream of EGFR by interacting with components of necrosomes including RIPK1 and with autophagy regulators SQSTM1 and BECN1 (PubMed:35831301, PubMed:38182563). Regulates miRNA biogenesis by forming a functional ternary complex with AGO2 and DICER1 (PubMed:37328606). Functions in the replication stress response by protecting DNA at stalled replication forks from MRE11-mediated degradation. Mechanistically, inhibits RAD51 ATPase activity to stabilize RAD51 on stalled replication forks (PubMed:38459011). Additionally, directly recruits and later releases MRE11 at DNA damage sites during the homology-directed repair (HDR) process (PubMed:34348893). {ECO:0000269|PubMed:11726515, ECO:0000269|PubMed:12171928, ECO:0000269|PubMed:1322798, ECO:0000269|PubMed:19815557, ECO:0000269|PubMed:25413232, ECO:0000269|PubMed:25870599, ECO:0000269|PubMed:29523808, ECO:0000269|PubMed:34348893, ECO:0000269|PubMed:35831301, ECO:0000269|PubMed:36864087, ECO:0000269|PubMed:37328606, ECO:0000269|PubMed:37626338, ECO:0000269|PubMed:38182563, ECO:0000269|PubMed:38459011, ECO:0000269|PubMed:9489702}.; FUNCTION: [Isoform 2]: Does not bind to phosphorylated epidermal growth factor receptor (EGFR) but inhibits EGF-induced transactivation of a RAS-responsive element. Acts as a dominant negative protein over GRB2 and by suppressing proliferative signals, may trigger active programmed cell death. Mechanistically, inhibits RAS-ERK signaling and downstream cell proliferation by competing with GRB2 for SOS1 binding and thus by regulating SOS1 membrane recruitment (PubMed:36171279). {ECO:0000269|PubMed:36171279, ECO:0000269|PubMed:8178156}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Non-enzymatic adapter protein that plays a pivotal role in precisely regulated signaling cascades from cell surface receptors to cellular responses, including signaling transduction and gene expression (PubMed:11726515, PubMed:37626338). Thus, participates in many biological processes including regulation of innate and adaptive immunity, autophagy, DNA repair or necroptosis (PubMed:35831301, PubMed:37626338, PubMed:38182563). Controls signaling complexes at the T-cell antigen receptor to facilitate the activation, differentiation, and function of T-cells (PubMed:36864087, PubMed:9489702). Mechanistically, engagement of the TCR leads to phosphorylation of the adapter protein LAT, which serves as docking site for GRB2 (PubMed:9489702). In turn, GRB2 establishes a a connection with SOS1 that acts as a guanine nucleotide exchange factor and serves as a critical regulator of KRAS/RAF1 leading to MAPKs translocation to the nucleus and activation (PubMed:12171928, PubMed:25870599). Functions also a role in B-cell activation by amplifying Ca(2+) mobilization and activation of the ERK MAP kinase pathway upon recruitment to the phosphorylated B-cell antigen receptor (BCR) (PubMed:25413232, PubMed:29523808). Plays a role in switching between autophagy and programmed necrosis upstream of EGFR by interacting with components of necrosomes including RIPK1 and with autophagy regulators SQSTM1 and BECN1 (PubMed:35831301, PubMed:38182563). Regulates miRNA biogenesis by forming a functional ternary complex with AGO2 and DICER1 (PubMed:37328606). Functions in the replication stress response by protecting DNA at stalled replication forks from MRE11-mediated degradation. Mechanistically, inhibits RAD51 ATPase activity to stabilize RAD51 on stalled replication forks (PubMed:38459011). Additionally, directly recruits and later releases MRE11 at DNA damage sites during the homology-directed repair (HDR) process (PubMed:34348893). {ECO:0000269|PubMed:11726515, ECO:0000269|PubMed:12171928, ECO:0000269|PubMed:1322798, ECO:0000269|PubMed:19815557, ECO:0000269|PubMed:25413232, ECO:0000269|PubMed:25870599, ECO:0000269|PubMed:29523808, ECO:0000269|PubMed:34348893, ECO:0000269|PubMed:35831301, ECO:0000269|PubMed:36864087, ECO:0000269|PubMed:37328606, ECO:0000269|PubMed:37626338, ECO:0000269|PubMed:38182563, ECO:0000269|PubMed:38459011, ECO:0000269|PubMed:9489702}.; FUNCTION: [Isoform 2]: Does not bind to phosphorylated epidermal growth factor receptor (EGFR) but inhibits EGF-induced transactivation of a RAS-responsive element. Acts as a dominant negative protein over GRB2 and by suppressing proliferative signals, may trigger active programmed cell death. Mechanistically, inhibits RAS-ERK signaling and downstream cell proliferation by competing with GRB2 for SOS1 binding and thus by regulating SOS1 membrane recruitment (PubMed:36171279). {ECO:0000269|PubMed:36171279, ECO:0000269|PubMed:8178156}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Non-enzymatic adapter protein that plays a pivotal role in precisely regulated signaling cascades from cell surface receptors to cellular responses, including signaling transduction and gene expression (PubMed:11726515, PubMed:37626338). Thus, participates in many biological processes including regulation of innate and adaptive immunity, autophagy, DNA repair or necroptosis (PubMed:35831301, PubMed:37626338, PubMed:38182563). Controls signaling complexes at the T-cell antigen receptor to facilitate the activation, differentiation, and function of T-cells (PubMed:36864087, PubMed:9489702). Mechanistically, engagement of the TCR leads to phosphorylation of the adapter protein LAT, which serves as docking site for GRB2 (PubMed:9489702). In turn, GRB2 establishes a a connection with SOS1 that acts as a guanine nucleotide exchange factor and serves as a critical regulator of KRAS/RAF1 leading to MAPKs translocation to the nucleus and activation (PubMed:12171928, PubMed:25870599). Functions also a role in B-cell activation by amplifying Ca(2+) mobilization and activation of the ERK MAP kinase pathway upon recruitment to the phosphorylated B-cell antigen receptor (BCR) (PubMed:25413232, PubMed:29523808). Plays a role in switching between autophagy and programmed necrosis upstream of EGFR by interacting with components of necrosomes including RIPK1 and with autophagy regulators SQSTM1 and BECN1 (PubMed:35831301, PubMed:38182563). Regulates miRNA biogenesis by forming a functional ternary complex with AGO2 and DICER1 (PubMed:37328606). Functions in the replication stress response by protecting DNA at stalled replication forks from MRE11-mediated degradation. Mechanistically, inhibits RAD51 ATPase activity to stabilize RAD51 on stalled replication forks (PubMed:38459011). Additionally, directly recruits and later releases MRE11 at DNA damage sites during the homology-directed repair (HDR) process (PubMed:34348893). {ECO:0000269|PubMed:11726515, ECO:0000269|PubMed:12171928, ECO:0000269|PubMed:1322798, ECO:0000269|PubMed:19815557, ECO:0000269|PubMed:25413232, ECO:0000269|PubMed:25870599, ECO:0000269|PubMed:29523808, ECO:0000269|PubMed:34348893, ECO:0000269|PubMed:35831301, ECO:0000269|PubMed:36864087, ECO:0000269|PubMed:37328606, ECO:0000269|PubMed:37626338, ECO:0000269|PubMed:38182563, ECO:0000269|PubMed:38459011, ECO:0000269|PubMed:9489702}.; FUNCTION: [Isoform 2]: Does not bind to phosphorylated epidermal growth factor receptor (EGFR) but inhibits EGF-induced transactivation of a RAS-responsive element. Acts as a dominant negative protein over GRB2 and by suppressing proliferative signals, may trigger active programmed cell death. Mechanistically, inhibits RAS-ERK signaling and downstream cell proliferation by competing with GRB2 for SOS1 binding and thus by regulating SOS1 membrane recruitment (PubMed:36171279). {ECO:0000269|PubMed:36171279, ECO:0000269|PubMed:8178156}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        229,
        187
      ],
      "fold_change_1": 0.678212,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        222,
        171
      ],
      "fold_change_2": 0.842639,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        247,
        236
      ],
      "fold_change_3": 0.190784,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        248,
        237
      ],
      "fold_change_4": 0.179664,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        240,
        217
      ],
      "fold_change_5": 0.372525,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P00533": {
      "label": "EGFR",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:10805725, PubMed:27153536, PubMed:2790960, PubMed:35538033). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:12297049, PubMed:15611079, PubMed:17909029, PubMed:20837704, PubMed:27153536, PubMed:2790960, PubMed:7679104, PubMed:8144591, PubMed:9419975). Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules (PubMed:27153536). May also activate the NF-kappa-B signaling cascade (PubMed:11116146). Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling (PubMed:11602604). Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin (PubMed:11483589). Positively regulates cell migration via interaction with CCDC88A/GIV which retains EGFR at the cell membrane following ligand stimulation, promoting EGFR signaling which triggers cell migration (PubMed:20462955). Plays a role in enhancing learning and memory performance (By similarity). Plays a role in mammalian pain signaling (long-lasting hypersensitivity) (By similarity). {ECO:0000250|UniProtKB:Q01279, ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11116146, ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:11602604, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:12873986, ECO:0000269|PubMed:15374980, ECO:0000269|PubMed:15590694, ECO:0000269|PubMed:15611079, ECO:0000269|PubMed:17115032, ECO:0000269|PubMed:17909029, ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:20462955, ECO:0000269|PubMed:20837704, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:2790960, ECO:0000269|PubMed:35538033, ECO:0000269|PubMed:7679104, ECO:0000269|PubMed:8144591, ECO:0000269|PubMed:9419975}.; FUNCTION: Isoform 2 may act as an antagonist of EGF action.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}.\",\"ACT_SITE 837; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:10805725, PubMed:27153536, PubMed:2790960, PubMed:35538033). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:12297049, PubMed:15611079, PubMed:17909029, PubMed:20837704, PubMed:27153536, PubMed:2790960, PubMed:7679104, PubMed:8144591, PubMed:9419975). Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules (PubMed:27153536). May also activate the NF-kappa-B signaling cascade (PubMed:11116146). Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling (PubMed:11602604). Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin (PubMed:11483589). Positively regulates cell migration via interaction with CCDC88A/GIV which retains EGFR at the cell membrane following ligand stimulation, promoting EGFR signaling which triggers cell migration (PubMed:20462955). Plays a role in enhancing learning and memory performance (By similarity). Plays a role in mammalian pain signaling (long-lasting hypersensitivity) (By similarity). {ECO:0000250|UniProtKB:Q01279, ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11116146, ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:11602604, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:12873986, ECO:0000269|PubMed:15374980, ECO:0000269|PubMed:15590694, ECO:0000269|PubMed:15611079, ECO:0000269|PubMed:17115032, ECO:0000269|PubMed:17909029, ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:20462955, ECO:0000269|PubMed:20837704, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:2790960, ECO:0000269|PubMed:35538033, ECO:0000269|PubMed:7679104, ECO:0000269|PubMed:8144591, ECO:0000269|PubMed:9419975}.; FUNCTION: Isoform 2 may act as an antagonist of EGF action.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}.\nT: Active site: ACT_SITE 837; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:10805725, PubMed:27153536, PubMed:2790960, PubMed:35538033). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:12297049, PubMed:15611079, PubMed:17909029, PubMed:20837704, PubMed:27153536, PubMed:2790960, PubMed:7679104, PubMed:8144591, PubMed:9419975). Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules (PubMed:27153536). May also activate the NF-kappa-B signaling cascade (PubMed:11116146). Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling (PubMed:11602604). Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin (PubMed:11483589). Positively regulates cell migration via interaction with CCDC88A/GIV which retains EGFR at the cell membrane following ligand stimulation, promoting EGFR signaling which triggers cell migration (PubMed:20462955). Plays a role in enhancing learning and memory performance (By similarity). Plays a role in mammalian pain signaling (long-lasting hypersensitivity) (By similarity). {ECO:0000250|UniProtKB:Q01279, ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11116146, ECO:0000269|PubMed:11483589, ECO:0000269|PubMed:11602604, ECO:0000269|PubMed:12297049, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:12873986, ECO:0000269|PubMed:15374980, ECO:0000269|PubMed:15590694, ECO:0000269|PubMed:15611079, ECO:0000269|PubMed:17115032, ECO:0000269|PubMed:17909029, ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:20462955, ECO:0000269|PubMed:20837704, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:2790960, ECO:0000269|PubMed:35538033, ECO:0000269|PubMed:7679104, ECO:0000269|PubMed:8144591, ECO:0000269|PubMed:9419975}.; FUNCTION: Isoform 2 may act as an antagonist of EGF action.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}.<br/><strong>T: Active site:</strong> ACT_SITE 837; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028&quot;",
      "PTMs": {
        "P00533_693": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P00533",
          "fc_color_1": [
            254,
            223,
            172
          ],
          "label": "693",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_2",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "x",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.ELVEPLT#PSGEAPNQALLR.I\nPSP: ON_FUNCTION: receptor internalization, induced; molecular association, regulation; receptor recycling, induced; receptor internalization, altered; activity, inhibited; phosphorylation\nPSP: ON_PROCESS: cell cycle regulation; signaling pathway regulation\nPSP: ON_PROT_INTERACT: EGF(INDUCES)\nPSP: NOTES: regulates phosphorylation of downstream proteins and recycling of FGFR2\nPSP: in_vivo_kinases: PKG2\nPSP: in_vitro_kinases: ERK1; P38A; ERK2",
          "tooltip_html": "<strong>T: sequence:</strong> R.ELVEPLT#PSGEAPNQALLR.I<br/><strong>PSP: ON_FUNCTION:</strong> receptor internalization, induced; molecular association, regulation; receptor recycling, induced; receptor internalization, altered; activity, inhibited; phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; signaling pathway regulation<br/><strong>PSP: ON_PROT_INTERACT:</strong> EGF(INDUCES)<br/><strong>PSP: NOTES:</strong> regulates phosphorylation of downstream proteins and recycling of FGFR2<br/><strong>PSP: in_vivo_kinases:</strong> PKG2<br/><strong>PSP: in_vitro_kinases:</strong> ERK1; P38A; ERK2",
          "fold_change_1": 0.829369,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            231,
            194
          ],
          "fold_change_2": 0.606731,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            252,
            247
          ],
          "fold_change_3": 0.076581,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            245,
            230
          ],
          "fold_change_4": 0.24952,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            251,
            245
          ],
          "fold_change_5": 0.090865,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 206.2,
          "shape_y": 298.5,
          "label_x": 201.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 205.89999999999998,
          "symbol_y": 298.5
        },
        "P00533_1026": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P00533",
          "fc_color_1": [
            254,
            254,
            253
          ],
          "label": "1026",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_2",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "x",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.ALM*DEEDM*DDVVDADEYLIPQQGFFSS#PSTSR.T\nPSP: ON_FUNCTION: activity, inhibited\nPSP: in_vitro_kinases: CDK1",
          "tooltip_html": "<strong>T: sequence:</strong> R.ALM*DEEDM*DDVVDADEYLIPQQGFFSS#PSTSR.T<br/><strong>PSP: ON_FUNCTION:</strong> activity, inhibited<br/><strong>PSP: in_vitro_kinases:</strong> CDK1",
          "fold_change_1": 0.0106025,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            253,
            249
          ],
          "fold_change_2": 0.051656,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            251,
            252,
            253
          ],
          "fold_change_3": -0.0256249,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            250,
            251,
            252
          ],
          "fold_change_4": -0.0383961,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            251,
            245
          ],
          "fold_change_5": 0.10016,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N2",
          "shape_x": 220.0,
          "shape_y": 298.5,
          "label_x": 220.0,
          "label_y": 290.5,
          "label_centering": "center",
          "symbol_x": 219.7,
          "symbol_y": 298.5
        },
        "P00533_1166": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P00533",
          "fc_color_1": [
            254,
            232,
            195
          ],
          "label": "1166",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.GSHQIS#LDNPDYQQDFFPK.E\nPSP: in_vitro_kinases: CAMK2A",
          "tooltip_html": "<strong>T: sequence:</strong> K.GSHQIS#LDNPDYQQDFFPK.E<br/><strong>PSP: in_vitro_kinases:</strong> CAMK2A",
          "fold_change_1": 0.597313,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            231,
            238,
            245
          ],
          "fold_change_2": -0.184984,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            239,
            244,
            248
          ],
          "fold_change_3": -0.122964,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            250,
            242
          ],
          "fold_change_4": 0.121048,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            185,
            207,
            226
          ],
          "fold_change_5": -0.54902,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 233.8,
          "shape_y": 298.5,
          "label_x": 238.8,
          "label_y": 293.5,
          "label_centering": "left",
          "symbol_x": 233.8,
          "symbol_y": 298.5
        }
      },
      "fc_color_1": [
        254,
        250,
        242
      ],
      "fold_change_1": 0.121235,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        246,
        232
      ],
      "fold_change_2": 0.227271,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        242,
        222
      ],
      "fold_change_3": 0.329454,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        238,
        212
      ],
      "fold_change_4": 0.430785,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        238,
        211
      ],
      "fold_change_5": 0.438166,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P29317": {
      "label": "EPHA2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis. {ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:16236711, ECO:0000269|PubMed:18339848, ECO:0000269|PubMed:19573808, ECO:0000269|PubMed:20679435, ECO:0000269|PubMed:20861311, ECO:0000269|PubMed:23358419, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:27385333}.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}.; FUNCTION: Acts as a receptor for human cytomegalovirus (HCMV) to mediate viral entry and fusion in glioblastoma cells. {ECO:0000269|PubMed:37146061}.\",\"ACT_SITE 739; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis. {ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:16236711, ECO:0000269|PubMed:18339848, ECO:0000269|PubMed:19573808, ECO:0000269|PubMed:20679435, ECO:0000269|PubMed:20861311, ECO:0000269|PubMed:23358419, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:27385333}.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}.; FUNCTION: Acts as a receptor for human cytomegalovirus (HCMV) to mediate viral entry and fusion in glioblastoma cells. {ECO:0000269|PubMed:37146061}.\nT: Active site: ACT_SITE 739; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis. {ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:16236711, ECO:0000269|PubMed:18339848, ECO:0000269|PubMed:19573808, ECO:0000269|PubMed:20679435, ECO:0000269|PubMed:20861311, ECO:0000269|PubMed:23358419, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:27385333}.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}.; FUNCTION: Acts as a receptor for human cytomegalovirus (HCMV) to mediate viral entry and fusion in glioblastoma cells. {ECO:0000269|PubMed:37146061}.<br/><strong>T: Active site:</strong> ACT_SITE 739; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028&quot;",
      "PTMs": {
        "P29317_892": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P29317",
          "fc_color_1": [
            245,
            248,
            250
          ],
          "label": "892",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: K.TLADFDPRVS#IR.L\nPSP: ON_PROCESS: signaling pathway regulation\nPSP: NOTES: MEK-ERK-RSK signaling\nPSP: in_vivo_kinases: PKCA; PKCB; PKCZ\nPSP: in_vitro_kinases: PKCA; PKCB; PKCZ",
          "tooltip_html": "<strong>T: sequence:</strong> K.TLADFDPRVS#IR.L<br/><strong>PSP: ON_PROCESS:</strong> signaling pathway regulation<br/><strong>PSP: NOTES:</strong> MEK-ERK-RSK signaling<br/><strong>PSP: in_vivo_kinases:</strong> PKCA; PKCB; PKCZ<br/><strong>PSP: in_vitro_kinases:</strong> PKCA; PKCB; PKCZ",
          "fold_change_1": -0.0770286,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            195,
            214,
            230
          ],
          "fold_change_2": -0.47027,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            200,
            217,
            232
          ],
          "fold_change_3": -0.427005,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            172,
            198,
            220
          ],
          "fold_change_4": -0.653673,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            182,
            204,
            224
          ],
          "fold_change_5": -0.576565,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 206.2,
          "shape_y": 298.5,
          "label_x": 201.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 206.1,
          "symbol_y": 298.5
        },
        "P29317_570": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P29317",
          "fc_color_1": [
            254,
            235,
            205
          ],
          "label": "570",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.ARQS#PEDVYFSK.S",
          "tooltip_html": "<strong>T: sequence:</strong> R.ARQS#PEDVYFSK.S",
          "fold_change_1": 0.500531,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            250,
            242
          ],
          "fold_change_2": 0.123228,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            238,
            211
          ],
          "fold_change_3": 0.43785,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            218,
            159
          ],
          "fold_change_4": 0.958601,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            231,
            194
          ],
          "fold_change_5": 0.611547,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N2",
          "shape_x": 220.0,
          "shape_y": 298.5,
          "label_x": 220.0,
          "label_y": 290.5,
          "label_centering": "center",
          "symbol_x": 220.0,
          "symbol_y": 298.5
        },
        "P29317_901": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P29317",
          "fc_color_1": [
            216,
            228,
            239
          ],
          "label": "901",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.LPSTSGS#EGVPFR.T",
          "tooltip_html": "<strong>T: sequence:</strong> R.LPSTSGS#EGVPFR.T",
          "fold_change_1": -0.302968,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            201,
            217,
            232
          ],
          "fold_change_2": -0.425289,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            243,
            247,
            250
          ],
          "fold_change_3": -0.0901456,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            214,
            227,
            238
          ],
          "fold_change_4": -0.319147,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            244,
            248,
            250
          ],
          "fold_change_5": -0.0799544,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 233.8,
          "shape_y": 298.5,
          "label_x": 238.8,
          "label_y": 293.5,
          "label_centering": "left",
          "symbol_x": 233.8,
          "symbol_y": 298.5
        }
      },
      "fc_color_1": [
        254,
        245,
        230
      ],
      "fold_change_1": 0.249259,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        246,
        232
      ],
      "fold_change_2": 0.221961,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        227
      ],
      "fold_change_3": 0.277088,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        240,
        217
      ],
      "fold_change_4": 0.374092,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        243,
        224
      ],
      "fold_change_5": 0.308839,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P04626": {
      "label": "ERBB2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. {ECO:0000305}.; FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. {ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:15380516, ECO:0000269|PubMed:21555369}.\",\"ACT_SITE 845; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. {ECO:0000305}.; FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. {ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:15380516, ECO:0000269|PubMed:21555369}.\nT: Active site: ACT_SITE 845; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. {ECO:0000305}.; FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5&#x27;-TCAAATTC-3&#x27; sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. {ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:15380516, ECO:0000269|PubMed:21555369}.<br/><strong>T: Active site:</strong> ACT_SITE 845; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028&quot;",
      "PTMs": {
        "P04626_760": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P04626",
          "fc_color_1": [
            82,
            136,
            183
          ],
          "label": "760",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.ENTS#PK.A",
          "tooltip_html": "<strong>T: sequence:</strong> R.ENTS#PK.A",
          "fold_change_1": -1.36197,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            132,
            170,
            203
          ],
          "fold_change_2": -0.971842,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            67,
            125,
            177
          ],
          "fold_change_3": -1.48562,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            53,
            116,
            171
          ],
          "fold_change_4": -1.59631,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            87,
            139,
            185
          ],
          "fold_change_5": -1.32644,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 206.2,
          "shape_y": 298.5,
          "label_x": 201.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 206.2,
          "symbol_y": 298.5
        }
      },
      "fc_color_1": [
        254,
        243,
        223
      ],
      "fold_change_1": 0.315161,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        246,
        232
      ],
      "fold_change_2": 0.224518,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        230,
        190
      ],
      "fold_change_3": 0.650212,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        228,
        185
      ],
      "fold_change_4": 0.703285,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        239,
        214
      ],
      "fold_change_5": 0.406018,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P11362": {
      "label": "FGFR1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation. {ECO:0000250|UniProtKB:P16092, ECO:0000269|PubMed:10830168, ECO:0000269|PubMed:11353842, ECO:0000269|PubMed:12181353, ECO:0000269|PubMed:1379697, ECO:0000269|PubMed:1379698, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:19224897, ECO:0000269|PubMed:19261810, ECO:0000269|PubMed:19665973, ECO:0000269|PubMed:20133753, ECO:0000269|PubMed:20139426, ECO:0000269|PubMed:21765395, ECO:0000269|PubMed:8622701, ECO:0000269|PubMed:8663044}.\",\"ACT_SITE 623; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:19224897\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation. {ECO:0000250|UniProtKB:P16092, ECO:0000269|PubMed:10830168, ECO:0000269|PubMed:11353842, ECO:0000269|PubMed:12181353, ECO:0000269|PubMed:1379697, ECO:0000269|PubMed:1379698, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:19224897, ECO:0000269|PubMed:19261810, ECO:0000269|PubMed:19665973, ECO:0000269|PubMed:20133753, ECO:0000269|PubMed:20139426, ECO:0000269|PubMed:21765395, ECO:0000269|PubMed:8622701, ECO:0000269|PubMed:8663044}.\nT: Active site: ACT_SITE 623; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:19224897\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation. {ECO:0000250|UniProtKB:P16092, ECO:0000269|PubMed:10830168, ECO:0000269|PubMed:11353842, ECO:0000269|PubMed:12181353, ECO:0000269|PubMed:1379697, ECO:0000269|PubMed:1379698, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:19224897, ECO:0000269|PubMed:19261810, ECO:0000269|PubMed:19665973, ECO:0000269|PubMed:20133753, ECO:0000269|PubMed:20139426, ECO:0000269|PubMed:21765395, ECO:0000269|PubMed:8622701, ECO:0000269|PubMed:8663044}.<br/><strong>T: Active site:</strong> ACT_SITE 623; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:19224897&quot;",
      "PTMs": {},
      "fc_color_1": [
        171,
        197,
        220
      ],
      "fold_change_1": -0.663047,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        240,
        245,
        249
      ],
      "fold_change_2": -0.113596,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        252,
        253,
        253
      ],
      "fold_change_3": -0.019814,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        227,
        236,
        243
      ],
      "fold_change_4": -0.213724,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        196,
        214,
        230
      ],
      "fold_change_5": -0.461156,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P22455": {
      "label": "FGFR4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4. Mutations that lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling. {ECO:0000269|PubMed:11433297, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:18670643, ECO:0000269|PubMed:20018895, ECO:0000269|PubMed:20683963, ECO:0000269|PubMed:20798051, ECO:0000269|PubMed:20876804, ECO:0000269|PubMed:21653700, ECO:0000269|PubMed:7518429, ECO:0000269|PubMed:7680645, ECO:0000269|PubMed:8663044}.\",\"ACT_SITE 612; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4. Mutations that lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling. {ECO:0000269|PubMed:11433297, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:18670643, ECO:0000269|PubMed:20018895, ECO:0000269|PubMed:20683963, ECO:0000269|PubMed:20798051, ECO:0000269|PubMed:20876804, ECO:0000269|PubMed:21653700, ECO:0000269|PubMed:7518429, ECO:0000269|PubMed:7680645, ECO:0000269|PubMed:8663044}.\nT: Active site: ACT_SITE 612; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4. Mutations that lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling. {ECO:0000269|PubMed:11433297, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:18670643, ECO:0000269|PubMed:20018895, ECO:0000269|PubMed:20683963, ECO:0000269|PubMed:20798051, ECO:0000269|PubMed:20876804, ECO:0000269|PubMed:21653700, ECO:0000269|PubMed:7518429, ECO:0000269|PubMed:7680645, ECO:0000269|PubMed:8663044}.<br/><strong>T: Active site:</strong> ACT_SITE 612; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028&quot;",
      "PTMs": {
        "P22455_419": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P22455",
          "fc_color_1": [
            254,
            246,
            231
          ],
          "label": "419",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.QFS#LESGSSGK.S",
          "tooltip_html": "<strong>T: sequence:</strong> R.QFS#LESGSSGK.S",
          "fold_change_1": 0.236006,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            240,
            217
          ],
          "fold_change_2": 0.378772,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            251,
            252,
            253
          ],
          "fold_change_3": -0.0278536,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            250,
            243
          ],
          "fold_change_4": 0.110804,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            160,
            189,
            215
          ],
          "fold_change_5": -0.750473,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 206.2,
          "shape_y": 298.5,
          "label_x": 201.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 206.2,
          "symbol_y": 298.5
        },
        "P22455_573": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P22455",
          "fc_color_1": [
            254,
            252,
            248
          ],
          "label": "573",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.RPPGPDLS#PDGPR.S",
          "tooltip_html": "<strong>T: sequence:</strong> R.RPPGPDLS#PDGPR.S",
          "fold_change_1": 0.0682051,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            206,
            128
          ],
          "fold_change_2": 1.27394,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            163,
            192,
            217
          ],
          "fold_change_3": -0.720887,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            243,
            225
          ],
          "fold_change_4": 0.29925,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            213,
            226,
            237
          ],
          "fold_change_5": -0.327276,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N2",
          "shape_x": 220.0,
          "shape_y": 298.5,
          "label_x": 220.0,
          "label_y": 290.5,
          "label_centering": "center",
          "symbol_x": 220.0,
          "symbol_y": 298.5
        }
      },
      "fc_color_1": [
        254,
        254,
        254
      ],
      "fold_change_1": -0.00256801,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        194,
        213,
        229
      ],
      "fold_change_2": -0.481794,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        243,
        225
      ],
      "fold_change_3": 0.29638,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        254,
        254
      ],
      "fold_change_4": -0.00330377,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        249,
        241
      ],
      "fold_change_5": 0.139881,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P08069": {
      "label": "IGF1R",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R.; FUNCTION: When present in a hybrid receptor with INSR, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin.\",\"ACT_SITE 1135; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R.; FUNCTION: When present in a hybrid receptor with INSR, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin.\nT: Active site: ACT_SITE 1135; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R.; FUNCTION: When present in a hybrid receptor with INSR, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin.<br/><strong>T: Active site:</strong> ACT_SITE 1135; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028&quot;",
      "PTMs": {
        "P08069_1339": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P08069",
          "fc_color_1": [
            254,
            235,
            203
          ],
          "label": "1339",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.AS#FDER.Q",
          "tooltip_html": "<strong>T: sequence:</strong> R.AS#FDER.Q",
          "fold_change_1": 0.518506,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            231,
            194
          ],
          "fold_change_2": 0.612492,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            253,
            214,
            149
          ],
          "fold_change_3": 1.05928,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            241,
            220
          ],
          "fold_change_4": 0.344912,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            253,
            179,
            56
          ],
          "fold_change_5": 2.13063,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 206.2,
          "shape_y": 298.5,
          "label_x": 201.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 206.2,
          "symbol_y": 298.5
        }
      },
      "fc_color_1": [
        254,
        243,
        224
      ],
      "fold_change_1": 0.309839,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        253,
        250
      ],
      "fold_change_2": 0.0408008,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        232,
        195
      ],
      "fold_change_3": 0.59961,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        236,
        206
      ],
      "fold_change_4": 0.491661,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        239,
        214
      ],
      "fold_change_5": 0.409206,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P06213": {
      "label": "INSR",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. In adipocytes, inhibits lipolysis (By similarity). {ECO:0000250|UniProtKB:P15208, ECO:0000269|PubMed:12138094, ECO:0000269|PubMed:16314505, ECO:0000269|PubMed:16831875, ECO:0000269|PubMed:8257688, ECO:0000269|PubMed:8276809, ECO:0000269|PubMed:8452530, ECO:0000269|PubMed:9428692}.\",\"ACT_SITE 1159; /note=\"Proton donor/acceptor\"; /evidence=\"ECO:0000269|PubMed:9312016\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. In adipocytes, inhibits lipolysis (By similarity). {ECO:0000250|UniProtKB:P15208, ECO:0000269|PubMed:12138094, ECO:0000269|PubMed:16314505, ECO:0000269|PubMed:16831875, ECO:0000269|PubMed:8257688, ECO:0000269|PubMed:8276809, ECO:0000269|PubMed:8452530, ECO:0000269|PubMed:9428692}.\nT: Active site: ACT_SITE 1159; /note=\"Proton donor/acceptor\"; /evidence=\"ECO:0000269|PubMed:9312016\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. PubMed:12138094 shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, PubMed:16831875 shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. In adipocytes, inhibits lipolysis (By similarity). {ECO:0000250|UniProtKB:P15208, ECO:0000269|PubMed:12138094, ECO:0000269|PubMed:16314505, ECO:0000269|PubMed:16831875, ECO:0000269|PubMed:8257688, ECO:0000269|PubMed:8276809, ECO:0000269|PubMed:8452530, ECO:0000269|PubMed:9428692}.<br/><strong>T: Active site:</strong> ACT_SITE 1159; /note=&quot;Proton donor/acceptor&quot;; /evidence=&quot;ECO:0000269|PubMed:9312016&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        244,
        228
      ],
      "fold_change_1": 0.270391,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        237,
        209
      ],
      "fold_change_2": 0.459317,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        234,
        201
      ],
      "fold_change_3": 0.538714,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        238,
        211
      ],
      "fold_change_4": 0.43751,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        249,
        241
      ],
      "fold_change_5": 0.132614,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9BXT2": {
      "label": "CCG6",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit. {ECO:0000269|PubMed:21127204}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit. {ECO:0000269|PubMed:21127204}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit. {ECO:0000269|PubMed:21127204}.",
      "PTMs": {},
      "fc_color_1": [
        191,
        211,
        228
      ],
      "fold_change_1": -0.50512,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        204,
        219,
        233
      ],
      "fold_change_2": -0.40297,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        253,
        250
      ],
      "fold_change_3": 0.0431728,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        202,
        218,
        233
      ],
      "fold_change_4": -0.416099,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        241,
        245,
        249
      ],
      "fold_change_5": -0.109581,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P54289": {
      "label": "CA2D1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity). {ECO:0000250, ECO:0000269|PubMed:35293990}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity). {ECO:0000250, ECO:0000269|PubMed:35293990}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity). {ECO:0000250, ECO:0000269|PubMed:35293990}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        252,
        247
      ],
      "fold_change_1": 0.0726278,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        246,
        233
      ],
      "fold_change_2": 0.212442,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        237,
        210
      ],
      "fold_change_3": 0.451396,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        234,
        201
      ],
      "fold_change_4": 0.533698,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        245,
        229
      ],
      "fold_change_5": 0.253633,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_62": {
      "label": "NR4A1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q13164": {
      "label": "MK07",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of STUB1-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction. {ECO:0000250|UniProtKB:P0C865, ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:11278431, ECO:0000269|PubMed:22869143, ECO:0000269|PubMed:9384584, ECO:0000269|PubMed:9790194}.\",\"ACT_SITE 182; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of STUB1-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction. {ECO:0000250|UniProtKB:P0C865, ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:11278431, ECO:0000269|PubMed:22869143, ECO:0000269|PubMed:9384584, ECO:0000269|PubMed:9790194}.\nT: Active site: ACT_SITE 182; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of STUB1-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction. {ECO:0000250|UniProtKB:P0C865, ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:11278431, ECO:0000269|PubMed:22869143, ECO:0000269|PubMed:9384584, ECO:0000269|PubMed:9790194}.<br/><strong>T: Active site:</strong> ACT_SITE 182; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        228,
        186
      ],
      "fold_change_1": 0.693148,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        254,
        252
      ],
      "fold_change_2": 0.0212016,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        226
      ],
      "fold_change_3": 0.288429,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        248
      ],
      "fold_change_4": 0.0681703,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        242,
        223
      ],
      "fold_change_5": 0.31949,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q13163": {
      "label": "MP2K5",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). {ECO:0000250|UniProtKB:Q62862, ECO:0000269|PubMed:7759517, ECO:0000269|PubMed:9384584}.\",\"ACT_SITE 283; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). {ECO:0000250|UniProtKB:Q62862, ECO:0000269|PubMed:7759517, ECO:0000269|PubMed:9384584}.\nT: Active site: ACT_SITE 283; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). {ECO:0000250|UniProtKB:Q62862, ECO:0000269|PubMed:7759517, ECO:0000269|PubMed:9384584}.<br/><strong>T: Active site:</strong> ACT_SITE 283; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        245,
        229
      ],
      "fold_change_1": 0.254651,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        171,
        197,
        220
      ],
      "fold_change_2": -0.658505,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        247,
        234
      ],
      "fold_change_3": 0.206235,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        244,
        227
      ],
      "fold_change_4": 0.279294,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        188,
        209,
        227
      ],
      "fold_change_5": -0.521871,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_65": {
      "label": "NLK",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_66": {
      "label": "CDC25B",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O75676": {
      "label": "KS6A4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. {ECO:0000269|PubMed:11035004, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:9792677}.\",\"ACT_SITE 161; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 530; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. {ECO:0000269|PubMed:11035004, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:9792677}.\nT: Active site: ACT_SITE 161; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 530; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates &#x27;Ser-10&#x27; of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate &#x27;Ser-28&#x27; of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. {ECO:0000269|PubMed:11035004, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:9792677}.<br/><strong>T: Active site:</strong> ACT_SITE 161; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;; ACT_SITE 530; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;",
      "PTMs": {},
      "fc_color_1": [
        252,
        253,
        253
      ],
      "fold_change_1": -0.0202096,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        240,
        217
      ],
      "fold_change_2": 0.373242,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        253,
        250
      ],
      "fold_change_3": 0.0494268,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        249,
        241
      ],
      "fold_change_4": 0.140194,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        243,
        225
      ],
      "fold_change_5": 0.296769,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O75582": {
      "label": "KS6A5",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes (PubMed:11909979, PubMed:12569367, PubMed:12763138, PubMed:18511904, PubMed:9687510, PubMed:9873047). Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin (PubMed:11909979, PubMed:9873047). Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression (PubMed:12628924, PubMed:18511904). In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress (PubMed:12628924). In erythropoietin-stimulated cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its transcriptional potential (PubMed:12763138). Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation (PubMed:12569367). Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A (PubMed:15010469). Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:12773393). May also phosphorylate 'Ser-28' of histone H3 (PubMed:12773393). Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14) (PubMed:12773393). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines (By similarity). Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors (By similarity). Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury (By similarity). Phosphorylates TRIM7 at 'Ser-107' in response to growth factor signaling via the MEK/ERK pathway, thereby stimulating its ubiquitin ligase activity (PubMed:25851810). {ECO:0000250|UniProtKB:Q8C050, ECO:0000269|PubMed:11909979, ECO:0000269|PubMed:12569367, ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:18511904, ECO:0000269|PubMed:25851810, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047}.\",\"ACT_SITE 177; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 544; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes (PubMed:11909979, PubMed:12569367, PubMed:12763138, PubMed:18511904, PubMed:9687510, PubMed:9873047). Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin (PubMed:11909979, PubMed:9873047). Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression (PubMed:12628924, PubMed:18511904). In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress (PubMed:12628924). In erythropoietin-stimulated cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its transcriptional potential (PubMed:12763138). Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation (PubMed:12569367). Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A (PubMed:15010469). Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:12773393). May also phosphorylate 'Ser-28' of histone H3 (PubMed:12773393). Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14) (PubMed:12773393). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines (By similarity). Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors (By similarity). Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury (By similarity). Phosphorylates TRIM7 at 'Ser-107' in response to growth factor signaling via the MEK/ERK pathway, thereby stimulating its ubiquitin ligase activity (PubMed:25851810). {ECO:0000250|UniProtKB:Q8C050, ECO:0000269|PubMed:11909979, ECO:0000269|PubMed:12569367, ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:18511904, ECO:0000269|PubMed:25851810, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047}.\nT: Active site: ACT_SITE 177; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 544; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes (PubMed:11909979, PubMed:12569367, PubMed:12763138, PubMed:18511904, PubMed:9687510, PubMed:9873047). Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin (PubMed:11909979, PubMed:9873047). Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression (PubMed:12628924, PubMed:18511904). In skeletal myoblasts is required for phosphorylation of RELA at &#x27;Ser-276&#x27; during oxidative stress (PubMed:12628924). In erythropoietin-stimulated cells, is necessary for the &#x27;Ser-727&#x27; phosphorylation of STAT3 and regulation of its transcriptional potential (PubMed:12763138). Phosphorylates ETV1/ER81 at &#x27;Ser-191&#x27; and &#x27;Ser-216&#x27;, and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation (PubMed:12569367). Directly represses transcription via phosphorylation of &#x27;Ser-1&#x27; of histone H2A (PubMed:15010469). Phosphorylates &#x27;Ser-10&#x27; of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:12773393). May also phosphorylate &#x27;Ser-28&#x27; of histone H3 (PubMed:12773393). Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14) (PubMed:12773393). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines (By similarity). Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors (By similarity). Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury (By similarity). Phosphorylates TRIM7 at &#x27;Ser-107&#x27; in response to growth factor signaling via the MEK/ERK pathway, thereby stimulating its ubiquitin ligase activity (PubMed:25851810). {ECO:0000250|UniProtKB:Q8C050, ECO:0000269|PubMed:11909979, ECO:0000269|PubMed:12569367, ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:18511904, ECO:0000269|PubMed:25851810, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047}.<br/><strong>T: Active site:</strong> ACT_SITE 177; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;; ACT_SITE 544; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        247,
        234
      ],
      "fold_change_1": 0.201544,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        227,
        184
      ],
      "fold_change_2": 0.71184,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        249,
        240
      ],
      "fold_change_3": 0.148437,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        249,
        240
      ],
      "fold_change_4": 0.150073,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        244,
        226
      ],
      "fold_change_5": 0.285338,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P49137": {
      "label": "MAPK2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Stress-activated serine/threonine-protein kinase involved in cytokine production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the interaction with HSP90 proteins and inhibiting HSF1 homotrimerization, DNA-binding and transactivation activities (PubMed:16278218). Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to the dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impairment of their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to the regulation of the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity, leading to inhibition of dependent degradation of ARE-containing transcripts. Phosphorylates CEP131 in response to cellular stress induced by ultraviolet irradiation which promotes binding of CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar satellites (PubMed:26616734). Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilization of GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:11844797, ECO:0000269|PubMed:12456657, ECO:0000269|PubMed:12565831, ECO:0000269|PubMed:14499342, ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:15629715, ECO:0000269|PubMed:16278218, ECO:0000269|PubMed:16456544, ECO:0000269|PubMed:17481585, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:26616734, ECO:0000269|PubMed:8093612, ECO:0000269|PubMed:8280084, ECO:0000269|PubMed:8774846}.\",\"ACT_SITE 186; /note=\"Proton acceptor\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Stress-activated serine/threonine-protein kinase involved in cytokine production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the interaction with HSP90 proteins and inhibiting HSF1 homotrimerization, DNA-binding and transactivation activities (PubMed:16278218). Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to the dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impairment of their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to the regulation of the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity, leading to inhibition of dependent degradation of ARE-containing transcripts. Phosphorylates CEP131 in response to cellular stress induced by ultraviolet irradiation which promotes binding of CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar satellites (PubMed:26616734). Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilization of GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:11844797, ECO:0000269|PubMed:12456657, ECO:0000269|PubMed:12565831, ECO:0000269|PubMed:14499342, ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:15629715, ECO:0000269|PubMed:16278218, ECO:0000269|PubMed:16456544, ECO:0000269|PubMed:17481585, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:26616734, ECO:0000269|PubMed:8093612, ECO:0000269|PubMed:8280084, ECO:0000269|PubMed:8774846}.\nT: Active site: ACT_SITE 186; /note=\"Proton acceptor\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Stress-activated serine/threonine-protein kinase involved in cytokine production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the interaction with HSP90 proteins and inhibiting HSF1 homotrimerization, DNA-binding and transactivation activities (PubMed:16278218). Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to the dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impairment of their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to the regulation of the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity, leading to inhibition of dependent degradation of ARE-containing transcripts. Phosphorylates CEP131 in response to cellular stress induced by ultraviolet irradiation which promotes binding of CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar satellites (PubMed:26616734). Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilization of GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:11844797, ECO:0000269|PubMed:12456657, ECO:0000269|PubMed:12565831, ECO:0000269|PubMed:14499342, ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:15629715, ECO:0000269|PubMed:16278218, ECO:0000269|PubMed:16456544, ECO:0000269|PubMed:17481585, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:26616734, ECO:0000269|PubMed:8093612, ECO:0000269|PubMed:8280084, ECO:0000269|PubMed:8774846}.<br/><strong>T: Active site:</strong> ACT_SITE 186; /note=&quot;Proton acceptor&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        239,
        214
      ],
      "fold_change_1": 0.409808,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        226,
        180
      ],
      "fold_change_2": 0.746144,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        237,
        209
      ],
      "fold_change_3": 0.46142,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        242,
        222
      ],
      "fold_change_4": 0.325144,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        230,
        191
      ],
      "fold_change_5": 0.639248,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_69": {
      "label": "ATF4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_70": {
      "label": "MEF2C",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P61244": {
      "label": "MAX",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5'-CAC[GA]TG-3'. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 'Lys-9' histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements. {ECO:0000269|PubMed:26070438}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5'-CAC[GA]TG-3'. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 'Lys-9' histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements. {ECO:0000269|PubMed:26070438}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5&#x27;-CAC[GA]TG-3&#x27;. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 &#x27;Lys-9&#x27; histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements. {ECO:0000269|PubMed:26070438}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        237,
        207
      ],
      "fold_change_1": 0.473254,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        253,
        254
      ],
      "fold_change_2": -0.0149193,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        224,
        174
      ],
      "fold_change_3": 0.811589,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        240,
        244,
        248
      ],
      "fold_change_4": -0.118301,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        249,
        239
      ],
      "fold_change_5": 0.151395,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P35638": {
      "label": "DDIT3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Multifunctional transcription factor in endoplasmic reticulum (ER) stress response (PubMed:15322075, PubMed:15775988, PubMed:19672300). Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress (PubMed:15322075, PubMed:15775988). Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes (By similarity). Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes (By similarity). Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L (PubMed:15775988, PubMed:17709599, PubMed:20876114, PubMed:22761832). Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:18940792, PubMed:19672300, PubMed:20829347). Together with ATF4, mediates ER-mediated cell death by promoting expression of genes involved in cellular amino acid metabolic processes, mRNA translation and the unfolded protein response (UPR) in response to ER stress (By similarity). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity (PubMed:16434966). Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response (By similarity). Acts as a major regulator of postnatal neovascularization through regulation of endothelial nitric oxide synthase (NOS3)-related signaling (By similarity). {ECO:0000250|UniProtKB:P35639, ECO:0000269|PubMed:15322075, ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:16434966, ECO:0000269|PubMed:17709599, ECO:0000269|PubMed:18940792, ECO:0000269|PubMed:19672300, ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:20876114, ECO:0000269|PubMed:22761832}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Multifunctional transcription factor in endoplasmic reticulum (ER) stress response (PubMed:15322075, PubMed:15775988, PubMed:19672300). Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress (PubMed:15322075, PubMed:15775988). Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes (By similarity). Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes (By similarity). Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L (PubMed:15775988, PubMed:17709599, PubMed:20876114, PubMed:22761832). Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:18940792, PubMed:19672300, PubMed:20829347). Together with ATF4, mediates ER-mediated cell death by promoting expression of genes involved in cellular amino acid metabolic processes, mRNA translation and the unfolded protein response (UPR) in response to ER stress (By similarity). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity (PubMed:16434966). Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response (By similarity). Acts as a major regulator of postnatal neovascularization through regulation of endothelial nitric oxide synthase (NOS3)-related signaling (By similarity). {ECO:0000250|UniProtKB:P35639, ECO:0000269|PubMed:15322075, ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:16434966, ECO:0000269|PubMed:17709599, ECO:0000269|PubMed:18940792, ECO:0000269|PubMed:19672300, ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:20876114, ECO:0000269|PubMed:22761832}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Multifunctional transcription factor in endoplasmic reticulum (ER) stress response (PubMed:15322075, PubMed:15775988, PubMed:19672300). Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress (PubMed:15322075, PubMed:15775988). Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes (By similarity). Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes (By similarity). Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L (PubMed:15775988, PubMed:17709599, PubMed:20876114, PubMed:22761832). Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:18940792, PubMed:19672300, PubMed:20829347). Together with ATF4, mediates ER-mediated cell death by promoting expression of genes involved in cellular amino acid metabolic processes, mRNA translation and the unfolded protein response (UPR) in response to ER stress (By similarity). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity (PubMed:16434966). Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response (By similarity). Acts as a major regulator of postnatal neovascularization through regulation of endothelial nitric oxide synthase (NOS3)-related signaling (By similarity). {ECO:0000250|UniProtKB:P35639, ECO:0000269|PubMed:15322075, ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:16434966, ECO:0000269|PubMed:17709599, ECO:0000269|PubMed:18940792, ECO:0000269|PubMed:19672300, ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:20876114, ECO:0000269|PubMed:22761832}.",
      "PTMs": {},
      "fc_color_1": [
        188,
        209,
        227
      ],
      "fold_change_1": -0.525652,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        125,
        166,
        201
      ],
      "fold_change_2": -1.02174,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        180,
        203,
        223
      ],
      "fold_change_3": -0.591342,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        167,
        195,
        218
      ],
      "fold_change_4": -0.689031,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        208,
        222,
        235
      ],
      "fold_change_5": -0.369094,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_73": {
      "label": "ELK4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P04637": {
      "label": "P53",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17189187, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:38653238, PubMed:9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed:12524540, PubMed:17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). {ECO:0000269|PubMed:11025664, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:15186775, ECO:0000269|PubMed:15340061, ECO:0000269|PubMed:17189187, ECO:0000269|PubMed:17317671, ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:20673990, ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:22726440, ECO:0000269|PubMed:24051492, ECO:0000269|PubMed:24652652, ECO:0000269|PubMed:35618207, ECO:0000269|PubMed:36634798, ECO:0000269|PubMed:38653238, ECO:0000269|PubMed:9840937}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17189187, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:38653238, PubMed:9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed:12524540, PubMed:17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). {ECO:0000269|PubMed:11025664, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:15186775, ECO:0000269|PubMed:15340061, ECO:0000269|PubMed:17189187, ECO:0000269|PubMed:17317671, ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:20673990, ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:22726440, ECO:0000269|PubMed:24051492, ECO:0000269|PubMed:24652652, ECO:0000269|PubMed:35618207, ECO:0000269|PubMed:36634798, ECO:0000269|PubMed:38653238, ECO:0000269|PubMed:9840937}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17189187, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:38653238, PubMed:9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed:12524540, PubMed:17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). {ECO:0000269|PubMed:11025664, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:15186775, ECO:0000269|PubMed:15340061, ECO:0000269|PubMed:17189187, ECO:0000269|PubMed:17317671, ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:20673990, ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:22726440, ECO:0000269|PubMed:24051492, ECO:0000269|PubMed:24652652, ECO:0000269|PubMed:35618207, ECO:0000269|PubMed:36634798, ECO:0000269|PubMed:38653238, ECO:0000269|PubMed:9840937}.",
      "PTMs": {
        "P04637_315": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P04637",
          "fc_color_1": [
            185,
            207,
            226
          ],
          "label": "315",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_3",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: R.ALPNNTSSS#PQPK.K\nPSP: ON_FUNCTION: activity, induced; protein degradation; molecular association, regulation; ubiquitination; intracellular localization; protein conformation; activity, inhibited\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, induced; apoptosis, altered; cell motility, induced; apoptosis, induced; cell motility, inhibited; transcription, induced; transcription, altered; cell growth, induced; apoptosis, inhibited; cell motility, altered; transcription, inhibited; cell growth, altered\nPSP: ON_PROT_INTERACT: PIN1(INDUCES); NFkB-p100(DISRUPTS); p53(DISRUPTS)\nPSP: ON_OTHER_INTERACT: DNA(INDUCES)\nPSP: in_vivo_kinases: AurA; CDK1; NEK2\nPSP: in_vitro_kinases: AurA; CDK1; CDK2; CDK9; NEK2",
          "tooltip_html": "<strong>T: sequence:</strong> R.ALPNNTSSS#PQPK.K<br/><strong>PSP: ON_FUNCTION:</strong> activity, induced; protein degradation; molecular association, regulation; ubiquitination; intracellular localization; protein conformation; activity, inhibited<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, induced; apoptosis, altered; cell motility, induced; apoptosis, induced; cell motility, inhibited; transcription, induced; transcription, altered; cell growth, induced; apoptosis, inhibited; cell motility, altered; transcription, inhibited; cell growth, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> PIN1(INDUCES); NFkB-p100(DISRUPTS); p53(DISRUPTS)<br/><strong>PSP: ON_OTHER_INTERACT:</strong> DNA(INDUCES)<br/><strong>PSP: in_vivo_kinases:</strong> AurA; CDK1; NEK2<br/><strong>PSP: in_vitro_kinases:</strong> AurA; CDK1; CDK2; CDK9; NEK2",
          "fold_change_1": -0.547628,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            233,
            240,
            246
          ],
          "fold_change_2": -0.171053,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            250,
            251,
            253
          ],
          "fold_change_3": -0.0365462,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            243,
            224
          ],
          "fold_change_4": 0.30546,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            240,
            217
          ],
          "fold_change_5": 0.375866,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 900.2,
          "shape_y": 626.5,
          "label_x": 895.2,
          "label_y": 631.5,
          "label_centering": "right",
          "symbol_x": 900.1,
          "symbol_y": 626.5
        }
      },
      "fc_color_1": [
        254,
        249,
        241
      ],
      "fold_change_1": 0.135155,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        243,
        246,
        250
      ],
      "fold_change_2": -0.0930295,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        243,
        246,
        250
      ],
      "fold_change_3": -0.0943761,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        246,
        249,
        251
      ],
      "fold_change_4": -0.0632417,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        249,
        241
      ],
      "fold_change_5": 0.136529,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_75": {
      "label": "ELK1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P15336": {
      "label": "ATF2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro (PubMed:10821277). In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type. {ECO:0000269|PubMed:10821277, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:22304920}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro (PubMed:10821277). In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type. {ECO:0000269|PubMed:10821277, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:22304920}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5&#x27;-TGACGTCA-3&#x27;) or to AP-1 (activator protein 1) consensus sequences (5&#x27;-TGACTCA-3&#x27;). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro (PubMed:10821277). In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type. {ECO:0000269|PubMed:10821277, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:22304920}.",
      "PTMs": {
        "P15336_136": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P15336",
          "fc_color_1": [
            253,
            212,
            143
          ],
          "label": "136",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.IEEPSVVETTHQDS#PLPHPESTTSDEK.E",
          "tooltip_html": "<strong>T: sequence:</strong> K.IEEPSVVETTHQDS#PLPHPESTTSDEK.E",
          "fold_change_1": 1.1229,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            230,
            191
          ],
          "fold_change_2": 0.635134,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            221,
            166
          ],
          "fold_change_3": 0.893674,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            239,
            213
          ],
          "fold_change_4": 0.419931,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            221,
            231,
            241
          ],
          "fold_change_5": -0.266635,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 900.2,
          "shape_y": 558.5,
          "label_x": 895.2,
          "label_y": 553.5,
          "label_centering": "right",
          "symbol_x": 900.2,
          "symbol_y": 558.5
        }
      },
      "fc_color_1": [
        203,
        219,
        233
      ],
      "fold_change_1": -0.404462,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        146,
        180,
        210
      ],
      "fold_change_2": -0.856584,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        245,
        248,
        250
      ],
      "fold_change_3": -0.0764072,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        212,
        225,
        237
      ],
      "fold_change_4": -0.33958,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        158,
        188,
        215
      ],
      "fold_change_5": -0.760922,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q16539": {
      "label": "MK14",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510, PubMed:9792677). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery (PubMed:9687510, PubMed:9792677). On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). MAPK14 also interacts with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53 (PubMed:10747897). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3 (PubMed:17003045). MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9 (PubMed:19893488). Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors (PubMed:16932740). Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17 (PubMed:20188673). Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:9430721, PubMed:9858528). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation (PubMed:11333986). Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation (PubMed:20932473). The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression (PubMed:10943842). Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis. Phosphorylates S100A9 at 'Thr-113' (PubMed:15905572). Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:10747897, ECO:0000269|PubMed:10943842, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:11333986, ECO:0000269|PubMed:15905572, ECO:0000269|PubMed:16932740, ECO:0000269|PubMed:17003045, ECO:0000269|PubMed:17724032, ECO:0000269|PubMed:19893488, ECO:0000269|PubMed:20188673, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:35857590, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9792677, ECO:0000269|PubMed:9858528}.; FUNCTION: (Microbial infection) Activated by phosphorylation by M.tuberculosis EsxA in T-cells leading to inhibition of IFN-gamma production; phosphorylation is apparent within 15 minutes and is inhibited by kinase-specific inhibitors SB203580 and siRNA (PubMed:21586573). {ECO:0000269|PubMed:21586573}.\",\"ACT_SITE 168; /note=\"Proton acceptor\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510, PubMed:9792677). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery (PubMed:9687510, PubMed:9792677). On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). MAPK14 also interacts with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53 (PubMed:10747897). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3 (PubMed:17003045). MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9 (PubMed:19893488). Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors (PubMed:16932740). Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17 (PubMed:20188673). Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:9430721, PubMed:9858528). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation (PubMed:11333986). Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation (PubMed:20932473). The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression (PubMed:10943842). Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis. Phosphorylates S100A9 at 'Thr-113' (PubMed:15905572). Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:10747897, ECO:0000269|PubMed:10943842, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:11333986, ECO:0000269|PubMed:15905572, ECO:0000269|PubMed:16932740, ECO:0000269|PubMed:17003045, ECO:0000269|PubMed:17724032, ECO:0000269|PubMed:19893488, ECO:0000269|PubMed:20188673, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:35857590, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9792677, ECO:0000269|PubMed:9858528}.; FUNCTION: (Microbial infection) Activated by phosphorylation by M.tuberculosis EsxA in T-cells leading to inhibition of IFN-gamma production; phosphorylation is apparent within 15 minutes and is inhibited by kinase-specific inhibitors SB203580 and siRNA (PubMed:21586573). {ECO:0000269|PubMed:21586573}.\nT: Active site: ACT_SITE 168; /note=\"Proton acceptor\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510, PubMed:9792677). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery (PubMed:9687510, PubMed:9792677). On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). MAPK14 also interacts with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53 (PubMed:10747897). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3 (PubMed:17003045). MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9 (PubMed:19893488). Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors (PubMed:16932740). Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17 (PubMed:20188673). Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:9430721, PubMed:9858528). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on &#x27;Ser-10&#x27; (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation (PubMed:11333986). Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation (PubMed:20932473). The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression (PubMed:10943842). Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis. Phosphorylates S100A9 at &#x27;Thr-113&#x27; (PubMed:15905572). Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:10747897, ECO:0000269|PubMed:10943842, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:11333986, ECO:0000269|PubMed:15905572, ECO:0000269|PubMed:16932740, ECO:0000269|PubMed:17003045, ECO:0000269|PubMed:17724032, ECO:0000269|PubMed:19893488, ECO:0000269|PubMed:20188673, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:35857590, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9792677, ECO:0000269|PubMed:9858528}.; FUNCTION: (Microbial infection) Activated by phosphorylation by M.tuberculosis EsxA in T-cells leading to inhibition of IFN-gamma production; phosphorylation is apparent within 15 minutes and is inhibited by kinase-specific inhibitors SB203580 and siRNA (PubMed:21586573). {ECO:0000269|PubMed:21586573}.<br/><strong>T: Active site:</strong> ACT_SITE 168; /note=&quot;Proton acceptor&quot;",
      "PTMs": {
        "Q16539_182": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q16539",
          "fc_color_1": [
            254,
            246,
            232
          ],
          "label": "182",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.HTDDEMTGY#VATR.W\nPSP: DOMAIN: Pkinase\nPSP: ON_FUNCTION: activity, induced; phosphorylation; enzymatic activity, induced\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, induced; apoptosis, altered; carcinogenesis, inhibited; apoptosis, induced; transcription, induced; signaling pathway regulation; autophagy, induced; cell growth, induced; cell motility, altered; cell adhesion, altered; cytoskeletal reorganization; transcription, inhibited\nPSP: ON_PROT_INTERACT: P38A(INDUCES)\nPSP: in_vivo_kinases: MEKK6; MKK4; ASK1; MKK6; MKK3\nPSP: in_vitro_kinases: MKK4; MKK6; MKK3; Ret",
          "tooltip_html": "<strong>T: sequence:</strong> R.HTDDEMTGY#VATR.W<br/><strong>PSP: DOMAIN:</strong> Pkinase<br/><strong>PSP: ON_FUNCTION:</strong> activity, induced; phosphorylation; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, induced; apoptosis, altered; carcinogenesis, inhibited; apoptosis, induced; transcription, induced; signaling pathway regulation; autophagy, induced; cell growth, induced; cell motility, altered; cell adhesion, altered; cytoskeletal reorganization; transcription, inhibited<br/><strong>PSP: ON_PROT_INTERACT:</strong> P38A(INDUCES)<br/><strong>PSP: in_vivo_kinases:</strong> MEKK6; MKK4; ASK1; MKK6; MKK3<br/><strong>PSP: in_vitro_kinases:</strong> MKK4; MKK6; MKK3; Ret",
          "fold_change_1": 0.225453,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            252,
            248
          ],
          "fold_change_2": 0.0664921,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            239,
            215
          ],
          "fold_change_3": 0.395407,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            229,
            237,
            244
          ],
          "fold_change_4": -0.198088,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            244,
            228
          ],
          "fold_change_5": 0.264764,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 749.2,
          "shape_y": 690.5,
          "label_x": 744.2,
          "label_y": 685.5,
          "label_centering": "right",
          "symbol_x": 749.1,
          "symbol_y": 690.0
        }
      },
      "fc_color_1": [
        254,
        221,
        168
      ],
      "fold_change_1": 0.869854,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        220,
        163
      ],
      "fold_change_2": 0.917307,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        236,
        205
      ],
      "fold_change_3": 0.494911,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        235,
        203
      ],
      "fold_change_4": 0.514985,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        225,
        176
      ],
      "fold_change_5": 0.787012,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q15759": {
      "label": "MK11",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors (PubMed:12452429, PubMed:20626350, PubMed:35857590). Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 functions are mostly redundant with those of MAPK14 (PubMed:12452429, PubMed:20626350, PubMed:35857590). Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets (PubMed:12452429, PubMed:20626350). RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Additional examples of p38 MAPK substrates are the FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:15356147, PubMed:9430721). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers (PubMed:10330143, PubMed:15356147, PubMed:9430721). The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). Phosphorylates methyltransferase DOT1L on 'Ser-834', 'Thr-900', 'Ser-902', 'Thr-984', 'Ser-1001', 'Ser-1009' and 'Ser-1104' (PubMed:38270553). {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:15356147, ECO:0000269|PubMed:35857590, ECO:0000269|PubMed:38270553, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:12452429, ECO:0000303|PubMed:20626350}.\",\"ACT_SITE 150; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors (PubMed:12452429, PubMed:20626350, PubMed:35857590). Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 functions are mostly redundant with those of MAPK14 (PubMed:12452429, PubMed:20626350, PubMed:35857590). Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets (PubMed:12452429, PubMed:20626350). RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Additional examples of p38 MAPK substrates are the FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:15356147, PubMed:9430721). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers (PubMed:10330143, PubMed:15356147, PubMed:9430721). The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). Phosphorylates methyltransferase DOT1L on 'Ser-834', 'Thr-900', 'Ser-902', 'Thr-984', 'Ser-1001', 'Ser-1009' and 'Ser-1104' (PubMed:38270553). {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:15356147, ECO:0000269|PubMed:35857590, ECO:0000269|PubMed:38270553, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:12452429, ECO:0000303|PubMed:20626350}.\nT: Active site: ACT_SITE 150; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors (PubMed:12452429, PubMed:20626350, PubMed:35857590). Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 functions are mostly redundant with those of MAPK14 (PubMed:12452429, PubMed:20626350, PubMed:35857590). Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets (PubMed:12452429, PubMed:20626350). RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Additional examples of p38 MAPK substrates are the FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:15356147, PubMed:9430721). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers (PubMed:10330143, PubMed:15356147, PubMed:9430721). The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on &#x27;Ser-10&#x27; (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). Phosphorylates methyltransferase DOT1L on &#x27;Ser-834&#x27;, &#x27;Thr-900&#x27;, &#x27;Ser-902&#x27;, &#x27;Thr-984&#x27;, &#x27;Ser-1001&#x27;, &#x27;Ser-1009&#x27; and &#x27;Ser-1104&#x27; (PubMed:38270553). {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:15356147, ECO:0000269|PubMed:35857590, ECO:0000269|PubMed:38270553, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:12452429, ECO:0000303|PubMed:20626350}.<br/><strong>T: Active site:</strong> ACT_SITE 150; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        237,
        208
      ],
      "fold_change_1": 0.472228,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        216,
        154
      ],
      "fold_change_2": 1.00614,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        240,
        216
      ],
      "fold_change_3": 0.388241,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        247,
        236
      ],
      "fold_change_4": 0.189515,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        245,
        230
      ],
      "fold_change_5": 0.248251,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P53778": {
      "label": "MK12",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK12 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors such as ELK1 and ATF2. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases such as MAPKAPK2, which are activated through phosphorylation and further phosphorylate additional targets. Plays a role in myoblast differentiation and also in the down-regulation of cyclin D1 in response to hypoxia in adrenal cells suggesting MAPK12 may inhibit cell proliferation while promoting differentiation. Phosphorylates DLG1. Following osmotic shock, MAPK12 in the cell nucleus increases its association with nuclear DLG1, thereby causing dissociation of DLG1-SFPQ complexes. This function is independent of its catalytic activity and could affect mRNA processing and/or gene transcription to aid cell adaptation to osmolarity changes in the environment. Regulates UV-induced checkpoint signaling and repair of UV-induced DNA damage and G2 arrest after gamma-radiation exposure. MAPK12 is involved in the regulation of SLC2A1 expression and basal glucose uptake in L6 myotubes; and negatively regulates SLC2A4 expression and contraction-mediated glucose uptake in adult skeletal muscle. C-Jun (JUN) phosphorylation is stimulated by MAPK14 and inhibited by MAPK12, leading to a distinct AP-1 regulation. MAPK12 is required for the normal kinetochore localization of PLK1, prevents chromosomal instability and supports mitotic cell viability. MAPK12-signaling is also positively regulating the expansion of transient amplifying myogenic precursor cells during muscle growth and regeneration. {ECO:0000269|PubMed:10848581, ECO:0000269|PubMed:14592936, ECO:0000269|PubMed:17724032, ECO:0000269|PubMed:20605917, ECO:0000269|PubMed:21172807, ECO:0000269|PubMed:8633070, ECO:0000269|PubMed:9430721}.\",\"ACT_SITE 153; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK12 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors such as ELK1 and ATF2. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases such as MAPKAPK2, which are activated through phosphorylation and further phosphorylate additional targets. Plays a role in myoblast differentiation and also in the down-regulation of cyclin D1 in response to hypoxia in adrenal cells suggesting MAPK12 may inhibit cell proliferation while promoting differentiation. Phosphorylates DLG1. Following osmotic shock, MAPK12 in the cell nucleus increases its association with nuclear DLG1, thereby causing dissociation of DLG1-SFPQ complexes. This function is independent of its catalytic activity and could affect mRNA processing and/or gene transcription to aid cell adaptation to osmolarity changes in the environment. Regulates UV-induced checkpoint signaling and repair of UV-induced DNA damage and G2 arrest after gamma-radiation exposure. MAPK12 is involved in the regulation of SLC2A1 expression and basal glucose uptake in L6 myotubes; and negatively regulates SLC2A4 expression and contraction-mediated glucose uptake in adult skeletal muscle. C-Jun (JUN) phosphorylation is stimulated by MAPK14 and inhibited by MAPK12, leading to a distinct AP-1 regulation. MAPK12 is required for the normal kinetochore localization of PLK1, prevents chromosomal instability and supports mitotic cell viability. MAPK12-signaling is also positively regulating the expansion of transient amplifying myogenic precursor cells during muscle growth and regeneration. {ECO:0000269|PubMed:10848581, ECO:0000269|PubMed:14592936, ECO:0000269|PubMed:17724032, ECO:0000269|PubMed:20605917, ECO:0000269|PubMed:21172807, ECO:0000269|PubMed:8633070, ECO:0000269|PubMed:9430721}.\nT: Active site: ACT_SITE 153; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK12 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors such as ELK1 and ATF2. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases such as MAPKAPK2, which are activated through phosphorylation and further phosphorylate additional targets. Plays a role in myoblast differentiation and also in the down-regulation of cyclin D1 in response to hypoxia in adrenal cells suggesting MAPK12 may inhibit cell proliferation while promoting differentiation. Phosphorylates DLG1. Following osmotic shock, MAPK12 in the cell nucleus increases its association with nuclear DLG1, thereby causing dissociation of DLG1-SFPQ complexes. This function is independent of its catalytic activity and could affect mRNA processing and/or gene transcription to aid cell adaptation to osmolarity changes in the environment. Regulates UV-induced checkpoint signaling and repair of UV-induced DNA damage and G2 arrest after gamma-radiation exposure. MAPK12 is involved in the regulation of SLC2A1 expression and basal glucose uptake in L6 myotubes; and negatively regulates SLC2A4 expression and contraction-mediated glucose uptake in adult skeletal muscle. C-Jun (JUN) phosphorylation is stimulated by MAPK14 and inhibited by MAPK12, leading to a distinct AP-1 regulation. MAPK12 is required for the normal kinetochore localization of PLK1, prevents chromosomal instability and supports mitotic cell viability. MAPK12-signaling is also positively regulating the expansion of transient amplifying myogenic precursor cells during muscle growth and regeneration. {ECO:0000269|PubMed:10848581, ECO:0000269|PubMed:14592936, ECO:0000269|PubMed:17724032, ECO:0000269|PubMed:20605917, ECO:0000269|PubMed:21172807, ECO:0000269|PubMed:8633070, ECO:0000269|PubMed:9430721}.<br/><strong>T: Active site:</strong> ACT_SITE 153; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        233,
        197
      ],
      "fold_change_1": 0.578652,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        229,
        187
      ],
      "fold_change_2": 0.68134,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        226
      ],
      "fold_change_3": 0.282513,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        244,
        226
      ],
      "fold_change_4": 0.282741,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        234,
        201
      ],
      "fold_change_5": 0.541246,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P53041": {
      "label": "PPP5",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein phosphatase that dephosphorylates a myriad of proteins involved in different signaling pathways including the kinases CSNK1E, ASK1/MAP3K5, PRKDC and RAF1, the nuclear receptors NR3C1, PPARG, ESR1 and ESR2, SMAD proteins and TAU/MAPT (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Implicated in wide ranging cellular processes, including apoptosis, differentiation, DNA damage response, cell survival, regulation of ion channels or circadian rhythms, in response to steroid and thyroid hormones, calcium, fatty acids, TGF-beta as well as oxidative and genotoxic stresses (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Participates in the control of DNA damage response mechanisms such as checkpoint activation and DNA damage repair through, for instance, the regulation ATM/ATR-signaling and dephosphorylation of PRKDC and TP53BP1 (PubMed:14871926, PubMed:16260606, PubMed:21144835). Inhibits ASK1/MAP3K5-mediated apoptosis induced by oxidative stress (PubMed:23102700). Plays a positive role in adipogenesis, mainly through the dephosphorylation and activation of PPARG transactivation function (By similarity). Also dephosphorylates and inhibits the anti-adipogenic effect of NR3C1 (By similarity). Regulates the circadian rhythms, through the dephosphorylation and activation of CSNK1E (PubMed:16790549). May modulate TGF-beta signaling pathway by the regulation of SMAD3 phosphorylation and protein expression levels (PubMed:22781750). Dephosphorylates and may play a role in the regulation of TAU/MAPT (PubMed:15546861). Through their dephosphorylation, may play a role in the regulation of ions channels such as KCNH2 (By similarity). Dephosphorylate FNIP1, disrupting interaction with HSP90AA1/Hsp90 (PubMed:30699359). {ECO:0000250|UniProtKB:P53042, ECO:0000250|UniProtKB:Q60676, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:14764652, ECO:0000269|PubMed:14871926, ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15546861, ECO:0000269|PubMed:16260606, ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:19176521, ECO:0000269|PubMed:19948726, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22399290, ECO:0000269|PubMed:22781750, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:30699359, ECO:0000269|PubMed:9000529}.\",\"ACT_SITE 304; /note=\"Proton donor/acceptor\"; /evidence=\"ECO:0000269|PubMed:15155720\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein phosphatase that dephosphorylates a myriad of proteins involved in different signaling pathways including the kinases CSNK1E, ASK1/MAP3K5, PRKDC and RAF1, the nuclear receptors NR3C1, PPARG, ESR1 and ESR2, SMAD proteins and TAU/MAPT (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Implicated in wide ranging cellular processes, including apoptosis, differentiation, DNA damage response, cell survival, regulation of ion channels or circadian rhythms, in response to steroid and thyroid hormones, calcium, fatty acids, TGF-beta as well as oxidative and genotoxic stresses (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Participates in the control of DNA damage response mechanisms such as checkpoint activation and DNA damage repair through, for instance, the regulation ATM/ATR-signaling and dephosphorylation of PRKDC and TP53BP1 (PubMed:14871926, PubMed:16260606, PubMed:21144835). Inhibits ASK1/MAP3K5-mediated apoptosis induced by oxidative stress (PubMed:23102700). Plays a positive role in adipogenesis, mainly through the dephosphorylation and activation of PPARG transactivation function (By similarity). Also dephosphorylates and inhibits the anti-adipogenic effect of NR3C1 (By similarity). Regulates the circadian rhythms, through the dephosphorylation and activation of CSNK1E (PubMed:16790549). May modulate TGF-beta signaling pathway by the regulation of SMAD3 phosphorylation and protein expression levels (PubMed:22781750). Dephosphorylates and may play a role in the regulation of TAU/MAPT (PubMed:15546861). Through their dephosphorylation, may play a role in the regulation of ions channels such as KCNH2 (By similarity). Dephosphorylate FNIP1, disrupting interaction with HSP90AA1/Hsp90 (PubMed:30699359). {ECO:0000250|UniProtKB:P53042, ECO:0000250|UniProtKB:Q60676, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:14764652, ECO:0000269|PubMed:14871926, ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15546861, ECO:0000269|PubMed:16260606, ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:19176521, ECO:0000269|PubMed:19948726, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22399290, ECO:0000269|PubMed:22781750, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:30699359, ECO:0000269|PubMed:9000529}.\nT: Active site: ACT_SITE 304; /note=\"Proton donor/acceptor\"; /evidence=\"ECO:0000269|PubMed:15155720\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein phosphatase that dephosphorylates a myriad of proteins involved in different signaling pathways including the kinases CSNK1E, ASK1/MAP3K5, PRKDC and RAF1, the nuclear receptors NR3C1, PPARG, ESR1 and ESR2, SMAD proteins and TAU/MAPT (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Implicated in wide ranging cellular processes, including apoptosis, differentiation, DNA damage response, cell survival, regulation of ion channels or circadian rhythms, in response to steroid and thyroid hormones, calcium, fatty acids, TGF-beta as well as oxidative and genotoxic stresses (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Participates in the control of DNA damage response mechanisms such as checkpoint activation and DNA damage repair through, for instance, the regulation ATM/ATR-signaling and dephosphorylation of PRKDC and TP53BP1 (PubMed:14871926, PubMed:16260606, PubMed:21144835). Inhibits ASK1/MAP3K5-mediated apoptosis induced by oxidative stress (PubMed:23102700). Plays a positive role in adipogenesis, mainly through the dephosphorylation and activation of PPARG transactivation function (By similarity). Also dephosphorylates and inhibits the anti-adipogenic effect of NR3C1 (By similarity). Regulates the circadian rhythms, through the dephosphorylation and activation of CSNK1E (PubMed:16790549). May modulate TGF-beta signaling pathway by the regulation of SMAD3 phosphorylation and protein expression levels (PubMed:22781750). Dephosphorylates and may play a role in the regulation of TAU/MAPT (PubMed:15546861). Through their dephosphorylation, may play a role in the regulation of ions channels such as KCNH2 (By similarity). Dephosphorylate FNIP1, disrupting interaction with HSP90AA1/Hsp90 (PubMed:30699359). {ECO:0000250|UniProtKB:P53042, ECO:0000250|UniProtKB:Q60676, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:14764652, ECO:0000269|PubMed:14871926, ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15546861, ECO:0000269|PubMed:16260606, ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:19176521, ECO:0000269|PubMed:19948726, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22399290, ECO:0000269|PubMed:22781750, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:30699359, ECO:0000269|PubMed:9000529}.<br/><strong>T: Active site:</strong> ACT_SITE 304; /note=&quot;Proton donor/acceptor&quot;; /evidence=&quot;ECO:0000269|PubMed:15155720&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        234,
        201
      ],
      "fold_change_1": 0.541305,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        228,
        186
      ],
      "fold_change_2": 0.687532,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        249,
        241
      ],
      "fold_change_3": 0.132944,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        249
      ],
      "fold_change_4": 0.0579517,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        242,
        221
      ],
      "fold_change_5": 0.337225,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_79": {
      "label": "MAP2K6",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P46734": {
      "label": "MP2K3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. {ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:8622669}.\",\"ACT_SITE 190; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. {ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:8622669}.\nT: Active site: ACT_SITE 190; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. {ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:8622669}.<br/><strong>T: Active site:</strong> ACT_SITE 190; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        229,
        187
      ],
      "fold_change_1": 0.677365,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        211,
        141
      ],
      "fold_change_2": 1.14263,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        241,
        220
      ],
      "fold_change_3": 0.344699,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        240,
        215
      ],
      "fold_change_4": 0.393835,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        227,
        183
      ],
      "fold_change_5": 0.717879,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_81": {
      "label": "DUSP10",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P35813": {
      "label": "PPM1A",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Enzyme with a broad specificity. Negatively regulates TGF-beta signaling through dephosphorylating SMAD2 and SMAD3, resulting in their dissociation from SMAD4, nuclear export of the SMADs and termination of the TGF-beta-mediated signaling. Dephosphorylates PRKAA1 and PRKAA2. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:18930133}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Enzyme with a broad specificity. Negatively regulates TGF-beta signaling through dephosphorylating SMAD2 and SMAD3, resulting in their dissociation from SMAD4, nuclear export of the SMADs and termination of the TGF-beta-mediated signaling. Dephosphorylates PRKAA1 and PRKAA2. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:18930133}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Enzyme with a broad specificity. Negatively regulates TGF-beta signaling through dephosphorylating SMAD2 and SMAD3, resulting in their dissociation from SMAD4, nuclear export of the SMADs and termination of the TGF-beta-mediated signaling. Dephosphorylates PRKAA1 and PRKAA2. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:18930133}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        248,
        237
      ],
      "fold_change_1": 0.17996,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        227,
        182
      ],
      "fold_change_2": 0.724698,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        227
      ],
      "fold_change_3": 0.27694,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        247,
        235
      ],
      "fold_change_4": 0.19149,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        239,
        214
      ],
      "fold_change_5": 0.4057,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9Y243": {
      "label": "AKT3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.\",\"ACT_SITE 271; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.\nT: Active site: ACT_SITE 271; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.<br/><strong>T: Active site:</strong> ACT_SITE 271; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "Q9Y243_447": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9Y243",
          "fc_color_1": [
            253,
            216,
            153
          ],
          "label": "447",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.YFDEEFTAQTITIT#PPEK.Y",
          "tooltip_html": "<strong>T: sequence:</strong> R.YFDEEFTAQTITIT#PPEK.Y",
          "fold_change_1": 1.0184,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            216,
            153
          ],
          "fold_change_2": 1.01658,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            234,
            200
          ],
          "fold_change_3": 0.548388,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            240,
            216
          ],
          "fold_change_4": 0.384532,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            238,
            213
          ],
          "fold_change_5": 0.42193,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 629.2,
          "shape_y": 601.5,
          "label_x": 624.2,
          "label_y": 596.5,
          "label_centering": "right",
          "symbol_x": 629.2,
          "symbol_y": 601.5
        }
      },
      "fc_color_1": [
        254,
        248,
        237
      ],
      "fold_change_1": 0.180546,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        240,
        216
      ],
      "fold_change_2": 0.389495,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        240,
        217
      ],
      "fold_change_3": 0.37247,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        253,
        254,
        254
      ],
      "fold_change_4": -0.00825739,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        228,
        185
      ],
      "fold_change_5": 0.697643,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P31749": {
      "label": "AKT1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.\",\"ACT_SITE 274; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.\nT: Active site: ACT_SITE 274; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at &#x27;Ser-50&#x27; negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at &#x27;Ser-21&#x27; and GSK3B at &#x27;Ser-9&#x27;, resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of &#x27;Ser-83&#x27; decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at &#x27;Ser-939&#x27; and &#x27;Thr-1462&#x27;, thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at &#x27;Thr-24&#x27;, &#x27;Ser-256&#x27; and &#x27;Ser-319&#x27; (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates &#x27;Ser-454&#x27; on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of &#x27;Ser-273&#x27;, resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on &#x27;Ser-318&#x27;, which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at &#x27;Thr-120&#x27; and &#x27;Thr-387&#x27; leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at &#x27;Thr-117&#x27; and &#x27;Thr-384&#x27; leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at &#x27;Ser-259&#x27; and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at &#x27;Thr-369&#x27; and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at &#x27;Thr-145&#x27; induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at &#x27;Ser-90&#x27;, reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.<br/><strong>T: Active site:</strong> ACT_SITE 274; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        227,
        183
      ],
      "fold_change_1": 0.720275,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        216,
        153
      ],
      "fold_change_2": 1.02054,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        234,
        201
      ],
      "fold_change_3": 0.534752,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        232,
        196
      ],
      "fold_change_4": 0.583639,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        234,
        201
      ],
      "fold_change_5": 0.533036,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P31751": {
      "label": "AKT2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1). AKT mediates the antiapoptotic effects of IGF1. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development (PubMed:21432781, PubMed:21620960). In response to lysophosphatidic acid stimulation, inhibits the ciliogenesis cascade. In this context, phosphorylates WDR44, hence stabilizing its interaction with Rab11 and preventing the formation of the ciliogenic Rab11-FIP3-RAB3IP complex. Also phosphorylates RAB3IP/Rabin8, thus may affect RAB3IP guanine nucleotide exchange factor (GEF) activity toward Rab8, which is important for cilia growth (PubMed:31204173). Phosphorylates PKP1, facilitating its interaction with YWHAG and translocation to the nucleus, ultimately resulting in a reduction in keratinocyte intercellular adhesion (By similarity). Phosphorylation of PKP1 increases PKP1 protein stability, translocation to the cytoplasm away from desmosome plaques and PKP1-driven cap-dependent translation (PubMed:23444369). {ECO:0000250|UniProtKB:Q60823, ECO:0000269|PubMed:23444369, ECO:0000269|PubMed:31204173, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.; FUNCTION: Several AKT2-specific substrates have been identified, including ANKRD2, C2CD5, CLK2 and PITX2. May play a role in myoblast differentiation. In this context, may act through PITX2 phosphorylation. Unphosphorylated PITX2 associates with an ELAVL1/HuR-containing complex, which stabilizes CCND1 cyclin mRNA, ensuring cell proliferation. Phosphorylation by AKT2 impairs this association, leading to CCND1 mRNA destabilization and progression towards differentiation (By similarity). Also involved in the negative regulation of myogenesis in response to stress conditions. In this context, acts by phosphorylating ANKRD2 (By similarity). May also be a key regulator of glucose uptake. Regulates insulin-stimulated glucose transport by the increase of glucose transporter GLUT4 translocation from intracellular stores to the plasma membrane. In this context, acts by phosphorylating C2CD5/CDP138 on 'Ser-197' in insulin-stimulated adipocytes (By similarity). Through the phosphorylation of CLK2 on 'Thr-343', involved in insulin-regulated suppression of hepatic gluconeogenesis (By similarity). {ECO:0000250|UniProtKB:Q60823}.\",\"ACT_SITE 275; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1). AKT mediates the antiapoptotic effects of IGF1. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development (PubMed:21432781, PubMed:21620960). In response to lysophosphatidic acid stimulation, inhibits the ciliogenesis cascade. In this context, phosphorylates WDR44, hence stabilizing its interaction with Rab11 and preventing the formation of the ciliogenic Rab11-FIP3-RAB3IP complex. Also phosphorylates RAB3IP/Rabin8, thus may affect RAB3IP guanine nucleotide exchange factor (GEF) activity toward Rab8, which is important for cilia growth (PubMed:31204173). Phosphorylates PKP1, facilitating its interaction with YWHAG and translocation to the nucleus, ultimately resulting in a reduction in keratinocyte intercellular adhesion (By similarity). Phosphorylation of PKP1 increases PKP1 protein stability, translocation to the cytoplasm away from desmosome plaques and PKP1-driven cap-dependent translation (PubMed:23444369). {ECO:0000250|UniProtKB:Q60823, ECO:0000269|PubMed:23444369, ECO:0000269|PubMed:31204173, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.; FUNCTION: Several AKT2-specific substrates have been identified, including ANKRD2, C2CD5, CLK2 and PITX2. May play a role in myoblast differentiation. In this context, may act through PITX2 phosphorylation. Unphosphorylated PITX2 associates with an ELAVL1/HuR-containing complex, which stabilizes CCND1 cyclin mRNA, ensuring cell proliferation. Phosphorylation by AKT2 impairs this association, leading to CCND1 mRNA destabilization and progression towards differentiation (By similarity). Also involved in the negative regulation of myogenesis in response to stress conditions. In this context, acts by phosphorylating ANKRD2 (By similarity). May also be a key regulator of glucose uptake. Regulates insulin-stimulated glucose transport by the increase of glucose transporter GLUT4 translocation from intracellular stores to the plasma membrane. In this context, acts by phosphorylating C2CD5/CDP138 on 'Ser-197' in insulin-stimulated adipocytes (By similarity). Through the phosphorylation of CLK2 on 'Thr-343', involved in insulin-regulated suppression of hepatic gluconeogenesis (By similarity). {ECO:0000250|UniProtKB:Q60823}.\nT: Active site: ACT_SITE 275; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at &#x27;Ser-50&#x27; negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at &#x27;Ser-21&#x27; and GSK3B at &#x27;Ser-9&#x27;, resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of &#x27;Ser-83&#x27; decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at &#x27;Ser-939&#x27; and &#x27;Thr-1462&#x27;, thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at &#x27;Thr-24&#x27;, &#x27;Ser-256&#x27; and &#x27;Ser-319&#x27;. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates &#x27;Ser-454&#x27; on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of &#x27;Ser-273&#x27;, resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on &#x27;Ser-318&#x27;, which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1). AKT mediates the antiapoptotic effects of IGF1. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development (PubMed:21432781, PubMed:21620960). In response to lysophosphatidic acid stimulation, inhibits the ciliogenesis cascade. In this context, phosphorylates WDR44, hence stabilizing its interaction with Rab11 and preventing the formation of the ciliogenic Rab11-FIP3-RAB3IP complex. Also phosphorylates RAB3IP/Rabin8, thus may affect RAB3IP guanine nucleotide exchange factor (GEF) activity toward Rab8, which is important for cilia growth (PubMed:31204173). Phosphorylates PKP1, facilitating its interaction with YWHAG and translocation to the nucleus, ultimately resulting in a reduction in keratinocyte intercellular adhesion (By similarity). Phosphorylation of PKP1 increases PKP1 protein stability, translocation to the cytoplasm away from desmosome plaques and PKP1-driven cap-dependent translation (PubMed:23444369). {ECO:0000250|UniProtKB:Q60823, ECO:0000269|PubMed:23444369, ECO:0000269|PubMed:31204173, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.; FUNCTION: Several AKT2-specific substrates have been identified, including ANKRD2, C2CD5, CLK2 and PITX2. May play a role in myoblast differentiation. In this context, may act through PITX2 phosphorylation. Unphosphorylated PITX2 associates with an ELAVL1/HuR-containing complex, which stabilizes CCND1 cyclin mRNA, ensuring cell proliferation. Phosphorylation by AKT2 impairs this association, leading to CCND1 mRNA destabilization and progression towards differentiation (By similarity). Also involved in the negative regulation of myogenesis in response to stress conditions. In this context, acts by phosphorylating ANKRD2 (By similarity). May also be a key regulator of glucose uptake. Regulates insulin-stimulated glucose transport by the increase of glucose transporter GLUT4 translocation from intracellular stores to the plasma membrane. In this context, acts by phosphorylating C2CD5/CDP138 on &#x27;Ser-197&#x27; in insulin-stimulated adipocytes (By similarity). Through the phosphorylation of CLK2 on &#x27;Thr-343&#x27;, involved in insulin-regulated suppression of hepatic gluconeogenesis (By similarity). {ECO:0000250|UniProtKB:Q60823}.<br/><strong>T: Active site:</strong> ACT_SITE 275; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "P31751_451": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P31751",
          "fc_color_1": [
            228,
            236,
            243
          ],
          "label": "451",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.YFDDEFTAQSITIT#PPDR.Y",
          "tooltip_html": "<strong>T: sequence:</strong> R.YFDDEFTAQSITIT#PPDR.Y",
          "fold_change_1": -0.211617,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            185,
            207,
            226
          ],
          "fold_change_2": -0.549435,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            200,
            217,
            232
          ],
          "fold_change_3": -0.430915,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            247,
            235
          ],
          "fold_change_4": 0.196179,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            246,
            232
          ],
          "fold_change_5": 0.222574,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 629.2,
          "shape_y": 601.5,
          "label_x": 624.2,
          "label_y": 596.5,
          "label_centering": "right",
          "symbol_x": 629.2,
          "symbol_y": 601.5
        }
      },
      "fc_color_1": [
        254,
        232,
        194
      ],
      "fold_change_1": 0.604981,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        236,
        207
      ],
      "fold_change_2": 0.480365,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        249,
        240
      ],
      "fold_change_3": 0.145661,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        244,
        228
      ],
      "fold_change_4": 0.270519,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        232,
        197
      ],
      "fold_change_5": 0.582364,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9H2K8": {
      "label": "TAOK3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of the MAPK8/JNK cascade and diminishes its activation in response to epidermal growth factor (EGF). Positively regulates canonical T cell receptor (TCR) signaling by preventing early PTPN6/SHP1-mediated inactivation of LCK, ensuring sustained TCR signaling that is required for optimal activation and differentiation of T cells (PubMed:30373850). Phosphorylates PTPN6/SHP1 on 'Thr-394', leading to its polyubiquitination and subsequent proteasomal degradation (PubMed:38166031). Required for cell surface expression of metalloprotease ADAM10 on type 1 transitional B cells which is necessary for their NOTCH-mediated development into marginal zone B cells (By similarity). Also required for the NOTCH-mediated terminal differentiation of splenic conventional type 2 dendritic cells (By similarity). Positively regulates osteoblast differentiation by acting as an upstream activator of the JNK pathway (PubMed:32807497). Promotes JNK signaling in hepatocytes and positively regulates hepatocyte lipid storage by inhibiting beta-oxidation and triacylglycerol secretion while enhancing lipid synthesis (PubMed:34634521). Restricts age-associated inflammation by negatively regulating differentiation of macrophages and their production of pro-inflammatory cytokines (By similarity). Plays a role in negatively regulating the abundance of regulatory T cells in white adipose tissue (By similarity). {ECO:0000250|UniProtKB:Q8BYC6, ECO:0000269|PubMed:10559204, ECO:0000269|PubMed:10924369, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:30373850, ECO:0000269|PubMed:32807497, ECO:0000269|PubMed:34634521, ECO:0000269|PubMed:38166031}.\",\"ACT_SITE 147; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of the MAPK8/JNK cascade and diminishes its activation in response to epidermal growth factor (EGF). Positively regulates canonical T cell receptor (TCR) signaling by preventing early PTPN6/SHP1-mediated inactivation of LCK, ensuring sustained TCR signaling that is required for optimal activation and differentiation of T cells (PubMed:30373850). Phosphorylates PTPN6/SHP1 on 'Thr-394', leading to its polyubiquitination and subsequent proteasomal degradation (PubMed:38166031). Required for cell surface expression of metalloprotease ADAM10 on type 1 transitional B cells which is necessary for their NOTCH-mediated development into marginal zone B cells (By similarity). Also required for the NOTCH-mediated terminal differentiation of splenic conventional type 2 dendritic cells (By similarity). Positively regulates osteoblast differentiation by acting as an upstream activator of the JNK pathway (PubMed:32807497). Promotes JNK signaling in hepatocytes and positively regulates hepatocyte lipid storage by inhibiting beta-oxidation and triacylglycerol secretion while enhancing lipid synthesis (PubMed:34634521). Restricts age-associated inflammation by negatively regulating differentiation of macrophages and their production of pro-inflammatory cytokines (By similarity). Plays a role in negatively regulating the abundance of regulatory T cells in white adipose tissue (By similarity). {ECO:0000250|UniProtKB:Q8BYC6, ECO:0000269|PubMed:10559204, ECO:0000269|PubMed:10924369, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:30373850, ECO:0000269|PubMed:32807497, ECO:0000269|PubMed:34634521, ECO:0000269|PubMed:38166031}.\nT: Active site: ACT_SITE 147; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of the MAPK8/JNK cascade and diminishes its activation in response to epidermal growth factor (EGF). Positively regulates canonical T cell receptor (TCR) signaling by preventing early PTPN6/SHP1-mediated inactivation of LCK, ensuring sustained TCR signaling that is required for optimal activation and differentiation of T cells (PubMed:30373850). Phosphorylates PTPN6/SHP1 on &#x27;Thr-394&#x27;, leading to its polyubiquitination and subsequent proteasomal degradation (PubMed:38166031). Required for cell surface expression of metalloprotease ADAM10 on type 1 transitional B cells which is necessary for their NOTCH-mediated development into marginal zone B cells (By similarity). Also required for the NOTCH-mediated terminal differentiation of splenic conventional type 2 dendritic cells (By similarity). Positively regulates osteoblast differentiation by acting as an upstream activator of the JNK pathway (PubMed:32807497). Promotes JNK signaling in hepatocytes and positively regulates hepatocyte lipid storage by inhibiting beta-oxidation and triacylglycerol secretion while enhancing lipid synthesis (PubMed:34634521). Restricts age-associated inflammation by negatively regulating differentiation of macrophages and their production of pro-inflammatory cytokines (By similarity). Plays a role in negatively regulating the abundance of regulatory T cells in white adipose tissue (By similarity). {ECO:0000250|UniProtKB:Q8BYC6, ECO:0000269|PubMed:10559204, ECO:0000269|PubMed:10924369, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:30373850, ECO:0000269|PubMed:32807497, ECO:0000269|PubMed:34634521, ECO:0000269|PubMed:38166031}.<br/><strong>T: Active site:</strong> ACT_SITE 147; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        246,
        233
      ],
      "fold_change_1": 0.216355,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        247,
        235
      ],
      "fold_change_2": 0.199932,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        250,
        243
      ],
      "fold_change_3": 0.110656,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        251,
        244
      ],
      "fold_change_4": 0.103954,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        248,
        237
      ],
      "fold_change_5": 0.176479,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q7L7X3": {
      "label": "TAOK1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. Plays an essential role in the regulation of neuronal development in the central nervous system (PubMed:33565190). Also plays a role in the regulation of neuronal migration to the cortical plate (By similarity). {ECO:0000250|UniProtKB:Q5F2E8, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936, ECO:0000269|PubMed:33565190}.\",\"ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. Plays an essential role in the regulation of neuronal development in the central nervous system (PubMed:33565190). Also plays a role in the regulation of neuronal migration to the cortical plate (By similarity). {ECO:0000250|UniProtKB:Q5F2E8, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936, ECO:0000269|PubMed:33565190}.\nT: Active site: ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating &#x27;Thr-208&#x27; of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. Plays an essential role in the regulation of neuronal development in the central nervous system (PubMed:33565190). Also plays a role in the regulation of neuronal migration to the cortical plate (By similarity). {ECO:0000250|UniProtKB:Q5F2E8, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936, ECO:0000269|PubMed:33565190}.<br/><strong>T: Active site:</strong> ACT_SITE 151; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "Q7L7X3_445": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q7L7X3",
          "fc_color_1": [
            253,
            197,
            104
          ],
          "label": "445",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.TAS#LVTR.Q",
          "tooltip_html": "<strong>T: sequence:</strong> R.TAS#LVTR.Q",
          "fold_change_1": 1.5175,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            220,
            165
          ],
          "fold_change_2": 0.898547,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            231,
            194
          ],
          "fold_change_3": 0.612873,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            237,
            209
          ],
          "fold_change_4": 0.455876,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            241,
            219
          ],
          "fold_change_5": 0.35414,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 566.2,
          "shape_y": 814.5,
          "label_x": 561.2,
          "label_y": 809.5,
          "label_centering": "right",
          "symbol_x": 566.2,
          "symbol_y": 814.5
        },
        "Q7L7X3_965": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q7L7X3",
          "fc_color_1": [
            218,
            229,
            239
          ],
          "label": "965",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.NS#PQALRR.T",
          "tooltip_html": "<strong>T: sequence:</strong> R.NS#PQALRR.T",
          "fold_change_1": -0.29185,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            251,
            246
          ],
          "fold_change_2": 0.0879031,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            251,
            252,
            253
          ],
          "fold_change_3": -0.0249293,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            176,
            200,
            222
          ],
          "fold_change_4": -0.620968,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            251,
            244
          ],
          "fold_change_5": 0.100939,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 593.8,
          "shape_y": 814.5,
          "label_x": 598.8,
          "label_y": 809.5,
          "label_centering": "left",
          "symbol_x": 593.8,
          "symbol_y": 814.5
        },
        "Q7L7X3_421": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q7L7X3",
          "fc_color_1": [
            254,
            252,
            247
          ],
          "label": "421",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.ASDPQS#PPQVSR.H",
          "tooltip_html": "<strong>T: sequence:</strong> R.ASDPQS#PPQVSR.H",
          "fold_change_1": 0.0760961,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            136,
            173,
            205
          ],
          "fold_change_2": -0.935317,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            254,
            254
          ],
          "fold_change_3": -0.00698885,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            236,
            242,
            247
          ],
          "fold_change_4": -0.143233,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            211,
            224,
            236
          ],
          "fold_change_5": -0.346573,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 566.2,
          "shape_y": 839.5,
          "label_x": 561.2,
          "label_y": 844.5,
          "label_centering": "right",
          "symbol_x": 566.2,
          "symbol_y": 839.5
        }
      },
      "fc_color_1": [
        254,
        252,
        248
      ],
      "fold_change_1": 0.0674543,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        240,
        218
      ],
      "fold_change_2": 0.368922,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        234,
        240,
        246
      ],
      "fold_change_3": -0.164856,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        251,
        246
      ],
      "fold_change_4": 0.0883553,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        251,
        252,
        253
      ],
      "fold_change_5": -0.028717,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9UL54": {
      "label": "TAOK2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Isoform 1, but not isoform 2, plays a role in apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation. This function, which requires the activation of MAPK8/JNK and nuclear localization of C-terminally truncated isoform 1, may be linked to the mitochondrial CASP9-associated death pathway. Isoform 1 binds to microtubules and affects their organization and stability independently of its kinase activity. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation, but not that of MAPK8/JNK. May play a role in the osmotic stress-MAPK8 pathway. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14 phosphorylation. {ECO:0000269|PubMed:10660600, ECO:0000269|PubMed:11279118, ECO:0000269|PubMed:12639963, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:17158878, ECO:0000269|PubMed:17396146}.\",\"ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Isoform 1, but not isoform 2, plays a role in apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation. This function, which requires the activation of MAPK8/JNK and nuclear localization of C-terminally truncated isoform 1, may be linked to the mitochondrial CASP9-associated death pathway. Isoform 1 binds to microtubules and affects their organization and stability independently of its kinase activity. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation, but not that of MAPK8/JNK. May play a role in the osmotic stress-MAPK8 pathway. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14 phosphorylation. {ECO:0000269|PubMed:10660600, ECO:0000269|PubMed:11279118, ECO:0000269|PubMed:12639963, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:17158878, ECO:0000269|PubMed:17396146}.\nT: Active site: ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Isoform 1, but not isoform 2, plays a role in apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation. This function, which requires the activation of MAPK8/JNK and nuclear localization of C-terminally truncated isoform 1, may be linked to the mitochondrial CASP9-associated death pathway. Isoform 1 binds to microtubules and affects their organization and stability independently of its kinase activity. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation, but not that of MAPK8/JNK. May play a role in the osmotic stress-MAPK8 pathway. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14 phosphorylation. {ECO:0000269|PubMed:10660600, ECO:0000269|PubMed:11279118, ECO:0000269|PubMed:12639963, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:17158878, ECO:0000269|PubMed:17396146}.<br/><strong>T: Active site:</strong> ACT_SITE 151; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        223,
        233,
        241
      ],
      "fold_change_1": -0.25033,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        248,
        238
      ],
      "fold_change_2": 0.165664,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        226
      ],
      "fold_change_3": 0.285239,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        251,
        245
      ],
      "fold_change_4": 0.0963221,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        217,
        229,
        239
      ],
      "fold_change_5": -0.298254,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9Y6R4": {
      "label": "M3K4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. {ECO:0000269|PubMed:12052864, ECO:0000269|PubMed:9305639}.\",\"ACT_SITE 1463; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. {ECO:0000269|PubMed:12052864, ECO:0000269|PubMed:9305639}.\nT: Active site: ACT_SITE 1463; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. {ECO:0000269|PubMed:12052864, ECO:0000269|PubMed:9305639}.<br/><strong>T: Active site:</strong> ACT_SITE 1463; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        234,
        200
      ],
      "fold_change_1": 0.548732,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        226,
        181
      ],
      "fold_change_2": 0.743542,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        241,
        219
      ],
      "fold_change_3": 0.358145,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        240,
        216
      ],
      "fold_change_4": 0.387625,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        235,
        204
      ],
      "fold_change_5": 0.509523,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P04792": {
      "label": "HSPB1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975). Plays a role in stress resistance and actin organization (PubMed:19166925). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742). {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:20178975, ECO:0000269|PubMed:23728742}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975). Plays a role in stress resistance and actin organization (PubMed:19166925). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742). {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:20178975, ECO:0000269|PubMed:23728742}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975). Plays a role in stress resistance and actin organization (PubMed:19166925). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742). {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:20178975, ECO:0000269|PubMed:23728742}.",
      "PTMs": {
        "P04792_15": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P04792",
          "fc_color_1": [
            253,
            179,
            56
          ],
          "label": "15",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: R.GPS#WDPFR.D\nPSP: ON_FUNCTION: protein degradation; sumoylation; protein stabilization; molecular association, regulation; protein conformation; phosphorylation\nPSP: ON_PROCESS: carcinogenesis, induced; apoptosis, altered; signaling pathway regulation; transcription, altered; apoptosis, inhibited; cytoskeletal reorganization; transcription, inhibited; cell growth, altered\nPSP: ON_PROT_INTERACT: p53(INDUCES); HSF1(DISRUPTS); hnRNP D0(DISRUPTS); HSP27(DISRUPTS)\nPSP: in_vivo_kinases: MAPKAPK2\nPSP: in_vitro_kinases: MAPKAPK2; PKG1 iso2",
          "tooltip_html": "<strong>T: sequence:</strong> R.GPS#WDPFR.D<br/><strong>PSP: ON_FUNCTION:</strong> protein degradation; sumoylation; protein stabilization; molecular association, regulation; protein conformation; phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> carcinogenesis, induced; apoptosis, altered; signaling pathway regulation; transcription, altered; apoptosis, inhibited; cytoskeletal reorganization; transcription, inhibited; cell growth, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> p53(INDUCES); HSF1(DISRUPTS); hnRNP D0(DISRUPTS); HSP27(DISRUPTS)<br/><strong>PSP: in_vivo_kinases:</strong> MAPKAPK2<br/><strong>PSP: in_vitro_kinases:</strong> MAPKAPK2; PKG1 iso2",
          "fold_change_1": 2.44338,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            225,
            177
          ],
          "fold_change_2": 0.780798,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            253,
            210,
            138
          ],
          "fold_change_3": 1.17089,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            253,
            203,
            119
          ],
          "fold_change_4": 1.36345,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            253,
            211,
            141
          ],
          "fold_change_5": 1.13799,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 900.2,
          "shape_y": 756.5,
          "label_x": 895.2,
          "label_y": 751.5,
          "label_centering": "right",
          "symbol_x": 900.1,
          "symbol_y": 756.5
        },
        "P04792_82": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P04792",
          "fc_color_1": [
            253,
            182,
            65
          ],
          "label": "82",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.Q@LS#SGVSEIR.H\nPSP: ON_FUNCTION: protein degradation; molecular association, regulation; phosphorylation; activity, induced; sumoylation; ubiquitination; intracellular localization; protein conformation\nPSP: ON_PROCESS: carcinogenesis, induced; apoptosis, altered; cell motility, induced; signaling pathway regulation; transcription, altered; cell differentiation, induced; cell growth, induced; apoptosis, inhibited; cytoskeletal reorganization; transcription, inhibited; cell growth, altered\nPSP: ON_PROT_INTERACT: TRAF6(DISRUPTS); TPM1(INDUCES); p53(INDUCES); HSF1(DISRUPTS); hnRNP D0(DISRUPTS); HSP27(DISRUPTS); Akt1(DISRUPTS)\nPSP: ON_OTHER_INTERACT: RNA(DISRUPTS)\nPSP: in_vivo_kinases: P70S6KB; PRKD1; MAPKAPK3; Akt1\nPSP: in_vitro_kinases: MAPKAPK2; PKACA; PKG1 iso2; PRKD1; Akt1",
          "tooltip_html": "<strong>T: sequence:</strong> R.Q@LS#SGVSEIR.H<br/><strong>PSP: ON_FUNCTION:</strong> protein degradation; molecular association, regulation; phosphorylation; activity, induced; sumoylation; ubiquitination; intracellular localization; protein conformation<br/><strong>PSP: ON_PROCESS:</strong> carcinogenesis, induced; apoptosis, altered; cell motility, induced; signaling pathway regulation; transcription, altered; cell differentiation, induced; cell growth, induced; apoptosis, inhibited; cytoskeletal reorganization; transcription, inhibited; cell growth, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> TRAF6(DISRUPTS); TPM1(INDUCES); p53(INDUCES); HSF1(DISRUPTS); hnRNP D0(DISRUPTS); HSP27(DISRUPTS); Akt1(DISRUPTS)<br/><strong>PSP: ON_OTHER_INTERACT:</strong> RNA(DISRUPTS)<br/><strong>PSP: in_vivo_kinases:</strong> P70S6KB; PRKD1; MAPKAPK3; Akt1<br/><strong>PSP: in_vitro_kinases:</strong> MAPKAPK2; PKACA; PKG1 iso2; PRKD1; Akt1",
          "fold_change_1": 1.90894,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            246,
            231
          ],
          "fold_change_2": 0.236181,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            224,
            174
          ],
          "fold_change_3": 0.811905,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            222,
            170
          ],
          "fold_change_4": 0.846185,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            238,
            211
          ],
          "fold_change_5": 0.43584,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 927.8,
          "shape_y": 756.5,
          "label_x": 932.8,
          "label_y": 751.5,
          "label_centering": "left",
          "symbol_x": 927.6999999999999,
          "symbol_y": 756.0
        },
        "P04792_176": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P04792",
          "fc_color_1": [
            68,
            126,
            177
          ],
          "label": "176",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.LATQS#NEITIPVTFESR.A\nPSP: in_vitro_kinases: P38A",
          "tooltip_html": "<strong>T: sequence:</strong> K.LATQS#NEITIPVTFESR.A<br/><strong>PSP: in_vitro_kinases:</strong> P38A",
          "fold_change_1": -1.47732,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            62,
            122,
            174
          ],
          "fold_change_2": -1.52523,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            218,
            230,
            240
          ],
          "fold_change_3": -0.285093,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            180,
            204,
            224
          ],
          "fold_change_4": -0.585864,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            153,
            185,
            213
          ],
          "fold_change_5": -0.799172,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 900.2,
          "shape_y": 781.5,
          "label_x": 895.2,
          "label_y": 786.5,
          "label_centering": "right",
          "symbol_x": 900.2,
          "symbol_y": 781.5
        },
        "P04792_202": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P04792",
          "fc_color_1": [
            215,
            227,
            238
          ],
          "label": "202",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.AQLGGPEAAKSDET#AAK.-",
          "tooltip_html": "<strong>T: sequence:</strong> R.AQLGGPEAAKSDET#AAK.-",
          "fold_change_1": -0.315264,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            116,
            159,
            197
          ],
          "fold_change_2": -1.09299,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            155,
            186,
            213
          ],
          "fold_change_3": -0.787732,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            152,
            184,
            212
          ],
          "fold_change_4": -0.810308,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            145,
            179,
            209
          ],
          "fold_change_5": -0.865746,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S3",
          "shape_x": 927.8,
          "shape_y": 781.5,
          "label_x": 932.8,
          "label_y": 786.5,
          "label_centering": "left",
          "symbol_x": 927.8,
          "symbol_y": 781.5
        }
      },
      "fc_color_1": [
        254,
        224,
        174
      ],
      "fold_change_1": 0.809289,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        237,
        210
      ],
      "fold_change_2": 0.449051,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        252,
        247
      ],
      "fold_change_3": 0.0765221,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        250,
        243
      ],
      "fold_change_4": 0.113106,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        224,
        174
      ],
      "fold_change_5": 0.80788,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O43318": {
      "label": "M3K7",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Plays an important role in the cascades of cellular responses evoked by changes in the environment (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR) (PubMed:16893890, PubMed:9079627). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7 (PubMed:11460167, PubMed:8663074). These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs); both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1) (PubMed:11460167, PubMed:12589052, PubMed:8663074). Independently of MAP2Ks and p38 MAPKs, acts as a key activator of NF-kappa-B by promoting activation of the I-kappa-B-kinase (IKK) core complex (PubMed:12589052, PubMed:8663074). Mechanistically, recruited to polyubiquitin chains of RIPK2 and IKBKG/NEMO via TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3, and catalyzes phosphorylation and activation of IKBKB/IKKB component of the IKK complex, leading to NF-kappa-B activation (PubMed:10094049, PubMed:11460167). In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B (PubMed:16893890). Promotes TRIM5 capsid-specific restriction activity (PubMed:21512573). Phosphorylates RIPK1 at 'Ser-321' which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). Phosphorylates STING1 in response to cGAMP-activation, promoting association between STEEP1 and STING1 and STING1 translocation to COPII vesicles (PubMed:37832545). {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:37832545, ECO:0000269|PubMed:8663074, ECO:0000269|PubMed:9079627}.\",\"ACT_SITE 156; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Plays an important role in the cascades of cellular responses evoked by changes in the environment (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR) (PubMed:16893890, PubMed:9079627). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7 (PubMed:11460167, PubMed:8663074). These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs); both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1) (PubMed:11460167, PubMed:12589052, PubMed:8663074). Independently of MAP2Ks and p38 MAPKs, acts as a key activator of NF-kappa-B by promoting activation of the I-kappa-B-kinase (IKK) core complex (PubMed:12589052, PubMed:8663074). Mechanistically, recruited to polyubiquitin chains of RIPK2 and IKBKG/NEMO via TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3, and catalyzes phosphorylation and activation of IKBKB/IKKB component of the IKK complex, leading to NF-kappa-B activation (PubMed:10094049, PubMed:11460167). In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B (PubMed:16893890). Promotes TRIM5 capsid-specific restriction activity (PubMed:21512573). Phosphorylates RIPK1 at 'Ser-321' which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). Phosphorylates STING1 in response to cGAMP-activation, promoting association between STEEP1 and STING1 and STING1 translocation to COPII vesicles (PubMed:37832545). {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:37832545, ECO:0000269|PubMed:8663074, ECO:0000269|PubMed:9079627}.\nT: Active site: ACT_SITE 156; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Plays an important role in the cascades of cellular responses evoked by changes in the environment (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR) (PubMed:16893890, PubMed:9079627). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7 (PubMed:11460167, PubMed:8663074). These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs); both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1) (PubMed:11460167, PubMed:12589052, PubMed:8663074). Independently of MAP2Ks and p38 MAPKs, acts as a key activator of NF-kappa-B by promoting activation of the I-kappa-B-kinase (IKK) core complex (PubMed:12589052, PubMed:8663074). Mechanistically, recruited to polyubiquitin chains of RIPK2 and IKBKG/NEMO via TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3, and catalyzes phosphorylation and activation of IKBKB/IKKB component of the IKK complex, leading to NF-kappa-B activation (PubMed:10094049, PubMed:11460167). In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B (PubMed:16893890). Promotes TRIM5 capsid-specific restriction activity (PubMed:21512573). Phosphorylates RIPK1 at &#x27;Ser-321&#x27; which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). Phosphorylates STING1 in response to cGAMP-activation, promoting association between STEEP1 and STING1 and STING1 translocation to COPII vesicles (PubMed:37832545). {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:37832545, ECO:0000269|PubMed:8663074, ECO:0000269|PubMed:9079627}.<br/><strong>T: Active site:</strong> ACT_SITE 156; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "O43318_439": {
          "ptm_type": "ptm_0",
          "uniprot_id": "O43318",
          "fc_color_1": [
            93,
            143,
            187
          ],
          "label": "439",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: R.S#IQDLTVTGTEPGQVSSR.S\nPSP: ON_FUNCTION: molecular association, regulation\nPSP: ON_PROT_INTERACT: IKKG(INDUCES)",
          "tooltip_html": "<strong>T: sequence:</strong> R.S#IQDLTVTGTEPGQVSSR.S<br/><strong>PSP: ON_FUNCTION:</strong> molecular association, regulation<br/><strong>PSP: ON_PROT_INTERACT:</strong> IKKG(INDUCES)",
          "fold_change_1": -1.28011,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            120,
            162,
            199
          ],
          "fold_change_2": -1.06029,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            161,
            190,
            216
          ],
          "fold_change_3": -0.736983,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            178,
            202,
            223
          ],
          "fold_change_4": -0.607169,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            128,
            168,
            202
          ],
          "fold_change_5": -0.997183,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 566.2,
          "shape_y": 720.5,
          "label_x": 561.2,
          "label_y": 715.5,
          "label_centering": "right",
          "symbol_x": 566.1,
          "symbol_y": 720.5
        },
        "O43318_389": {
          "ptm_type": "ptm_0",
          "uniprot_id": "O43318",
          "fc_color_1": [
            197,
            215,
            230
          ],
          "label": "389",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.RMS#ADMSEIEAR.I",
          "tooltip_html": "<strong>T: sequence:</strong> K.RMS#ADMSEIEAR.I",
          "fold_change_1": -0.457164,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            250,
            251,
            253
          ],
          "fold_change_2": -0.0378381,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            211,
            224,
            236
          ],
          "fold_change_3": -0.346523,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            241,
            245,
            249
          ],
          "fold_change_4": -0.109272,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            187,
            208,
            227
          ],
          "fold_change_5": -0.531692,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 593.8,
          "shape_y": 720.5,
          "label_x": 598.8,
          "label_y": 715.5,
          "label_centering": "left",
          "symbol_x": 593.8,
          "symbol_y": 720.5
        }
      },
      "fc_color_1": [
        253,
        216,
        154
      ],
      "fold_change_1": 1.00685,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        216,
        155
      ],
      "fold_change_2": 1.00022,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        235,
        204
      ],
      "fold_change_3": 0.506196,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        237,
        210
      ],
      "fold_change_4": 0.45061,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        229,
        188
      ],
      "fold_change_5": 0.668398,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q99683": {
      "label": "M3K5",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). {ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:10849426, ECO:0000269|PubMed:11029458, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685, ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544, ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:17220297, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:26095851, ECO:0000269|PubMed:8940179, ECO:0000269|PubMed:8974401, ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}.\",\"ACT_SITE 803; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). {ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:10849426, ECO:0000269|PubMed:11029458, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685, ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544, ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:17220297, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:26095851, ECO:0000269|PubMed:8940179, ECO:0000269|PubMed:8974401, ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}.\nT: Active site: ACT_SITE 803; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). {ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:10849426, ECO:0000269|PubMed:11029458, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685, ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544, ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:17220297, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:26095851, ECO:0000269|PubMed:8940179, ECO:0000269|PubMed:8974401, ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}.<br/><strong>T: Active site:</strong> ACT_SITE 803; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        234,
        200
      ],
      "fold_change_1": 0.549295,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        220,
        163
      ],
      "fold_change_2": 0.921003,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        228,
        184
      ],
      "fold_change_3": 0.709574,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        243,
        223
      ],
      "fold_change_4": 0.312668,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        234,
        201
      ],
      "fold_change_5": 0.541412,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O95382": {
      "label": "M3K6",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. {ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:9875215}.\",\"ACT_SITE 771; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. {ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:9875215}.\nT: Active site: ACT_SITE 771; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. {ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:9875215}.<br/><strong>T: Active site:</strong> ACT_SITE 771; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        244,
        228
      ],
      "fold_change_1": 0.271083,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        238,
        212
      ],
      "fold_change_2": 0.425527,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        245,
        229
      ],
      "fold_change_3": 0.254821,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        246,
        232
      ],
      "fold_change_4": 0.225271,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        236,
        207
      ],
      "fold_change_5": 0.478118,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_91": {
      "label": "MAP3K20",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_92": {
      "label": "MAP3K12",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_93": {
      "label": "MAP3K9",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q12851": {
      "label": "M4K2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidine (poly(IC)), lipopolysaccharides (LPS), lipid A, peptidoglycan (PGN), or bacterial flagellin. To a lesser degree, IL-1 and engagement of CD40 also stimulate MAP4K2-mediated JNKs activation. The requirement for MAP4K2/GCK is most pronounced for LPS signaling, and extends to LPS stimulation of c-Jun phosphorylation and induction of IL-8. Enhances MAP3K1 oligomerization, which may relieve N-terminal mediated MAP3K1 autoinhibition and lead to activation following autophosphorylation. Also mediates the SAP/JNK signaling pathway and the p38 MAPKs signaling pathway through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3. May play a role in the regulation of vesicle targeting or fusion. regulation of vesicle targeting or fusion. Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:15456887, ECO:0000269|PubMed:17584736, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:7477268, ECO:0000269|PubMed:7515885, ECO:0000269|PubMed:9712898}.\",\"ACT_SITE 136; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidine (poly(IC)), lipopolysaccharides (LPS), lipid A, peptidoglycan (PGN), or bacterial flagellin. To a lesser degree, IL-1 and engagement of CD40 also stimulate MAP4K2-mediated JNKs activation. The requirement for MAP4K2/GCK is most pronounced for LPS signaling, and extends to LPS stimulation of c-Jun phosphorylation and induction of IL-8. Enhances MAP3K1 oligomerization, which may relieve N-terminal mediated MAP3K1 autoinhibition and lead to activation following autophosphorylation. Also mediates the SAP/JNK signaling pathway and the p38 MAPKs signaling pathway through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3. May play a role in the regulation of vesicle targeting or fusion. regulation of vesicle targeting or fusion. Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:15456887, ECO:0000269|PubMed:17584736, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:7477268, ECO:0000269|PubMed:7515885, ECO:0000269|PubMed:9712898}.\nT: Active site: ACT_SITE 136; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidine (poly(IC)), lipopolysaccharides (LPS), lipid A, peptidoglycan (PGN), or bacterial flagellin. To a lesser degree, IL-1 and engagement of CD40 also stimulate MAP4K2-mediated JNKs activation. The requirement for MAP4K2/GCK is most pronounced for LPS signaling, and extends to LPS stimulation of c-Jun phosphorylation and induction of IL-8. Enhances MAP3K1 oligomerization, which may relieve N-terminal mediated MAP3K1 autoinhibition and lead to activation following autophosphorylation. Also mediates the SAP/JNK signaling pathway and the p38 MAPKs signaling pathway through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3. May play a role in the regulation of vesicle targeting or fusion. regulation of vesicle targeting or fusion. Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:15456887, ECO:0000269|PubMed:17584736, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:7477268, ECO:0000269|PubMed:7515885, ECO:0000269|PubMed:9712898}.<br/><strong>T: Active site:</strong> ACT_SITE 136; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {
        "Q12851_328": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q12851",
          "fc_color_1": [
            254,
            229,
            187
          ],
          "label": "328",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.TPS#EIQFHQVK.F",
          "tooltip_html": "<strong>T: sequence:</strong> R.TPS#EIQFHQVK.F",
          "fold_change_1": 0.683053,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            212,
            144
          ],
          "fold_change_2": 1.1092,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            218,
            160
          ],
          "fold_change_3": 0.954052,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            221,
            166
          ],
          "fold_change_4": 0.894134,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            222,
            170
          ],
          "fold_change_5": 0.849108,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 480.2,
          "shape_y": 640.5,
          "label_x": 475.2,
          "label_y": 635.5,
          "label_centering": "right",
          "symbol_x": 480.2,
          "symbol_y": 640.5
        }
      },
      "fc_color_1": [
        254,
        250,
        243
      ],
      "fold_change_1": 0.118994,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        226,
        235,
        243
      ],
      "fold_change_2": -0.226291,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        250,
        251,
        252
      ],
      "fold_change_3": -0.0393083,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        246,
        233
      ],
      "fold_change_4": 0.2176,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        252,
        249
      ],
      "fold_change_5": 0.0532131,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q13188": {
      "label": "STK3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation (PubMed:11278283, PubMed:8566796, PubMed:8816758). Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714, PubMed:29063833, PubMed:30622739). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714). STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By similarity). Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosome, and its ability to phosphorylate CROCC and CEP250 (PubMed:21076410, PubMed:21723128). In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation (PubMed:21104395). Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259' (PubMed:20212043). Phosphorylates MOBKL1A and RASSF2 (PubMed:19525978). Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38 (PubMed:18328708, PubMed:18362890). {ECO:0000250|UniProtKB:Q9JI10, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18362890, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:20212043, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:21723128, ECO:0000269|PubMed:23972470, ECO:0000269|PubMed:28087714, ECO:0000269|PubMed:29063833, ECO:0000269|PubMed:30622739, ECO:0000269|PubMed:8566796, ECO:0000269|PubMed:8816758}.\",\"ACT_SITE 146; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation (PubMed:11278283, PubMed:8566796, PubMed:8816758). Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714, PubMed:29063833, PubMed:30622739). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714). STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By similarity). Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosome, and its ability to phosphorylate CROCC and CEP250 (PubMed:21076410, PubMed:21723128). In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation (PubMed:21104395). Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259' (PubMed:20212043). Phosphorylates MOBKL1A and RASSF2 (PubMed:19525978). Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38 (PubMed:18328708, PubMed:18362890). {ECO:0000250|UniProtKB:Q9JI10, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18362890, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:20212043, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:21723128, ECO:0000269|PubMed:23972470, ECO:0000269|PubMed:28087714, ECO:0000269|PubMed:29063833, ECO:0000269|PubMed:30622739, ECO:0000269|PubMed:8566796, ECO:0000269|PubMed:8816758}.\nT: Active site: ACT_SITE 146; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation (PubMed:11278283, PubMed:8566796, PubMed:8816758). Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714, PubMed:29063833, PubMed:30622739). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714). STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By similarity). Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosome, and its ability to phosphorylate CROCC and CEP250 (PubMed:21076410, PubMed:21723128). In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation (PubMed:21104395). Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on &#x27;Ser-259&#x27; (PubMed:20212043). Phosphorylates MOBKL1A and RASSF2 (PubMed:19525978). Phosphorylates MOBKL1B on &#x27;Thr-74&#x27;. Acts cooperatively with MOBKL1B to activate STK38 (PubMed:18328708, PubMed:18362890). {ECO:0000250|UniProtKB:Q9JI10, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18362890, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:20212043, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:21723128, ECO:0000269|PubMed:23972470, ECO:0000269|PubMed:28087714, ECO:0000269|PubMed:29063833, ECO:0000269|PubMed:30622739, ECO:0000269|PubMed:8566796, ECO:0000269|PubMed:8816758}.<br/><strong>T: Active site:</strong> ACT_SITE 146; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {
        "Q13188_384": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13188",
          "fc_color_1": [
            201,
            218,
            232
          ],
          "label": "384",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_2",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "x",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 8,
          "tooltip": "T: sequence: R.NAT#SPQVQRPSFM*DYFDK.Q\nPSP: ON_FUNCTION: molecular association, regulation; enzymatic activity, inhibited\nPSP: ON_PROCESS: apoptosis, altered; signaling pathway regulation\nPSP: ON_PROT_INTERACT: MST2(DISRUPTS); RASSF1(DISRUPTS); RAF1(INDUCES)\nPSP: in_vivo_kinases: Akt1\nPSP: in_vitro_kinases: Akt1",
          "tooltip_html": "<strong>T: sequence:</strong> R.NAT#SPQVQRPSFM*DYFDK.Q<br/><strong>PSP: ON_FUNCTION:</strong> molecular association, regulation; enzymatic activity, inhibited<br/><strong>PSP: ON_PROCESS:</strong> apoptosis, altered; signaling pathway regulation<br/><strong>PSP: ON_PROT_INTERACT:</strong> MST2(DISRUPTS); RASSF1(DISRUPTS); RAF1(INDUCES)<br/><strong>PSP: in_vivo_kinases:</strong> Akt1<br/><strong>PSP: in_vitro_kinases:</strong> Akt1",
          "fold_change_1": -0.421879,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            237,
            243,
            247
          ],
          "fold_change_2": -0.135628,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            226,
            235,
            243
          ],
          "fold_change_3": -0.223394,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            244,
            228
          ],
          "fold_change_4": 0.263665,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            242,
            246,
            250
          ],
          "fold_change_5": -0.0948876,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 480.2,
          "shape_y": 600.5,
          "label_x": 475.2,
          "label_y": 595.5,
          "label_centering": "right",
          "symbol_x": 479.9,
          "symbol_y": 600.5
        },
        "Q13188_316": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13188",
          "fc_color_1": [
            238,
            243,
            248
          ],
          "label": "316",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: R.ELEEEEENS#DEDELDSHTMVK.T\nPSP: ON_FUNCTION: molecular association, regulation\nPSP: ON_PROCESS: cell cycle regulation\nPSP: ON_PROT_INTERACT: NEK2(DISRUPTS)\nPSP: in_vivo_kinases: PLK1\nPSP: in_vitro_kinases: PLK1",
          "tooltip_html": "<strong>T: sequence:</strong> R.ELEEEEENS#DEDELDSHTMVK.T<br/><strong>PSP: ON_FUNCTION:</strong> molecular association, regulation<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation<br/><strong>PSP: ON_PROT_INTERACT:</strong> NEK2(DISRUPTS)<br/><strong>PSP: in_vivo_kinases:</strong> PLK1<br/><strong>PSP: in_vitro_kinases:</strong> PLK1",
          "fold_change_1": -0.133055,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            238,
            243,
            248
          ],
          "fold_change_2": -0.133039,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            243,
            224
          ],
          "fold_change_3": 0.309168,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            250,
            243
          ],
          "fold_change_4": 0.119914,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            254,
            252
          ],
          "fold_change_5": 0.0247559,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 507.8,
          "shape_y": 600.5,
          "label_x": 512.8,
          "label_y": 595.5,
          "label_centering": "left",
          "symbol_x": 507.7,
          "symbol_y": 600.5
        }
      },
      "fc_color_1": [
        254,
        229,
        188
      ],
      "fold_change_1": 0.663908,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        220,
        165
      ],
      "fold_change_2": 0.898121,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        247,
        235
      ],
      "fold_change_3": 0.194387,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        250,
        243
      ],
      "fold_change_4": 0.11757,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        242,
        223
      ],
      "fold_change_5": 0.320777,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q13043": {
      "label": "STK4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. {ECO:0000250|UniProtKB:Q9JI11, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:11517310, ECO:0000269|PubMed:12757711, ECO:0000269|PubMed:15109305, ECO:0000269|PubMed:16510573, ECO:0000269|PubMed:16751106, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:17932490, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18986304, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:21212262, ECO:0000269|PubMed:21245099, ECO:0000269|PubMed:21512132, ECO:0000269|PubMed:8702870, ECO:0000269|PubMed:8816758}.\",\"ACT_SITE 149; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. {ECO:0000250|UniProtKB:Q9JI11, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:11517310, ECO:0000269|PubMed:12757711, ECO:0000269|PubMed:15109305, ECO:0000269|PubMed:16510573, ECO:0000269|PubMed:16751106, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:17932490, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18986304, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:21212262, ECO:0000269|PubMed:21245099, ECO:0000269|PubMed:21512132, ECO:0000269|PubMed:8702870, ECO:0000269|PubMed:8816758}.\nT: Active site: ACT_SITE 149; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates &#x27;Ser-14&#x27; of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on &#x27;Ser-212&#x27; and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on &#x27;Ser-650&#x27; and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. {ECO:0000250|UniProtKB:Q9JI11, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:11517310, ECO:0000269|PubMed:12757711, ECO:0000269|PubMed:15109305, ECO:0000269|PubMed:16510573, ECO:0000269|PubMed:16751106, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:17932490, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18986304, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:21212262, ECO:0000269|PubMed:21245099, ECO:0000269|PubMed:21512132, ECO:0000269|PubMed:8702870, ECO:0000269|PubMed:8816758}.<br/><strong>T: Active site:</strong> ACT_SITE 149; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {
        "Q13043_414": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13043",
          "fc_color_1": [
            253,
            179,
            56
          ],
          "label": "414",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.S#VPGPLK.N",
          "tooltip_html": "<strong>T: sequence:</strong> K.S#VPGPLK.N",
          "fold_change_1": 3.65869,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            231,
            194
          ],
          "fold_change_2": 0.611612,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            233,
            198
          ],
          "fold_change_3": 0.571255,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            225,
            178
          ],
          "fold_change_4": 0.771735,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            218,
            159
          ],
          "fold_change_5": 0.960097,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 480.2,
          "shape_y": 600.5,
          "label_x": 475.2,
          "label_y": 595.5,
          "label_centering": "right",
          "symbol_x": 480.2,
          "symbol_y": 600.5
        },
        "Q13043_410": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13043",
          "fc_color_1": [
            253,
            205,
            126
          ],
          "label": "410",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.ENQINS#FGK.S",
          "tooltip_html": "<strong>T: sequence:</strong> K.ENQINS#FGK.S",
          "fold_change_1": 1.29366,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            201,
            217,
            232
          ],
          "fold_change_2": -0.426087,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            242,
            223
          ],
          "fold_change_3": 0.316633,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            254,
            252
          ],
          "fold_change_4": 0.0248859,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            219,
            230,
            240
          ],
          "fold_change_5": -0.278001,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 507.8,
          "shape_y": 600.5,
          "label_x": 512.8,
          "label_y": 595.5,
          "label_centering": "left",
          "symbol_x": 507.8,
          "symbol_y": 600.5
        }
      },
      "fc_color_1": [
        254,
        230,
        191
      ],
      "fold_change_1": 0.635257,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        228,
        184
      ],
      "fold_change_2": 0.708697,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        251,
        244
      ],
      "fold_change_3": 0.101613,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        246,
        231
      ],
      "fold_change_4": 0.23585,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        244,
        228
      ],
      "fold_change_5": 0.268504,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9BQ95": {
      "label": "ECSIT",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Adapter protein that plays a role in different signaling pathways including TLRs and IL-1 pathways or innate antiviral induction signaling. Plays a role in the activation of NF-kappa-B by forming a signal complex with TRAF6 and TAK1/MAP3K7 to activate TAK1/MAP3K7 leading to activation of IKKs (PubMed:25355951, PubMed:31281713). Once ubiquitinated, interacts with the dissociated RELA and NFKB1 proteins and translocates to the nucleus where it induces NF-kappa-B-dependent gene expression (PubMed:25355951). Plays a role in innate antiviral immune response by bridging the pattern recognition receptors RIGI and MDA5/IFIT1 to the MAVS complex at the mitochondrion (PubMed:25228397). Promotes proteolytic activation of MAP3K1. Involved in the BMP signaling pathway. Required for normal embryonic development (By similarity). {ECO:0000250, ECO:0000269|PubMed:25228397, ECO:0000269|PubMed:25355951, ECO:0000269|PubMed:31281713}.; FUNCTION: As part of the MCIA complex, involved in the assembly of the mitochondrial complex I. {ECO:0000269|PubMed:32320651}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Adapter protein that plays a role in different signaling pathways including TLRs and IL-1 pathways or innate antiviral induction signaling. Plays a role in the activation of NF-kappa-B by forming a signal complex with TRAF6 and TAK1/MAP3K7 to activate TAK1/MAP3K7 leading to activation of IKKs (PubMed:25355951, PubMed:31281713). Once ubiquitinated, interacts with the dissociated RELA and NFKB1 proteins and translocates to the nucleus where it induces NF-kappa-B-dependent gene expression (PubMed:25355951). Plays a role in innate antiviral immune response by bridging the pattern recognition receptors RIGI and MDA5/IFIT1 to the MAVS complex at the mitochondrion (PubMed:25228397). Promotes proteolytic activation of MAP3K1. Involved in the BMP signaling pathway. Required for normal embryonic development (By similarity). {ECO:0000250, ECO:0000269|PubMed:25228397, ECO:0000269|PubMed:25355951, ECO:0000269|PubMed:31281713}.; FUNCTION: As part of the MCIA complex, involved in the assembly of the mitochondrial complex I. {ECO:0000269|PubMed:32320651}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Adapter protein that plays a role in different signaling pathways including TLRs and IL-1 pathways or innate antiviral induction signaling. Plays a role in the activation of NF-kappa-B by forming a signal complex with TRAF6 and TAK1/MAP3K7 to activate TAK1/MAP3K7 leading to activation of IKKs (PubMed:25355951, PubMed:31281713). Once ubiquitinated, interacts with the dissociated RELA and NFKB1 proteins and translocates to the nucleus where it induces NF-kappa-B-dependent gene expression (PubMed:25355951). Plays a role in innate antiviral immune response by bridging the pattern recognition receptors RIGI and MDA5/IFIT1 to the MAVS complex at the mitochondrion (PubMed:25228397). Promotes proteolytic activation of MAP3K1. Involved in the BMP signaling pathway. Required for normal embryonic development (By similarity). {ECO:0000250, ECO:0000269|PubMed:25228397, ECO:0000269|PubMed:25355951, ECO:0000269|PubMed:31281713}.; FUNCTION: As part of the MCIA complex, involved in the assembly of the mitochondrial complex I. {ECO:0000269|PubMed:32320651}.",
      "PTMs": {},
      "fc_color_1": [
        192,
        212,
        229
      ],
      "fold_change_1": -0.491945,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        172,
        198,
        220
      ],
      "fold_change_2": -0.654955,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        189,
        209,
        227
      ],
      "fold_change_3": -0.518924,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        217,
        228,
        239
      ],
      "fold_change_4": -0.299834,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        190,
        210,
        228
      ],
      "fold_change_5": -0.511433,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9NYJ8": {
      "label": "TAB2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020, PubMed:33184450, PubMed:36681779). Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to 'Lys-63'-linked polyubiquitin chains (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020). The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63'-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 (PubMed:15327770, PubMed:18079694, PubMed:22158122). Also recognizes and binds Lys-63'-linked polyubiquitin chains of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains (PubMed:27746020). Regulates the IL1-mediated translocation of NCOR1 out of the nucleus (By similarity). Involved in heart development (PubMed:20493459). {ECO:0000250|UniProtKB:Q99K90, ECO:0000269|PubMed:10882101, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:15327770, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:20493459, ECO:0000269|PubMed:22158122, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:33184450, ECO:0000269|PubMed:36681779}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020, PubMed:33184450, PubMed:36681779). Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to 'Lys-63'-linked polyubiquitin chains (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020). The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63'-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 (PubMed:15327770, PubMed:18079694, PubMed:22158122). Also recognizes and binds Lys-63'-linked polyubiquitin chains of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains (PubMed:27746020). Regulates the IL1-mediated translocation of NCOR1 out of the nucleus (By similarity). Involved in heart development (PubMed:20493459). {ECO:0000250|UniProtKB:Q99K90, ECO:0000269|PubMed:10882101, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:15327770, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:20493459, ECO:0000269|PubMed:22158122, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:33184450, ECO:0000269|PubMed:36681779}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of &#x27;Lys-63&#x27;-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020, PubMed:33184450, PubMed:36681779). Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to &#x27;Lys-63&#x27;-linked polyubiquitin chains (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020). The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63&#x27;-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 (PubMed:15327770, PubMed:18079694, PubMed:22158122). Also recognizes and binds Lys-63&#x27;-linked polyubiquitin chains of heterotypic &#x27;Lys-63&#x27;-/&#x27;Lys-48&#x27;-linked branched ubiquitin chains (PubMed:27746020). Regulates the IL1-mediated translocation of NCOR1 out of the nucleus (By similarity). Involved in heart development (PubMed:20493459). {ECO:0000250|UniProtKB:Q99K90, ECO:0000269|PubMed:10882101, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:15327770, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:20493459, ECO:0000269|PubMed:22158122, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:33184450, ECO:0000269|PubMed:36681779}.",
      "PTMs": {
        "Q9NYJ8_524": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9NYJ8",
          "fc_color_1": [
            149,
            182,
            211
          ],
          "label": "524",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.KLS#M*GSDDAAYTQALLVHQK.A",
          "tooltip_html": "<strong>T: sequence:</strong> R.KLS#M*GSDDAAYTQALLVHQK.A",
          "fold_change_1": -0.830977,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            248,
            237
          ],
          "fold_change_2": 0.173364,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            250,
            243
          ],
          "fold_change_3": 0.119922,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            252,
            253,
            253
          ],
          "fold_change_4": -0.0221602,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            238,
            212
          ],
          "fold_change_5": 0.424345,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "W1",
          "shape_x": 400.0,
          "shape_y": 749.11,
          "label_x": 395.0,
          "label_y": 747.11,
          "label_centering": "right",
          "symbol_x": 400.0,
          "symbol_y": 749.11
        },
        "Q9NYJ8_580": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9NYJ8",
          "fc_color_1": [
            254,
            240,
            217
          ],
          "label": "580",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.S#NSISQIPSLEEM*QQLR.S",
          "tooltip_html": "<strong>T: sequence:</strong> R.S#NSISQIPSLEEM*QQLR.S",
          "fold_change_1": 0.381284,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            214,
            147
          ],
          "fold_change_2": 1.07585,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            219,
            162
          ],
          "fold_change_3": 0.928141,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            238,
            212
          ],
          "fold_change_4": 0.431172,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            240,
            216
          ],
          "fold_change_5": 0.387435,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "E1",
          "shape_x": 454.0,
          "shape_y": 749.11,
          "label_x": 459.0,
          "label_y": 747.11,
          "label_centering": "left",
          "symbol_x": 454.0,
          "symbol_y": 749.11
        }
      },
      "fc_color_1": [
        254,
        254,
        254
      ],
      "fold_change_1": 0.00699544,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        236,
        242,
        247
      ],
      "fold_change_2": -0.146208,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        253,
        250
      ],
      "fold_change_3": 0.0422728,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        246,
        233
      ],
      "fold_change_4": 0.215169,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        253,
        251
      ],
      "fold_change_5": 0.0327804,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q15750": {
      "label": "TAB1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Key adapter protein that plays an essential role in JNK and NF-kappa-B activation and proinflammatory cytokines production in response to stimulation with TLRs and cytokines (PubMed:22307082, PubMed:24403530). Mechanistically, associates with the catalytic domain of MAP3K7/TAK1 to trigger MAP3K7/TAK1 autophosphorylation leading to its full activation (PubMed:10838074, PubMed:25260751, PubMed:37832545). Similarly, associates with MAPK14 and triggers its autophosphorylation and subsequent activation (PubMed:11847341, PubMed:29229647). In turn, MAPK14 phosphorylates TAB1 and inhibits MAP3K7/TAK1 activation in a feedback control mechanism (PubMed:14592977). Also plays a role in recruiting MAPK14 to the TAK1 complex for the phosphorylation of the TAB2 and TAB3 regulatory subunits (PubMed:18021073). {ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:11847341, ECO:0000269|PubMed:14592977, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:22307082, ECO:0000269|PubMed:24403530, ECO:0000269|PubMed:25260751, ECO:0000269|PubMed:29229647, ECO:0000269|PubMed:37832545}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Key adapter protein that plays an essential role in JNK and NF-kappa-B activation and proinflammatory cytokines production in response to stimulation with TLRs and cytokines (PubMed:22307082, PubMed:24403530). Mechanistically, associates with the catalytic domain of MAP3K7/TAK1 to trigger MAP3K7/TAK1 autophosphorylation leading to its full activation (PubMed:10838074, PubMed:25260751, PubMed:37832545). Similarly, associates with MAPK14 and triggers its autophosphorylation and subsequent activation (PubMed:11847341, PubMed:29229647). In turn, MAPK14 phosphorylates TAB1 and inhibits MAP3K7/TAK1 activation in a feedback control mechanism (PubMed:14592977). Also plays a role in recruiting MAPK14 to the TAK1 complex for the phosphorylation of the TAB2 and TAB3 regulatory subunits (PubMed:18021073). {ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:11847341, ECO:0000269|PubMed:14592977, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:22307082, ECO:0000269|PubMed:24403530, ECO:0000269|PubMed:25260751, ECO:0000269|PubMed:29229647, ECO:0000269|PubMed:37832545}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Key adapter protein that plays an essential role in JNK and NF-kappa-B activation and proinflammatory cytokines production in response to stimulation with TLRs and cytokines (PubMed:22307082, PubMed:24403530). Mechanistically, associates with the catalytic domain of MAP3K7/TAK1 to trigger MAP3K7/TAK1 autophosphorylation leading to its full activation (PubMed:10838074, PubMed:25260751, PubMed:37832545). Similarly, associates with MAPK14 and triggers its autophosphorylation and subsequent activation (PubMed:11847341, PubMed:29229647). In turn, MAPK14 phosphorylates TAB1 and inhibits MAP3K7/TAK1 activation in a feedback control mechanism (PubMed:14592977). Also plays a role in recruiting MAPK14 to the TAK1 complex for the phosphorylation of the TAB2 and TAB3 regulatory subunits (PubMed:18021073). {ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:11847341, ECO:0000269|PubMed:14592977, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:22307082, ECO:0000269|PubMed:24403530, ECO:0000269|PubMed:25260751, ECO:0000269|PubMed:29229647, ECO:0000269|PubMed:37832545}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        246,
        233
      ],
      "fold_change_1": 0.214725,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        208,
        222,
        235
      ],
      "fold_change_2": -0.368952,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        249,
        251,
        252
      ],
      "fold_change_3": -0.042222,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        254,
        253
      ],
      "fold_change_4": 0.0128124,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        249,
        240
      ],
      "fold_change_5": 0.142573,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_99": {
      "label": "GADD45G",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_100": {
      "label": "TRAF6",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9UER7": {
      "label": "DAXX",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Transcription corepressor known to repress transcriptional potential of several sumoylated transcription factors. Down-regulates basal and activated transcription. Its transcription repressor activity is modulated by recruiting it to subnuclear compartments like the nucleolus or PML/POD/ND10 nuclear bodies through interactions with MCSR1 and PML, respectively. Seems to regulate transcription in PML/POD/ND10 nuclear bodies together with PML and may influence TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional activation of PAX3 and ETS1 through direct protein-protein interactions. Modulates PAX5 activity; the function seems to involve CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by regulating the RING-finger E3 ligase MDM2 ubiquitination activity. Under non-stress condition, in association with the deubiquitinating USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3 ligase activity of MDM2 towards TP53, thereby promoting TP53 ubiquitination and subsequent proteasomal degradation. Upon DNA damage, its association with MDM2 and USP7 is disrupted, resulting in increased MDM2 autoubiquitination and consequently, MDM2 degradation, which leads to TP53 stabilization. Acts as a histone chaperone that facilitates deposition of histone H3.3. Acts as a targeting component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Does not affect the ATPase activity of ATRX but alleviates its transcription repression activity. Upon neuronal activation associates with regulatory elements of selected immediate early genes where it promotes deposition of histone H3.3 which may be linked to transcriptional induction of these genes. Required for the recruitment of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested to function as regulatory sites for the incorporation of newly synthesized histone H3.3 into chromatin. In case of overexpression of centromeric histone variant CENPA (as found in various tumors) is involved in its mislocalization to chromosomes; the ectopic localization involves a heterotypic tetramer containing CENPA, and histones H3.3 and H4 and decreases binding of CTCF to chromatin. Proposed to mediate activation of the JNK pathway and apoptosis via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may not involve DAXX. Shows restriction activity towards human cytomegalovirus (HCMV). Plays a role as a positive regulator of the heat shock transcription factor HSF1 activity during the stress protein response (PubMed:15016915). {ECO:0000269|PubMed:12140263, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:15016915, ECO:0000269|PubMed:15364927, ECO:0000269|PubMed:16845383, ECO:0000269|PubMed:17081986, ECO:0000269|PubMed:17942542, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:23222847, ECO:0000269|PubMed:24200965, ECO:0000269|PubMed:24530302}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Transcription corepressor known to repress transcriptional potential of several sumoylated transcription factors. Down-regulates basal and activated transcription. Its transcription repressor activity is modulated by recruiting it to subnuclear compartments like the nucleolus or PML/POD/ND10 nuclear bodies through interactions with MCSR1 and PML, respectively. Seems to regulate transcription in PML/POD/ND10 nuclear bodies together with PML and may influence TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional activation of PAX3 and ETS1 through direct protein-protein interactions. Modulates PAX5 activity; the function seems to involve CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by regulating the RING-finger E3 ligase MDM2 ubiquitination activity. Under non-stress condition, in association with the deubiquitinating USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3 ligase activity of MDM2 towards TP53, thereby promoting TP53 ubiquitination and subsequent proteasomal degradation. Upon DNA damage, its association with MDM2 and USP7 is disrupted, resulting in increased MDM2 autoubiquitination and consequently, MDM2 degradation, which leads to TP53 stabilization. Acts as a histone chaperone that facilitates deposition of histone H3.3. Acts as a targeting component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Does not affect the ATPase activity of ATRX but alleviates its transcription repression activity. Upon neuronal activation associates with regulatory elements of selected immediate early genes where it promotes deposition of histone H3.3 which may be linked to transcriptional induction of these genes. Required for the recruitment of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested to function as regulatory sites for the incorporation of newly synthesized histone H3.3 into chromatin. In case of overexpression of centromeric histone variant CENPA (as found in various tumors) is involved in its mislocalization to chromosomes; the ectopic localization involves a heterotypic tetramer containing CENPA, and histones H3.3 and H4 and decreases binding of CTCF to chromatin. Proposed to mediate activation of the JNK pathway and apoptosis via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may not involve DAXX. Shows restriction activity towards human cytomegalovirus (HCMV). Plays a role as a positive regulator of the heat shock transcription factor HSF1 activity during the stress protein response (PubMed:15016915). {ECO:0000269|PubMed:12140263, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:15016915, ECO:0000269|PubMed:15364927, ECO:0000269|PubMed:16845383, ECO:0000269|PubMed:17081986, ECO:0000269|PubMed:17942542, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:23222847, ECO:0000269|PubMed:24200965, ECO:0000269|PubMed:24530302}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription corepressor known to repress transcriptional potential of several sumoylated transcription factors. Down-regulates basal and activated transcription. Its transcription repressor activity is modulated by recruiting it to subnuclear compartments like the nucleolus or PML/POD/ND10 nuclear bodies through interactions with MCSR1 and PML, respectively. Seems to regulate transcription in PML/POD/ND10 nuclear bodies together with PML and may influence TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional activation of PAX3 and ETS1 through direct protein-protein interactions. Modulates PAX5 activity; the function seems to involve CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by regulating the RING-finger E3 ligase MDM2 ubiquitination activity. Under non-stress condition, in association with the deubiquitinating USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3 ligase activity of MDM2 towards TP53, thereby promoting TP53 ubiquitination and subsequent proteasomal degradation. Upon DNA damage, its association with MDM2 and USP7 is disrupted, resulting in increased MDM2 autoubiquitination and consequently, MDM2 degradation, which leads to TP53 stabilization. Acts as a histone chaperone that facilitates deposition of histone H3.3. Acts as a targeting component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Does not affect the ATPase activity of ATRX but alleviates its transcription repression activity. Upon neuronal activation associates with regulatory elements of selected immediate early genes where it promotes deposition of histone H3.3 which may be linked to transcriptional induction of these genes. Required for the recruitment of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested to function as regulatory sites for the incorporation of newly synthesized histone H3.3 into chromatin. In case of overexpression of centromeric histone variant CENPA (as found in various tumors) is involved in its mislocalization to chromosomes; the ectopic localization involves a heterotypic tetramer containing CENPA, and histones H3.3 and H4 and decreases binding of CTCF to chromatin. Proposed to mediate activation of the JNK pathway and apoptosis via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may not involve DAXX. Shows restriction activity towards human cytomegalovirus (HCMV). Plays a role as a positive regulator of the heat shock transcription factor HSF1 activity during the stress protein response (PubMed:15016915). {ECO:0000269|PubMed:12140263, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:15016915, ECO:0000269|PubMed:15364927, ECO:0000269|PubMed:16845383, ECO:0000269|PubMed:17081986, ECO:0000269|PubMed:17942542, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:23222847, ECO:0000269|PubMed:24200965, ECO:0000269|PubMed:24530302}.",
      "PTMs": {
        "Q9UER7_671": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9UER7",
          "fc_color_1": [
            117,
            160,
            198
          ],
          "label": "671",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.ICTLPSPPS#PLASLAPVADSSTR.V",
          "tooltip_html": "<strong>T: sequence:</strong> K.ICTLPSPPS#PLASLAPVADSSTR.V",
          "fold_change_1": -1.0836,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            185,
            207,
            226
          ],
          "fold_change_2": -0.551347,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            250,
            242
          ],
          "fold_change_3": 0.127143,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            246,
            233
          ],
          "fold_change_4": 0.215369,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            240,
            244,
            248
          ],
          "fold_change_5": -0.117275,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 441.2,
          "shape_y": 690.5,
          "label_x": 436.2,
          "label_y": 685.5,
          "label_centering": "right",
          "symbol_x": 441.2,
          "symbol_y": 690.5
        },
        "Q9UER7_495": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9UER7",
          "fc_color_1": [
            152,
            184,
            212
          ],
          "label": "495",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.S#PM*SSLQISNEK.N",
          "tooltip_html": "<strong>T: sequence:</strong> K.S#PM*SSLQISNEK.N",
          "fold_change_1": -0.810253,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            188,
            209,
            227
          ],
          "fold_change_2": -0.525695,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            243,
            226
          ],
          "fold_change_3": 0.289814,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            251,
            246
          ],
          "fold_change_4": 0.0848965,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            248,
            238
          ],
          "fold_change_5": 0.166833,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N2",
          "shape_x": 455.0,
          "shape_y": 690.5,
          "label_x": 455.0,
          "label_y": 682.5,
          "label_centering": "center",
          "symbol_x": 455.0,
          "symbol_y": 690.5
        },
        "Q9UER7_213": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9UER7",
          "fc_color_1": [
            157,
            188,
            214
          ],
          "label": "213",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.ELDLS#ELDDPDSAYLQEAR.L",
          "tooltip_html": "<strong>T: sequence:</strong> K.ELDLS#ELDDPDSAYLQEAR.L",
          "fold_change_1": -0.768226,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            227,
            236,
            243
          ],
          "fold_change_2": -0.21513,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            248,
            238
          ],
          "fold_change_3": 0.167426,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            241,
            219
          ],
          "fold_change_4": 0.356488,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            254,
            254
          ],
          "fold_change_5": 0.00289037,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 468.8,
          "shape_y": 690.5,
          "label_x": 473.8,
          "label_y": 685.5,
          "label_centering": "left",
          "symbol_x": 468.8,
          "symbol_y": 690.5
        },
        "Q9UER7_688": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9UER7",
          "fc_color_1": [
            178,
            202,
            223
          ],
          "label": "688",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.VDS#PSHGLVTSSLCIPSPAR.L",
          "tooltip_html": "<strong>T: sequence:</strong> R.VDS#PSHGLVTSSLCIPSPAR.L",
          "fold_change_1": -0.605738,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            222,
            232,
            241
          ],
          "fold_change_2": -0.258353,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            246,
            232
          ],
          "fold_change_3": 0.225073,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            232,
            194
          ],
          "fold_change_4": 0.604566,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            251,
            246
          ],
          "fold_change_5": 0.081486,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 441.2,
          "shape_y": 715.5,
          "label_x": 436.2,
          "label_y": 720.5,
          "label_centering": "right",
          "symbol_x": 441.2,
          "symbol_y": 715.5
        }
      },
      "fc_color_1": [
        254,
        239,
        215
      ],
      "fold_change_1": 0.395347,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        247,
        236
      ],
      "fold_change_2": 0.185471,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        215,
        227,
        238
      ],
      "fold_change_3": -0.313529,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        211,
        224,
        236
      ],
      "fold_change_4": -0.347623,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        223,
        233,
        241
      ],
      "fold_change_5": -0.251362,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q12933": {
      "label": "TRAF2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: E3 ubiquitin-protein ligase that regulates activation of NF-kappa-B and JNK and plays a central role in the regulation of cell survival and apoptosis (PubMed:10346818, PubMed:11784851, PubMed:12917689, PubMed:15383523, PubMed:18981220, PubMed:19150425, PubMed:19810754, PubMed:19918265, PubMed:19937093, PubMed:20047764, PubMed:20064526, PubMed:20385093, PubMed:20577214, PubMed:22212761). Catalyzes 'Lys-63'-linked ubiquitination of target proteins, such as BIRC3, IKBKE, MLST8, RIPK1 and TICAM1 (PubMed:23453969, PubMed:28489822). Is an essential constituent of several E3 ubiquitin-protein ligase complexes, where it promotes the ubiquitination of target proteins by bringing them into contact with other E3 ubiquitin ligases (PubMed:15383523, PubMed:18981220). Regulates BIRC2 and BIRC3 protein levels by inhibiting their autoubiquitination and subsequent degradation; this does not depend on the TRAF2 RING-type zinc finger domain (PubMed:11907583, PubMed:19506082). Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR (PubMed:15121867). In complex with BIRC2 or BIRC3, promotes ubiquitination of IKBKE (PubMed:23453969). Acts as a regulator of mTORC1 and mTORC2 assembly by mediating 'Lys-63'-linked ubiquitination of MLST8, thereby inhibiting formation of the mTORC2 complex, while facilitating assembly of the mTORC1 complex (PubMed:28489822). Required for normal antibody isotype switching from IgM to IgG (By similarity). {ECO:0000250|UniProtKB:P39429, ECO:0000269|PubMed:10346818, ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:11907583, ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:15121867, ECO:0000269|PubMed:15383523, ECO:0000269|PubMed:18981220, ECO:0000269|PubMed:19150425, ECO:0000269|PubMed:19506082, ECO:0000269|PubMed:19810754, ECO:0000269|PubMed:19918265, ECO:0000269|PubMed:19937093, ECO:0000269|PubMed:20047764, ECO:0000269|PubMed:20064526, ECO:0000269|PubMed:20385093, ECO:0000269|PubMed:20577214, ECO:0000269|PubMed:22212761, ECO:0000269|PubMed:23453969, ECO:0000269|PubMed:28489822}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: E3 ubiquitin-protein ligase that regulates activation of NF-kappa-B and JNK and plays a central role in the regulation of cell survival and apoptosis (PubMed:10346818, PubMed:11784851, PubMed:12917689, PubMed:15383523, PubMed:18981220, PubMed:19150425, PubMed:19810754, PubMed:19918265, PubMed:19937093, PubMed:20047764, PubMed:20064526, PubMed:20385093, PubMed:20577214, PubMed:22212761). Catalyzes 'Lys-63'-linked ubiquitination of target proteins, such as BIRC3, IKBKE, MLST8, RIPK1 and TICAM1 (PubMed:23453969, PubMed:28489822). Is an essential constituent of several E3 ubiquitin-protein ligase complexes, where it promotes the ubiquitination of target proteins by bringing them into contact with other E3 ubiquitin ligases (PubMed:15383523, PubMed:18981220). Regulates BIRC2 and BIRC3 protein levels by inhibiting their autoubiquitination and subsequent degradation; this does not depend on the TRAF2 RING-type zinc finger domain (PubMed:11907583, PubMed:19506082). Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR (PubMed:15121867). In complex with BIRC2 or BIRC3, promotes ubiquitination of IKBKE (PubMed:23453969). Acts as a regulator of mTORC1 and mTORC2 assembly by mediating 'Lys-63'-linked ubiquitination of MLST8, thereby inhibiting formation of the mTORC2 complex, while facilitating assembly of the mTORC1 complex (PubMed:28489822). Required for normal antibody isotype switching from IgM to IgG (By similarity). {ECO:0000250|UniProtKB:P39429, ECO:0000269|PubMed:10346818, ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:11907583, ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:15121867, ECO:0000269|PubMed:15383523, ECO:0000269|PubMed:18981220, ECO:0000269|PubMed:19150425, ECO:0000269|PubMed:19506082, ECO:0000269|PubMed:19810754, ECO:0000269|PubMed:19918265, ECO:0000269|PubMed:19937093, ECO:0000269|PubMed:20047764, ECO:0000269|PubMed:20064526, ECO:0000269|PubMed:20385093, ECO:0000269|PubMed:20577214, ECO:0000269|PubMed:22212761, ECO:0000269|PubMed:23453969, ECO:0000269|PubMed:28489822}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: E3 ubiquitin-protein ligase that regulates activation of NF-kappa-B and JNK and plays a central role in the regulation of cell survival and apoptosis (PubMed:10346818, PubMed:11784851, PubMed:12917689, PubMed:15383523, PubMed:18981220, PubMed:19150425, PubMed:19810754, PubMed:19918265, PubMed:19937093, PubMed:20047764, PubMed:20064526, PubMed:20385093, PubMed:20577214, PubMed:22212761). Catalyzes &#x27;Lys-63&#x27;-linked ubiquitination of target proteins, such as BIRC3, IKBKE, MLST8, RIPK1 and TICAM1 (PubMed:23453969, PubMed:28489822). Is an essential constituent of several E3 ubiquitin-protein ligase complexes, where it promotes the ubiquitination of target proteins by bringing them into contact with other E3 ubiquitin ligases (PubMed:15383523, PubMed:18981220). Regulates BIRC2 and BIRC3 protein levels by inhibiting their autoubiquitination and subsequent degradation; this does not depend on the TRAF2 RING-type zinc finger domain (PubMed:11907583, PubMed:19506082). Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR (PubMed:15121867). In complex with BIRC2 or BIRC3, promotes ubiquitination of IKBKE (PubMed:23453969). Acts as a regulator of mTORC1 and mTORC2 assembly by mediating &#x27;Lys-63&#x27;-linked ubiquitination of MLST8, thereby inhibiting formation of the mTORC2 complex, while facilitating assembly of the mTORC1 complex (PubMed:28489822). Required for normal antibody isotype switching from IgM to IgG (By similarity). {ECO:0000250|UniProtKB:P39429, ECO:0000269|PubMed:10346818, ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:11907583, ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:15121867, ECO:0000269|PubMed:15383523, ECO:0000269|PubMed:18981220, ECO:0000269|PubMed:19150425, ECO:0000269|PubMed:19506082, ECO:0000269|PubMed:19810754, ECO:0000269|PubMed:19918265, ECO:0000269|PubMed:19937093, ECO:0000269|PubMed:20047764, ECO:0000269|PubMed:20064526, ECO:0000269|PubMed:20385093, ECO:0000269|PubMed:20577214, ECO:0000269|PubMed:22212761, ECO:0000269|PubMed:23453969, ECO:0000269|PubMed:28489822}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        235,
        203
      ],
      "fold_change_1": 0.512805,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        220,
        164
      ],
      "fold_change_2": 0.911631,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        246,
        231
      ],
      "fold_change_3": 0.233276,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        240,
        216
      ],
      "fold_change_4": 0.387118,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        245,
        229
      ],
      "fold_change_5": 0.259752,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P42574": {
      "label": "CASP3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:35338844, PubMed:35446120, PubMed:7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond (PubMed:10497198, PubMed:16374543, PubMed:7596430, PubMed:7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed:7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed:37993714, PubMed:9334240). Involved in the cleavage of huntingtin (PubMed:8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed:21357690). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed:23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed:30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed:35338844, PubMed:35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed:23845944, PubMed:33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed:36758104, PubMed:36758106). {ECO:0000250|UniProtKB:Q60431, ECO:0000269|PubMed:10497198, ECO:0000269|PubMed:16374543, ECO:0000269|PubMed:18723680, ECO:0000269|PubMed:20566630, ECO:0000269|PubMed:21357690, ECO:0000269|PubMed:23152800, ECO:0000269|PubMed:23650375, ECO:0000269|PubMed:23845944, ECO:0000269|PubMed:30878284, ECO:0000269|PubMed:33725486, ECO:0000269|PubMed:35338844, ECO:0000269|PubMed:35446120, ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758106, ECO:0000269|PubMed:37993714, ECO:0000269|PubMed:7596430, ECO:0000269|PubMed:7774019, ECO:0000269|PubMed:8696339, ECO:0000269|PubMed:9334240}.\",\"ACT_SITE 121; /evidence=\"ECO:0000250|UniProtKB:P29466\"; ACT_SITE 163; /evidence=\"ECO:0000250|UniProtKB:P29466\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:35338844, PubMed:35446120, PubMed:7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond (PubMed:10497198, PubMed:16374543, PubMed:7596430, PubMed:7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed:7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed:37993714, PubMed:9334240). Involved in the cleavage of huntingtin (PubMed:8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed:21357690). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed:23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed:30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed:35338844, PubMed:35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed:23845944, PubMed:33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed:36758104, PubMed:36758106). {ECO:0000250|UniProtKB:Q60431, ECO:0000269|PubMed:10497198, ECO:0000269|PubMed:16374543, ECO:0000269|PubMed:18723680, ECO:0000269|PubMed:20566630, ECO:0000269|PubMed:21357690, ECO:0000269|PubMed:23152800, ECO:0000269|PubMed:23650375, ECO:0000269|PubMed:23845944, ECO:0000269|PubMed:30878284, ECO:0000269|PubMed:33725486, ECO:0000269|PubMed:35338844, ECO:0000269|PubMed:35446120, ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758106, ECO:0000269|PubMed:37993714, ECO:0000269|PubMed:7596430, ECO:0000269|PubMed:7774019, ECO:0000269|PubMed:8696339, ECO:0000269|PubMed:9334240}.\nT: Active site: ACT_SITE 121; /evidence=\"ECO:0000250|UniProtKB:P29466\"; ACT_SITE 163; /evidence=\"ECO:0000250|UniProtKB:P29466\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:35338844, PubMed:35446120, PubMed:7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a &#x27;216-Asp-|-Gly-217&#x27; bond (PubMed:10497198, PubMed:16374543, PubMed:7596430, PubMed:7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed:7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed:37993714, PubMed:9334240). Involved in the cleavage of huntingtin (PubMed:8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed:21357690). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed:23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed:30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed:35338844, PubMed:35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed:23845944, PubMed:33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed:36758104, PubMed:36758106). {ECO:0000250|UniProtKB:Q60431, ECO:0000269|PubMed:10497198, ECO:0000269|PubMed:16374543, ECO:0000269|PubMed:18723680, ECO:0000269|PubMed:20566630, ECO:0000269|PubMed:21357690, ECO:0000269|PubMed:23152800, ECO:0000269|PubMed:23650375, ECO:0000269|PubMed:23845944, ECO:0000269|PubMed:30878284, ECO:0000269|PubMed:33725486, ECO:0000269|PubMed:35338844, ECO:0000269|PubMed:35446120, ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758106, ECO:0000269|PubMed:37993714, ECO:0000269|PubMed:7596430, ECO:0000269|PubMed:7774019, ECO:0000269|PubMed:8696339, ECO:0000269|PubMed:9334240}.<br/><strong>T: Active site:</strong> ACT_SITE 121; /evidence=&quot;ECO:0000250|UniProtKB:P29466&quot;; ACT_SITE 163; /evidence=&quot;ECO:0000250|UniProtKB:P29466&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        219,
        161
      ],
      "fold_change_1": 0.93911,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        198,
        108
      ],
      "fold_change_2": 1.47563,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        220,
        164
      ],
      "fold_change_3": 0.91388,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        233,
        199
      ],
      "fold_change_4": 0.556549,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        253,
        207,
        130
      ],
      "fold_change_5": 1.25316,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_104": {
      "label": "CD14",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P36897": {
      "label": "TGFR1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis (PubMed:33914044). The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation. {ECO:0000269|PubMed:15761148, ECO:0000269|PubMed:16754747, ECO:0000269|PubMed:18758450, ECO:0000269|PubMed:33914044, ECO:0000269|PubMed:7774578, ECO:0000269|PubMed:8752209, ECO:0000269|PubMed:8980228, ECO:0000269|PubMed:9346908}.\",\"ACT_SITE 333; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis (PubMed:33914044). The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation. {ECO:0000269|PubMed:15761148, ECO:0000269|PubMed:16754747, ECO:0000269|PubMed:18758450, ECO:0000269|PubMed:33914044, ECO:0000269|PubMed:7774578, ECO:0000269|PubMed:8752209, ECO:0000269|PubMed:8980228, ECO:0000269|PubMed:9346908}.\nT: Active site: ACT_SITE 333; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis (PubMed:33914044). The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation. {ECO:0000269|PubMed:15761148, ECO:0000269|PubMed:16754747, ECO:0000269|PubMed:18758450, ECO:0000269|PubMed:33914044, ECO:0000269|PubMed:7774578, ECO:0000269|PubMed:8752209, ECO:0000269|PubMed:8980228, ECO:0000269|PubMed:9346908}.<br/><strong>T: Active site:</strong> ACT_SITE 333; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        217,
        229,
        239
      ],
      "fold_change_1": -0.295676,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        228,
        237,
        244
      ],
      "fold_change_2": -0.206672,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        247,
        234
      ],
      "fold_change_3": 0.208077,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        248
      ],
      "fold_change_4": 0.0684247,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        252,
        247
      ],
      "fold_change_5": 0.0723789,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P37173": {
      "label": "TGFR2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and thus regulates a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. {ECO:0000269|PubMed:7774578}.; FUNCTION: [Isoform 1]: Has transforming growth factor beta-activated receptor activity. {ECO:0000269|PubMed:8635485}.; FUNCTION: [Isoform 2]: Has transforming growth factor beta-activated receptor activity. {ECO:0000269|PubMed:8635485}.; FUNCTION: [Isoform 3]: Binds TGFB1, TGFB2 and TGFB3 in the picomolar affinity range without the participation of additional receptors. Blocks activation of SMAD2 and SMAD3 by TGFB1. {ECO:0000269|PubMed:34568316}.\",\"ACT_SITE 379; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and thus regulates a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. {ECO:0000269|PubMed:7774578}.; FUNCTION: [Isoform 1]: Has transforming growth factor beta-activated receptor activity. {ECO:0000269|PubMed:8635485}.; FUNCTION: [Isoform 2]: Has transforming growth factor beta-activated receptor activity. {ECO:0000269|PubMed:8635485}.; FUNCTION: [Isoform 3]: Binds TGFB1, TGFB2 and TGFB3 in the picomolar affinity range without the participation of additional receptors. Blocks activation of SMAD2 and SMAD3 by TGFB1. {ECO:0000269|PubMed:34568316}.\nT: Active site: ACT_SITE 379; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and thus regulates a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. {ECO:0000269|PubMed:7774578}.; FUNCTION: [Isoform 1]: Has transforming growth factor beta-activated receptor activity. {ECO:0000269|PubMed:8635485}.; FUNCTION: [Isoform 2]: Has transforming growth factor beta-activated receptor activity. {ECO:0000269|PubMed:8635485}.; FUNCTION: [Isoform 3]: Binds TGFB1, TGFB2 and TGFB3 in the picomolar affinity range without the participation of additional receptors. Blocks activation of SMAD2 and SMAD3 by TGFB1. {ECO:0000269|PubMed:34568316}.<br/><strong>T: Active site:</strong> ACT_SITE 379; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        242,
        246,
        249
      ],
      "fold_change_1": -0.0960159,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        249,
        239
      ],
      "fold_change_2": 0.153076,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        248,
        237
      ],
      "fold_change_3": 0.174491,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        247
      ],
      "fold_change_4": 0.0725012,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        249,
        240
      ],
      "fold_change_5": 0.143865,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P25445": {
      "label": "TNR6",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase CASP8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs CASP8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). {ECO:0000269|PubMed:19118384, ECO:0000269|PubMed:7533181, ECO:0000269|PubMed:9184224}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase CASP8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs CASP8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). {ECO:0000269|PubMed:19118384, ECO:0000269|PubMed:7533181, ECO:0000269|PubMed:9184224}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase CASP8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs CASP8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). {ECO:0000269|PubMed:19118384, ECO:0000269|PubMed:7533181, ECO:0000269|PubMed:9184224}.",
      "PTMs": {
        "P25445_293": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P25445",
          "fc_color_1": [
            254,
            228,
            186
          ],
          "label": "293",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.EAYDT#LIK.D",
          "tooltip_html": "<strong>T: sequence:</strong> K.EAYDT#LIK.D",
          "fold_change_1": 0.686791,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            210,
            137
          ],
          "fold_change_2": 1.18058,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            253,
            214,
            147
          ],
          "fold_change_3": 1.07777,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            229,
            187
          ],
          "fold_change_4": 0.679608,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            253,
            212,
            143
          ],
          "fold_change_5": 1.11702,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "W1",
          "shape_x": 193.0,
          "shape_y": 686.11,
          "label_x": 188.0,
          "label_y": 684.11,
          "label_centering": "right",
          "symbol_x": 193.0,
          "symbol_y": 686.11
        },
        "P25445_212": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P25445",
          "fc_color_1": [
            254,
            249,
            239
          ],
          "label": "212",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.ENQGSHES#PTLNPETVAINLSDVDLSK.Y",
          "tooltip_html": "<strong>T: sequence:</strong> K.ENQGSHES#PTLNPETVAINLSDVDLSK.Y",
          "fold_change_1": 0.156871,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            249,
            240
          ],
          "fold_change_2": 0.147833,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            242,
            221
          ],
          "fold_change_3": 0.332104,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            252,
            249
          ],
          "fold_change_4": 0.0568135,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            244,
            227
          ],
          "fold_change_5": 0.275554,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "E1",
          "shape_x": 247.0,
          "shape_y": 686.11,
          "label_x": 252.0,
          "label_y": 684.11,
          "label_centering": "left",
          "symbol_x": 247.0,
          "symbol_y": 686.11
        },
        "P25445_305": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P25445",
          "fc_color_1": [
            254,
            252,
            248
          ],
          "label": "305",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.ANLCT#LAEK.I",
          "tooltip_html": "<strong>T: sequence:</strong> K.ANLCT#LAEK.I",
          "fold_change_1": 0.0687498,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            221,
            167
          ],
          "fold_change_2": 0.874986,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            253,
            190,
            86
          ],
          "fold_change_3": 1.69833,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            229,
            237,
            244
          ],
          "fold_change_4": -0.203894,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            254,
            254
          ],
          "fold_change_5": -0.00762979,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "W2",
          "shape_x": 193.0,
          "shape_y": 697.72,
          "label_x": 188.0,
          "label_y": 699.72,
          "label_centering": "right",
          "symbol_x": 193.0,
          "symbol_y": 697.72
        }
      },
      "fc_color_1": [
        246,
        249,
        251
      ],
      "fold_change_1": -0.066679,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        245,
        248,
        250
      ],
      "fold_change_2": -0.0767338,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        241,
        245,
        249
      ],
      "fold_change_3": -0.104587,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        244,
        226
      ],
      "fold_change_4": 0.287166,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        251,
        252,
        253
      ],
      "fold_change_5": -0.0277948,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P14778": {
      "label": "IL1R1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Receptor for IL1A, IL1B and IL1RN (PubMed:2950091, PubMed:37315560). After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (PubMed:10653850). {ECO:0000269|PubMed:10653850, ECO:0000269|PubMed:10671496, ECO:0000269|PubMed:2950091, ECO:0000269|PubMed:37315560}.\",\"ACT_SITE 470; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00204\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Receptor for IL1A, IL1B and IL1RN (PubMed:2950091, PubMed:37315560). After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (PubMed:10653850). {ECO:0000269|PubMed:10653850, ECO:0000269|PubMed:10671496, ECO:0000269|PubMed:2950091, ECO:0000269|PubMed:37315560}.\nT: Active site: ACT_SITE 470; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00204\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Receptor for IL1A, IL1B and IL1RN (PubMed:2950091, PubMed:37315560). After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (PubMed:10653850). {ECO:0000269|PubMed:10653850, ECO:0000269|PubMed:10671496, ECO:0000269|PubMed:2950091, ECO:0000269|PubMed:37315560}.<br/><strong>T: Active site:</strong> ACT_SITE 470; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00204&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        217,
        155
      ],
      "fold_change_1": 0.999481,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        208,
        132
      ],
      "fold_change_2": 1.23012,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        229,
        187
      ],
      "fold_change_3": 0.681575,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        232,
        195
      ],
      "fold_change_4": 0.60047,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        242,
        221
      ],
      "fold_change_5": 0.336913,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9NPH3": {
      "label": "IL1AP",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Coreceptor for IL1RL2 in the IL-36 signaling system (By similarity). Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Coreceptor for IL1RL1 in the IL-33 signaling system. Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (Probable). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:10799889, ECO:0000269|PubMed:9371760, ECO:0000305|PubMed:10653850, ECO:0000305|PubMed:19836339}.; FUNCTION: [Isoform 2]: Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors (PubMed:12530978). Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling (By similarity). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:12530978}.; FUNCTION: [Isoform 4]: Unable to mediate canonical IL-1 signaling (PubMed:19481478). Required for Src phosphorylation by IL1B. May be involved in IL1B-potentiated NMDA-induced calcium influx in neurons (By similarity). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:19481478}.\",\"ACT_SITE 482; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00204\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Coreceptor for IL1RL2 in the IL-36 signaling system (By similarity). Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Coreceptor for IL1RL1 in the IL-33 signaling system. Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (Probable). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:10799889, ECO:0000269|PubMed:9371760, ECO:0000305|PubMed:10653850, ECO:0000305|PubMed:19836339}.; FUNCTION: [Isoform 2]: Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors (PubMed:12530978). Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling (By similarity). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:12530978}.; FUNCTION: [Isoform 4]: Unable to mediate canonical IL-1 signaling (PubMed:19481478). Required for Src phosphorylation by IL1B. May be involved in IL1B-potentiated NMDA-induced calcium influx in neurons (By similarity). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:19481478}.\nT: Active site: ACT_SITE 482; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00204\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Coreceptor for IL1RL2 in the IL-36 signaling system (By similarity). Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Coreceptor for IL1RL1 in the IL-33 signaling system. Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD (By similarity). May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (Probable). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:10799889, ECO:0000269|PubMed:9371760, ECO:0000305|PubMed:10653850, ECO:0000305|PubMed:19836339}.; FUNCTION: [Isoform 2]: Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors (PubMed:12530978). Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling (By similarity). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:12530978}.; FUNCTION: [Isoform 4]: Unable to mediate canonical IL-1 signaling (PubMed:19481478). Required for Src phosphorylation by IL1B. May be involved in IL1B-potentiated NMDA-induced calcium influx in neurons (By similarity). {ECO:0000250|UniProtKB:Q61730, ECO:0000269|PubMed:19481478}.<br/><strong>T: Active site:</strong> ACT_SITE 482; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00204&quot;",
      "PTMs": {},
      "fc_color_1": [
        239,
        244,
        248
      ],
      "fold_change_1": -0.118945,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        189,
        209,
        227
      ],
      "fold_change_2": -0.517355,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        240,
        216
      ],
      "fold_change_3": 0.387255,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        249,
        240
      ],
      "fold_change_4": 0.141751,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        250,
        242
      ],
      "fold_change_5": 0.123932,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_108": {
      "label": "TNFRSF1A",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P01137": {
      "label": "TGFB1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively. {ECO:0000269|PubMed:29109152, ECO:0000303|PubMed:27252363}.; FUNCTION: [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-1 (TGF-beta-1) chain in a latent state during storage in extracellular matrix (PubMed:28117447). Associates non-covalently with TGF-beta-1 and regulates its activation via interaction with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS, that control activation of TGF-beta-1 (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). Interaction with LRRC33/NRROS regulates activation of TGF-beta-1 in macrophages and microglia (Probable). Interaction with LRRC32/GARP controls activation of TGF-beta-1 on the surface of activated regulatory T-cells (Tregs) (PubMed:19651619, PubMed:19750484, PubMed:22278742). Interaction with integrins (ITGAV:ITGB6 or ITGAV:ITGB8) results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). {ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931, ECO:0000305|PubMed:29909984}.; FUNCTION: [Transforming growth factor beta-1]: Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains remain non-covalently linked rendering TGF-beta-1 inactive during storage in extracellular matrix (PubMed:29109152). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS that control activation of TGF-beta-1 and maintain it in a latent state during storage in extracellular milieus (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). TGF-beta-1 is released from LAP by integrins (ITGAV:ITGB6 or ITGAV:ITGB8): integrin-binding to LAP stabilizes an alternative conformation of the LAP bowtie tail and results in distortion of the LAP chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). Once activated following release of LAP, TGF-beta-1 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (PubMed:20207738). While expressed by many cells types, TGF-beta-1 only has a very localized range of action within cell environment thanks to fine regulation of its activation by Latency-associated peptide chain (LAP) and 'milieu molecules' (By similarity). Plays an important role in bone remodeling: acts as a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner (By similarity). At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development (By similarity). At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed:25310401). Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed:25893292, PubMed:29483653, PubMed:30696809). Positively regulates odontoblastic differentiation in dental papilla cells, via promotion of IPO7-mediated translocation of phosphorylated SMAD2 to the nucleus and subsequent transcription of target genes (By similarity). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed:25893292, PubMed:30696809). {ECO:0000250|UniProtKB:P04202, ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:20207738, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:25310401, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:29109152, ECO:0000269|PubMed:29483653, ECO:0000269|PubMed:30696809, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively. {ECO:0000269|PubMed:29109152, ECO:0000303|PubMed:27252363}.; FUNCTION: [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-1 (TGF-beta-1) chain in a latent state during storage in extracellular matrix (PubMed:28117447). Associates non-covalently with TGF-beta-1 and regulates its activation via interaction with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS, that control activation of TGF-beta-1 (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). Interaction with LRRC33/NRROS regulates activation of TGF-beta-1 in macrophages and microglia (Probable). Interaction with LRRC32/GARP controls activation of TGF-beta-1 on the surface of activated regulatory T-cells (Tregs) (PubMed:19651619, PubMed:19750484, PubMed:22278742). Interaction with integrins (ITGAV:ITGB6 or ITGAV:ITGB8) results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). {ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931, ECO:0000305|PubMed:29909984}.; FUNCTION: [Transforming growth factor beta-1]: Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains remain non-covalently linked rendering TGF-beta-1 inactive during storage in extracellular matrix (PubMed:29109152). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS that control activation of TGF-beta-1 and maintain it in a latent state during storage in extracellular milieus (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). TGF-beta-1 is released from LAP by integrins (ITGAV:ITGB6 or ITGAV:ITGB8): integrin-binding to LAP stabilizes an alternative conformation of the LAP bowtie tail and results in distortion of the LAP chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). Once activated following release of LAP, TGF-beta-1 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (PubMed:20207738). While expressed by many cells types, TGF-beta-1 only has a very localized range of action within cell environment thanks to fine regulation of its activation by Latency-associated peptide chain (LAP) and 'milieu molecules' (By similarity). Plays an important role in bone remodeling: acts as a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner (By similarity). At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development (By similarity). At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed:25310401). Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed:25893292, PubMed:29483653, PubMed:30696809). Positively regulates odontoblastic differentiation in dental papilla cells, via promotion of IPO7-mediated translocation of phosphorylated SMAD2 to the nucleus and subsequent transcription of target genes (By similarity). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed:25893292, PubMed:30696809). {ECO:0000250|UniProtKB:P04202, ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:20207738, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:25310401, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:29109152, ECO:0000269|PubMed:29483653, ECO:0000269|PubMed:30696809, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively. {ECO:0000269|PubMed:29109152, ECO:0000303|PubMed:27252363}.; FUNCTION: [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-1 (TGF-beta-1) chain in a latent state during storage in extracellular matrix (PubMed:28117447). Associates non-covalently with TGF-beta-1 and regulates its activation via interaction with &#x27;milieu molecules&#x27;, such as LTBP1, LRRC32/GARP and LRRC33/NRROS, that control activation of TGF-beta-1 (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). Interaction with LRRC33/NRROS regulates activation of TGF-beta-1 in macrophages and microglia (Probable). Interaction with LRRC32/GARP controls activation of TGF-beta-1 on the surface of activated regulatory T-cells (Tregs) (PubMed:19651619, PubMed:19750484, PubMed:22278742). Interaction with integrins (ITGAV:ITGB6 or ITGAV:ITGB8) results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). {ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931, ECO:0000305|PubMed:29909984}.; FUNCTION: [Transforming growth factor beta-1]: Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains remain non-covalently linked rendering TGF-beta-1 inactive during storage in extracellular matrix (PubMed:29109152). At the same time, LAP chain interacts with &#x27;milieu molecules&#x27;, such as LTBP1, LRRC32/GARP and LRRC33/NRROS that control activation of TGF-beta-1 and maintain it in a latent state during storage in extracellular milieus (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). TGF-beta-1 is released from LAP by integrins (ITGAV:ITGB6 or ITGAV:ITGB8): integrin-binding to LAP stabilizes an alternative conformation of the LAP bowtie tail and results in distortion of the LAP chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). Once activated following release of LAP, TGF-beta-1 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (PubMed:20207738). While expressed by many cells types, TGF-beta-1 only has a very localized range of action within cell environment thanks to fine regulation of its activation by Latency-associated peptide chain (LAP) and &#x27;milieu molecules&#x27; (By similarity). Plays an important role in bone remodeling: acts as a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner (By similarity). At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development (By similarity). At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed:25310401). Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed:25893292, PubMed:29483653, PubMed:30696809). Positively regulates odontoblastic differentiation in dental papilla cells, via promotion of IPO7-mediated translocation of phosphorylated SMAD2 to the nucleus and subsequent transcription of target genes (By similarity). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed:25893292, PubMed:30696809). {ECO:0000250|UniProtKB:P04202, ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:20207738, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:25310401, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:29109152, ECO:0000269|PubMed:29483653, ECO:0000269|PubMed:30696809, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}.",
      "PTMs": {},
      "fc_color_1": [
        211,
        224,
        236
      ],
      "fold_change_1": -0.346986,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        198,
        216,
        231
      ],
      "fold_change_2": -0.443807,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        229,
        237,
        244
      ],
      "fold_change_3": -0.199431,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        210,
        224,
        236
      ],
      "fold_change_4": -0.351985,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        201,
        218,
        232
      ],
      "fold_change_5": -0.424084,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_110": {
      "label": "IL1A",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_111": {
      "label": "TNF",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q8IW41": {
      "label": "MAPK5",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Tumor suppressor serine/threonine-protein kinase involved in mTORC1 signaling and post-transcriptional regulation. Phosphorylates FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB. Acts as a tumor suppressor by mediating Ras-induced senescence and phosphorylating p53/TP53. Involved in post-transcriptional regulation of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3 leads to promote nuclear localization of FOXO3, enabling expression of miR-34b and miR-34c, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent MYC translation. Acts as a negative regulator of mTORC1 signaling by mediating phosphorylation and inhibition of RHEB. Part of the atypical MAPK signaling via its interaction with ERK3/MAPK6 or ERK4/MAPK4: the precise role of the complex formed with ERK3/MAPK6 or ERK4/MAPK4 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPK (ERK3/MAPK6 or ERK4/MAPK4), ERK3/MAPK6 (or ERK4/MAPK4) is phosphorylated and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6 (or ERK4/MAPK4). Mediates phosphorylation of HSP27/HSPB1 in response to PKA/PRKACA stimulation, inducing F-actin rearrangement. {ECO:0000269|PubMed:17254968, ECO:0000269|PubMed:17728103, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874}.\",\"ACT_SITE 148; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Tumor suppressor serine/threonine-protein kinase involved in mTORC1 signaling and post-transcriptional regulation. Phosphorylates FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB. Acts as a tumor suppressor by mediating Ras-induced senescence and phosphorylating p53/TP53. Involved in post-transcriptional regulation of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3 leads to promote nuclear localization of FOXO3, enabling expression of miR-34b and miR-34c, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent MYC translation. Acts as a negative regulator of mTORC1 signaling by mediating phosphorylation and inhibition of RHEB. Part of the atypical MAPK signaling via its interaction with ERK3/MAPK6 or ERK4/MAPK4: the precise role of the complex formed with ERK3/MAPK6 or ERK4/MAPK4 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPK (ERK3/MAPK6 or ERK4/MAPK4), ERK3/MAPK6 (or ERK4/MAPK4) is phosphorylated and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6 (or ERK4/MAPK4). Mediates phosphorylation of HSP27/HSPB1 in response to PKA/PRKACA stimulation, inducing F-actin rearrangement. {ECO:0000269|PubMed:17254968, ECO:0000269|PubMed:17728103, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874}.\nT: Active site: ACT_SITE 148; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Tumor suppressor serine/threonine-protein kinase involved in mTORC1 signaling and post-transcriptional regulation. Phosphorylates FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB. Acts as a tumor suppressor by mediating Ras-induced senescence and phosphorylating p53/TP53. Involved in post-transcriptional regulation of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3 leads to promote nuclear localization of FOXO3, enabling expression of miR-34b and miR-34c, 2 post-transcriptional regulators of MYC that bind to the 3&#x27;UTR of MYC transcript and prevent MYC translation. Acts as a negative regulator of mTORC1 signaling by mediating phosphorylation and inhibition of RHEB. Part of the atypical MAPK signaling via its interaction with ERK3/MAPK6 or ERK4/MAPK4: the precise role of the complex formed with ERK3/MAPK6 or ERK4/MAPK4 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPK (ERK3/MAPK6 or ERK4/MAPK4), ERK3/MAPK6 (or ERK4/MAPK4) is phosphorylated and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6 (or ERK4/MAPK4). Mediates phosphorylation of HSP27/HSPB1 in response to PKA/PRKACA stimulation, inducing F-actin rearrangement. {ECO:0000269|PubMed:17254968, ECO:0000269|PubMed:17728103, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874}.<br/><strong>T: Active site:</strong> ACT_SITE 148; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        242,
        246,
        249
      ],
      "fold_change_1": -0.100245,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        209,
        223,
        235
      ],
      "fold_change_2": -0.36261,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        236,
        205
      ],
      "fold_change_3": 0.494555,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        251,
        245
      ],
      "fold_change_4": 0.0943682,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        236,
        242,
        247
      ],
      "fold_change_5": -0.142849,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P63000": {
      "label": "RAC1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization, neurons adhesion, migration and differentiation, and growth-factor induced formation of membrane ruffles (PubMed:1643658, PubMed:22843693, PubMed:23512198, PubMed:28886345). Rac1 p21/rho GDI heterodimer is the active component of the cytosolic factor sigma 1, which is involved in stimulation of the NADPH oxidase activity in macrophages. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. Stimulates PKN2 kinase activity (PubMed:9121475). In concert with RAB7A, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts (PubMed:1643658). In podocytes, promotes nuclear shuttling of NR3C2; this modulation is required for a proper kidney functioning. Required for atypical chemokine receptor ACKR2-induced LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. In neurons, is involved in dendritic spine formation and synaptic plasticity (By similarity). In hippocampal neurons, involved in spine morphogenesis and synapse formation, through local activation at synapses by guanine nucleotide exchange factors (GEFs), such as ARHGEF6/ARHGEF7/PIX (PubMed:12695502). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3. In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in PAK1 activation and eventually F-actin stabilization (By similarity). Required for DSG3 translocation to cell-cell junctions, DSG3-mediated organization of cortical F-actin bundles and anchoring of actin at cell junctions; via interaction with DSG3 (PubMed:22796473). Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:38355798). {ECO:0000250|UniProtKB:P63001, ECO:0000250|UniProtKB:Q6RUV5, ECO:0000269|PubMed:12695502, ECO:0000269|PubMed:1643658, ECO:0000269|PubMed:22796473, ECO:0000269|PubMed:22843693, ECO:0000269|PubMed:23512198, ECO:0000269|PubMed:28886345, ECO:0000269|PubMed:38355798, ECO:0000269|PubMed:9121475}.; FUNCTION: [Isoform B]: Isoform B has an accelerated GEF-independent GDP/GTP exchange and an impaired GTP hydrolysis, which is restored partially by GTPase-activating proteins (PubMed:14625275). It is able to bind to the GTPase-binding domain of PAK but not full-length PAK in a GTP-dependent manner, suggesting that the insertion does not completely abolish effector interaction (PubMed:14625275). {ECO:0000269|PubMed:14625275}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization, neurons adhesion, migration and differentiation, and growth-factor induced formation of membrane ruffles (PubMed:1643658, PubMed:22843693, PubMed:23512198, PubMed:28886345). Rac1 p21/rho GDI heterodimer is the active component of the cytosolic factor sigma 1, which is involved in stimulation of the NADPH oxidase activity in macrophages. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. Stimulates PKN2 kinase activity (PubMed:9121475). In concert with RAB7A, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts (PubMed:1643658). In podocytes, promotes nuclear shuttling of NR3C2; this modulation is required for a proper kidney functioning. Required for atypical chemokine receptor ACKR2-induced LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. In neurons, is involved in dendritic spine formation and synaptic plasticity (By similarity). In hippocampal neurons, involved in spine morphogenesis and synapse formation, through local activation at synapses by guanine nucleotide exchange factors (GEFs), such as ARHGEF6/ARHGEF7/PIX (PubMed:12695502). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3. In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in PAK1 activation and eventually F-actin stabilization (By similarity). Required for DSG3 translocation to cell-cell junctions, DSG3-mediated organization of cortical F-actin bundles and anchoring of actin at cell junctions; via interaction with DSG3 (PubMed:22796473). Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:38355798). {ECO:0000250|UniProtKB:P63001, ECO:0000250|UniProtKB:Q6RUV5, ECO:0000269|PubMed:12695502, ECO:0000269|PubMed:1643658, ECO:0000269|PubMed:22796473, ECO:0000269|PubMed:22843693, ECO:0000269|PubMed:23512198, ECO:0000269|PubMed:28886345, ECO:0000269|PubMed:38355798, ECO:0000269|PubMed:9121475}.; FUNCTION: [Isoform B]: Isoform B has an accelerated GEF-independent GDP/GTP exchange and an impaired GTP hydrolysis, which is restored partially by GTPase-activating proteins (PubMed:14625275). It is able to bind to the GTPase-binding domain of PAK but not full-length PAK in a GTP-dependent manner, suggesting that the insertion does not completely abolish effector interaction (PubMed:14625275). {ECO:0000269|PubMed:14625275}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization, neurons adhesion, migration and differentiation, and growth-factor induced formation of membrane ruffles (PubMed:1643658, PubMed:22843693, PubMed:23512198, PubMed:28886345). Rac1 p21/rho GDI heterodimer is the active component of the cytosolic factor sigma 1, which is involved in stimulation of the NADPH oxidase activity in macrophages. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. Stimulates PKN2 kinase activity (PubMed:9121475). In concert with RAB7A, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts (PubMed:1643658). In podocytes, promotes nuclear shuttling of NR3C2; this modulation is required for a proper kidney functioning. Required for atypical chemokine receptor ACKR2-induced LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. In neurons, is involved in dendritic spine formation and synaptic plasticity (By similarity). In hippocampal neurons, involved in spine morphogenesis and synapse formation, through local activation at synapses by guanine nucleotide exchange factors (GEFs), such as ARHGEF6/ARHGEF7/PIX (PubMed:12695502). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3. In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in PAK1 activation and eventually F-actin stabilization (By similarity). Required for DSG3 translocation to cell-cell junctions, DSG3-mediated organization of cortical F-actin bundles and anchoring of actin at cell junctions; via interaction with DSG3 (PubMed:22796473). Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:38355798). {ECO:0000250|UniProtKB:P63001, ECO:0000250|UniProtKB:Q6RUV5, ECO:0000269|PubMed:12695502, ECO:0000269|PubMed:1643658, ECO:0000269|PubMed:22796473, ECO:0000269|PubMed:22843693, ECO:0000269|PubMed:23512198, ECO:0000269|PubMed:28886345, ECO:0000269|PubMed:38355798, ECO:0000269|PubMed:9121475}.; FUNCTION: [Isoform B]: Isoform B has an accelerated GEF-independent GDP/GTP exchange and an impaired GTP hydrolysis, which is restored partially by GTPase-activating proteins (PubMed:14625275). It is able to bind to the GTPase-binding domain of PAK but not full-length PAK in a GTP-dependent manner, suggesting that the insertion does not completely abolish effector interaction (PubMed:14625275). {ECO:0000269|PubMed:14625275}.",
      "PTMs": {},
      "fc_color_1": [
        235,
        241,
        246
      ],
      "fold_change_1": -0.155131,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        200,
        217,
        232
      ],
      "fold_change_2": -0.42753,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        214,
        227,
        238
      ],
      "fold_change_3": -0.319599,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        232,
        239,
        245
      ],
      "fold_change_4": -0.180369,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        197,
        215,
        230
      ],
      "fold_change_5": -0.457378,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P15153": {
      "label": "RAC2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Plasma membrane-associated small GTPase which cycles between an active GTP-bound and inactive GDP-bound state (PubMed:30723080). In its active state, binds to a variety of effector proteins to regulate cellular responses, such as secretory processes, phagocytose of apoptotic cells and epithelial cell polarization. Regulatory subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:1660188). {ECO:0000269|PubMed:1660188, ECO:0000269|PubMed:30723080}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Plasma membrane-associated small GTPase which cycles between an active GTP-bound and inactive GDP-bound state (PubMed:30723080). In its active state, binds to a variety of effector proteins to regulate cellular responses, such as secretory processes, phagocytose of apoptotic cells and epithelial cell polarization. Regulatory subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:1660188). {ECO:0000269|PubMed:1660188, ECO:0000269|PubMed:30723080}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plasma membrane-associated small GTPase which cycles between an active GTP-bound and inactive GDP-bound state (PubMed:30723080). In its active state, binds to a variety of effector proteins to regulate cellular responses, such as secretory processes, phagocytose of apoptotic cells and epithelial cell polarization. Regulatory subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:1660188). {ECO:0000269|PubMed:1660188, ECO:0000269|PubMed:30723080}.",
      "PTMs": {},
      "fc_color_1": [
        245,
        248,
        251
      ],
      "fold_change_1": -0.0749679,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        238,
        243,
        248
      ],
      "fold_change_2": -0.128812,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        253,
        252
      ],
      "fold_change_3": 0.029371,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        254,
        252
      ],
      "fold_change_4": 0.025651,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        245,
        248,
        251
      ],
      "fold_change_5": -0.0729654,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P60953": {
      "label": "CDC42",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Plasma membrane-associated small GTPase which cycles between an active GTP-bound and an inactive GDP-bound state. In active state binds to a variety of effector proteins to regulate cellular responses. Involved in epithelial cell polarization processes. Regulates the bipolar attachment of spindle microtubules to kinetochores before chromosome congression in metaphase (PubMed:15642749). Regulates cell migration (PubMed:17038317, PubMed:22843693). In neurons, plays a role in the extension and maintenance of the formation of filopodia, thin and actin-rich surface projections (PubMed:14978216). Required for DOCK10-mediated spine formation in Purkinje cells and hippocampal neurons. In podocytes, facilitates filopodia and podosomes formation upon DOCK11-activation (PubMed:33523862). Upon activation by CaMKII, modulates dendritic spine structural plasticity by relaying CaMKII transient activation to synapse-specific, long-term signaling (By similarity). Also plays a role in phagocytosis through organization of the F-actin cytoskeleton associated with forming phagocytic cups (PubMed:26465210). Upon activation by PLEKHG4B, involved in actin cytoskeletal remodeling during epithelial cell-cell junction formation (PubMed:33310911). {ECO:0000250|UniProtKB:P60766, ECO:0000250|UniProtKB:Q8CFN2, ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:17038317, ECO:0000269|PubMed:22843693, ECO:0000269|PubMed:26465210, ECO:0000269|PubMed:33310911, ECO:0000269|PubMed:33523862}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Plasma membrane-associated small GTPase which cycles between an active GTP-bound and an inactive GDP-bound state. In active state binds to a variety of effector proteins to regulate cellular responses. Involved in epithelial cell polarization processes. Regulates the bipolar attachment of spindle microtubules to kinetochores before chromosome congression in metaphase (PubMed:15642749). Regulates cell migration (PubMed:17038317, PubMed:22843693). In neurons, plays a role in the extension and maintenance of the formation of filopodia, thin and actin-rich surface projections (PubMed:14978216). Required for DOCK10-mediated spine formation in Purkinje cells and hippocampal neurons. In podocytes, facilitates filopodia and podosomes formation upon DOCK11-activation (PubMed:33523862). Upon activation by CaMKII, modulates dendritic spine structural plasticity by relaying CaMKII transient activation to synapse-specific, long-term signaling (By similarity). Also plays a role in phagocytosis through organization of the F-actin cytoskeleton associated with forming phagocytic cups (PubMed:26465210). Upon activation by PLEKHG4B, involved in actin cytoskeletal remodeling during epithelial cell-cell junction formation (PubMed:33310911). {ECO:0000250|UniProtKB:P60766, ECO:0000250|UniProtKB:Q8CFN2, ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:17038317, ECO:0000269|PubMed:22843693, ECO:0000269|PubMed:26465210, ECO:0000269|PubMed:33310911, ECO:0000269|PubMed:33523862}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plasma membrane-associated small GTPase which cycles between an active GTP-bound and an inactive GDP-bound state. In active state binds to a variety of effector proteins to regulate cellular responses. Involved in epithelial cell polarization processes. Regulates the bipolar attachment of spindle microtubules to kinetochores before chromosome congression in metaphase (PubMed:15642749). Regulates cell migration (PubMed:17038317, PubMed:22843693). In neurons, plays a role in the extension and maintenance of the formation of filopodia, thin and actin-rich surface projections (PubMed:14978216). Required for DOCK10-mediated spine formation in Purkinje cells and hippocampal neurons. In podocytes, facilitates filopodia and podosomes formation upon DOCK11-activation (PubMed:33523862). Upon activation by CaMKII, modulates dendritic spine structural plasticity by relaying CaMKII transient activation to synapse-specific, long-term signaling (By similarity). Also plays a role in phagocytosis through organization of the F-actin cytoskeleton associated with forming phagocytic cups (PubMed:26465210). Upon activation by PLEKHG4B, involved in actin cytoskeletal remodeling during epithelial cell-cell junction formation (PubMed:33310911). {ECO:0000250|UniProtKB:P60766, ECO:0000250|UniProtKB:Q8CFN2, ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:17038317, ECO:0000269|PubMed:22843693, ECO:0000269|PubMed:26465210, ECO:0000269|PubMed:33310911, ECO:0000269|PubMed:33523862}.",
      "PTMs": {},
      "fc_color_1": [
        234,
        240,
        246
      ],
      "fold_change_1": -0.163098,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        228,
        236,
        243
      ],
      "fold_change_2": -0.213264,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        251,
        252,
        253
      ],
      "fold_change_3": -0.0308015,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        247
      ],
      "fold_change_4": 0.0715361,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        241,
        245,
        249
      ],
      "fold_change_5": -0.107577,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q13153": {
      "label": "PAK1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Protein kinase involved in intracellular signaling pathways downstream of integrins and receptor-type kinases that plays an important role in cytoskeleton dynamics, in cell adhesion, migration, proliferation, apoptosis, mitosis, and in vesicle-mediated transport processes (PubMed:10551809, PubMed:11896197, PubMed:12876277, PubMed:14585966, PubMed:15611088, PubMed:17726028, PubMed:17989089, PubMed:30290153, PubMed:17420447). Can directly phosphorylate BAD and protects cells against apoptosis (By similarity). Activated by interaction with CDC42 and RAC1 (PubMed:8805275, PubMed:9528787). Functions as a GTPase effector that links the Rho-related GTPases CDC42 and RAC1 to the JNK MAP kinase pathway (PubMed:8805275, PubMed:9528787). Phosphorylates and activates MAP2K1, and thereby mediates activation of downstream MAP kinases (By similarity). Involved in the reorganization of the actin cytoskeleton, actin stress fibers and of focal adhesion complexes (PubMed:9032240, PubMed:9395435). Phosphorylates the tubulin chaperone TBCB and thereby plays a role in the regulation of microtubule biogenesis and organization of the tubulin cytoskeleton (PubMed:15831477). Plays a role in the regulation of insulin secretion in response to elevated glucose levels (PubMed:22669945). Part of a ternary complex that contains PAK1, DVL1 and MUSK that is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ) (By similarity). Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2 (PubMed:12624090). Phosphorylates MYL9/MLC2 (By similarity). Phosphorylates RAF1 at 'Ser-338' and 'Ser-339' resulting in: activation of RAF1, stimulation of RAF1 translocation to mitochondria, phosphorylation of BAD by RAF1, and RAF1 binding to BCL2 (PubMed:11733498). Phosphorylates SNAI1 at 'Ser-246' promoting its transcriptional repressor activity by increasing its accumulation in the nucleus (PubMed:15833848). In podocytes, promotes NR3C2 nuclear localization (By similarity). Required for atypical chemokine receptor ACKR2-induced phosphorylation of LIMK1 and cofilin (CFL1) and for the up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation (PubMed:23633677). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3, maybe through CFL1 phosphorylation and inactivation (By similarity). Plays a role in RUFY3-mediated facilitating gastric cancer cells migration and invasion (PubMed:25766321). In response to DNA damage, phosphorylates MORC2 which activates its ATPase activity and facilitates chromatin remodeling (PubMed:23260667). In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in F-actin stabilization (By similarity). In hippocampal neurons, necessary for the formation of dendritic spines and excitatory synapses; this function is dependent on kinase activity and may be exerted by the regulation of actomyosin contractility through the phosphorylation of myosin II regulatory light chain (MLC) (By similarity). Along with GIT1, positively regulates microtubule nucleation during interphase (PubMed:27012601). Phosphorylates FXR1, promoting its localization to stress granules and activity (PubMed:20417602). Phosphorylates ILK on 'Thr-173' and 'Ser-246', promoting nuclear export of ILK (PubMed:17420447). {ECO:0000250|UniProtKB:O88643, ECO:0000250|UniProtKB:P35465, ECO:0000269|PubMed:10551809, ECO:0000269|PubMed:11733498, ECO:0000269|PubMed:11896197, ECO:0000269|PubMed:12624090, ECO:0000269|PubMed:12876277, ECO:0000269|PubMed:14585966, ECO:0000269|PubMed:15611088, ECO:0000269|PubMed:15831477, ECO:0000269|PubMed:15833848, ECO:0000269|PubMed:17420447, ECO:0000269|PubMed:17726028, ECO:0000269|PubMed:17989089, ECO:0000269|PubMed:20417602, ECO:0000269|PubMed:22669945, ECO:0000269|PubMed:23260667, ECO:0000269|PubMed:23633677, ECO:0000269|PubMed:25766321, ECO:0000269|PubMed:27012601, ECO:0000269|PubMed:30290153, ECO:0000269|PubMed:8805275, ECO:0000269|PubMed:9032240, ECO:0000269|PubMed:9395435, ECO:0000269|PubMed:9528787}.\",\"ACT_SITE 389; /note=\"Proton acceptor\"; /evidence=\"ECO:0000269|PubMed:22153498\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Protein kinase involved in intracellular signaling pathways downstream of integrins and receptor-type kinases that plays an important role in cytoskeleton dynamics, in cell adhesion, migration, proliferation, apoptosis, mitosis, and in vesicle-mediated transport processes (PubMed:10551809, PubMed:11896197, PubMed:12876277, PubMed:14585966, PubMed:15611088, PubMed:17726028, PubMed:17989089, PubMed:30290153, PubMed:17420447). Can directly phosphorylate BAD and protects cells against apoptosis (By similarity). Activated by interaction with CDC42 and RAC1 (PubMed:8805275, PubMed:9528787). Functions as a GTPase effector that links the Rho-related GTPases CDC42 and RAC1 to the JNK MAP kinase pathway (PubMed:8805275, PubMed:9528787). Phosphorylates and activates MAP2K1, and thereby mediates activation of downstream MAP kinases (By similarity). Involved in the reorganization of the actin cytoskeleton, actin stress fibers and of focal adhesion complexes (PubMed:9032240, PubMed:9395435). Phosphorylates the tubulin chaperone TBCB and thereby plays a role in the regulation of microtubule biogenesis and organization of the tubulin cytoskeleton (PubMed:15831477). Plays a role in the regulation of insulin secretion in response to elevated glucose levels (PubMed:22669945). Part of a ternary complex that contains PAK1, DVL1 and MUSK that is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ) (By similarity). Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2 (PubMed:12624090). Phosphorylates MYL9/MLC2 (By similarity). Phosphorylates RAF1 at 'Ser-338' and 'Ser-339' resulting in: activation of RAF1, stimulation of RAF1 translocation to mitochondria, phosphorylation of BAD by RAF1, and RAF1 binding to BCL2 (PubMed:11733498). Phosphorylates SNAI1 at 'Ser-246' promoting its transcriptional repressor activity by increasing its accumulation in the nucleus (PubMed:15833848). In podocytes, promotes NR3C2 nuclear localization (By similarity). Required for atypical chemokine receptor ACKR2-induced phosphorylation of LIMK1 and cofilin (CFL1) and for the up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation (PubMed:23633677). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3, maybe through CFL1 phosphorylation and inactivation (By similarity). Plays a role in RUFY3-mediated facilitating gastric cancer cells migration and invasion (PubMed:25766321). In response to DNA damage, phosphorylates MORC2 which activates its ATPase activity and facilitates chromatin remodeling (PubMed:23260667). In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in F-actin stabilization (By similarity). In hippocampal neurons, necessary for the formation of dendritic spines and excitatory synapses; this function is dependent on kinase activity and may be exerted by the regulation of actomyosin contractility through the phosphorylation of myosin II regulatory light chain (MLC) (By similarity). Along with GIT1, positively regulates microtubule nucleation during interphase (PubMed:27012601). Phosphorylates FXR1, promoting its localization to stress granules and activity (PubMed:20417602). Phosphorylates ILK on 'Thr-173' and 'Ser-246', promoting nuclear export of ILK (PubMed:17420447). {ECO:0000250|UniProtKB:O88643, ECO:0000250|UniProtKB:P35465, ECO:0000269|PubMed:10551809, ECO:0000269|PubMed:11733498, ECO:0000269|PubMed:11896197, ECO:0000269|PubMed:12624090, ECO:0000269|PubMed:12876277, ECO:0000269|PubMed:14585966, ECO:0000269|PubMed:15611088, ECO:0000269|PubMed:15831477, ECO:0000269|PubMed:15833848, ECO:0000269|PubMed:17420447, ECO:0000269|PubMed:17726028, ECO:0000269|PubMed:17989089, ECO:0000269|PubMed:20417602, ECO:0000269|PubMed:22669945, ECO:0000269|PubMed:23260667, ECO:0000269|PubMed:23633677, ECO:0000269|PubMed:25766321, ECO:0000269|PubMed:27012601, ECO:0000269|PubMed:30290153, ECO:0000269|PubMed:8805275, ECO:0000269|PubMed:9032240, ECO:0000269|PubMed:9395435, ECO:0000269|PubMed:9528787}.\nT: Active site: ACT_SITE 389; /note=\"Proton acceptor\"; /evidence=\"ECO:0000269|PubMed:22153498\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Protein kinase involved in intracellular signaling pathways downstream of integrins and receptor-type kinases that plays an important role in cytoskeleton dynamics, in cell adhesion, migration, proliferation, apoptosis, mitosis, and in vesicle-mediated transport processes (PubMed:10551809, PubMed:11896197, PubMed:12876277, PubMed:14585966, PubMed:15611088, PubMed:17726028, PubMed:17989089, PubMed:30290153, PubMed:17420447). Can directly phosphorylate BAD and protects cells against apoptosis (By similarity). Activated by interaction with CDC42 and RAC1 (PubMed:8805275, PubMed:9528787). Functions as a GTPase effector that links the Rho-related GTPases CDC42 and RAC1 to the JNK MAP kinase pathway (PubMed:8805275, PubMed:9528787). Phosphorylates and activates MAP2K1, and thereby mediates activation of downstream MAP kinases (By similarity). Involved in the reorganization of the actin cytoskeleton, actin stress fibers and of focal adhesion complexes (PubMed:9032240, PubMed:9395435). Phosphorylates the tubulin chaperone TBCB and thereby plays a role in the regulation of microtubule biogenesis and organization of the tubulin cytoskeleton (PubMed:15831477). Plays a role in the regulation of insulin secretion in response to elevated glucose levels (PubMed:22669945). Part of a ternary complex that contains PAK1, DVL1 and MUSK that is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ) (By similarity). Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2 (PubMed:12624090). Phosphorylates MYL9/MLC2 (By similarity). Phosphorylates RAF1 at &#x27;Ser-338&#x27; and &#x27;Ser-339&#x27; resulting in: activation of RAF1, stimulation of RAF1 translocation to mitochondria, phosphorylation of BAD by RAF1, and RAF1 binding to BCL2 (PubMed:11733498). Phosphorylates SNAI1 at &#x27;Ser-246&#x27; promoting its transcriptional repressor activity by increasing its accumulation in the nucleus (PubMed:15833848). In podocytes, promotes NR3C2 nuclear localization (By similarity). Required for atypical chemokine receptor ACKR2-induced phosphorylation of LIMK1 and cofilin (CFL1) and for the up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation (PubMed:23633677). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3, maybe through CFL1 phosphorylation and inactivation (By similarity). Plays a role in RUFY3-mediated facilitating gastric cancer cells migration and invasion (PubMed:25766321). In response to DNA damage, phosphorylates MORC2 which activates its ATPase activity and facilitates chromatin remodeling (PubMed:23260667). In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in F-actin stabilization (By similarity). In hippocampal neurons, necessary for the formation of dendritic spines and excitatory synapses; this function is dependent on kinase activity and may be exerted by the regulation of actomyosin contractility through the phosphorylation of myosin II regulatory light chain (MLC) (By similarity). Along with GIT1, positively regulates microtubule nucleation during interphase (PubMed:27012601). Phosphorylates FXR1, promoting its localization to stress granules and activity (PubMed:20417602). Phosphorylates ILK on &#x27;Thr-173&#x27; and &#x27;Ser-246&#x27;, promoting nuclear export of ILK (PubMed:17420447). {ECO:0000250|UniProtKB:O88643, ECO:0000250|UniProtKB:P35465, ECO:0000269|PubMed:10551809, ECO:0000269|PubMed:11733498, ECO:0000269|PubMed:11896197, ECO:0000269|PubMed:12624090, ECO:0000269|PubMed:12876277, ECO:0000269|PubMed:14585966, ECO:0000269|PubMed:15611088, ECO:0000269|PubMed:15831477, ECO:0000269|PubMed:15833848, ECO:0000269|PubMed:17420447, ECO:0000269|PubMed:17726028, ECO:0000269|PubMed:17989089, ECO:0000269|PubMed:20417602, ECO:0000269|PubMed:22669945, ECO:0000269|PubMed:23260667, ECO:0000269|PubMed:23633677, ECO:0000269|PubMed:25766321, ECO:0000269|PubMed:27012601, ECO:0000269|PubMed:30290153, ECO:0000269|PubMed:8805275, ECO:0000269|PubMed:9032240, ECO:0000269|PubMed:9395435, ECO:0000269|PubMed:9528787}.<br/><strong>T: Active site:</strong> ACT_SITE 389; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000269|PubMed:22153498&quot;",
      "PTMs": {
        "Q13153_144": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13153",
          "fc_color_1": [
            254,
            222,
            169
          ],
          "label": "144",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.YMS#FTDK.S\nPSP: ON_FUNCTION: intracellular localization; enzymatic activity, induced\nPSP: ON_PROCESS: carcinogenesis, induced; cell growth, induced; cytoskeletal reorganization\nPSP: NOTES: Inhibitors decreased the tumor growth by inhibiting the phosphorylation; PAK activation induces PAK translocation, increased membrane permeability and MRLC1 phosphorylation.   \nPSP: in_vitro_kinases: PAK1",
          "tooltip_html": "<strong>T: sequence:</strong> K.YMS#FTDK.S<br/><strong>PSP: ON_FUNCTION:</strong> intracellular localization; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> carcinogenesis, induced; cell growth, induced; cytoskeletal reorganization<br/><strong>PSP: NOTES:</strong> Inhibitors decreased the tumor growth by inhibiting the phosphorylation; PAK activation induces PAK translocation, increased membrane permeability and MRLC1 phosphorylation.   <br/><strong>PSP: in_vitro_kinases:</strong> PAK1",
          "fold_change_1": 0.859124,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            215,
            151
          ],
          "fold_change_2": 1.03733,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            242,
            221
          ],
          "fold_change_3": 0.336175,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            245,
            231
          ],
          "fold_change_4": 0.238031,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            253,
            251
          ],
          "fold_change_5": 0.0369034,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 480.2,
          "shape_y": 539.5,
          "label_x": 475.2,
          "label_y": 534.5,
          "label_centering": "right",
          "symbol_x": 480.09999999999997,
          "symbol_y": 539.0
        },
        "Q13153_139": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13153",
          "fc_color_1": [
            254,
            231,
            194
          ],
          "label": "139",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.TSNS#QK.Y",
          "tooltip_html": "<strong>T: sequence:</strong> K.TSNS#QK.Y",
          "fold_change_1": 0.610764,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            217,
            157
          ],
          "fold_change_2": 0.982445,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            227,
            182
          ],
          "fold_change_3": 0.729608,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            235,
            204
          ],
          "fold_change_4": 0.508355,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            230,
            190
          ],
          "fold_change_5": 0.644317,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 507.8,
          "shape_y": 539.5,
          "label_x": 512.8,
          "label_y": 534.5,
          "label_centering": "left",
          "symbol_x": 507.8,
          "symbol_y": 539.5
        },
        "Q13153_219": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13153",
          "fc_color_1": [
            254,
            233,
            198
          ],
          "label": "219",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.DVAT#SPISPTENNTTPPDALTR.N",
          "tooltip_html": "<strong>T: sequence:</strong> R.DVAT#SPISPTENNTTPPDALTR.N",
          "fold_change_1": 0.563194,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            242,
            221
          ],
          "fold_change_2": 0.334723,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            208,
            223,
            235
          ],
          "fold_change_3": -0.367344,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            219,
            161
          ],
          "fold_change_4": 0.940184,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            250,
            243
          ],
          "fold_change_5": 0.113593,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 480.2,
          "shape_y": 564.5,
          "label_x": 475.2,
          "label_y": 569.5,
          "label_centering": "right",
          "symbol_x": 480.2,
          "symbol_y": 564.5
        },
        "Q13153_185": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13153",
          "fc_color_1": [
            243,
            246,
            250
          ],
          "label": "185",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.AVSETPAVPPVSEDEDDDDDDAT#PPPVIAPRPEHTK.S",
          "tooltip_html": "<strong>T: sequence:</strong> K.AVSETPAVPPVSEDEDDDDDDAT#PPPVIAPRPEHTK.S",
          "fold_change_1": -0.0941333,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            252,
            247
          ],
          "fold_change_2": 0.0772306,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            238,
            243,
            248
          ],
          "fold_change_3": -0.129845,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            249,
            239
          ],
          "fold_change_4": 0.15559,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            220,
            231,
            240
          ],
          "fold_change_5": -0.273614,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S3",
          "shape_x": 507.8,
          "shape_y": 564.5,
          "label_x": 512.8,
          "label_y": 569.5,
          "label_centering": "left",
          "symbol_x": 507.8,
          "symbol_y": 564.5
        }
      },
      "fc_color_1": [
        254,
        231,
        192
      ],
      "fold_change_1": 0.62504,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        222,
        170
      ],
      "fold_change_2": 0.853774,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        243,
        224
      ],
      "fold_change_3": 0.305753,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        241,
        220
      ],
      "fold_change_4": 0.350735,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        234,
        201
      ],
      "fold_change_5": 0.542145,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q13177": {
      "label": "PAK2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues (PubMed:7744004). Full-length PAK2 stimulates cell survival and cell growth (PubMed:7744004). Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration (PubMed:21317288). Phosphorylates JUN and plays an important role in EGF-induced cell proliferation (PubMed:21177766). Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP (PubMed:21724829). Phosphorylates CASP7, thereby preventing its activity (PubMed:21555521, PubMed:27889207). Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis (PubMed:19273597, PubMed:19923322). On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway (PubMed:12853446, PubMed:16617111, PubMed:9171063). Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation (PubMed:15234964). {ECO:0000269|PubMed:12853446, ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:16617111, ECO:0000269|PubMed:19273597, ECO:0000269|PubMed:19923322, ECO:0000269|PubMed:21177766, ECO:0000269|PubMed:21317288, ECO:0000269|PubMed:21555521, ECO:0000269|PubMed:21724829, ECO:0000269|PubMed:27889207, ECO:0000269|PubMed:33693784, ECO:0000269|PubMed:7744004, ECO:0000269|PubMed:9171063}.\",\"ACT_SITE 367; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues (PubMed:7744004). Full-length PAK2 stimulates cell survival and cell growth (PubMed:7744004). Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration (PubMed:21317288). Phosphorylates JUN and plays an important role in EGF-induced cell proliferation (PubMed:21177766). Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP (PubMed:21724829). Phosphorylates CASP7, thereby preventing its activity (PubMed:21555521, PubMed:27889207). Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis (PubMed:19273597, PubMed:19923322). On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway (PubMed:12853446, PubMed:16617111, PubMed:9171063). Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation (PubMed:15234964). {ECO:0000269|PubMed:12853446, ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:16617111, ECO:0000269|PubMed:19273597, ECO:0000269|PubMed:19923322, ECO:0000269|PubMed:21177766, ECO:0000269|PubMed:21317288, ECO:0000269|PubMed:21555521, ECO:0000269|PubMed:21724829, ECO:0000269|PubMed:27889207, ECO:0000269|PubMed:33693784, ECO:0000269|PubMed:7744004, ECO:0000269|PubMed:9171063}.\nT: Active site: ACT_SITE 367; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues (PubMed:7744004). Full-length PAK2 stimulates cell survival and cell growth (PubMed:7744004). Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration (PubMed:21317288). Phosphorylates JUN and plays an important role in EGF-induced cell proliferation (PubMed:21177766). Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP (PubMed:21724829). Phosphorylates CASP7, thereby preventing its activity (PubMed:21555521, PubMed:27889207). Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis (PubMed:19273597, PubMed:19923322). On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway (PubMed:12853446, PubMed:16617111, PubMed:9171063). Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation (PubMed:15234964). {ECO:0000269|PubMed:12853446, ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:16617111, ECO:0000269|PubMed:19273597, ECO:0000269|PubMed:19923322, ECO:0000269|PubMed:21177766, ECO:0000269|PubMed:21317288, ECO:0000269|PubMed:21555521, ECO:0000269|PubMed:21724829, ECO:0000269|PubMed:27889207, ECO:0000269|PubMed:33693784, ECO:0000269|PubMed:7744004, ECO:0000269|PubMed:9171063}.<br/><strong>T: Active site:</strong> ACT_SITE 367; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "Q13177_134": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13177",
          "fc_color_1": [
            48,
            113,
            169
          ],
          "label": "134",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: K.FYDSNT#VK.Q\nPSP: ON_FUNCTION: phosphorylation\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, induced; cell growth, induced; signaling pathway regulation\nPSP: NOTES: induces phosphorylation of mEK and ERK, induces MAPK signaling pathway\nPSP: in_vivo_kinases: CDK12\nPSP: in_vitro_kinases: CDK12",
          "tooltip_html": "<strong>T: sequence:</strong> K.FYDSNT#VK.Q<br/><strong>PSP: ON_FUNCTION:</strong> phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, induced; cell growth, induced; signaling pathway regulation<br/><strong>PSP: NOTES:</strong> induces phosphorylation of mEK and ERK, induces MAPK signaling pathway<br/><strong>PSP: in_vivo_kinases:</strong> CDK12<br/><strong>PSP: in_vitro_kinases:</strong> CDK12",
          "fold_change_1": -1.63164,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            253,
            251
          ],
          "fold_change_2": 0.0304104,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            203,
            219,
            233
          ],
          "fold_change_3": -0.404986,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            122,
            163,
            199
          ],
          "fold_change_4": -1.04897,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            42,
            109,
            166
          ],
          "fold_change_5": -1.67701,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 480.2,
          "shape_y": 539.5,
          "label_x": 475.2,
          "label_y": 534.5,
          "label_centering": "right",
          "symbol_x": 480.09999999999997,
          "symbol_y": 539.5
        },
        "Q13177_20": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13177",
          "fc_color_1": [
            86,
            139,
            185
          ],
          "label": "20",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: R.M*SS#TIFSTGGK.D\nPSP: ON_PROCESS: carcinogenesis, induced; cell growth, induced\nPSP: in_vivo_kinases: AMPKA2\nPSP: in_vitro_kinases: AMPKA2",
          "tooltip_html": "<strong>T: sequence:</strong> R.M*SS#TIFSTGGK.D<br/><strong>PSP: ON_PROCESS:</strong> carcinogenesis, induced; cell growth, induced<br/><strong>PSP: in_vivo_kinases:</strong> AMPKA2<br/><strong>PSP: in_vitro_kinases:</strong> AMPKA2",
          "fold_change_1": -1.32828,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            207,
            222,
            235
          ],
          "fold_change_2": -0.377787,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            231,
            194
          ],
          "fold_change_3": 0.609622,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            253,
            203,
            120
          ],
          "fold_change_4": 1.34833,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            251,
            252,
            253
          ],
          "fold_change_5": -0.0264659,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 507.8,
          "shape_y": 539.5,
          "label_x": 512.8,
          "label_y": 534.5,
          "label_centering": "left",
          "symbol_x": 507.7,
          "symbol_y": 539.5
        },
        "Q13177_141": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13177",
          "fc_color_1": [
            253,
            209,
            134
          ],
          "label": "141",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.YLS#FTPPEK.D\nPSP: ON_FUNCTION: enzymatic activity, induced\nPSP: in_vitro_kinases: PAK2",
          "tooltip_html": "<strong>T: sequence:</strong> K.YLS#FTPPEK.D<br/><strong>PSP: ON_FUNCTION:</strong> enzymatic activity, induced<br/><strong>PSP: in_vitro_kinases:</strong> PAK2",
          "fold_change_1": 1.20671,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            211,
            140
          ],
          "fold_change_2": 1.14637,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            245,
            228
          ],
          "fold_change_3": 0.261874,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            251,
            245
          ],
          "fold_change_4": 0.0977372,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            254,
            254
          ],
          "fold_change_5": 0.00795662,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 480.2,
          "shape_y": 564.5,
          "label_x": 475.2,
          "label_y": 569.5,
          "label_centering": "right",
          "symbol_x": 480.09999999999997,
          "symbol_y": 564.0
        },
        "Q13177_169": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13177",
          "fc_color_1": [
            161,
            190,
            216
          ],
          "label": "169",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: K.GTEAPAVVT#EEEDDDEETAPPVIAPRPDHTK.S\nPSP: ON_FUNCTION: phosphorylation\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, induced; cell growth, induced; signaling pathway regulation\nPSP: NOTES: induces phosphorylation of mEK and ERK, induces MAPK signaling pathway\nPSP: in_vivo_kinases: CDK12\nPSP: in_vitro_kinases: CDK12",
          "tooltip_html": "<strong>T: sequence:</strong> K.GTEAPAVVT#EEEDDDEETAPPVIAPRPDHTK.S<br/><strong>PSP: ON_FUNCTION:</strong> phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, induced; cell growth, induced; signaling pathway regulation<br/><strong>PSP: NOTES:</strong> induces phosphorylation of mEK and ERK, induces MAPK signaling pathway<br/><strong>PSP: in_vivo_kinases:</strong> CDK12<br/><strong>PSP: in_vitro_kinases:</strong> CDK12",
          "fold_change_1": -0.740363,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            154,
            186,
            213
          ],
          "fold_change_2": -0.792318,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            189,
            210,
            227
          ],
          "fold_change_3": -0.515658,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            226,
            235,
            243
          ],
          "fold_change_4": -0.228449,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            213,
            226,
            237
          ],
          "fold_change_5": -0.329308,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S3",
          "shape_x": 507.8,
          "shape_y": 564.5,
          "label_x": 512.8,
          "label_y": 569.5,
          "label_centering": "left",
          "symbol_x": 507.7,
          "symbol_y": 564.5
        },
        "Q13177_152": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13177",
          "fc_color_1": [
            254,
            239,
            215
          ],
          "label": "152",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.DGFPS#GTPALNAK.G",
          "tooltip_html": "<strong>T: sequence:</strong> K.DGFPS#GTPALNAK.G",
          "fold_change_1": 0.396161,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            210,
            137
          ],
          "fold_change_2": 1.17978,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            249,
            241
          ],
          "fold_change_3": 0.136028,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            198,
            216,
            231
          ],
          "fold_change_4": -0.447185,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            253,
            253,
            254
          ],
          "fold_change_5": -0.0121623,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": ""
        },
        "Q13177_132": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13177",
          "fc_color_1": [
            248,
            250,
            252
          ],
          "label": "132",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.FYDS#NTVK.Q",
          "tooltip_html": "<strong>T: sequence:</strong> K.FYDS#NTVK.Q",
          "fold_change_1": -0.0525044,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            239,
            214
          ],
          "fold_change_2": 0.404256,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            240,
            217
          ],
          "fold_change_3": 0.378506,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            242,
            222
          ],
          "fold_change_4": 0.330122,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            244,
            227
          ],
          "fold_change_5": 0.27612,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": ""
        },
        "Q13177_143": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q13177",
          "fc_color_1": [
            254,
            253,
            249
          ],
          "label": "143",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.YLS#FT#PPEK.D",
          "tooltip_html": "<strong>T: sequence:</strong> K.YLS#FT#PPEK.D",
          "fold_change_1": 0.0506469,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            214,
            227,
            238
          ],
          "fold_change_2": -0.321827,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            223,
            233,
            241
          ],
          "fold_change_3": -0.251476,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            254,
            253
          ],
          "fold_change_4": 0.0100524,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            252,
            247
          ],
          "fold_change_5": 0.0762859,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": ""
        }
      },
      "fc_color_1": [
        254,
        228,
        185
      ],
      "fold_change_1": 0.696893,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        220,
        165
      ],
      "fold_change_2": 0.895646,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        226
      ],
      "fold_change_3": 0.288588,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        241,
        219
      ],
      "fold_change_4": 0.35954,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        231,
        193
      ],
      "fold_change_5": 0.616266,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9Y2U5": {
      "label": "M3K2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}.\",\"ACT_SITE 483; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}.\nT: Active site: ACT_SITE 483; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}.<br/><strong>T: Active site:</strong> ACT_SITE 483; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {
        "Q9Y2U5_163": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9Y2U5",
          "fc_color_1": [
            126,
            166,
            201
          ],
          "label": "163",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.DRS#SPPPGYIPDELHQVAR.N",
          "tooltip_html": "<strong>T: sequence:</strong> R.DRS#SPPPGYIPDELHQVAR.N",
          "fold_change_1": -1.01528,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            90,
            141,
            186
          ],
          "fold_change_2": -1.30297,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            167,
            194,
            218
          ],
          "fold_change_3": -0.689898,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            230,
            238,
            245
          ],
          "fold_change_4": -0.189943,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            135,
            173,
            205
          ],
          "fold_change_5": -0.942356,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 566.2,
          "shape_y": 539.5,
          "label_x": 561.2,
          "label_y": 534.5,
          "label_centering": "right",
          "symbol_x": 566.2,
          "symbol_y": 539.5
        },
        "Q9Y2U5_239": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9Y2U5",
          "fc_color_1": [
            187,
            208,
            226
          ],
          "label": "239",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.AQS#YPDNHQEFSDYDNPIFEK.F",
          "tooltip_html": "<strong>T: sequence:</strong> R.AQS#YPDNHQEFSDYDNPIFEK.F",
          "fold_change_1": -0.534969,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            221,
            232,
            241
          ],
          "fold_change_2": -0.261534,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            221,
            232,
            241
          ],
          "fold_change_3": -0.263358,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            254,
            253
          ],
          "fold_change_4": 0.0143495,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            175,
            200,
            222
          ],
          "fold_change_5": -0.6262,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 593.8,
          "shape_y": 539.5,
          "label_x": 598.8,
          "label_y": 534.5,
          "label_centering": "left",
          "symbol_x": 593.8,
          "symbol_y": 539.5
        }
      },
      "fc_color_1": [
        253,
        213,
        146
      ],
      "fold_change_1": 1.08567,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        211,
        142
      ],
      "fold_change_2": 1.13352,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        235,
        204
      ],
      "fold_change_3": 0.506276,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        243,
        225
      ],
      "fold_change_4": 0.293428,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        221,
        167
      ],
      "fold_change_5": 0.876946,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q99759": {
      "label": "M3K3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. {ECO:0000269|PubMed:12912994, ECO:0000269|PubMed:14661019, ECO:0000269|PubMed:14743216, ECO:0000269|PubMed:33729480, ECO:0000269|PubMed:33891857, ECO:0000269|PubMed:9006902}.\",\"ACT_SITE 489; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. {ECO:0000269|PubMed:12912994, ECO:0000269|PubMed:14661019, ECO:0000269|PubMed:14743216, ECO:0000269|PubMed:33729480, ECO:0000269|PubMed:33891857, ECO:0000269|PubMed:9006902}.\nT: Active site: ACT_SITE 489; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. {ECO:0000269|PubMed:12912994, ECO:0000269|PubMed:14661019, ECO:0000269|PubMed:14743216, ECO:0000269|PubMed:33729480, ECO:0000269|PubMed:33891857, ECO:0000269|PubMed:9006902}.<br/><strong>T: Active site:</strong> ACT_SITE 489; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {
        "Q99759_176": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q99759",
          "fc_color_1": [
            42,
            108,
            166
          ],
          "label": "176",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.SS#PPPGYVPER.Q",
          "tooltip_html": "<strong>T: sequence:</strong> R.SS#PPPGYVPER.Q",
          "fold_change_1": -1.67895,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            115,
            159,
            197
          ],
          "fold_change_2": -1.10153,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            129,
            168,
            203
          ],
          "fold_change_3": -0.989411,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            137,
            174,
            206
          ],
          "fold_change_4": -0.927817,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            180,
            203,
            224
          ],
          "fold_change_5": -0.587736,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 566.2,
          "shape_y": 539.5,
          "label_x": 561.2,
          "label_y": 534.5,
          "label_centering": "right",
          "symbol_x": 566.2,
          "symbol_y": 539.5
        },
        "Q99759_274": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q99759",
          "fc_color_1": [
            254,
            224,
            175
          ],
          "label": "274",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.GGT#YPR.R",
          "tooltip_html": "<strong>T: sequence:</strong> K.GGT#YPR.R",
          "fold_change_1": 0.800283,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            224,
            174
          ],
          "fold_change_2": 0.808643,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            250,
            242
          ],
          "fold_change_3": 0.12863,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            223,
            233,
            241
          ],
          "fold_change_4": -0.249946,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            239,
            215
          ],
          "fold_change_5": 0.400749,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 593.8,
          "shape_y": 539.5,
          "label_x": 598.8,
          "label_y": 534.5,
          "label_centering": "left",
          "symbol_x": 593.8,
          "symbol_y": 539.5
        },
        "Q99759_237": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q99759",
          "fc_color_1": [
            207,
            222,
            235
          ],
          "label": "237",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.SADS#PSFR.K",
          "tooltip_html": "<strong>T: sequence:</strong> R.SADS#PSFR.K",
          "fold_change_1": -0.378248,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            143,
            178,
            208
          ],
          "fold_change_2": -0.877767,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            232,
            239,
            245
          ],
          "fold_change_3": -0.180822,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            225,
            234,
            242
          ],
          "fold_change_4": -0.233699,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            190,
            210,
            228
          ],
          "fold_change_5": -0.5135,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 566.2,
          "shape_y": 564.5,
          "label_x": 561.2,
          "label_y": 569.5,
          "label_centering": "right",
          "symbol_x": 566.2,
          "symbol_y": 564.5
        }
      },
      "fc_color_1": [
        253,
        213,
        145
      ],
      "fold_change_1": 1.10512,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        226,
        181
      ],
      "fold_change_2": 0.739358,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        240,
        217
      ],
      "fold_change_3": 0.373617,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        233,
        198
      ],
      "fold_change_4": 0.57285,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        237,
        208
      ],
      "fold_change_5": 0.463074,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_116": {
      "label": "MAPK8IP2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q16584": {
      "label": "M3K11",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}.\",\"ACT_SITE 241; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250|UniProtKB:Q02779, ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}.\nT: Active site: ACT_SITE 241; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250|UniProtKB:Q02779, ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}.<br/><strong>T: Active site:</strong> ACT_SITE 241; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250|UniProtKB:Q02779, ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "Q16584_524": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q16584",
          "fc_color_1": [
            171,
            197,
            220
          ],
          "label": "524",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.NVFEVGPGDS#PTFPR.F",
          "tooltip_html": "<strong>T: sequence:</strong> R.NVFEVGPGDS#PTFPR.F",
          "fold_change_1": -0.663761,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            242,
            246,
            249
          ],
          "fold_change_2": -0.0961346,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            185,
            207,
            226
          ],
          "fold_change_3": -0.551406,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            252,
            248
          ],
          "fold_change_4": 0.0671622,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            237,
            208
          ],
          "fold_change_5": 0.467902,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 566.2,
          "shape_y": 507.5,
          "label_x": 561.2,
          "label_y": 502.5,
          "label_centering": "right",
          "symbol_x": 566.2,
          "symbol_y": 507.5
        }
      },
      "fc_color_1": [
        254,
        240,
        218
      ],
      "fold_change_1": 0.371462,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        239,
        214
      ],
      "fold_change_2": 0.41052,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        242,
        221
      ],
      "fold_change_3": 0.334138,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        243,
        224
      ],
      "fold_change_4": 0.30465,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        247,
        235
      ],
      "fold_change_5": 0.193692,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O14733": {
      "label": "MP2K7",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by pro-inflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Part of a non-canonical MAPK signaling pathway, composed of the upstream MAP3K12 kinase and downstream MAP kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated transcription of APP in response to APOE (PubMed:28111074). {ECO:0000269|PubMed:28111074, ECO:0000269|PubMed:9312068, ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930, ECO:0000269|Ref.5}.\",\"ACT_SITE 243; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by pro-inflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Part of a non-canonical MAPK signaling pathway, composed of the upstream MAP3K12 kinase and downstream MAP kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated transcription of APP in response to APOE (PubMed:28111074). {ECO:0000269|PubMed:28111074, ECO:0000269|PubMed:9312068, ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930, ECO:0000269|Ref.5}.\nT: Active site: ACT_SITE 243; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by pro-inflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Part of a non-canonical MAPK signaling pathway, composed of the upstream MAP3K12 kinase and downstream MAP kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated transcription of APP in response to APOE (PubMed:28111074). {ECO:0000269|PubMed:28111074, ECO:0000269|PubMed:9312068, ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930, ECO:0000269|Ref.5}.<br/><strong>T: Active site:</strong> ACT_SITE 243; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        231,
        194
      ],
      "fold_change_1": 0.610063,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        197,
        104
      ],
      "fold_change_2": 1.51393,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        223,
        172
      ],
      "fold_change_3": 0.830843,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        232,
        197
      ],
      "fold_change_4": 0.579624,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        223,
        172
      ],
      "fold_change_5": 0.827455,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P45983": {
      "label": "MK08",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway (PubMed:28943315). In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:18307971). Phosphorylates the replication licensing factor CDT1, inhibiting the interaction between CDT1 and the histone H4 acetylase HBO1 to replication origins (PubMed:21856198). Loss of this interaction abrogates the acetylation required for replication initiation (PubMed:21856198). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including p53/TP53 and Yes-associates protein YAP1 (PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Contributes to the survival of erythroid cells by phosphorylating the antagonist of cell death BAD upon EPO stimulation (PubMed:21095239). Mediates starvation-induced BCL2 phosphorylation, BCL2 dissociation from BECN1, and thus activation of autophagy (PubMed:18570871). Phosphorylates STMN2 and hence regulates microtubule dynamics, controlling neurite elongation in cortical neurons (By similarity). In the developing brain, through its cytoplasmic activity on STMN2, negatively regulates the rate of exit from multipolar stage and of radial migration from the ventricular zone (By similarity). Phosphorylates several other substrates including heat shock factor protein 4 (HSF4), the deacetylase SIRT1, ELK1, or the E3 ligase ITCH (PubMed:16581800, PubMed:17296730, PubMed:20027304). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates the heat shock transcription factor HSF1, suppressing HSF1-induced transcriptional activity (PubMed:10747973). Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates JUND and this phosphorylation is inhibited in the presence of MEN1 (PubMed:22327296). In neurons, phosphorylates SYT4 which captures neuronal dense core vesicles at synapses (By similarity). Phosphorylates EIF4ENIF1/4-ET in response to oxidative stress, promoting P-body assembly (PubMed:22966201). Phosphorylates SIRT6 in response to oxidative stress, stimulating its mono-ADP-ribosyltransferase activity (PubMed:27568560). Phosphorylates NLRP3, promoting assembly of the NLRP3 inflammasome (PubMed:28943315). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). {ECO:0000250|UniProtKB:P49185, ECO:0000250|UniProtKB:Q91Y86, ECO:0000269|PubMed:10747973, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:17296730, ECO:0000269|PubMed:18307971, ECO:0000269|PubMed:18570871, ECO:0000269|PubMed:20027304, ECO:0000269|PubMed:21095239, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22327296, ECO:0000269|PubMed:22441692, ECO:0000269|PubMed:22966201, ECO:0000269|PubMed:27568560, ECO:0000269|PubMed:28943315, ECO:0000269|PubMed:34048572}.; FUNCTION: JNK1 isoforms display different binding patterns: beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms.\",\"ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway (PubMed:28943315). In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:18307971). Phosphorylates the replication licensing factor CDT1, inhibiting the interaction between CDT1 and the histone H4 acetylase HBO1 to replication origins (PubMed:21856198). Loss of this interaction abrogates the acetylation required for replication initiation (PubMed:21856198). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including p53/TP53 and Yes-associates protein YAP1 (PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Contributes to the survival of erythroid cells by phosphorylating the antagonist of cell death BAD upon EPO stimulation (PubMed:21095239). Mediates starvation-induced BCL2 phosphorylation, BCL2 dissociation from BECN1, and thus activation of autophagy (PubMed:18570871). Phosphorylates STMN2 and hence regulates microtubule dynamics, controlling neurite elongation in cortical neurons (By similarity). In the developing brain, through its cytoplasmic activity on STMN2, negatively regulates the rate of exit from multipolar stage and of radial migration from the ventricular zone (By similarity). Phosphorylates several other substrates including heat shock factor protein 4 (HSF4), the deacetylase SIRT1, ELK1, or the E3 ligase ITCH (PubMed:16581800, PubMed:17296730, PubMed:20027304). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates the heat shock transcription factor HSF1, suppressing HSF1-induced transcriptional activity (PubMed:10747973). Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates JUND and this phosphorylation is inhibited in the presence of MEN1 (PubMed:22327296). In neurons, phosphorylates SYT4 which captures neuronal dense core vesicles at synapses (By similarity). Phosphorylates EIF4ENIF1/4-ET in response to oxidative stress, promoting P-body assembly (PubMed:22966201). Phosphorylates SIRT6 in response to oxidative stress, stimulating its mono-ADP-ribosyltransferase activity (PubMed:27568560). Phosphorylates NLRP3, promoting assembly of the NLRP3 inflammasome (PubMed:28943315). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). {ECO:0000250|UniProtKB:P49185, ECO:0000250|UniProtKB:Q91Y86, ECO:0000269|PubMed:10747973, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:17296730, ECO:0000269|PubMed:18307971, ECO:0000269|PubMed:18570871, ECO:0000269|PubMed:20027304, ECO:0000269|PubMed:21095239, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22327296, ECO:0000269|PubMed:22441692, ECO:0000269|PubMed:22966201, ECO:0000269|PubMed:27568560, ECO:0000269|PubMed:28943315, ECO:0000269|PubMed:34048572}.; FUNCTION: JNK1 isoforms display different binding patterns: beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms.\nT: Active site: ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway (PubMed:28943315). In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:18307971). Phosphorylates the replication licensing factor CDT1, inhibiting the interaction between CDT1 and the histone H4 acetylase HBO1 to replication origins (PubMed:21856198). Loss of this interaction abrogates the acetylation required for replication initiation (PubMed:21856198). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including p53/TP53 and Yes-associates protein YAP1 (PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Contributes to the survival of erythroid cells by phosphorylating the antagonist of cell death BAD upon EPO stimulation (PubMed:21095239). Mediates starvation-induced BCL2 phosphorylation, BCL2 dissociation from BECN1, and thus activation of autophagy (PubMed:18570871). Phosphorylates STMN2 and hence regulates microtubule dynamics, controlling neurite elongation in cortical neurons (By similarity). In the developing brain, through its cytoplasmic activity on STMN2, negatively regulates the rate of exit from multipolar stage and of radial migration from the ventricular zone (By similarity). Phosphorylates several other substrates including heat shock factor protein 4 (HSF4), the deacetylase SIRT1, ELK1, or the E3 ligase ITCH (PubMed:16581800, PubMed:17296730, PubMed:20027304). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates the heat shock transcription factor HSF1, suppressing HSF1-induced transcriptional activity (PubMed:10747973). Phosphorylates POU5F1, which results in the inhibition of POU5F1&#x27;s transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates JUND and this phosphorylation is inhibited in the presence of MEN1 (PubMed:22327296). In neurons, phosphorylates SYT4 which captures neuronal dense core vesicles at synapses (By similarity). Phosphorylates EIF4ENIF1/4-ET in response to oxidative stress, promoting P-body assembly (PubMed:22966201). Phosphorylates SIRT6 in response to oxidative stress, stimulating its mono-ADP-ribosyltransferase activity (PubMed:27568560). Phosphorylates NLRP3, promoting assembly of the NLRP3 inflammasome (PubMed:28943315). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). {ECO:0000250|UniProtKB:P49185, ECO:0000250|UniProtKB:Q91Y86, ECO:0000269|PubMed:10747973, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:17296730, ECO:0000269|PubMed:18307971, ECO:0000269|PubMed:18570871, ECO:0000269|PubMed:20027304, ECO:0000269|PubMed:21095239, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22327296, ECO:0000269|PubMed:22441692, ECO:0000269|PubMed:22966201, ECO:0000269|PubMed:27568560, ECO:0000269|PubMed:28943315, ECO:0000269|PubMed:34048572}.; FUNCTION: JNK1 isoforms display different binding patterns: beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms.<br/><strong>T: Active site:</strong> ACT_SITE 151; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        232,
        197
      ],
      "fold_change_1": 0.580114,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        229,
        187
      ],
      "fold_change_2": 0.677467,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        247,
        236
      ],
      "fold_change_3": 0.190149,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        241,
        218
      ],
      "fold_change_4": 0.362824,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        237,
        208
      ],
      "fold_change_5": 0.464457,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P45984": {
      "label": "MK09",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK9/JNK2 (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). In turn, MAPK9/JNK2 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:10376527). In response to oxidative or ribotoxic stresses, inhibits rRNA synthesis by phosphorylating and inactivating the RNA polymerase 1-specific transcription initiation factor RRN3 (PubMed:15805466). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including TP53 and YAP1 (PubMed:17525747, PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells (PubMed:19290929). Upon T-cell receptor (TCR) stimulation, is activated by CARMA1, BCL10, MAP2K7 and MAP3K7/TAK1 to regulate JUN protein levels (PubMed:19290929). Plays an important role in the osmotic stress-induced epithelial tight-junctions disruption (PubMed:20595622). When activated, promotes beta-catenin/CTNNB1 degradation and inhibits the canonical Wnt signaling pathway (PubMed:19675674). Also participates in neurite growth in spiral ganglion neurons (By similarity). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). {ECO:0000250|UniProtKB:Q9WTU6, ECO:0000269|PubMed:10376527, ECO:0000269|PubMed:15805466, ECO:0000269|PubMed:17525747, ECO:0000269|PubMed:19675674, ECO:0000269|PubMed:20595622, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:22441692, ECO:0000269|PubMed:34048572, ECO:0000303|PubMed:19290929}.; FUNCTION: MAPK9 isoforms display different binding patterns: alpha-1 and alpha-2 preferentially bind to JUN, whereas beta-1 and beta-2 bind to ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms. JUNB is not a substrate for JNK2 alpha-2, and JUND binds only weakly to it.\",\"ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK9/JNK2 (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). In turn, MAPK9/JNK2 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:10376527). In response to oxidative or ribotoxic stresses, inhibits rRNA synthesis by phosphorylating and inactivating the RNA polymerase 1-specific transcription initiation factor RRN3 (PubMed:15805466). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including TP53 and YAP1 (PubMed:17525747, PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells (PubMed:19290929). Upon T-cell receptor (TCR) stimulation, is activated by CARMA1, BCL10, MAP2K7 and MAP3K7/TAK1 to regulate JUN protein levels (PubMed:19290929). Plays an important role in the osmotic stress-induced epithelial tight-junctions disruption (PubMed:20595622). When activated, promotes beta-catenin/CTNNB1 degradation and inhibits the canonical Wnt signaling pathway (PubMed:19675674). Also participates in neurite growth in spiral ganglion neurons (By similarity). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). {ECO:0000250|UniProtKB:Q9WTU6, ECO:0000269|PubMed:10376527, ECO:0000269|PubMed:15805466, ECO:0000269|PubMed:17525747, ECO:0000269|PubMed:19675674, ECO:0000269|PubMed:20595622, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:22441692, ECO:0000269|PubMed:34048572, ECO:0000303|PubMed:19290929}.; FUNCTION: MAPK9 isoforms display different binding patterns: alpha-1 and alpha-2 preferentially bind to JUN, whereas beta-1 and beta-2 bind to ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms. JUNB is not a substrate for JNK2 alpha-2, and JUND binds only weakly to it.\nT: Active site: ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK9/JNK2 (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). In turn, MAPK9/JNK2 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:10376527). In response to oxidative or ribotoxic stresses, inhibits rRNA synthesis by phosphorylating and inactivating the RNA polymerase 1-specific transcription initiation factor RRN3 (PubMed:15805466). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including TP53 and YAP1 (PubMed:17525747, PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells (PubMed:19290929). Upon T-cell receptor (TCR) stimulation, is activated by CARMA1, BCL10, MAP2K7 and MAP3K7/TAK1 to regulate JUN protein levels (PubMed:19290929). Plays an important role in the osmotic stress-induced epithelial tight-junctions disruption (PubMed:20595622). When activated, promotes beta-catenin/CTNNB1 degradation and inhibits the canonical Wnt signaling pathway (PubMed:19675674). Also participates in neurite growth in spiral ganglion neurons (By similarity). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates POU5F1, which results in the inhibition of POU5F1&#x27;s transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). {ECO:0000250|UniProtKB:Q9WTU6, ECO:0000269|PubMed:10376527, ECO:0000269|PubMed:15805466, ECO:0000269|PubMed:17525747, ECO:0000269|PubMed:19675674, ECO:0000269|PubMed:20595622, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:22441692, ECO:0000269|PubMed:34048572, ECO:0000303|PubMed:19290929}.; FUNCTION: MAPK9 isoforms display different binding patterns: alpha-1 and alpha-2 preferentially bind to JUN, whereas beta-1 and beta-2 bind to ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms. JUNB is not a substrate for JNK2 alpha-2, and JUND binds only weakly to it.<br/><strong>T: Active site:</strong> ACT_SITE 151; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        227,
        182
      ],
      "fold_change_1": 0.72624,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        218,
        160
      ],
      "fold_change_2": 0.950067,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        243,
        224
      ],
      "fold_change_3": 0.305365,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        245,
        228
      ],
      "fold_change_4": 0.261584,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        231,
        193
      ],
      "fold_change_5": 0.619792,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P45985": {
      "label": "MP2K4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to pro-inflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. {ECO:0000269|PubMed:7716521}.\",\"ACT_SITE 229; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to pro-inflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. {ECO:0000269|PubMed:7716521}.\nT: Active site: ACT_SITE 229; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to pro-inflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. {ECO:0000269|PubMed:7716521}.<br/><strong>T: Active site:</strong> ACT_SITE 229; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {
        "P45985_394": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P45985",
          "fc_color_1": [
            222,
            232,
            241
          ],
          "label": "394",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.ILDQMPATPSS#PMYVD.-",
          "tooltip_html": "<strong>T: sequence:</strong> K.ILDQMPATPSS#PMYVD.-",
          "fold_change_1": -0.257049,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            89,
            141,
            186
          ],
          "fold_change_2": -1.30652,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            253,
            252
          ],
          "fold_change_3": 0.0291474,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            253,
            252
          ],
          "fold_change_4": 0.0278907,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            90,
            141,
            186
          ],
          "fold_change_5": -1.30167,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 662.2,
          "shape_y": 474.5,
          "label_x": 657.2,
          "label_y": 469.5,
          "label_centering": "right",
          "symbol_x": 662.2,
          "symbol_y": 474.5
        },
        "P45985_90": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P45985",
          "fc_color_1": [
            254,
            246,
            232
          ],
          "label": "90",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.LKIS#PEQHWDFTAEDLK.D",
          "tooltip_html": "<strong>T: sequence:</strong> K.LKIS#PEQHWDFTAEDLK.D",
          "fold_change_1": 0.227724,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            155,
            186,
            213
          ],
          "fold_change_2": -0.789691,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            254,
            254
          ],
          "fold_change_3": 0.00696252,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            227,
            182
          ],
          "fold_change_4": 0.729604,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            222,
            232,
            241
          ],
          "fold_change_5": -0.257186,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 689.8,
          "shape_y": 474.5,
          "label_x": 694.8,
          "label_y": 469.5,
          "label_centering": "left",
          "symbol_x": 689.8,
          "symbol_y": 474.5
        }
      },
      "fc_color_1": [
        254,
        228,
        185
      ],
      "fold_change_1": 0.696512,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        253,
        212,
        144
      ],
      "fold_change_2": 1.10668,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        240,
        216
      ],
      "fold_change_3": 0.391606,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        242,
        222
      ],
      "fold_change_4": 0.322459,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        229,
        189
      ],
      "fold_change_5": 0.66251,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P46108": {
      "label": "CRK",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Involved in cell branching and adhesion mediated by BCAR1-CRK-RAPGEF1 signaling and activation of RAP1. {ECO:0000269|PubMed:12432078}.; FUNCTION: [Isoform Crk-II]: Regulates cell adhesion, spreading and migration (PubMed:31311869). Mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4 (PubMed:19004829). May regulate the EFNA5-EPHA3 signaling (By similarity). {ECO:0000250|UniProtKB:Q64010, ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:1630456, ECO:0000269|PubMed:17515907, ECO:0000269|PubMed:19004829, ECO:0000269|PubMed:31311869}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Involved in cell branching and adhesion mediated by BCAR1-CRK-RAPGEF1 signaling and activation of RAP1. {ECO:0000269|PubMed:12432078}.; FUNCTION: [Isoform Crk-II]: Regulates cell adhesion, spreading and migration (PubMed:31311869). Mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4 (PubMed:19004829). May regulate the EFNA5-EPHA3 signaling (By similarity). {ECO:0000250|UniProtKB:Q64010, ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:1630456, ECO:0000269|PubMed:17515907, ECO:0000269|PubMed:19004829, ECO:0000269|PubMed:31311869}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Involved in cell branching and adhesion mediated by BCAR1-CRK-RAPGEF1 signaling and activation of RAP1. {ECO:0000269|PubMed:12432078}.; FUNCTION: [Isoform Crk-II]: Regulates cell adhesion, spreading and migration (PubMed:31311869). Mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4 (PubMed:19004829). May regulate the EFNA5-EPHA3 signaling (By similarity). {ECO:0000250|UniProtKB:Q64010, ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:1630456, ECO:0000269|PubMed:17515907, ECO:0000269|PubMed:19004829, ECO:0000269|PubMed:31311869}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        225,
        179
      ],
      "fold_change_1": 0.763288,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        225,
        178
      ],
      "fold_change_2": 0.770585,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        248,
        236
      ],
      "fold_change_3": 0.180957,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        244,
        227
      ],
      "fold_change_4": 0.27919,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        237,
        209
      ],
      "fold_change_5": 0.45258,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P46109": {
      "label": "CRKL",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: May mediate the transduction of intracellular signals.\"",
      "tooltip": "T: Function [CC]: FUNCTION: May mediate the transduction of intracellular signals.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: May mediate the transduction of intracellular signals.",
      "PTMs": {
        "P46109_107": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P46109",
          "fc_color_1": [
            161,
            190,
            216
          ],
          "label": "107",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.YPS#PPMGSVSAPNLPTAEDNLEYVR.T",
          "tooltip_html": "<strong>T: sequence:</strong> R.YPS#PPMGSVSAPNLPTAEDNLEYVR.T",
          "fold_change_1": -0.740893,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            201,
            217,
            232
          ],
          "fold_change_2": -0.425771,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            239,
            244,
            248
          ],
          "fold_change_3": -0.12172,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            205,
            220,
            234
          ],
          "fold_change_4": -0.392209,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            215,
            227,
            238
          ],
          "fold_change_5": -0.313898,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 704.2,
          "shape_y": 463.5,
          "label_x": 699.2,
          "label_y": 468.5,
          "label_centering": "right",
          "symbol_x": 704.2,
          "symbol_y": 463.5
        },
        "P46109_220": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P46109",
          "fc_color_1": [
            217,
            228,
            239
          ],
          "label": "220",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.NSNSYGIPEPAHAYAQPQTTTPLPAVS#GSPGAAITPLPSTQNGPVFAK.A",
          "tooltip_html": "<strong>T: sequence:</strong> R.NSNSYGIPEPAHAYAQPQTTTPLPAVS#GSPGAAITPLPSTQNGPVFAK.A",
          "fold_change_1": -0.299503,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            238,
            212
          ],
          "fold_change_2": 0.430535,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            251,
            252,
            253
          ],
          "fold_change_3": -0.0290715,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            245,
            228
          ],
          "fold_change_4": 0.263117,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            156,
            187,
            214
          ],
          "fold_change_5": -0.778526,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S2",
          "shape_x": 718.0,
          "shape_y": 463.5,
          "label_x": 718.0,
          "label_y": 473.5,
          "label_centering": "center",
          "symbol_x": 718.0,
          "symbol_y": 463.5
        },
        "P46109_185": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P46109",
          "fc_color_1": [
            223,
            233,
            241
          ],
          "label": "185",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.SS#PHGK.H",
          "tooltip_html": "<strong>T: sequence:</strong> R.SS#PHGK.H",
          "fold_change_1": -0.251279,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            232,
            195
          ],
          "fold_change_2": 0.595617,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            242,
            222
          ],
          "fold_change_3": 0.326344,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            240,
            217
          ],
          "fold_change_4": 0.379969,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            231,
            192
          ],
          "fold_change_5": 0.628061,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S3",
          "shape_x": 731.8,
          "shape_y": 463.5,
          "label_x": 736.8,
          "label_y": 468.5,
          "label_centering": "left",
          "symbol_x": 731.8,
          "symbol_y": 463.5
        }
      },
      "fc_color_1": [
        254,
        236,
        207
      ],
      "fold_change_1": 0.477243,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        238,
        213
      ],
      "fold_change_2": 0.421863,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        251,
        244
      ],
      "fold_change_3": 0.103211,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        247,
        235
      ],
      "fold_change_4": 0.199921,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        247,
        235
      ],
      "fold_change_5": 0.191624,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P32121": {
      "label": "ARRB2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Involved in internalization of P2RY1, P2RY4, P2RY6 and P2RY11 and ATP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 and subsequent recycling or degradation. Involved in ubiquitination of IGF1R. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as a signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2) and MAPK10 (JNK3). ERK1/2 and JNK3 activated by the beta-arrestin scaffold are largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Acts as a signaling scaffold for the AKT1 pathway. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Increases ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Involved in CCR7-mediated ERK1/2 signaling involving ligand CCL19. Is involved in type-1A angiotensin II receptor/AGTR1-mediated ERK activity. Is involved in type-1A angiotensin II receptor/AGTR1-mediated MAPK10 activity. Is involved in dopamine-stimulated AKT1 activity in the striatum by disrupting the association of AKT1 with its negative regulator PP2A. Involved in AGTR1-mediated chemotaxis. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. Suppresses UV-induced NF-kappa-B-dependent activation by interacting with CHUK. The function is promoted by stimulation of ADRB2 and dephosphorylation of ARRB2. Involved in p53/TP53-mediated apoptosis by regulating MDM2 and reducing the MDM2-mediated degradation of p53/TP53. May serve as nuclear messenger for GPCRs. Upon stimulation of OR1D2, may be involved in regulation of gene expression during the early processes of fertilization. Also involved in regulation of receptors other than GPCRs. Involved in endocytosis of TGFBR2 and TGFBR3 and down-regulates TGF-beta signaling such as NF-kappa-B activation. Involved in endocytosis of low-density lipoprotein receptor/LDLR. Involved in endocytosis of smoothened homolog/Smo, which also requires GRK2. Involved in endocytosis of SLC9A5. Involved in endocytosis of ENG and subsequent TGF-beta-mediated ERK activation and migration of epithelial cells. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN (PubMed:26839314). Involved in insulin resistance by acting as insulin-induced signaling scaffold for SRC, AKT1 and INSR. Involved in regulation of inhibitory signaling of natural killer cells by recruiting PTPN6 and PTPN11 to KIR2DL1. Involved in IL8-mediated granule release in neutrophils. Involved in the internalization of the atypical chemokine receptor ACKR3. Acts as an adapter protein coupling FFAR4 receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis (PubMed:22282525, PubMed:23809162). During the activation step of NLRP3 inflammasome, directly associates with NLRP3 leading to inhibition of pro-inflammatory cytokine release and inhibition of inflammation (PubMed:23809162). {ECO:0000269|PubMed:10644702, ECO:0000269|PubMed:11877451, ECO:0000269|PubMed:12488444, ECO:0000269|PubMed:12582207, ECO:0000269|PubMed:12949261, ECO:0000269|PubMed:12958365, ECO:0000269|PubMed:14711824, ECO:0000269|PubMed:15054093, ECO:0000269|PubMed:15125834, ECO:0000269|PubMed:15205453, ECO:0000269|PubMed:15475570, ECO:0000269|PubMed:15618519, ECO:0000269|PubMed:15635042, ECO:0000269|PubMed:15671180, ECO:0000269|PubMed:15699339, ECO:0000269|PubMed:15878855, ECO:0000269|PubMed:16144840, ECO:0000269|PubMed:16280323, ECO:0000269|PubMed:16378096, ECO:0000269|PubMed:16492667, ECO:0000269|PubMed:16820410, ECO:0000269|PubMed:17540773, ECO:0000269|PubMed:18419762, ECO:0000269|PubMed:18604210, ECO:0000269|PubMed:19325136, ECO:0000269|PubMed:19620252, ECO:0000269|PubMed:19643177, ECO:0000269|PubMed:20048153, ECO:0000269|PubMed:22282525, ECO:0000269|PubMed:22457824, ECO:0000269|PubMed:23809162, ECO:0000269|PubMed:24817116, ECO:0000269|PubMed:26839314}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Involved in internalization of P2RY1, P2RY4, P2RY6 and P2RY11 and ATP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 and subsequent recycling or degradation. Involved in ubiquitination of IGF1R. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as a signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2) and MAPK10 (JNK3). ERK1/2 and JNK3 activated by the beta-arrestin scaffold are largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Acts as a signaling scaffold for the AKT1 pathway. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Increases ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Involved in CCR7-mediated ERK1/2 signaling involving ligand CCL19. Is involved in type-1A angiotensin II receptor/AGTR1-mediated ERK activity. Is involved in type-1A angiotensin II receptor/AGTR1-mediated MAPK10 activity. Is involved in dopamine-stimulated AKT1 activity in the striatum by disrupting the association of AKT1 with its negative regulator PP2A. Involved in AGTR1-mediated chemotaxis. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. Suppresses UV-induced NF-kappa-B-dependent activation by interacting with CHUK. The function is promoted by stimulation of ADRB2 and dephosphorylation of ARRB2. Involved in p53/TP53-mediated apoptosis by regulating MDM2 and reducing the MDM2-mediated degradation of p53/TP53. May serve as nuclear messenger for GPCRs. Upon stimulation of OR1D2, may be involved in regulation of gene expression during the early processes of fertilization. Also involved in regulation of receptors other than GPCRs. Involved in endocytosis of TGFBR2 and TGFBR3 and down-regulates TGF-beta signaling such as NF-kappa-B activation. Involved in endocytosis of low-density lipoprotein receptor/LDLR. Involved in endocytosis of smoothened homolog/Smo, which also requires GRK2. Involved in endocytosis of SLC9A5. Involved in endocytosis of ENG and subsequent TGF-beta-mediated ERK activation and migration of epithelial cells. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN (PubMed:26839314). Involved in insulin resistance by acting as insulin-induced signaling scaffold for SRC, AKT1 and INSR. Involved in regulation of inhibitory signaling of natural killer cells by recruiting PTPN6 and PTPN11 to KIR2DL1. Involved in IL8-mediated granule release in neutrophils. Involved in the internalization of the atypical chemokine receptor ACKR3. Acts as an adapter protein coupling FFAR4 receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis (PubMed:22282525, PubMed:23809162). During the activation step of NLRP3 inflammasome, directly associates with NLRP3 leading to inhibition of pro-inflammatory cytokine release and inhibition of inflammation (PubMed:23809162). {ECO:0000269|PubMed:10644702, ECO:0000269|PubMed:11877451, ECO:0000269|PubMed:12488444, ECO:0000269|PubMed:12582207, ECO:0000269|PubMed:12949261, ECO:0000269|PubMed:12958365, ECO:0000269|PubMed:14711824, ECO:0000269|PubMed:15054093, ECO:0000269|PubMed:15125834, ECO:0000269|PubMed:15205453, ECO:0000269|PubMed:15475570, ECO:0000269|PubMed:15618519, ECO:0000269|PubMed:15635042, ECO:0000269|PubMed:15671180, ECO:0000269|PubMed:15699339, ECO:0000269|PubMed:15878855, ECO:0000269|PubMed:16144840, ECO:0000269|PubMed:16280323, ECO:0000269|PubMed:16378096, ECO:0000269|PubMed:16492667, ECO:0000269|PubMed:16820410, ECO:0000269|PubMed:17540773, ECO:0000269|PubMed:18419762, ECO:0000269|PubMed:18604210, ECO:0000269|PubMed:19325136, ECO:0000269|PubMed:19620252, ECO:0000269|PubMed:19643177, ECO:0000269|PubMed:20048153, ECO:0000269|PubMed:22282525, ECO:0000269|PubMed:22457824, ECO:0000269|PubMed:23809162, ECO:0000269|PubMed:24817116, ECO:0000269|PubMed:26839314}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Involved in internalization of P2RY1, P2RY4, P2RY6 and P2RY11 and ATP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 and subsequent recycling or degradation. Involved in ubiquitination of IGF1R. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as a signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2) and MAPK10 (JNK3). ERK1/2 and JNK3 activated by the beta-arrestin scaffold are largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Acts as a signaling scaffold for the AKT1 pathway. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Increases ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Involved in CCR7-mediated ERK1/2 signaling involving ligand CCL19. Is involved in type-1A angiotensin II receptor/AGTR1-mediated ERK activity. Is involved in type-1A angiotensin II receptor/AGTR1-mediated MAPK10 activity. Is involved in dopamine-stimulated AKT1 activity in the striatum by disrupting the association of AKT1 with its negative regulator PP2A. Involved in AGTR1-mediated chemotaxis. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. Suppresses UV-induced NF-kappa-B-dependent activation by interacting with CHUK. The function is promoted by stimulation of ADRB2 and dephosphorylation of ARRB2. Involved in p53/TP53-mediated apoptosis by regulating MDM2 and reducing the MDM2-mediated degradation of p53/TP53. May serve as nuclear messenger for GPCRs. Upon stimulation of OR1D2, may be involved in regulation of gene expression during the early processes of fertilization. Also involved in regulation of receptors other than GPCRs. Involved in endocytosis of TGFBR2 and TGFBR3 and down-regulates TGF-beta signaling such as NF-kappa-B activation. Involved in endocytosis of low-density lipoprotein receptor/LDLR. Involved in endocytosis of smoothened homolog/Smo, which also requires GRK2. Involved in endocytosis of SLC9A5. Involved in endocytosis of ENG and subsequent TGF-beta-mediated ERK activation and migration of epithelial cells. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN (PubMed:26839314). Involved in insulin resistance by acting as insulin-induced signaling scaffold for SRC, AKT1 and INSR. Involved in regulation of inhibitory signaling of natural killer cells by recruiting PTPN6 and PTPN11 to KIR2DL1. Involved in IL8-mediated granule release in neutrophils. Involved in the internalization of the atypical chemokine receptor ACKR3. Acts as an adapter protein coupling FFAR4 receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis (PubMed:22282525, PubMed:23809162). During the activation step of NLRP3 inflammasome, directly associates with NLRP3 leading to inhibition of pro-inflammatory cytokine release and inhibition of inflammation (PubMed:23809162). {ECO:0000269|PubMed:10644702, ECO:0000269|PubMed:11877451, ECO:0000269|PubMed:12488444, ECO:0000269|PubMed:12582207, ECO:0000269|PubMed:12949261, ECO:0000269|PubMed:12958365, ECO:0000269|PubMed:14711824, ECO:0000269|PubMed:15054093, ECO:0000269|PubMed:15125834, ECO:0000269|PubMed:15205453, ECO:0000269|PubMed:15475570, ECO:0000269|PubMed:15618519, ECO:0000269|PubMed:15635042, ECO:0000269|PubMed:15671180, ECO:0000269|PubMed:15699339, ECO:0000269|PubMed:15878855, ECO:0000269|PubMed:16144840, ECO:0000269|PubMed:16280323, ECO:0000269|PubMed:16378096, ECO:0000269|PubMed:16492667, ECO:0000269|PubMed:16820410, ECO:0000269|PubMed:17540773, ECO:0000269|PubMed:18419762, ECO:0000269|PubMed:18604210, ECO:0000269|PubMed:19325136, ECO:0000269|PubMed:19620252, ECO:0000269|PubMed:19643177, ECO:0000269|PubMed:20048153, ECO:0000269|PubMed:22282525, ECO:0000269|PubMed:22457824, ECO:0000269|PubMed:23809162, ECO:0000269|PubMed:24817116, ECO:0000269|PubMed:26839314}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        243,
        225
      ],
      "fold_change_1": 0.293272,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        234,
        201
      ],
      "fold_change_2": 0.539601,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        252,
        253,
        253
      ],
      "fold_change_3": -0.0198729,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        242,
        246,
        249
      ],
      "fold_change_4": -0.0987587,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        246,
        234
      ],
      "fold_change_5": 0.210949,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_123": {
      "label": "MECOM",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P0DMV9": {
      "label": "HS71B",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). {ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). {ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). {ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}.",
      "PTMs": {
        "P0DMV9_633": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P0DMV9",
          "fc_color_1": [
            254,
            248,
            238
          ],
          "label": "633",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.GGSGS#GPTIEEVD.-",
          "tooltip_html": "<strong>T: sequence:</strong> K.GGSGS#GPTIEEVD.-",
          "fold_change_1": 0.166221,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            248,
            250,
            252
          ],
          "fold_change_2": -0.0486034,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            232,
            239,
            245
          ],
          "fold_change_3": -0.174731,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            217,
            157
          ],
          "fold_change_4": 0.977755,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            190,
            210,
            228
          ],
          "fold_change_5": -0.506576,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 779.2,
          "shape_y": 421.5,
          "label_x": 774.2,
          "label_y": 416.5,
          "label_centering": "right",
          "symbol_x": 779.2,
          "symbol_y": 421.5
        },
        "P0DMV9_631": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P0DMV9",
          "fc_color_1": [
            243,
            247,
            250
          ],
          "label": "631",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.GGS#GSGPTIEEVD.-",
          "tooltip_html": "<strong>T: sequence:</strong> K.GGS#GSGPTIEEVD.-",
          "fold_change_1": -0.0898869,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            239,
            213
          ],
          "fold_change_2": 0.41313,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            245,
            230
          ],
          "fold_change_3": 0.241884,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            241,
            219
          ],
          "fold_change_4": 0.353956,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            242,
            222
          ],
          "fold_change_5": 0.324771,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N2",
          "shape_x": 793.0,
          "shape_y": 421.5,
          "label_x": 793.0,
          "label_y": 413.5,
          "label_centering": "center",
          "symbol_x": 793.0,
          "symbol_y": 421.5
        }
      },
      "fc_color_1": [
        254,
        247,
        235
      ],
      "fold_change_1": 0.199233,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        254,
        253
      ],
      "fold_change_2": 0.0150647,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        195,
        214,
        230
      ],
      "fold_change_3": -0.467805,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        196,
        214,
        230
      ],
      "fold_change_4": -0.459932,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        247,
        249,
        251
      ],
      "fold_change_5": -0.0582781,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P34931": {
      "label": "HS71L",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). Positive regulator of PRKN translocation to damaged mitochondria (PubMed:24270810). {ECO:0000269|PubMed:24270810, ECO:0000303|PubMed:26865365}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). Positive regulator of PRKN translocation to damaged mitochondria (PubMed:24270810). {ECO:0000269|PubMed:24270810, ECO:0000303|PubMed:26865365}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). Positive regulator of PRKN translocation to damaged mitochondria (PubMed:24270810). {ECO:0000269|PubMed:24270810, ECO:0000303|PubMed:26865365}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        250,
        243
      ],
      "fold_change_1": 0.119693,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        236,
        205
      ],
      "fold_change_2": 0.492799,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        227
      ],
      "fold_change_3": 0.280003,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        254,
        254
      ],
      "fold_change_4": -0.00581574,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        235,
        204
      ],
      "fold_change_5": 0.503625,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P17066": {
      "label": "HSP76",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). {ECO:0000303|PubMed:26865365}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). {ECO:0000303|PubMed:26865365}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). {ECO:0000303|PubMed:26865365}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        244,
        228
      ],
      "fold_change_1": 0.263183,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        251,
        244
      ],
      "fold_change_2": 0.103579,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        200,
        217,
        232
      ],
      "fold_change_3": -0.427958,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        227,
        236,
        243
      ],
      "fold_change_4": -0.216095,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        247,
        234
      ],
      "fold_change_5": 0.209752,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P11142": {
      "label": "HSP7C",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, chaperone-mediated autophagy, activation of proteolysis of misfolded proteins, formation and dissociation of protein complexes, and antigen presentation. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation (PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661, PubMed:2799391, PubMed:36586411). This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The co-chaperones have been shown to not only regulate different steps of the ATPase cycle of HSP70, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The affinity of HSP70 for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. HSP70 goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The HSP70-associated co-chaperones are of three types: J-domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24121476, PubMed:24318877, PubMed:26865365, PubMed:27474739). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Acts as a repressor of transcriptional activation. Inhibits the transcriptional coactivator activity of CITED1 on Smad-mediated transcription. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:10722728, PubMed:11276205). Substrate recognition component in chaperone-mediated autophagy (CMA), a selective protein degradation process that mediates degradation of proteins with a -KFERQ motif: HSPA8/HSC70 specifically recognizes and binds cytosolic proteins bearing a -KFERQ motif and promotes their recruitment to the surface of the lysosome where they bind to lysosomal protein LAMP2 (PubMed:11559757, PubMed:2799391, PubMed:36586411). KFERQ motif-containing proteins are eventually transported into the lysosomal lumen where they are degraded (PubMed:11559757, PubMed:2799391, PubMed:36586411). In conjunction with LAMP2, facilitates MHC class II presentation of cytoplasmic antigens by guiding antigens to the lysosomal membrane for interaction with LAMP2 which then elicits MHC class II presentation of peptides to the cell membrane (PubMed:15894275). Participates in the ER-associated degradation (ERAD) quality control pathway in conjunction with J domain-containing co-chaperones and the E3 ligase STUB1 (PubMed:23990462). It is recruited to clathrin-coated vesicles through its interaction with DNAJC6 leading to activation of HSPA8/HSC70 ATPase activity and therefore uncoating of clathrin-coated vesicles (By similarity). {ECO:0000250|UniProtKB:P19120, ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11559757, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15894275, ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488, ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:2799391, ECO:0000269|PubMed:36586411, ECO:0000303|PubMed:24121476, ECO:0000303|PubMed:26865365}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, chaperone-mediated autophagy, activation of proteolysis of misfolded proteins, formation and dissociation of protein complexes, and antigen presentation. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation (PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661, PubMed:2799391, PubMed:36586411). This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The co-chaperones have been shown to not only regulate different steps of the ATPase cycle of HSP70, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The affinity of HSP70 for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. HSP70 goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The HSP70-associated co-chaperones are of three types: J-domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24121476, PubMed:24318877, PubMed:26865365, PubMed:27474739). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Acts as a repressor of transcriptional activation. Inhibits the transcriptional coactivator activity of CITED1 on Smad-mediated transcription. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:10722728, PubMed:11276205). Substrate recognition component in chaperone-mediated autophagy (CMA), a selective protein degradation process that mediates degradation of proteins with a -KFERQ motif: HSPA8/HSC70 specifically recognizes and binds cytosolic proteins bearing a -KFERQ motif and promotes their recruitment to the surface of the lysosome where they bind to lysosomal protein LAMP2 (PubMed:11559757, PubMed:2799391, PubMed:36586411). KFERQ motif-containing proteins are eventually transported into the lysosomal lumen where they are degraded (PubMed:11559757, PubMed:2799391, PubMed:36586411). In conjunction with LAMP2, facilitates MHC class II presentation of cytoplasmic antigens by guiding antigens to the lysosomal membrane for interaction with LAMP2 which then elicits MHC class II presentation of peptides to the cell membrane (PubMed:15894275). Participates in the ER-associated degradation (ERAD) quality control pathway in conjunction with J domain-containing co-chaperones and the E3 ligase STUB1 (PubMed:23990462). It is recruited to clathrin-coated vesicles through its interaction with DNAJC6 leading to activation of HSPA8/HSC70 ATPase activity and therefore uncoating of clathrin-coated vesicles (By similarity). {ECO:0000250|UniProtKB:P19120, ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11559757, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15894275, ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488, ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:2799391, ECO:0000269|PubMed:36586411, ECO:0000303|PubMed:24121476, ECO:0000303|PubMed:26865365}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, chaperone-mediated autophagy, activation of proteolysis of misfolded proteins, formation and dissociation of protein complexes, and antigen presentation. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation (PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661, PubMed:2799391, PubMed:36586411). This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The co-chaperones have been shown to not only regulate different steps of the ATPase cycle of HSP70, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The affinity of HSP70 for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. HSP70 goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The HSP70-associated co-chaperones are of three types: J-domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24121476, PubMed:24318877, PubMed:26865365, PubMed:27474739). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Acts as a repressor of transcriptional activation. Inhibits the transcriptional coactivator activity of CITED1 on Smad-mediated transcription. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:10722728, PubMed:11276205). Substrate recognition component in chaperone-mediated autophagy (CMA), a selective protein degradation process that mediates degradation of proteins with a -KFERQ motif: HSPA8/HSC70 specifically recognizes and binds cytosolic proteins bearing a -KFERQ motif and promotes their recruitment to the surface of the lysosome where they bind to lysosomal protein LAMP2 (PubMed:11559757, PubMed:2799391, PubMed:36586411). KFERQ motif-containing proteins are eventually transported into the lysosomal lumen where they are degraded (PubMed:11559757, PubMed:2799391, PubMed:36586411). In conjunction with LAMP2, facilitates MHC class II presentation of cytoplasmic antigens by guiding antigens to the lysosomal membrane for interaction with LAMP2 which then elicits MHC class II presentation of peptides to the cell membrane (PubMed:15894275). Participates in the ER-associated degradation (ERAD) quality control pathway in conjunction with J domain-containing co-chaperones and the E3 ligase STUB1 (PubMed:23990462). It is recruited to clathrin-coated vesicles through its interaction with DNAJC6 leading to activation of HSPA8/HSC70 ATPase activity and therefore uncoating of clathrin-coated vesicles (By similarity). {ECO:0000250|UniProtKB:P19120, ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11559757, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15894275, ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488, ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:2799391, ECO:0000269|PubMed:36586411, ECO:0000303|PubMed:24121476, ECO:0000303|PubMed:26865365}.",
      "PTMs": {
        "P11142_254": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P11142",
          "fc_color_1": [
            206,
            221,
            234
          ],
          "label": "254",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.DIS#ENK.R",
          "tooltip_html": "<strong>T: sequence:</strong> K.DIS#ENK.R",
          "fold_change_1": -0.383326,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            233,
            239,
            245
          ],
          "fold_change_2": -0.172703,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            248,
            239
          ],
          "fold_change_3": 0.158336,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            238,
            211
          ],
          "fold_change_4": 0.441625,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            236,
            242,
            247
          ],
          "fold_change_5": -0.146937,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 779.2,
          "shape_y": 421.5,
          "label_x": 774.2,
          "label_y": 416.5,
          "label_centering": "right",
          "symbol_x": 779.2,
          "symbol_y": 421.5
        }
      },
      "fc_color_1": [
        254,
        246,
        232
      ],
      "fold_change_1": 0.230838,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        253,
        251
      ],
      "fold_change_2": 0.0316803,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        252,
        249
      ],
      "fold_change_3": 0.0584157,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        248
      ],
      "fold_change_4": 0.0620658,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        241,
        220
      ],
      "fold_change_5": 0.342695,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P17535": {
      "label": "JUND",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Transcription factor binding AP-1 sites (PubMed:9989505). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription factor complex, thereby enhancing their DNA binding activity to an AP-1 consensus sequence 3'-TGA[GC]TCA-5' and enhancing their transcriptional activity (PubMed:28981703, PubMed:9989505). {ECO:0000269|PubMed:28981703, ECO:0000269|PubMed:9989505}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Transcription factor binding AP-1 sites (PubMed:9989505). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription factor complex, thereby enhancing their DNA binding activity to an AP-1 consensus sequence 3'-TGA[GC]TCA-5' and enhancing their transcriptional activity (PubMed:28981703, PubMed:9989505). {ECO:0000269|PubMed:28981703, ECO:0000269|PubMed:9989505}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription factor binding AP-1 sites (PubMed:9989505). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription factor complex, thereby enhancing their DNA binding activity to an AP-1 consensus sequence 3&#x27;-TGA[GC]TCA-5&#x27; and enhancing their transcriptional activity (PubMed:28981703, PubMed:9989505). {ECO:0000269|PubMed:28981703, ECO:0000269|PubMed:9989505}.",
      "PTMs": {
        "P17535_100": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P17535",
          "fc_color_1": [
            254,
            232,
            195
          ],
          "label": "100",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: K.LAS#PELER.L\nPSP: DOMAIN: Jun\nPSP: ON_FUNCTION: molecular association, regulation\nPSP: ON_PROCESS: transcription, induced\nPSP: ON_PROT_INTERACT: MEN1(DISRUPTS)\nPSP: in_vitro_kinases: JNK1",
          "tooltip_html": "<strong>T: sequence:</strong> K.LAS#PELER.L<br/><strong>PSP: DOMAIN:</strong> Jun<br/><strong>PSP: ON_FUNCTION:</strong> molecular association, regulation<br/><strong>PSP: ON_PROCESS:</strong> transcription, induced<br/><strong>PSP: ON_PROT_INTERACT:</strong> MEN1(DISRUPTS)<br/><strong>PSP: in_vitro_kinases:</strong> JNK1",
          "fold_change_1": 0.595911,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            179,
            56
          ],
          "fold_change_2": 2.20236,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            253,
            206,
            128
          ],
          "fold_change_3": 1.26722,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            224,
            174
          ],
          "fold_change_4": 0.809399,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            224,
            175
          ],
          "fold_change_5": 0.794245,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 900.2,
          "shape_y": 526.5,
          "label_x": 895.2,
          "label_y": 531.5,
          "label_centering": "right",
          "symbol_x": 900.1,
          "symbol_y": 526.5
        },
        "P17535_90": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P17535",
          "fc_color_1": [
            253,
            193,
            93
          ],
          "label": "90",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.ADGAPSAAPPDGLLAS#PDLGLLK.L",
          "tooltip_html": "<strong>T: sequence:</strong> R.ADGAPSAAPPDGLLAS#PDLGLLK.L",
          "fold_change_1": 1.62245,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            198,
            106
          ],
          "fold_change_2": 1.49409,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            246,
            232
          ],
          "fold_change_3": 0.223841,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            190,
            210,
            228
          ],
          "fold_change_4": -0.507439,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            253,
            253,
            254
          ],
          "fold_change_5": -0.0137988,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S3",
          "shape_x": 927.8,
          "shape_y": 526.5,
          "label_x": 932.8,
          "label_y": 531.5,
          "label_centering": "left",
          "symbol_x": 927.8,
          "symbol_y": 526.5
        },
        "P17535_255": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P17535",
          "fc_color_1": [
            220,
            231,
            240
          ],
          "label": "255",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.DEPQTVPDVPSFGES#PPLSPIDMDTQER.I",
          "tooltip_html": "<strong>T: sequence:</strong> K.DEPQTVPDVPSFGES#PPLSPIDMDTQER.I",
          "fold_change_1": -0.269543,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            199,
            217,
            232
          ],
          "fold_change_2": -0.43626,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            209,
            223,
            236
          ],
          "fold_change_3": -0.358227,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            252,
            248
          ],
          "fold_change_4": 0.0631058,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            241,
            246,
            249
          ],
          "fold_change_5": -0.102982,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "E2",
          "shape_x": 941.0,
          "shape_y": 516.72,
          "label_x": 946.0,
          "label_y": 518.72,
          "label_centering": "left",
          "symbol_x": 941.0,
          "symbol_y": 516.72
        }
      },
      "fc_color_1": [
        201,
        218,
        232
      ],
      "fold_change_1": -0.421759,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        189,
        210,
        227
      ],
      "fold_change_2": -0.514684,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        215,
        227,
        238
      ],
      "fold_change_3": -0.313222,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        224,
        233,
        242
      ],
      "fold_change_4": -0.244094,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        191,
        211,
        228
      ],
      "fold_change_5": -0.502441,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P05412": {
      "label": "JUN",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Transcription factor that recognizes and binds to the AP-1 consensus motif 5'-TGA[GC]TCA-3' (PubMed:10995748, PubMed:22083952). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription complex, thereby enhancing its DNA binding activity to the AP-1 consensus sequence 5'-TGA[GC]TCA-3' and enhancing its transcriptional activity (By similarity). Together with FOSB, plays a role in activation-induced cell death of T cells by binding to the AP-1 promoter site of FASLG/CD95L, and inducing its transcription in response to activation of the TCR/CD3 signaling pathway (PubMed:12618758). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306). {ECO:0000250|UniProtKB:P05627, ECO:0000269|PubMed:10995748, ECO:0000269|PubMed:12618758, ECO:0000269|PubMed:17210646, ECO:0000269|PubMed:22083952, ECO:0000269|PubMed:24623306}.; FUNCTION: (Microbial infection) Upon Epstein-Barr virus (EBV) infection, binds to viral BZLF1 Z promoter and activates viral BZLF1 expression. {ECO:0000269|PubMed:31341047}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Transcription factor that recognizes and binds to the AP-1 consensus motif 5'-TGA[GC]TCA-3' (PubMed:10995748, PubMed:22083952). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription complex, thereby enhancing its DNA binding activity to the AP-1 consensus sequence 5'-TGA[GC]TCA-3' and enhancing its transcriptional activity (By similarity). Together with FOSB, plays a role in activation-induced cell death of T cells by binding to the AP-1 promoter site of FASLG/CD95L, and inducing its transcription in response to activation of the TCR/CD3 signaling pathway (PubMed:12618758). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306). {ECO:0000250|UniProtKB:P05627, ECO:0000269|PubMed:10995748, ECO:0000269|PubMed:12618758, ECO:0000269|PubMed:17210646, ECO:0000269|PubMed:22083952, ECO:0000269|PubMed:24623306}.; FUNCTION: (Microbial infection) Upon Epstein-Barr virus (EBV) infection, binds to viral BZLF1 Z promoter and activates viral BZLF1 expression. {ECO:0000269|PubMed:31341047}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription factor that recognizes and binds to the AP-1 consensus motif 5&#x27;-TGA[GC]TCA-3&#x27; (PubMed:10995748, PubMed:22083952). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription complex, thereby enhancing its DNA binding activity to the AP-1 consensus sequence 5&#x27;-TGA[GC]TCA-3&#x27; and enhancing its transcriptional activity (By similarity). Together with FOSB, plays a role in activation-induced cell death of T cells by binding to the AP-1 promoter site of FASLG/CD95L, and inducing its transcription in response to activation of the TCR/CD3 signaling pathway (PubMed:12618758). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306). {ECO:0000250|UniProtKB:P05627, ECO:0000269|PubMed:10995748, ECO:0000269|PubMed:12618758, ECO:0000269|PubMed:17210646, ECO:0000269|PubMed:22083952, ECO:0000269|PubMed:24623306}.; FUNCTION: (Microbial infection) Upon Epstein-Barr virus (EBV) infection, binds to viral BZLF1 Z promoter and activates viral BZLF1 expression. {ECO:0000269|PubMed:31341047}.",
      "PTMs": {
        "P05412_63": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P05412",
          "fc_color_1": [
            253,
            179,
            56
          ],
          "label": "63",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.N@SDLLTS#PDVGLLK.L\nPSP: DOMAIN: Jun\nPSP: ON_FUNCTION: activity, induced; acetylation; protein stabilization; molecular association, regulation; enzymatic activity, induced\nPSP: ON_PROCESS: cell cycle regulation; carcinogenesis, induced; apoptosis, altered; carcinogenesis, inhibited; cell motility, induced; apoptosis, induced; transcription, induced; transcription, altered; cell growth, induced; transcription, inhibited; cell growth, altered\nPSP: ON_PROT_INTERACT: HDAC3(DISRUPTS); JNK1(DISRUPTS); PIN1(INDUCES); NFkB-p65(INDUCES)\nPSP: ON_OTHER_INTERACT: DNA(INDUCES); DNA(DISRUPTS)\nPSP: in_vivo_kinases: ERK1; CDK3; VRK1; ERK2; JNK2; JNK1; PBK; PLK3; ERK7\nPSP: in_vitro_kinases: ERK1; CDK3; VRK1; PRKD1; ERK2; JNK2; JNK1; PBK; ERK7",
          "tooltip_html": "<strong>T: sequence:</strong> K.N@SDLLTS#PDVGLLK.L<br/><strong>PSP: DOMAIN:</strong> Jun<br/><strong>PSP: ON_FUNCTION:</strong> activity, induced; acetylation; protein stabilization; molecular association, regulation; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> cell cycle regulation; carcinogenesis, induced; apoptosis, altered; carcinogenesis, inhibited; cell motility, induced; apoptosis, induced; transcription, induced; transcription, altered; cell growth, induced; transcription, inhibited; cell growth, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> HDAC3(DISRUPTS); JNK1(DISRUPTS); PIN1(INDUCES); NFkB-p65(INDUCES)<br/><strong>PSP: ON_OTHER_INTERACT:</strong> DNA(INDUCES); DNA(DISRUPTS)<br/><strong>PSP: in_vivo_kinases:</strong> ERK1; CDK3; VRK1; ERK2; JNK2; JNK1; PBK; PLK3; ERK7<br/><strong>PSP: in_vitro_kinases:</strong> ERK1; CDK3; VRK1; PRKD1; ERK2; JNK2; JNK1; PBK; ERK7",
          "fold_change_1": 2.72803,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            179,
            56
          ],
          "fold_change_2": 2.23969,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            217,
            155
          ],
          "fold_change_3": 0.997765,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            253,
            215,
            151
          ],
          "fold_change_4": 1.03894,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            253,
            215,
            152
          ],
          "fold_change_5": 1.02812,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "W1",
          "shape_x": 887.0,
          "shape_y": 486.11,
          "label_x": 882.0,
          "label_y": 484.11,
          "label_centering": "right",
          "symbol_x": 886.9,
          "symbol_y": 485.61
        },
        "P05412_243": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P05412",
          "fc_color_1": [
            254,
            226,
            181
          ],
          "label": "243",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_2",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "x",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.EEPQTVPEM*PGETPPLS#PIDMESQER.I\nPSP: ON_FUNCTION: molecular association, regulation; ubiquitination; activity, inhibited; phosphorylation\nPSP: ON_PROCESS: transcription, altered\nPSP: ON_PROT_INTERACT: FBXW7(INDUCES); FBXW7(DISRUPTS); SP1(DISRUPTS)\nPSP: in_vitro_kinases: CK2A1; GSK3B",
          "tooltip_html": "<strong>T: sequence:</strong> K.EEPQTVPEM*PGETPPLS#PIDMESQER.I<br/><strong>PSP: ON_FUNCTION:</strong> molecular association, regulation; ubiquitination; activity, inhibited; phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> transcription, altered<br/><strong>PSP: ON_PROT_INTERACT:</strong> FBXW7(INDUCES); FBXW7(DISRUPTS); SP1(DISRUPTS)<br/><strong>PSP: in_vitro_kinases:</strong> CK2A1; GSK3B",
          "fold_change_1": 0.741709,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            243,
            224
          ],
          "fold_change_2": 0.307705,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            214,
            227,
            238
          ],
          "fold_change_3": -0.316634,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            253,
            252
          ],
          "fold_change_4": 0.0285877,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            242,
            222
          ],
          "fold_change_5": 0.330018,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "E1",
          "shape_x": 941.0,
          "shape_y": 486.11,
          "label_x": 946.0,
          "label_y": 484.11,
          "label_centering": "left",
          "symbol_x": 940.7,
          "symbol_y": 486.11
        }
      },
      "fc_color_1": [
        157,
        187,
        214
      ],
      "fold_change_1": -0.771689,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        178,
        202,
        223
      ],
      "fold_change_2": -0.603518,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        245,
        229
      ],
      "fold_change_3": 0.253722,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        248
      ],
      "fold_change_4": 0.0637171,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        221,
        231,
        241
      ],
      "fold_change_5": -0.264414,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_127": {
      "label": "NFATC3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "O95644": {
      "label": "NFAC1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells (PubMed:10358178). Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function (By similarity). {ECO:0000250|UniProtKB:O88942, ECO:0000269|PubMed:10358178}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells (PubMed:10358178). Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function (By similarity). {ECO:0000250|UniProtKB:O88942, ECO:0000269|PubMed:10358178}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells (PubMed:10358178). Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function (By similarity). {ECO:0000250|UniProtKB:O88942, ECO:0000269|PubMed:10358178}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        235,
        205
      ],
      "fold_change_1": 0.501804,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        248,
        238
      ],
      "fold_change_2": 0.161553,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        252,
        248
      ],
      "fold_change_3": 0.0613277,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        249,
        241
      ],
      "fold_change_4": 0.134839,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        247,
        235
      ],
      "fold_change_5": 0.195967,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q08209": {
      "label": "PP2BA",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:15671020, PubMed:18838687, PubMed:19154138, PubMed:23468591, PubMed:30254215). Many of the substrates contain a PxIxIT motif and/or a LxVP motif (PubMed:17498738, PubMed:17502104, PubMed:22343722, PubMed:23468591, PubMed:27974827). In response to increased Ca(2+) levels, dephosphorylates and activates phosphatase SSH1 which results in cofilin dephosphorylation (PubMed:15671020). In response to increased Ca(2+) levels following mitochondrial depolarization, dephosphorylates DNM1L inducing DNM1L translocation to the mitochondrion (PubMed:18838687). Positively regulates the CACNA1B/CAV2.2-mediated Ca(2+) release probability at hippocampal neuronal soma and synaptic terminals (By similarity). Dephosphorylates heat shock protein HSPB1 (By similarity). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). In response to increased Ca(2+) levels, regulates NFAT-mediated transcription probably by dephosphorylating NFAT and promoting its nuclear translocation (PubMed:26248042). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). May dephosphorylate CRTC2 at 'Ser-171' resulting in CRTC2 dissociation from 14-3-3 proteins (PubMed:30611118). Dephosphorylates transcription factor TFEB at 'Ser-211' following Coxsackievirus B3 infection, promoting nuclear translocation (PubMed:33691586). Required for postnatal development of the nephrogenic zone and superficial glomeruli in the kidneys, cell cycle homeostasis in the nephrogenic zone, and ultimately normal kidney function (By similarity). Plays a role in intracellular AQP2 processing and localization to the apical membrane in the kidney, may thereby be required for efficient kidney filtration (By similarity). Required for secretion of salivary enzymes amylase, peroxidase, lysozyme and sialic acid via formation of secretory vesicles in the submandibular glands (By similarity). Required for calcineurin activity and homosynaptic depotentiation in the hippocampus (By similarity). Required for normal differentiation and survival of keratinocytes and therefore required for epidermis superstructure formation (By similarity). Positively regulates osteoblastic bone formation, via promotion of osteoblast differentiation (By similarity). Positively regulates osteoclast differentiation, potentially via NFATC1 signaling (By similarity). May play a role in skeletal muscle fiber type specification, potentially via NFATC1 signaling (By similarity). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). Required for antigen-specific T-cell proliferation response (By similarity). Dephosphorylates KLHL3, promoting the interaction between KLHL3 and WNK4 and subsequent degradation of WNK4 (PubMed:30718414). Negatively regulates SLC9A1 activity (PubMed:31375679). {ECO:0000250|UniProtKB:P48452, ECO:0000250|UniProtKB:P63328, ECO:0000250|UniProtKB:P63329, ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:17498738, ECO:0000269|PubMed:17502104, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:22343722, ECO:0000269|PubMed:23468591, ECO:0000269|PubMed:26248042, ECO:0000269|PubMed:27974827, ECO:0000269|PubMed:30254215, ECO:0000269|PubMed:30611118, ECO:0000269|PubMed:30718414, ECO:0000269|PubMed:31375679, ECO:0000269|PubMed:33691586}.\",\"ACT_SITE 151; /note=\"Proton donor\"; /evidence=\"ECO:0000305|PubMed:8524402\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:15671020, PubMed:18838687, PubMed:19154138, PubMed:23468591, PubMed:30254215). Many of the substrates contain a PxIxIT motif and/or a LxVP motif (PubMed:17498738, PubMed:17502104, PubMed:22343722, PubMed:23468591, PubMed:27974827). In response to increased Ca(2+) levels, dephosphorylates and activates phosphatase SSH1 which results in cofilin dephosphorylation (PubMed:15671020). In response to increased Ca(2+) levels following mitochondrial depolarization, dephosphorylates DNM1L inducing DNM1L translocation to the mitochondrion (PubMed:18838687). Positively regulates the CACNA1B/CAV2.2-mediated Ca(2+) release probability at hippocampal neuronal soma and synaptic terminals (By similarity). Dephosphorylates heat shock protein HSPB1 (By similarity). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). In response to increased Ca(2+) levels, regulates NFAT-mediated transcription probably by dephosphorylating NFAT and promoting its nuclear translocation (PubMed:26248042). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). May dephosphorylate CRTC2 at 'Ser-171' resulting in CRTC2 dissociation from 14-3-3 proteins (PubMed:30611118). Dephosphorylates transcription factor TFEB at 'Ser-211' following Coxsackievirus B3 infection, promoting nuclear translocation (PubMed:33691586). Required for postnatal development of the nephrogenic zone and superficial glomeruli in the kidneys, cell cycle homeostasis in the nephrogenic zone, and ultimately normal kidney function (By similarity). Plays a role in intracellular AQP2 processing and localization to the apical membrane in the kidney, may thereby be required for efficient kidney filtration (By similarity). Required for secretion of salivary enzymes amylase, peroxidase, lysozyme and sialic acid via formation of secretory vesicles in the submandibular glands (By similarity). Required for calcineurin activity and homosynaptic depotentiation in the hippocampus (By similarity). Required for normal differentiation and survival of keratinocytes and therefore required for epidermis superstructure formation (By similarity). Positively regulates osteoblastic bone formation, via promotion of osteoblast differentiation (By similarity). Positively regulates osteoclast differentiation, potentially via NFATC1 signaling (By similarity). May play a role in skeletal muscle fiber type specification, potentially via NFATC1 signaling (By similarity). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). Required for antigen-specific T-cell proliferation response (By similarity). Dephosphorylates KLHL3, promoting the interaction between KLHL3 and WNK4 and subsequent degradation of WNK4 (PubMed:30718414). Negatively regulates SLC9A1 activity (PubMed:31375679). {ECO:0000250|UniProtKB:P48452, ECO:0000250|UniProtKB:P63328, ECO:0000250|UniProtKB:P63329, ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:17498738, ECO:0000269|PubMed:17502104, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:22343722, ECO:0000269|PubMed:23468591, ECO:0000269|PubMed:26248042, ECO:0000269|PubMed:27974827, ECO:0000269|PubMed:30254215, ECO:0000269|PubMed:30611118, ECO:0000269|PubMed:30718414, ECO:0000269|PubMed:31375679, ECO:0000269|PubMed:33691586}.\nT: Active site: ACT_SITE 151; /note=\"Proton donor\"; /evidence=\"ECO:0000305|PubMed:8524402\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:15671020, PubMed:18838687, PubMed:19154138, PubMed:23468591, PubMed:30254215). Many of the substrates contain a PxIxIT motif and/or a LxVP motif (PubMed:17498738, PubMed:17502104, PubMed:22343722, PubMed:23468591, PubMed:27974827). In response to increased Ca(2+) levels, dephosphorylates and activates phosphatase SSH1 which results in cofilin dephosphorylation (PubMed:15671020). In response to increased Ca(2+) levels following mitochondrial depolarization, dephosphorylates DNM1L inducing DNM1L translocation to the mitochondrion (PubMed:18838687). Positively regulates the CACNA1B/CAV2.2-mediated Ca(2+) release probability at hippocampal neuronal soma and synaptic terminals (By similarity). Dephosphorylates heat shock protein HSPB1 (By similarity). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). In response to increased Ca(2+) levels, regulates NFAT-mediated transcription probably by dephosphorylating NFAT and promoting its nuclear translocation (PubMed:26248042). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). May dephosphorylate CRTC2 at &#x27;Ser-171&#x27; resulting in CRTC2 dissociation from 14-3-3 proteins (PubMed:30611118). Dephosphorylates transcription factor TFEB at &#x27;Ser-211&#x27; following Coxsackievirus B3 infection, promoting nuclear translocation (PubMed:33691586). Required for postnatal development of the nephrogenic zone and superficial glomeruli in the kidneys, cell cycle homeostasis in the nephrogenic zone, and ultimately normal kidney function (By similarity). Plays a role in intracellular AQP2 processing and localization to the apical membrane in the kidney, may thereby be required for efficient kidney filtration (By similarity). Required for secretion of salivary enzymes amylase, peroxidase, lysozyme and sialic acid via formation of secretory vesicles in the submandibular glands (By similarity). Required for calcineurin activity and homosynaptic depotentiation in the hippocampus (By similarity). Required for normal differentiation and survival of keratinocytes and therefore required for epidermis superstructure formation (By similarity). Positively regulates osteoblastic bone formation, via promotion of osteoblast differentiation (By similarity). Positively regulates osteoclast differentiation, potentially via NFATC1 signaling (By similarity). May play a role in skeletal muscle fiber type specification, potentially via NFATC1 signaling (By similarity). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). Required for antigen-specific T-cell proliferation response (By similarity). Dephosphorylates KLHL3, promoting the interaction between KLHL3 and WNK4 and subsequent degradation of WNK4 (PubMed:30718414). Negatively regulates SLC9A1 activity (PubMed:31375679). {ECO:0000250|UniProtKB:P48452, ECO:0000250|UniProtKB:P63328, ECO:0000250|UniProtKB:P63329, ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:17498738, ECO:0000269|PubMed:17502104, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:22343722, ECO:0000269|PubMed:23468591, ECO:0000269|PubMed:26248042, ECO:0000269|PubMed:27974827, ECO:0000269|PubMed:30254215, ECO:0000269|PubMed:30611118, ECO:0000269|PubMed:30718414, ECO:0000269|PubMed:31375679, ECO:0000269|PubMed:33691586}.<br/><strong>T: Active site:</strong> ACT_SITE 151; /note=&quot;Proton donor&quot;; /evidence=&quot;ECO:0000305|PubMed:8524402&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        247,
        234
      ],
      "fold_change_1": 0.209012,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        246,
        232
      ],
      "fold_change_2": 0.223954,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        250,
        243
      ],
      "fold_change_3": 0.11672,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        253,
        250
      ],
      "fold_change_4": 0.0492322,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        247,
        234
      ],
      "fold_change_5": 0.207086,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P16298": {
      "label": "PP2BB",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:19154138, PubMed:25720963, PubMed:26794871, PubMed:32753672). Dephosphorylates TFEB in response to lysosomal Ca(2+) release, resulting in TFEB nuclear translocation and stimulation of lysosomal biogenesis (PubMed:25720963, PubMed:32753672). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). May play a role in skeletal muscle fiber type specification (By similarity). {ECO:0000250|UniProtKB:P48453, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:25720963, ECO:0000269|PubMed:26794871, ECO:0000269|PubMed:32753672}.\",\"ACT_SITE 160; /note=\"Proton donor\"; /evidence=\"ECO:0000250|UniProtKB:Q08209\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:19154138, PubMed:25720963, PubMed:26794871, PubMed:32753672). Dephosphorylates TFEB in response to lysosomal Ca(2+) release, resulting in TFEB nuclear translocation and stimulation of lysosomal biogenesis (PubMed:25720963, PubMed:32753672). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). May play a role in skeletal muscle fiber type specification (By similarity). {ECO:0000250|UniProtKB:P48453, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:25720963, ECO:0000269|PubMed:26794871, ECO:0000269|PubMed:32753672}.\nT: Active site: ACT_SITE 160; /note=\"Proton donor\"; /evidence=\"ECO:0000250|UniProtKB:Q08209\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:19154138, PubMed:25720963, PubMed:26794871, PubMed:32753672). Dephosphorylates TFEB in response to lysosomal Ca(2+) release, resulting in TFEB nuclear translocation and stimulation of lysosomal biogenesis (PubMed:25720963, PubMed:32753672). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). Negatively regulates MAP3K14/NIK signaling via inhibition of nuclear translocation of the transcription factors RELA and RELB (By similarity). May play a role in skeletal muscle fiber type specification (By similarity). {ECO:0000250|UniProtKB:P48453, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:25720963, ECO:0000269|PubMed:26794871, ECO:0000269|PubMed:32753672}.<br/><strong>T: Active site:</strong> ACT_SITE 160; /note=&quot;Proton donor&quot;; /evidence=&quot;ECO:0000250|UniProtKB:Q08209&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        223,
        172
      ],
      "fold_change_1": 0.826976,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        224,
        175
      ],
      "fold_change_2": 0.802974,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        240,
        215
      ],
      "fold_change_3": 0.39229,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        244,
        228
      ],
      "fold_change_4": 0.268218,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        235,
        204
      ],
      "fold_change_5": 0.507968,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P48454": {
      "label": "PP2BC",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals. Dephosphorylates and activates transcription factor NFATC1. Dephosphorylates and inactivates transcription factor ELK1. Dephosphorylates DARPP32. {ECO:0000269|PubMed:19154138}.\",\"ACT_SITE 147; /note=\"Proton donor\"; /evidence=\"ECO:0000250|UniProtKB:Q08209\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals. Dephosphorylates and activates transcription factor NFATC1. Dephosphorylates and inactivates transcription factor ELK1. Dephosphorylates DARPP32. {ECO:0000269|PubMed:19154138}.\nT: Active site: ACT_SITE 147; /note=\"Proton donor\"; /evidence=\"ECO:0000250|UniProtKB:Q08209\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals. Dephosphorylates and activates transcription factor NFATC1. Dephosphorylates and inactivates transcription factor ELK1. Dephosphorylates DARPP32. {ECO:0000269|PubMed:19154138}.<br/><strong>T: Active site:</strong> ACT_SITE 147; /note=&quot;Proton donor&quot;; /evidence=&quot;ECO:0000250|UniProtKB:Q08209&quot;",
      "PTMs": {},
      "fc_color_1": [
        253,
        212,
        143
      ],
      "fold_change_1": 1.12353,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        223,
        172
      ],
      "fold_change_2": 0.829086,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        231,
        238,
        245
      ],
      "fold_change_3": -0.188201,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        253,
        252
      ],
      "fold_change_4": 0.0272121,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        236,
        205
      ],
      "fold_change_5": 0.494356,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P63098": {
      "label": "CANB1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Regulatory subunit of calcineurin, a calcium-dependent, calmodulin stimulated protein phosphatase. Confers calcium sensitivity. {ECO:0000269|PubMed:26794871}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Regulatory subunit of calcineurin, a calcium-dependent, calmodulin stimulated protein phosphatase. Confers calcium sensitivity. {ECO:0000269|PubMed:26794871}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Regulatory subunit of calcineurin, a calcium-dependent, calmodulin stimulated protein phosphatase. Confers calcium sensitivity. {ECO:0000269|PubMed:26794871}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        227,
        183
      ],
      "fold_change_1": 0.714587,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        218,
        158
      ],
      "fold_change_2": 0.970268,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        234,
        200
      ],
      "fold_change_3": 0.552234,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        228,
        186
      ],
      "fold_change_4": 0.684918,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        222,
        169
      ],
      "fold_change_5": 0.861205,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9UPT6": {
      "label": "JIP3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:12189133). May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins (By similarity). Promotes neuronal axon elongation in a kinesin- and JNK-dependent manner. Activates cofilin at axon tips via local activation of JNK, thereby regulating filopodial dynamics and enhancing axon elongation. Its binding to kinesin heavy chains (KHC), promotes kinesin-1 motility along microtubules and is essential for axon elongation and regeneration. Regulates cortical neuronal migration by mediating NTRK2/TRKB anterograde axonal transport during brain development (By similarity). Acts as an adapter that bridges the interaction between NTRK2/TRKB and KLC1 and drives NTRK2/TRKB axonal but not dendritic anterograde transport, which is essential for subsequent BDNF-triggered signaling and filopodia formation (PubMed:21775604). {ECO:0000250|UniProtKB:Q9ESN9, ECO:0000269|PubMed:12189133, ECO:0000269|PubMed:21775604}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:12189133). May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins (By similarity). Promotes neuronal axon elongation in a kinesin- and JNK-dependent manner. Activates cofilin at axon tips via local activation of JNK, thereby regulating filopodial dynamics and enhancing axon elongation. Its binding to kinesin heavy chains (KHC), promotes kinesin-1 motility along microtubules and is essential for axon elongation and regeneration. Regulates cortical neuronal migration by mediating NTRK2/TRKB anterograde axonal transport during brain development (By similarity). Acts as an adapter that bridges the interaction between NTRK2/TRKB and KLC1 and drives NTRK2/TRKB axonal but not dendritic anterograde transport, which is essential for subsequent BDNF-triggered signaling and filopodia formation (PubMed:21775604). {ECO:0000250|UniProtKB:Q9ESN9, ECO:0000269|PubMed:12189133, ECO:0000269|PubMed:21775604}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:12189133). May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins (By similarity). Promotes neuronal axon elongation in a kinesin- and JNK-dependent manner. Activates cofilin at axon tips via local activation of JNK, thereby regulating filopodial dynamics and enhancing axon elongation. Its binding to kinesin heavy chains (KHC), promotes kinesin-1 motility along microtubules and is essential for axon elongation and regeneration. Regulates cortical neuronal migration by mediating NTRK2/TRKB anterograde axonal transport during brain development (By similarity). Acts as an adapter that bridges the interaction between NTRK2/TRKB and KLC1 and drives NTRK2/TRKB axonal but not dendritic anterograde transport, which is essential for subsequent BDNF-triggered signaling and filopodia formation (PubMed:21775604). {ECO:0000250|UniProtKB:Q9ESN9, ECO:0000269|PubMed:12189133, ECO:0000269|PubMed:21775604}.",
      "PTMs": {
        "Q9UPT6_365": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9UPT6",
          "fc_color_1": [
            254,
            236,
            205
          ],
          "label": "365",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.TGSS#PTQGIVNK.A\nPSP: in_vivo_kinases: ROCK1\nPSP: in_vitro_kinases: ROCK1",
          "tooltip_html": "<strong>T: sequence:</strong> R.TGSS#PTQGIVNK.A<br/><strong>PSP: in_vivo_kinases:</strong> ROCK1<br/><strong>PSP: in_vitro_kinases:</strong> ROCK1",
          "fold_change_1": 0.496392,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            220,
            165
          ],
          "fold_change_2": 0.900093,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            253,
            203,
            119
          ],
          "fold_change_3": 1.3603,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            253,
            213,
            145
          ],
          "fold_change_4": 1.10262,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            228,
            184
          ],
          "fold_change_5": 0.706551,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 723.2,
          "shape_y": 417.5,
          "label_x": 718.2,
          "label_y": 412.5,
          "label_centering": "right",
          "symbol_x": 723.2,
          "symbol_y": 417.5
        },
        "Q9UPT6_585": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9UPT6",
          "fc_color_1": [
            254,
            246,
            232
          ],
          "label": "585",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.LFSSSSS#PPPAK.R",
          "tooltip_html": "<strong>T: sequence:</strong> R.LFSSSSS#PPPAK.R",
          "fold_change_1": 0.228029,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            249,
            240
          ],
          "fold_change_2": 0.148218,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            234,
            201
          ],
          "fold_change_3": 0.542296,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            238,
            210
          ],
          "fold_change_4": 0.444518,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            231,
            194
          ],
          "fold_change_5": 0.609194,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N3",
          "shape_x": 750.8,
          "shape_y": 417.5,
          "label_x": 755.8,
          "label_y": 412.5,
          "label_centering": "left",
          "symbol_x": 750.8,
          "symbol_y": 417.5
        }
      },
      "fc_color_1": [
        254,
        226,
        180
      ],
      "fold_change_1": 0.743754,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        220,
        165
      ],
      "fold_change_2": 0.89505,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        248,
        238
      ],
      "fold_change_3": 0.16978,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        252,
        248
      ],
      "fold_change_4": 0.0683455,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        237,
        208
      ],
      "fold_change_5": 0.46822,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_132": {
      "label": "FLNA",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_133": {
      "label": "MAP3K1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_134": {
      "label": "MAP3K8",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_135": {
      "label": "MAP4K1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q8IVH8": {
      "label": "M4K3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine kinase that plays a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway (PubMed:9275185). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:9275185}.\",\"ACT_SITE 136; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase that plays a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway (PubMed:9275185). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:9275185}.\nT: Active site: ACT_SITE 136; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase that plays a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway (PubMed:9275185). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:9275185}.<br/><strong>T: Active site:</strong> ACT_SITE 136; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        240,
        216
      ],
      "fold_change_1": 0.385532,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        235,
        203
      ],
      "fold_change_2": 0.517386,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        236,
        205
      ],
      "fold_change_3": 0.49875,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        242,
        221
      ],
      "fold_change_4": 0.340249,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        240,
        217
      ],
      "fold_change_5": 0.375292,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_137": {
      "label": "FOS",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_138": {
      "label": "SRF",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_139": {
      "label": "MYC",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_140": {
      "label": "ELK4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_141": {
      "label": "ELK1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_142": {
      "label": "ATF4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9UK32": {
      "label": "KS6A6",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis. {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.\",\"ACT_SITE 198; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 543; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis. {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.\nT: Active site: ACT_SITE 198; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 543; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis. {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.<br/><strong>T: Active site:</strong> ACT_SITE 198; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;; ACT_SITE 543; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        243,
        223
      ],
      "fold_change_1": 0.314442,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        246,
        249,
        251
      ],
      "fold_change_2": -0.0665095,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        254,
        253
      ],
      "fold_change_3": 0.0185788,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        249,
        239
      ],
      "fold_change_4": 0.157505,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        244,
        226
      ],
      "fold_change_5": 0.282825,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q15418": {
      "label": "KS6A1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:10679322, PubMed:12213813, PubMed:15117958, PubMed:16223362, PubMed:17360704, PubMed:18722121, PubMed:26158630, PubMed:35772404, PubMed:9430688). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:18508509, PubMed:18813292). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:12213813, PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:18508509, PubMed:18813292). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:16763566). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:15342917). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:10679322, PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:11684016). Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (PubMed:18508509, PubMed:18813292). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). In response to mTORC1 activation, phosphorylates EIF4B at 'Ser-406' and 'Ser-422' which stimulates bicarbonate cotransporter SLC4A7 mRNA translation, increasing SLC4A7 protein abundance and function (PubMed:35772404). {ECO:0000269|PubMed:10679322, ECO:0000269|PubMed:11684016, ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:16763566, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:35772404, ECO:0000269|PubMed:9430688, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.; FUNCTION: (Microbial infection) Promotes the late transcription and translation of viral lytic genes during Kaposi's sarcoma-associated herpesvirus/HHV-8 infection, when constitutively activated. {ECO:0000269|PubMed:30842327}.\",\"ACT_SITE 187; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 535; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:10679322, PubMed:12213813, PubMed:15117958, PubMed:16223362, PubMed:17360704, PubMed:18722121, PubMed:26158630, PubMed:35772404, PubMed:9430688). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:18508509, PubMed:18813292). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:12213813, PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:18508509, PubMed:18813292). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:16763566). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:15342917). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:10679322, PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:11684016). Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (PubMed:18508509, PubMed:18813292). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). In response to mTORC1 activation, phosphorylates EIF4B at 'Ser-406' and 'Ser-422' which stimulates bicarbonate cotransporter SLC4A7 mRNA translation, increasing SLC4A7 protein abundance and function (PubMed:35772404). {ECO:0000269|PubMed:10679322, ECO:0000269|PubMed:11684016, ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:16763566, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:35772404, ECO:0000269|PubMed:9430688, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.; FUNCTION: (Microbial infection) Promotes the late transcription and translation of viral lytic genes during Kaposi's sarcoma-associated herpesvirus/HHV-8 infection, when constitutively activated. {ECO:0000269|PubMed:30842327}.\nT: Active site: ACT_SITE 187; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 535; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:10679322, PubMed:12213813, PubMed:15117958, PubMed:16223362, PubMed:17360704, PubMed:18722121, PubMed:26158630, PubMed:35772404, PubMed:9430688). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:18508509, PubMed:18813292). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:12213813, PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at &#x27;Ser-9&#x27; and inhibiting its activity (PubMed:18508509, PubMed:18813292). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:16763566). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at &#x27;Ser-1798&#x27;, which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:15342917). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:10679322, PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:11684016). Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (PubMed:18508509, PubMed:18813292). Phosphorylates EPHA2 at &#x27;Ser-897&#x27;, the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). In response to mTORC1 activation, phosphorylates EIF4B at &#x27;Ser-406&#x27; and &#x27;Ser-422&#x27; which stimulates bicarbonate cotransporter SLC4A7 mRNA translation, increasing SLC4A7 protein abundance and function (PubMed:35772404). {ECO:0000269|PubMed:10679322, ECO:0000269|PubMed:11684016, ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:16763566, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:35772404, ECO:0000269|PubMed:9430688, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.; FUNCTION: (Microbial infection) Promotes the late transcription and translation of viral lytic genes during Kaposi&#x27;s sarcoma-associated herpesvirus/HHV-8 infection, when constitutively activated. {ECO:0000269|PubMed:30842327}.<br/><strong>T: Active site:</strong> ACT_SITE 187; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;; ACT_SITE 535; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;",
      "PTMs": {
        "Q15418_380": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q15418",
          "fc_color_1": [
            241,
            245,
            249
          ],
          "label": "380",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_4",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "+",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 9,
          "tooltip": "T: sequence: R.GFS#FVATGLMEDDGKPR.A\nPSP: DOMAIN: Pkinase_C\nPSP: ON_FUNCTION: protein degradation; ubiquitination; phosphorylation\nPSP: ON_PROCESS: signaling pathway regulation\nPSP: NOTES: ERK phosphorylation\nPSP: in_vitro_kinases: Cot",
          "tooltip_html": "<strong>T: sequence:</strong> R.GFS#FVATGLMEDDGKPR.A<br/><strong>PSP: DOMAIN:</strong> Pkinase_C<br/><strong>PSP: ON_FUNCTION:</strong> protein degradation; ubiquitination; phosphorylation<br/><strong>PSP: ON_PROCESS:</strong> signaling pathway regulation<br/><strong>PSP: NOTES:</strong> ERK phosphorylation<br/><strong>PSP: in_vitro_kinases:</strong> Cot",
          "fold_change_1": -0.108884,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            242,
            223
          ],
          "fold_change_2": 0.321426,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            181,
            204,
            224
          ],
          "fold_change_3": -0.582656,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            154,
            185,
            213
          ],
          "fold_change_4": -0.796665,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            232,
            239,
            245
          ],
          "fold_change_5": -0.177377,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 836.2,
          "shape_y": 294.5,
          "label_x": 831.2,
          "label_y": 299.5,
          "label_centering": "right",
          "symbol_x": 836.1,
          "symbol_y": 294.5
        },
        "Q15418_732": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q15418",
          "fc_color_1": [
            254,
            233,
            197
          ],
          "label": "732",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.KLPS#TTL.-",
          "tooltip_html": "<strong>T: sequence:</strong> R.KLPS#TTL.-",
          "fold_change_1": 0.574787,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            180,
            60
          ],
          "fold_change_2": 1.95797,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            156,
            187,
            214
          ],
          "fold_change_3": -0.778378,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            209,
            223,
            236
          ],
          "fold_change_4": -0.35772,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            217,
            229,
            239
          ],
          "fold_change_5": -0.295835,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S2",
          "shape_x": 850.0,
          "shape_y": 294.5,
          "label_x": 850.0,
          "label_y": 304.5,
          "label_centering": "center",
          "symbol_x": 850.0,
          "symbol_y": 294.5
        }
      },
      "fc_color_1": [
        254,
        233,
        198
      ],
      "fold_change_1": 0.569907,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        238,
        210
      ],
      "fold_change_2": 0.446914,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        245,
        231
      ],
      "fold_change_3": 0.241079,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        243,
        224
      ],
      "fold_change_4": 0.304012,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        237,
        209
      ],
      "fold_change_5": 0.457285,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P51812": {
      "label": "KS6A3",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:16213824, PubMed:16223362, PubMed:17360704, PubMed:9770464). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:10436156, PubMed:9770464). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:8250835). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:18508509, PubMed:18813292). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:18722121). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.\",\"ACT_SITE 193; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 539; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:16213824, PubMed:16223362, PubMed:17360704, PubMed:9770464). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:10436156, PubMed:9770464). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:8250835). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:18508509, PubMed:18813292). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:18722121). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.\nT: Active site: ACT_SITE 193; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 539; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:16213824, PubMed:16223362, PubMed:17360704, PubMed:9770464). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at &#x27;Ser-10&#x27;, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:10436156, PubMed:9770464). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at &#x27;Ser-9&#x27; and inhibiting its activity (PubMed:8250835). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:18508509, PubMed:18813292). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at &#x27;Ser-1798&#x27;, which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:18722121). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at &#x27;Ser-1134&#x27; and &#x27;Ser-1161&#x27; that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at &#x27;Ser-897&#x27;, the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.<br/><strong>T: Active site:</strong> ACT_SITE 193; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;; ACT_SITE 539; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;",
      "PTMs": {
        "P51812_369": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P51812",
          "fc_color_1": [
            254,
            227,
            182
          ],
          "label": "369",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.DS#PGIPPSANAHQLFR.G\nPSP: DOMAIN: Pkinase_C\nPSP: ON_FUNCTION: protein conformation; enzymatic activity, induced\nPSP: ON_PROCESS: transcription, induced",
          "tooltip_html": "<strong>T: sequence:</strong> K.DS#PGIPPSANAHQLFR.G<br/><strong>PSP: DOMAIN:</strong> Pkinase_C<br/><strong>PSP: ON_FUNCTION:</strong> protein conformation; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> transcription, induced",
          "fold_change_1": 0.731229,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            254,
            247,
            234
          ],
          "fold_change_2": 0.201812,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            227,
            183
          ],
          "fold_change_3": 0.715763,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            232,
            196
          ],
          "fold_change_4": 0.585139,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            239,
            244,
            248
          ],
          "fold_change_5": -0.126092,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S1",
          "shape_x": 836.2,
          "shape_y": 294.5,
          "label_x": 831.2,
          "label_y": 299.5,
          "label_centering": "right",
          "symbol_x": 836.1,
          "symbol_y": 294.0
        },
        "P51812_227": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P51812",
          "fc_color_1": [
            231,
            238,
            245
          ],
          "label": "227",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "symbol_label_1",
          "annotated": "+",
          "shape": "Circle",
          "symbol": "\u2191",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Segoe UI Symbol",
          "symbol_size": 8,
          "tooltip": "T: sequence: K.AYS#FCGTVEYMAPEVVNR.R\nPSP: DOMAIN: Pkinase\nPSP: ON_FUNCTION: activity, induced; enzymatic activity, induced\nPSP: ON_PROCESS: carcinogenesis, induced; cell growth, induced; apoptosis, inhibited\nPSP: NOTES: upregulation of c-Myc, p21WAF1/CIP1, CCND2 and MCL1",
          "tooltip_html": "<strong>T: sequence:</strong> K.AYS#FCGTVEYMAPEVVNR.R<br/><strong>PSP: DOMAIN:</strong> Pkinase<br/><strong>PSP: ON_FUNCTION:</strong> activity, induced; enzymatic activity, induced<br/><strong>PSP: ON_PROCESS:</strong> carcinogenesis, induced; cell growth, induced; apoptosis, inhibited<br/><strong>PSP: NOTES:</strong> upregulation of c-Myc, p21WAF1/CIP1, CCND2 and MCL1",
          "fold_change_1": -0.186882,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            238,
            243,
            248
          ],
          "fold_change_2": -0.129227,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            251,
            252,
            253
          ],
          "fold_change_3": -0.0311613,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            239,
            244,
            248
          ],
          "fold_change_4": -0.121986,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            243,
            247,
            250
          ],
          "fold_change_5": -0.0912941,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S2",
          "shape_x": 850.0,
          "shape_y": 294.5,
          "label_x": 850.0,
          "label_y": 304.5,
          "label_centering": "center",
          "symbol_x": 849.9,
          "symbol_y": 294.0
        },
        "P51812_386": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P51812",
          "fc_color_1": [
            132,
            170,
            203
          ],
          "label": "386",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.GFS#FVAITSDDESQAM*QTVGVHSIVQQLHR.N",
          "tooltip_html": "<strong>T: sequence:</strong> R.GFS#FVAITSDDESQAM*QTVGVHSIVQQLHR.N",
          "fold_change_1": -0.971575,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            175,
            200,
            221
          ],
          "fold_change_2": -0.629118,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            206,
            221,
            235
          ],
          "fold_change_3": -0.38015,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            254,
            251,
            245
          ],
          "fold_change_4": 0.0991296,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            247,
            236
          ],
          "fold_change_5": 0.187492,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "S3",
          "shape_x": 863.8,
          "shape_y": 294.5,
          "label_x": 868.8,
          "label_y": 299.5,
          "label_centering": "left",
          "symbol_x": 863.8,
          "symbol_y": 294.5
        },
        "P51812_415": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P51812",
          "fc_color_1": [
            214,
            227,
            238
          ],
          "label": "415",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.NS#IQFTDGYEVK.E",
          "tooltip_html": "<strong>T: sequence:</strong> R.NS#IQFTDGYEVK.E",
          "fold_change_1": -0.320939,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            220,
            231,
            240
          ],
          "fold_change_2": -0.274928,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            254,
            252,
            247
          ],
          "fold_change_3": 0.0741268,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            186,
            207,
            226
          ],
          "fold_change_4": -0.545168,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            251,
            246
          ],
          "fold_change_5": 0.0878339,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "E2",
          "shape_x": 877.0,
          "shape_y": 284.72,
          "label_x": 882.0,
          "label_y": 286.72,
          "label_centering": "left",
          "symbol_x": 877.0,
          "symbol_y": 284.72
        }
      },
      "fc_color_1": [
        254,
        236,
        206
      ],
      "fold_change_1": 0.487463,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        227,
        183
      ],
      "fold_change_2": 0.715078,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        245,
        229
      ],
      "fold_change_3": 0.252851,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        245,
        229
      ],
      "fold_change_4": 0.261054,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        239,
        213
      ],
      "fold_change_5": 0.415303,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "unknown_144": {
      "label": "MKNK2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "",
      "tooltip": "",
      "tooltip_html": "",
      "PTMs": {},
      "fc_color_1": [
        128,
        128,
        128
      ],
      "fold_change_1": null,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        128,
        128,
        128
      ],
      "fold_change_2": null,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        128,
        128,
        128
      ],
      "fold_change_3": null,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        128,
        128,
        128
      ],
      "fold_change_4": null,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        128,
        128,
        128
      ],
      "fold_change_5": null,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P09603": {
      "label": "CSF1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Cytokine that plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of pro-inflammatory chemokines, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast proliferation and differentiation, the regulation of bone resorption, and is required for normal bone development. Required for normal male and female fertility. Promotes reorganization of the actin cytoskeleton, regulates formation of membrane ruffles, cell adhesion and cell migration. Plays a role in lipoprotein clearance. {ECO:0000269|PubMed:16337366, ECO:0000269|PubMed:19934330, ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:20829061, ECO:0000269|PubMed:8051056}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Cytokine that plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of pro-inflammatory chemokines, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast proliferation and differentiation, the regulation of bone resorption, and is required for normal bone development. Required for normal male and female fertility. Promotes reorganization of the actin cytoskeleton, regulates formation of membrane ruffles, cell adhesion and cell migration. Plays a role in lipoprotein clearance. {ECO:0000269|PubMed:16337366, ECO:0000269|PubMed:19934330, ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:20829061, ECO:0000269|PubMed:8051056}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Cytokine that plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of pro-inflammatory chemokines, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast proliferation and differentiation, the regulation of bone resorption, and is required for normal bone development. Required for normal male and female fertility. Promotes reorganization of the actin cytoskeleton, regulates formation of membrane ruffles, cell adhesion and cell migration. Plays a role in lipoprotein clearance. {ECO:0000269|PubMed:16337366, ECO:0000269|PubMed:19934330, ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:20829061, ECO:0000269|PubMed:8051056}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        251,
        244
      ],
      "fold_change_1": 0.101171,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        232,
        196
      ],
      "fold_change_2": 0.588975,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        227,
        235,
        243
      ],
      "fold_change_3": -0.219007,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        224,
        234,
        242
      ],
      "fold_change_4": -0.239343,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        147,
        180,
        210
      ],
      "fold_change_5": -0.853541,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P05230": {
      "label": "FGF1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Plays an important role in the regulation of cell survival, cell division, angiogenesis, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Acts as a ligand for FGFR1 and integrins. Binds to FGFR1 in the presence of heparin leading to FGFR1 dimerization and activation via sequential autophosphorylation on tyrosine residues which act as docking sites for interacting proteins, leading to the activation of several signaling cascades. Binds to integrin ITGAV:ITGB3. Its binding to integrin, subsequent ternary complex formation with integrin and FGFR1, and the recruitment of PTPN11 to the complex are essential for FGF1 signaling. Induces the phosphorylation and activation of FGFR1, FRS2, MAPK3/ERK1, MAPK1/ERK2 and AKT1 (PubMed:18441324, PubMed:20422052). Can induce angiogenesis (PubMed:23469107). {ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:20145243, ECO:0000269|PubMed:20422052, ECO:0000269|PubMed:23469107, ECO:0000269|PubMed:8663044}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Plays an important role in the regulation of cell survival, cell division, angiogenesis, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Acts as a ligand for FGFR1 and integrins. Binds to FGFR1 in the presence of heparin leading to FGFR1 dimerization and activation via sequential autophosphorylation on tyrosine residues which act as docking sites for interacting proteins, leading to the activation of several signaling cascades. Binds to integrin ITGAV:ITGB3. Its binding to integrin, subsequent ternary complex formation with integrin and FGFR1, and the recruitment of PTPN11 to the complex are essential for FGF1 signaling. Induces the phosphorylation and activation of FGFR1, FRS2, MAPK3/ERK1, MAPK1/ERK2 and AKT1 (PubMed:18441324, PubMed:20422052). Can induce angiogenesis (PubMed:23469107). {ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:20145243, ECO:0000269|PubMed:20422052, ECO:0000269|PubMed:23469107, ECO:0000269|PubMed:8663044}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plays an important role in the regulation of cell survival, cell division, angiogenesis, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Acts as a ligand for FGFR1 and integrins. Binds to FGFR1 in the presence of heparin leading to FGFR1 dimerization and activation via sequential autophosphorylation on tyrosine residues which act as docking sites for interacting proteins, leading to the activation of several signaling cascades. Binds to integrin ITGAV:ITGB3. Its binding to integrin, subsequent ternary complex formation with integrin and FGFR1, and the recruitment of PTPN11 to the complex are essential for FGF1 signaling. Induces the phosphorylation and activation of FGFR1, FRS2, MAPK3/ERK1, MAPK1/ERK2 and AKT1 (PubMed:18441324, PubMed:20422052). Can induce angiogenesis (PubMed:23469107). {ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:20145243, ECO:0000269|PubMed:20422052, ECO:0000269|PubMed:23469107, ECO:0000269|PubMed:8663044}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        235,
        203
      ],
      "fold_change_1": 0.522372,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        227,
        182
      ],
      "fold_change_2": 0.728044,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        234,
        200
      ],
      "fold_change_3": 0.547736,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        253,
        208,
        134
      ],
      "fold_change_4": 1.211,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        219,
        163
      ],
      "fold_change_5": 0.921718,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P09038": {
      "label": "FGF2",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4 (PubMed:8663044). Also acts as an integrin ligand which is required for FGF2 signaling (PubMed:28302677). Binds to integrin ITGAV:ITGB3 (PubMed:28302677). Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration (PubMed:28302677, PubMed:8663044). Functions as a potent mitogen in vitro (PubMed:1721615, PubMed:3732516, PubMed:3964259). Can induce angiogenesis (PubMed:23469107, PubMed:28302677). Mediates phosphorylation of ERK1/2 and thereby promotes retinal lens fiber differentiation (PubMed:29501879). {ECO:0000269|PubMed:1721615, ECO:0000269|PubMed:29501879, ECO:0000269|PubMed:3732516, ECO:0000269|PubMed:3964259}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4 (PubMed:8663044). Also acts as an integrin ligand which is required for FGF2 signaling (PubMed:28302677). Binds to integrin ITGAV:ITGB3 (PubMed:28302677). Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration (PubMed:28302677, PubMed:8663044). Functions as a potent mitogen in vitro (PubMed:1721615, PubMed:3732516, PubMed:3964259). Can induce angiogenesis (PubMed:23469107, PubMed:28302677). Mediates phosphorylation of ERK1/2 and thereby promotes retinal lens fiber differentiation (PubMed:29501879). {ECO:0000269|PubMed:1721615, ECO:0000269|PubMed:29501879, ECO:0000269|PubMed:3732516, ECO:0000269|PubMed:3964259}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4 (PubMed:8663044). Also acts as an integrin ligand which is required for FGF2 signaling (PubMed:28302677). Binds to integrin ITGAV:ITGB3 (PubMed:28302677). Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration (PubMed:28302677, PubMed:8663044). Functions as a potent mitogen in vitro (PubMed:1721615, PubMed:3732516, PubMed:3964259). Can induce angiogenesis (PubMed:23469107, PubMed:28302677). Mediates phosphorylation of ERK1/2 and thereby promotes retinal lens fiber differentiation (PubMed:29501879). {ECO:0000269|PubMed:1721615, ECO:0000269|PubMed:29501879, ECO:0000269|PubMed:3732516, ECO:0000269|PubMed:3964259}.",
      "PTMs": {
        "P09038_189": {
          "ptm_type": "ptm_0",
          "uniprot_id": "P09038",
          "fc_color_1": [
            194,
            213,
            230
          ],
          "label": "189",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: K.S#DPHIK.L",
          "tooltip_html": "<strong>T: sequence:</strong> K.S#DPHIK.L",
          "fold_change_1": -0.475125,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            253,
            254,
            254
          ],
          "fold_change_2": -0.0103689,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            169,
            196,
            219
          ],
          "fold_change_3": -0.676818,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            165,
            193,
            217
          ],
          "fold_change_4": -0.70959,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            254,
            245,
            229
          ],
          "fold_change_5": 0.257652,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 123.2,
          "shape_y": 298.5,
          "label_x": 118.2,
          "label_y": 293.5,
          "label_centering": "right",
          "symbol_x": 123.2,
          "symbol_y": 298.5
        }
      },
      "fc_color_1": [
        226,
        235,
        243
      ],
      "fold_change_1": -0.225659,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        180,
        203,
        224
      ],
      "fold_change_2": -0.589196,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        224,
        234,
        242
      ],
      "fold_change_3": -0.238095,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        253,
        250
      ],
      "fold_change_4": 0.0489912,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        244,
        247,
        250
      ],
      "fold_change_5": -0.080503,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P14210": {
      "label": "HGF",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types (PubMed:20624990). Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization (PubMed:15167892, PubMed:20977675). Activates MAPK signaling following TMPRSS13 cleavage and activation (PubMed:20977675). {ECO:0000269|PubMed:15167892, ECO:0000269|PubMed:20624990, ECO:0000269|PubMed:20977675}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types (PubMed:20624990). Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization (PubMed:15167892, PubMed:20977675). Activates MAPK signaling following TMPRSS13 cleavage and activation (PubMed:20977675). {ECO:0000269|PubMed:15167892, ECO:0000269|PubMed:20624990, ECO:0000269|PubMed:20977675}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types (PubMed:20624990). Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization (PubMed:15167892, PubMed:20977675). Activates MAPK signaling following TMPRSS13 cleavage and activation (PubMed:20977675). {ECO:0000269|PubMed:15167892, ECO:0000269|PubMed:20624990, ECO:0000269|PubMed:20977675}.",
      "PTMs": {},
      "fc_color_1": [
        50,
        114,
        170
      ],
      "fold_change_1": -1.61283,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        79,
        134,
        182
      ],
      "fold_change_2": -1.38963,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        163,
        192,
        217
      ],
      "fold_change_3": -0.723552,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        58,
        119,
        173
      ],
      "fold_change_4": -1.55526,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        89,
        140,
        186
      ],
      "fold_change_5": -1.3111,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q15628": {
      "label": "TRADD",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Adapter molecule for TNFRSF1A/TNFR1 that specifically associates with the cytoplasmic domain of activated TNFRSF1A/TNFR1 mediating its interaction with FADD (PubMed:23955153, PubMed:7758105, PubMed:8612133). Overexpression of TRADD leads to two major TNF-induced responses, apoptosis and activation of NF-kappa-B (PubMed:7758105, PubMed:8612133). The nuclear form acts as a tumor suppressor by preventing ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A by TRIP12: acts by interacting with TRIP12, leading to disrupt interaction between TRIP12 and isoform p19ARF/ARF of CDKN2A (By similarity). {ECO:0000250|UniProtKB:Q3U0V2, ECO:0000269|PubMed:23955153, ECO:0000269|PubMed:7758105, ECO:0000269|PubMed:8612133}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Adapter molecule for TNFRSF1A/TNFR1 that specifically associates with the cytoplasmic domain of activated TNFRSF1A/TNFR1 mediating its interaction with FADD (PubMed:23955153, PubMed:7758105, PubMed:8612133). Overexpression of TRADD leads to two major TNF-induced responses, apoptosis and activation of NF-kappa-B (PubMed:7758105, PubMed:8612133). The nuclear form acts as a tumor suppressor by preventing ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A by TRIP12: acts by interacting with TRIP12, leading to disrupt interaction between TRIP12 and isoform p19ARF/ARF of CDKN2A (By similarity). {ECO:0000250|UniProtKB:Q3U0V2, ECO:0000269|PubMed:23955153, ECO:0000269|PubMed:7758105, ECO:0000269|PubMed:8612133}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Adapter molecule for TNFRSF1A/TNFR1 that specifically associates with the cytoplasmic domain of activated TNFRSF1A/TNFR1 mediating its interaction with FADD (PubMed:23955153, PubMed:7758105, PubMed:8612133). Overexpression of TRADD leads to two major TNF-induced responses, apoptosis and activation of NF-kappa-B (PubMed:7758105, PubMed:8612133). The nuclear form acts as a tumor suppressor by preventing ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A by TRIP12: acts by interacting with TRIP12, leading to disrupt interaction between TRIP12 and isoform p19ARF/ARF of CDKN2A (By similarity). {ECO:0000250|UniProtKB:Q3U0V2, ECO:0000269|PubMed:23955153, ECO:0000269|PubMed:7758105, ECO:0000269|PubMed:8612133}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        234,
        200
      ],
      "fold_change_1": 0.551195,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        232,
        196
      ],
      "fold_change_2": 0.589727,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        244,
        227
      ],
      "fold_change_3": 0.279364,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        241,
        220
      ],
      "fold_change_4": 0.343811,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        228,
        185
      ],
      "fold_change_5": 0.695899,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q99836": {
      "label": "MYD88",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response (PubMed:15361868, PubMed:18292575, PubMed:33718825, PubMed:37971847). Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:15361868, PubMed:19506249, PubMed:24316379). Increases IL-8 transcription (PubMed:9013863). Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8 activation by GU-rich single-stranded RNA (GU-rich RNA) derived from viruses such as SARS-CoV-2, SARS-CoV and HIV-1, induces IL1B release through NLRP3 inflammasome activation (PubMed:33718825). MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity). {ECO:0000250|UniProtKB:P22366, ECO:0000269|PubMed:15361868, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:19506249, ECO:0000269|PubMed:20855887, ECO:0000269|PubMed:24316379, ECO:0000269|PubMed:33718825, ECO:0000269|PubMed:37971847, ECO:0000269|PubMed:9013863}.\"",
      "tooltip": "T: Function [CC]: FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response (PubMed:15361868, PubMed:18292575, PubMed:33718825, PubMed:37971847). Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:15361868, PubMed:19506249, PubMed:24316379). Increases IL-8 transcription (PubMed:9013863). Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8 activation by GU-rich single-stranded RNA (GU-rich RNA) derived from viruses such as SARS-CoV-2, SARS-CoV and HIV-1, induces IL1B release through NLRP3 inflammasome activation (PubMed:33718825). MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity). {ECO:0000250|UniProtKB:P22366, ECO:0000269|PubMed:15361868, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:19506249, ECO:0000269|PubMed:20855887, ECO:0000269|PubMed:24316379, ECO:0000269|PubMed:33718825, ECO:0000269|PubMed:37971847, ECO:0000269|PubMed:9013863}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response (PubMed:15361868, PubMed:18292575, PubMed:33718825, PubMed:37971847). Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:15361868, PubMed:19506249, PubMed:24316379). Increases IL-8 transcription (PubMed:9013863). Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8 activation by GU-rich single-stranded RNA (GU-rich RNA) derived from viruses such as SARS-CoV-2, SARS-CoV and HIV-1, induces IL1B release through NLRP3 inflammasome activation (PubMed:33718825). MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity). {ECO:0000250|UniProtKB:P22366, ECO:0000269|PubMed:15361868, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:19506249, ECO:0000269|PubMed:20855887, ECO:0000269|PubMed:24316379, ECO:0000269|PubMed:33718825, ECO:0000269|PubMed:37971847, ECO:0000269|PubMed:9013863}.",
      "PTMs": {},
      "fc_color_1": [
        254,
        228,
        184
      ],
      "fold_change_1": 0.706755,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        227,
        181
      ],
      "fold_change_2": 0.733777,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        234,
        201
      ],
      "fold_change_3": 0.537105,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        241,
        220
      ],
      "fold_change_4": 0.345464,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        221,
        168
      ],
      "fold_change_5": 0.87295,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P51617": {
      "label": "IRAK1",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3. {ECO:0000269|PubMed:11397809, ECO:0000269|PubMed:12860405, ECO:0000269|PubMed:14684752, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:15465816, ECO:0000269|PubMed:15767370, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509}.\",\"ACT_SITE 340; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3. {ECO:0000269|PubMed:11397809, ECO:0000269|PubMed:12860405, ECO:0000269|PubMed:14684752, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:15465816, ECO:0000269|PubMed:15767370, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509}.\nT: Active site: ACT_SITE 340; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3. {ECO:0000269|PubMed:11397809, ECO:0000269|PubMed:12860405, ECO:0000269|PubMed:14684752, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:15465816, ECO:0000269|PubMed:15767370, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509}.<br/><strong>T: Active site:</strong> ACT_SITE 340; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        254,
        253,
        250
      ],
      "fold_change_1": 0.0443347,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        232,
        197
      ],
      "fold_change_2": 0.580801,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        245,
        229
      ],
      "fold_change_3": 0.260996,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        247,
        235
      ],
      "fold_change_4": 0.200707,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        232,
        196
      ],
      "fold_change_5": 0.589801,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "Q9NWZ3": {
      "label": "IRAK4",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections. {ECO:0000269|PubMed:11960013, ECO:0000269|PubMed:12538665, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:17217339, ECO:0000269|PubMed:17337443, ECO:0000269|PubMed:17878374, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509, ECO:0000269|PubMed:24316379}.\",\"ACT_SITE 311; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections. {ECO:0000269|PubMed:11960013, ECO:0000269|PubMed:12538665, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:17217339, ECO:0000269|PubMed:17337443, ECO:0000269|PubMed:17878374, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509, ECO:0000269|PubMed:24316379}.\nT: Active site: ACT_SITE 311; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections. {ECO:0000269|PubMed:11960013, ECO:0000269|PubMed:12538665, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:17217339, ECO:0000269|PubMed:17337443, ECO:0000269|PubMed:17878374, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509, ECO:0000269|PubMed:24316379}.<br/><strong>T: Active site:</strong> ACT_SITE 311; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "PTMs": {
        "Q9NWZ3_145": {
          "ptm_type": "ptm_0",
          "uniprot_id": "Q9NWZ3",
          "fc_color_1": [
            160,
            189,
            215
          ],
          "label": "145",
          "label_color": [
            0,
            0,
            0
          ],
          "symbol_type": "none",
          "annotated": "",
          "shape": "Circle",
          "symbol": "",
          "symbol_color": [
            0,
            0,
            0
          ],
          "symbol_font": "Arial",
          "symbol_size": 6,
          "tooltip": "T: sequence: R.TLMTPVQNLEQSY#MPPDSSSPENK.S",
          "tooltip_html": "<strong>T: sequence:</strong> R.TLMTPVQNLEQSY#MPPDSSSPENK.S",
          "fold_change_1": -0.750376,
          "outline_color_1": [
            0,
            0,
            0
          ],
          "outline_fold_change_1": null,
          "fc_color_2": [
            112,
            157,
            195
          ],
          "fold_change_2": -1.12445,
          "outline_color_2": [
            0,
            0,
            0
          ],
          "outline_fold_change_2": null,
          "fc_color_3": [
            235,
            241,
            246
          ],
          "fold_change_3": -0.156467,
          "outline_color_3": [
            0,
            0,
            0
          ],
          "outline_fold_change_3": null,
          "fc_color_4": [
            207,
            222,
            235
          ],
          "fold_change_4": -0.374084,
          "outline_color_4": [
            0,
            0,
            0
          ],
          "outline_fold_change_4": null,
          "fc_color_5": [
            210,
            224,
            236
          ],
          "fold_change_5": -0.351731,
          "outline_color_5": [
            0,
            0,
            0
          ],
          "outline_fold_change_5": null,
          "ptm_position": "N1",
          "shape_x": 315.2,
          "shape_y": 703.5,
          "label_x": 310.2,
          "label_y": 698.5,
          "label_centering": "right",
          "symbol_x": 315.2,
          "symbol_y": 703.5
        }
      },
      "fc_color_1": [
        254,
        229,
        188
      ],
      "fold_change_1": 0.667725,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        220,
        165
      ],
      "fold_change_2": 0.901054,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        254,
        246,
        233
      ],
      "fold_change_3": 0.215569,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        247,
        234
      ],
      "fold_change_4": 0.205938,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        254,
        233,
        199
      ],
      "fold_change_5": 0.556552,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    },
    "P10398": {
      "label": "ARAF",
      "label_color": [
        0,
        0,
        0
      ],
      "transcriptomic_color": [],
      "annotations": "\"FUNCTION: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. Phosphorylates PFKFB2 (PubMed:36402789). {ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:36402789}.; FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. {ECO:0000269|PubMed:22609986}.\",\"ACT_SITE 429; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"\"",
      "tooltip": "T: Function [CC]: FUNCTION: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. Phosphorylates PFKFB2 (PubMed:36402789). {ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:36402789}.; FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. {ECO:0000269|PubMed:22609986}.\nT: Active site: ACT_SITE 429; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. Phosphorylates PFKFB2 (PubMed:36402789). {ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:36402789}.; FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. {ECO:0000269|PubMed:22609986}.<br/><strong>T: Active site:</strong> ACT_SITE 429; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "PTMs": {},
      "fc_color_1": [
        208,
        223,
        235
      ],
      "fold_change_1": -0.366373,
      "outline_color_1": [
        0,
        0,
        0
      ],
      "outline_fold_change_1": null,
      "fc_color_2": [
        254,
        253,
        252
      ],
      "fold_change_2": 0.0271301,
      "outline_color_2": [
        0,
        0,
        0
      ],
      "outline_fold_change_2": null,
      "fc_color_3": [
        223,
        233,
        241
      ],
      "fold_change_3": -0.250282,
      "outline_color_3": [
        0,
        0,
        0
      ],
      "outline_fold_change_3": null,
      "fc_color_4": [
        254,
        249,
        240
      ],
      "fold_change_4": 0.149091,
      "outline_color_4": [
        0,
        0,
        0
      ],
      "outline_fold_change_4": null,
      "fc_color_5": [
        200,
        217,
        232
      ],
      "fold_change_5": -0.427551,
      "outline_color_5": [
        0,
        0,
        0
      ],
      "outline_fold_change_5": null
    }
  },
  "protbox_data": [
    {
      "protbox_id": "20",
      "proteins": [],
      "backup_label": "RASGRF1",
      "x": 369.0,
      "y": 227.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "21",
      "proteins": [],
      "backup_label": "DUSP10",
      "x": 766.0,
      "y": 355.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "22",
      "proteins": [
        "P51452"
      ],
      "backup_label": "DUSP3",
      "x": 717.0,
      "y": 355.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines (PubMed:10224087, PubMed:11863439). Specifically dephosphorylates and inactivates ERK1 and ERK2 (PubMed:10224087, PubMed:11863439). {ECO:0000269|PubMed:10224087, ECO:0000269|PubMed:11863439}.\nT: Active site: ACT_SITE 124; /note=\"Phosphocysteine intermediate\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00160\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines (PubMed:10224087, PubMed:11863439). Specifically dephosphorylates and inactivates ERK1 and ERK2 (PubMed:10224087, PubMed:11863439). {ECO:0000269|PubMed:10224087, ECO:0000269|PubMed:11863439}.<br/><strong>T: Active site:</strong> ACT_SITE 124; /note=&quot;Phosphocysteine intermediate&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00160&quot;"
    },
    {
      "protbox_id": "23",
      "proteins": [
        "O75688"
      ],
      "backup_label": "PPM1B",
      "x": 573.0,
      "y": 761.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Enzyme with a broad specificity. Dephosphorylates CDK2 and CDK6 in vitro. Dephosphorylates PRKAA1 and PRKAA2. Inhibits TBK1-mediated antiviral signaling by dephosphorylating it at 'Ser-172'. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:18930133, ECO:0000269|PubMed:22750291}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Enzyme with a broad specificity. Dephosphorylates CDK2 and CDK6 in vitro. Dephosphorylates PRKAA1 and PRKAA2. Inhibits TBK1-mediated antiviral signaling by dephosphorylating it at &#x27;Ser-172&#x27;. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:18930133, ECO:0000269|PubMed:22750291}."
    },
    {
      "protbox_id": "24",
      "proteins": [],
      "backup_label": "FASLG",
      "x": 114.0,
      "y": 683.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "29",
      "proteins": [],
      "backup_label": "MAP4K4",
      "x": 471.0,
      "y": 478.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "30",
      "proteins": [
        "Q9UP65"
      ],
      "backup_label": "PLA2G4B",
      "x": 827.0,
      "y": 210.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Calcium-independent phospholipase, lysophospholipase and O-acyltransferase involved in phospholipid remodeling with implications in endoplasmic reticulum membrane homeostasis and lipid droplet biogenesis (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Preferentially hydrolyzes the ester bond of the fatty acyl group attached at the sn-2 position of phospholipids with choline and ethanolamine head groups, producing lysophospholipids that are used in deacylation-reacylation cycles (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Transfers the sn-1 fatty acyl from one lysophospholipid molecule to the sn-2 position of another lysophospholipid to form diacyl, alkylacyl and alkenylacyl glycerophospholipids. Cleaves ester bonds but not alkyl or alkenyl ether bonds at sn-1 position of lysophospholipids (PubMed:15944408, PubMed:19501189). Catalyzes sn-2 fatty acyl transfer from phospholipids to the sn-2 position of 1-O-alkyl or 1-O-alkenyl lysophospholipids with lower efficiency (PubMed:15944408, PubMed:19501189). In response to dietary fatty acids, may play a role in the formation of nascent lipid droplets from the endoplasmic reticulum likely by regulating the phospholipid composition of these organelles (PubMed:28336330). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:15944408, ECO:0000269|PubMed:19501189, ECO:0000269|PubMed:28336330, ECO:0000269|PubMed:9705332}.; FUNCTION: (Microbial infection) May play a role in replication and assembly of human hepatitis C virus (HCV) (PubMed:23015700, PubMed:28336330). In response to HCV infection, promotes remodeling of host endoplasmic reticulum membranes to form organelle-like structures called membranous web, where HCV replication occur (PubMed:23015700). Can further mediate translocation of replication complexes to lipid droplets to enable virion assembly (PubMed:23015700, PubMed:28336330). {ECO:0000269|PubMed:23015700, ECO:0000269|PubMed:28336330}.; FUNCTION: (Microbial infection) May facilitate human T-lymphotropic virus type 1 (HTLV-1) infection by promoting leukotriene B4 (LTB4) biosynthesis. LTB4 acts as a chemoattractant for HTLV-1-infected CD4-positive T cells and favors cell to cell viral transmission. {ECO:0000269|PubMed:28639618}.\nT: Active site: ACT_SITE 82; /note=\"Nucleophile\"; /evidence=\"ECO:0000305|PubMed:10085124\"; ACT_SITE 385; /note=\"Proton acceptor\"; /evidence=\"ECO:0000305|PubMed:10085124\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Calcium-independent phospholipase, lysophospholipase and O-acyltransferase involved in phospholipid remodeling with implications in endoplasmic reticulum membrane homeostasis and lipid droplet biogenesis (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Preferentially hydrolyzes the ester bond of the fatty acyl group attached at the sn-2 position of phospholipids with choline and ethanolamine head groups, producing lysophospholipids that are used in deacylation-reacylation cycles (PubMed:10085124, PubMed:10358058, PubMed:19501189, PubMed:28336330, PubMed:9705332). Transfers the sn-1 fatty acyl from one lysophospholipid molecule to the sn-2 position of another lysophospholipid to form diacyl, alkylacyl and alkenylacyl glycerophospholipids. Cleaves ester bonds but not alkyl or alkenyl ether bonds at sn-1 position of lysophospholipids (PubMed:15944408, PubMed:19501189). Catalyzes sn-2 fatty acyl transfer from phospholipids to the sn-2 position of 1-O-alkyl or 1-O-alkenyl lysophospholipids with lower efficiency (PubMed:15944408, PubMed:19501189). In response to dietary fatty acids, may play a role in the formation of nascent lipid droplets from the endoplasmic reticulum likely by regulating the phospholipid composition of these organelles (PubMed:28336330). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:15944408, ECO:0000269|PubMed:19501189, ECO:0000269|PubMed:28336330, ECO:0000269|PubMed:9705332}.; FUNCTION: (Microbial infection) May play a role in replication and assembly of human hepatitis C virus (HCV) (PubMed:23015700, PubMed:28336330). In response to HCV infection, promotes remodeling of host endoplasmic reticulum membranes to form organelle-like structures called membranous web, where HCV replication occur (PubMed:23015700). Can further mediate translocation of replication complexes to lipid droplets to enable virion assembly (PubMed:23015700, PubMed:28336330). {ECO:0000269|PubMed:23015700, ECO:0000269|PubMed:28336330}.; FUNCTION: (Microbial infection) May facilitate human T-lymphotropic virus type 1 (HTLV-1) infection by promoting leukotriene B4 (LTB4) biosynthesis. LTB4 acts as a chemoattractant for HTLV-1-infected CD4-positive T cells and favors cell to cell viral transmission. {ECO:0000269|PubMed:28639618}.<br/><strong>T: Active site:</strong> ACT_SITE 82; /note=&quot;Nucleophile&quot;; /evidence=&quot;ECO:0000305|PubMed:10085124&quot;; ACT_SITE 385; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000305|PubMed:10085124&quot;",
      "ptm_overrides": {
        "Q9UP65": {
          "Q9UP65_337": {
            "shape_x": 836.2,
            "shape_y": 231.5,
            "label_x": 831.2,
            "label_y": 236.5,
            "label_centering": "right",
            "symbol_x": 836.2,
            "symbol_y": 231.5,
            "ptm_position": "S1"
          }
        }
      }
    },
    {
      "protbox_id": "31",
      "proteins": [
        "P16949"
      ],
      "backup_label": "STMN1",
      "x": 827.0,
      "y": 186.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). {ECO:0000250}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity). {ECO:0000250}.",
      "ptm_overrides": {
        "P16949": {
          "P16949_16": {
            "shape_x": 823.0,
            "shape_y": 189.11,
            "label_x": 818.0,
            "label_y": 187.11,
            "label_centering": "right",
            "symbol_x": 822.7,
            "symbol_y": 189.11,
            "ptm_position": "W1"
          },
          "P16949_63": {
            "shape_x": 877.0,
            "shape_y": 189.11,
            "label_x": 882.0,
            "label_y": 187.11,
            "label_centering": "left",
            "symbol_x": 876.7,
            "symbol_y": 189.11,
            "ptm_position": "E1"
          },
          "P16949_25": {
            "shape_x": 823.0,
            "shape_y": 200.72,
            "label_x": 818.0,
            "label_y": 202.72,
            "label_centering": "right",
            "symbol_x": 822.7,
            "symbol_y": 200.72,
            "ptm_position": "W2"
          },
          "P16949_38": {
            "shape_x": 877.0,
            "shape_y": 200.72,
            "label_x": 882.0,
            "label_y": 202.72,
            "label_centering": "left",
            "symbol_x": 876.7,
            "symbol_y": 200.72,
            "ptm_position": "E2"
          }
        }
      }
    },
    {
      "protbox_id": "32",
      "proteins": [],
      "backup_label": "MAPT",
      "x": 827.0,
      "y": 165.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "33",
      "proteins": [
        "P19838",
        "Q00653",
        "Q01201"
      ],
      "backup_label": "NFKB1",
      "x": 891.0,
      "y": 122.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105. {ECO:0000269|PubMed:15485931, ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:2203531, ECO:0000269|PubMed:2234062, ECO:0000269|PubMed:7830764}.; FUNCTION: [Nuclear factor NF-kappa-B p105 subunit]: P105 is the precursor of the active p50 subunit (Nuclear factor NF-kappa-B p50 subunit) of the nuclear factor NF-kappa-B (PubMed:1423592). Acts as a cytoplasmic retention of attached NF-kappa-B proteins by p105 (PubMed:1423592). {ECO:0000269|PubMed:1423592}.; FUNCTION: [Nuclear factor NF-kappa-B p50 subunit]: Constitutes the active form, which associates with RELA/p65 to form the NF-kappa-B p65-p50 complex to form a transcription factor (PubMed:1740106, PubMed:7830764). Together with RELA/p65, binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions (PubMed:1740106, PubMed:7830764). {ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:7830764}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5&#x27;-GGRNNYYCC-3&#x27;, located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105. {ECO:0000269|PubMed:15485931, ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:2203531, ECO:0000269|PubMed:2234062, ECO:0000269|PubMed:7830764}.; FUNCTION: [Nuclear factor NF-kappa-B p105 subunit]: P105 is the precursor of the active p50 subunit (Nuclear factor NF-kappa-B p50 subunit) of the nuclear factor NF-kappa-B (PubMed:1423592). Acts as a cytoplasmic retention of attached NF-kappa-B proteins by p105 (PubMed:1423592). {ECO:0000269|PubMed:1423592}.; FUNCTION: [Nuclear factor NF-kappa-B p50 subunit]: Constitutes the active form, which associates with RELA/p65 to form the NF-kappa-B p65-p50 complex to form a transcription factor (PubMed:1740106, PubMed:7830764). Together with RELA/p65, binds to the kappa-B consensus sequence 5&#x27;-GGRNNYYCC-3&#x27;, located in the enhancer region of genes involved in immune response and acute phase reactions (PubMed:1740106, PubMed:7830764). {ECO:0000269|PubMed:1740106, ECO:0000269|PubMed:7830764}.",
      "ptm_overrides": {
        "Q01201": {
          "Q01201_573": {
            "shape_x": 900.2,
            "shape_y": 118.5,
            "label_x": 895.2,
            "label_y": 113.5,
            "label_centering": "right",
            "symbol_x": 900.2,
            "symbol_y": 118.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "34",
      "proteins": [
        "Q9Y6K9",
        "O15111",
        "O14920"
      ],
      "backup_label": "CHUK",
      "x": 763.0,
      "y": 133.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor (PubMed:14695475, PubMed:20724660, PubMed:21518757, PubMed:9751060). Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308, PubMed:33567255). Can recognize and bind both 'Lys-63'-linked and linear polyubiquitin upon cell stimulation, with a much higher affinity for linear polyubiquitin (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308). Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3 (PubMed:19854139). Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination (PubMed:20724660). {ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:16547522, ECO:0000269|PubMed:18287044, ECO:0000269|PubMed:19033441, ECO:0000269|PubMed:19185524, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20724660, ECO:0000269|PubMed:21518757, ECO:0000269|PubMed:21606507, ECO:0000269|PubMed:27777308, ECO:0000269|PubMed:33567255, ECO:0000269|PubMed:9751060}.; FUNCTION: (Microbial infection) Also considered to be a mediator for HTLV-1 Tax oncoprotein activation of NF-kappa-B. {ECO:0000269|PubMed:10364167, ECO:0000269|PubMed:11064457}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor (PubMed:14695475, PubMed:20724660, PubMed:21518757, PubMed:9751060). Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308, PubMed:33567255). Can recognize and bind both &#x27;Lys-63&#x27;-linked and linear polyubiquitin upon cell stimulation, with a much higher affinity for linear polyubiquitin (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308). Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3 (PubMed:19854139). Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires &#x27;Lys-27&#x27;-linked polyubiquitination (PubMed:20724660). {ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:16547522, ECO:0000269|PubMed:18287044, ECO:0000269|PubMed:19033441, ECO:0000269|PubMed:19185524, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20724660, ECO:0000269|PubMed:21518757, ECO:0000269|PubMed:21606507, ECO:0000269|PubMed:27777308, ECO:0000269|PubMed:33567255, ECO:0000269|PubMed:9751060}.; FUNCTION: (Microbial infection) Also considered to be a mediator for HTLV-1 Tax oncoprotein activation of NF-kappa-B. {ECO:0000269|PubMed:10364167, ECO:0000269|PubMed:11064457}."
    },
    {
      "protbox_id": "35",
      "proteins": [],
      "backup_label": "MAP3K14",
      "x": 763.0,
      "y": 112.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "36",
      "proteins": [
        "P28482",
        "P27361"
      ],
      "backup_label": "MAPK1",
      "x": 740.0,
      "y": 302.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1 and FXR1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity). Phosphorylates phosphoglycerate kinase PGK1 under hypoxic conditions to promote its targeting to the mitochondrion and suppress the formation of acetyl-coenzyme A from pyruvate (PubMed:26942675). {ECO:0000250|UniProtKB:P63086, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:10637505, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12792650, ECO:0000269|PubMed:12794087, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15184391, ECO:0000269|PubMed:15241487, ECO:0000269|PubMed:15616583, ECO:0000269|PubMed:15664191, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19879846, ECO:0000269|PubMed:22033920, ECO:0000269|PubMed:26942675, ECO:0000269|PubMed:32721402, ECO:0000269|PubMed:7588608, ECO:0000269|PubMed:8622688, ECO:0000269|PubMed:9480836, ECO:0000269|PubMed:9596579, ECO:0000269|PubMed:9649500, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:16393692, ECO:0000303|PubMed:19565474, ECO:0000303|PubMed:21779493}.; FUNCTION: Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity. {ECO:0000269|PubMed:19879846}.\nT: Active site: ACT_SITE 149; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1 and FXR1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity). Phosphorylates phosphoglycerate kinase PGK1 under hypoxic conditions to promote its targeting to the mitochondrion and suppress the formation of acetyl-coenzyme A from pyruvate (PubMed:26942675). {ECO:0000250|UniProtKB:P63086, ECO:0000269|PubMed:10617468, ECO:0000269|PubMed:10637505, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:12792650, ECO:0000269|PubMed:12794087, ECO:0000269|PubMed:12974390, ECO:0000269|PubMed:15184391, ECO:0000269|PubMed:15241487, ECO:0000269|PubMed:15616583, ECO:0000269|PubMed:15664191, ECO:0000269|PubMed:15788397, ECO:0000269|PubMed:15952796, ECO:0000269|PubMed:16581800, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19879846, ECO:0000269|PubMed:22033920, ECO:0000269|PubMed:26942675, ECO:0000269|PubMed:32721402, ECO:0000269|PubMed:7588608, ECO:0000269|PubMed:8622688, ECO:0000269|PubMed:9480836, ECO:0000269|PubMed:9596579, ECO:0000269|PubMed:9649500, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:16393692, ECO:0000303|PubMed:19565474, ECO:0000303|PubMed:21779493}.; FUNCTION: Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity. {ECO:0000269|PubMed:19879846}.<br/><strong>T: Active site:</strong> ACT_SITE 149; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "P28482": {
          "P28482_185": {
            "shape_x": 749.2,
            "shape_y": 298.5,
            "label_x": 744.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 749.1,
            "symbol_y": 298.0,
            "ptm_position": "N1"
          },
          "P28482_187": {
            "shape_x": 763.0,
            "shape_y": 298.5,
            "label_x": 763.0,
            "label_y": 290.5,
            "label_centering": "center",
            "symbol_x": 762.9,
            "symbol_y": 298.0,
            "ptm_position": "N2"
          }
        },
        "P27361": {
          "P27361_204": {
            "shape_x": 749.2,
            "shape_y": 298.5,
            "label_x": 744.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 749.1,
            "symbol_y": 298.0,
            "ptm_position": "N1"
          },
          "P27361_202": {
            "shape_x": 763.0,
            "shape_y": 298.5,
            "label_x": 763.0,
            "label_y": 290.5,
            "label_centering": "center",
            "symbol_x": 762.9,
            "symbol_y": 298.0,
            "ptm_position": "N2"
          }
        }
      }
    },
    {
      "protbox_id": "37",
      "proteins": [
        "Q9UHA4"
      ],
      "backup_label": "LAMTOR3",
      "x": 714.0,
      "y": 277.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids (PubMed:20381137, PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator plays a dual role for the small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD): it (1) acts as a guanine nucleotide exchange factor (GEF), activating the small GTPases Rag and (2) mediates recruitment of Rag GTPases to the lysosome membrane (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Adapter protein that enhances the efficiency of the MAP kinase cascade facilitating the activation of MAPK2 (By similarity). {ECO:0000250|UniProtKB:O88653, ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:22980980, ECO:0000269|PubMed:28935770, ECO:0000269|PubMed:29107538, ECO:0000269|PubMed:29123114, ECO:0000269|PubMed:29158492, ECO:0000269|PubMed:30181260}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids (PubMed:20381137, PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator plays a dual role for the small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD): it (1) acts as a guanine nucleotide exchange factor (GEF), activating the small GTPases Rag and (2) mediates recruitment of Rag GTPases to the lysosome membrane (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated (PubMed:22980980, PubMed:28935770, PubMed:29107538, PubMed:29123114, PubMed:29158492, PubMed:30181260). Adapter protein that enhances the efficiency of the MAP kinase cascade facilitating the activation of MAPK2 (By similarity). {ECO:0000250|UniProtKB:O88653, ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:22980980, ECO:0000269|PubMed:28935770, ECO:0000269|PubMed:29107538, ECO:0000269|PubMed:29123114, ECO:0000269|PubMed:29158492, ECO:0000269|PubMed:30181260}."
    },
    {
      "protbox_id": "38",
      "proteins": [
        "P36507"
      ],
      "backup_label": "MAP2K2",
      "x": 653.0,
      "y": 313.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.\nT: Active site: ACT_SITE 194; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). {ECO:0000250|UniProtKB:Q63932, ECO:0000269|PubMed:29433126}.<br/><strong>T: Active site:</strong> ACT_SITE 194; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "P36507": {
          "P36507_394": {
            "shape_x": 662.2,
            "shape_y": 334.5,
            "label_x": 657.2,
            "label_y": 339.5,
            "label_centering": "right",
            "symbol_x": 662.1,
            "symbol_y": 334.0,
            "ptm_position": "S1"
          },
          "P36507_23": {
            "shape_x": 676.0,
            "shape_y": 334.5,
            "label_x": 676.0,
            "label_y": 344.5,
            "label_centering": "center",
            "symbol_x": 676.0,
            "symbol_y": 334.5,
            "ptm_position": "S2"
          },
          "P36507_295": {
            "shape_x": 689.8,
            "shape_y": 334.5,
            "label_x": 694.8,
            "label_y": 339.5,
            "label_centering": "left",
            "symbol_x": 689.8,
            "symbol_y": 334.5,
            "ptm_position": "S3"
          }
        }
      }
    },
    {
      "protbox_id": "39",
      "proteins": [
        "Q02750"
      ],
      "backup_label": "MAP2K1",
      "x": 653.0,
      "y": 291.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. {ECO:0000269|PubMed:14737111, ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:29433126}.\nT: Active site: ACT_SITE 190; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. {ECO:0000269|PubMed:14737111, ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:29433126}.<br/><strong>T: Active site:</strong> ACT_SITE 190; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "40",
      "proteins": [
        "P04049"
      ],
      "backup_label": "RAF1",
      "x": 558.0,
      "y": 327.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}.\nT: Active site: ACT_SITE 468; /note=\"Proton acceptor\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at &#x27;Ser-75&#x27;. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}.<br/><strong>T: Active site:</strong> ACT_SITE 468; /note=&quot;Proton acceptor&quot;",
      "ptm_overrides": {
        "P04049": {
          "P04049_621": {
            "shape_x": 567.2,
            "shape_y": 348.5,
            "label_x": 562.2,
            "label_y": 353.5,
            "label_centering": "right",
            "symbol_x": 567.1,
            "symbol_y": 348.5,
            "ptm_position": "S1"
          },
          "P04049_258": {
            "shape_x": 581.0,
            "shape_y": 348.5,
            "label_x": 581.0,
            "label_y": 358.5,
            "label_centering": "center",
            "symbol_x": 581.0,
            "symbol_y": 348.5,
            "ptm_position": "S2"
          }
        }
      }
    },
    {
      "protbox_id": "41",
      "proteins": [],
      "backup_label": "BRAF",
      "x": 558.0,
      "y": 303.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "42",
      "proteins": [
        "P20936"
      ],
      "backup_label": "RASA1",
      "x": 398.0,
      "y": 362.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Stimulates the GTPase of normal but not oncogenic Ras p21; this stimulation may be further increased in the presence of NCK1. {ECO:0000269|PubMed:11389730, ECO:0000269|PubMed:8360177}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Stimulates the GTPase of normal but not oncogenic Ras p21; this stimulation may be further increased in the presence of NCK1. {ECO:0000269|PubMed:11389730, ECO:0000269|PubMed:8360177}."
    },
    {
      "protbox_id": "43",
      "proteins": [
        "P21359"
      ],
      "backup_label": "NF1",
      "x": 398.0,
      "y": 341.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity. {ECO:0000269|PubMed:2121371, ECO:0000269|PubMed:8417346}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity. {ECO:0000269|PubMed:2121371, ECO:0000269|PubMed:8417346}.",
      "ptm_overrides": {
        "P21359": {
          "P21359_2829": {
            "shape_x": 407.2,
            "shape_y": 337.5,
            "label_x": 402.2,
            "label_y": 332.5,
            "label_centering": "right",
            "symbol_x": 407.2,
            "symbol_y": 337.5,
            "ptm_position": "N1"
          },
          "P21359_2565": {
            "shape_x": 434.8,
            "shape_y": 337.5,
            "label_x": 439.8,
            "label_y": 332.5,
            "label_centering": "left",
            "symbol_x": 434.8,
            "symbol_y": 337.5,
            "ptm_position": "N3"
          },
          "P21359_2521": {
            "shape_x": 448.0,
            "shape_y": 347.11,
            "label_x": 453.0,
            "label_y": 345.11,
            "label_centering": "left",
            "symbol_x": 448.0,
            "symbol_y": 347.11,
            "ptm_position": "E1"
          },
          "P21359_2597": {
            "shape_x": 394.0,
            "shape_y": 347.11,
            "label_x": 389.0,
            "label_y": 345.11,
            "label_centering": "right",
            "symbol_x": 394.0,
            "symbol_y": 347.11,
            "ptm_position": "W1"
          },
          "P21359_653": {
            "shape_x": null,
            "shape_y": null,
            "label_x": null,
            "label_y": null,
            "label_centering": null,
            "symbol_x": null,
            "symbol_y": null,
            "ptm_position": ""
          },
          "P21359_2496": {
            "shape_x": null,
            "shape_y": null,
            "label_x": null,
            "label_y": null,
            "label_centering": null,
            "symbol_x": null,
            "symbol_y": null,
            "ptm_position": ""
          },
          "P21359_2543": {
            "shape_x": null,
            "shape_y": null,
            "label_x": null,
            "label_y": null,
            "label_centering": null,
            "symbol_x": null,
            "symbol_y": null,
            "ptm_position": ""
          },
          "P21359_2515": {
            "shape_x": null,
            "shape_y": null,
            "label_x": null,
            "label_y": null,
            "label_centering": null,
            "symbol_x": null,
            "symbol_y": null,
            "ptm_position": ""
          },
          "P21359_2817": {
            "shape_x": null,
            "shape_y": null,
            "label_x": null,
            "label_y": null,
            "label_centering": null,
            "symbol_x": null,
            "symbol_y": null,
            "ptm_position": ""
          }
        }
      }
    },
    {
      "protbox_id": "44",
      "proteins": [
        "P17252"
      ],
      "backup_label": "PRKCA",
      "x": 464.0,
      "y": 248.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at 'Ser-52' facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P20444, ECO:0000269|PubMed:10848585, ECO:0000269|PubMed:11909826, ECO:0000269|PubMed:12724315, ECO:0000269|PubMed:12832403, ECO:0000269|PubMed:15016832, ECO:0000269|PubMed:15504744, ECO:0000269|PubMed:15526160, ECO:0000269|PubMed:18056764, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:21576361, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:28028151, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9738012, ECO:0000269|PubMed:9830023, ECO:0000269|PubMed:9873035, ECO:0000269|PubMed:9927633}.\nT: Active site: ACT_SITE 463; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at &#x27;Ser-52&#x27; facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P20444, ECO:0000269|PubMed:10848585, ECO:0000269|PubMed:11909826, ECO:0000269|PubMed:12724315, ECO:0000269|PubMed:12832403, ECO:0000269|PubMed:15016832, ECO:0000269|PubMed:15504744, ECO:0000269|PubMed:15526160, ECO:0000269|PubMed:18056764, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:21576361, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:28028151, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9738012, ECO:0000269|PubMed:9830023, ECO:0000269|PubMed:9873035, ECO:0000269|PubMed:9927633}.<br/><strong>T: Active site:</strong> ACT_SITE 463; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "P17252": {
          "P17252_226": {
            "shape_x": 473.2,
            "shape_y": 244.5,
            "label_x": 468.2,
            "label_y": 239.5,
            "label_centering": "right",
            "symbol_x": 473.09999999999997,
            "symbol_y": 244.0,
            "ptm_position": "N1"
          },
          "P17252_497": {
            "shape_x": 487.0,
            "shape_y": 244.5,
            "label_x": 487.0,
            "label_y": 236.5,
            "label_centering": "center",
            "symbol_x": 487.0,
            "symbol_y": 244.5,
            "ptm_position": "N2"
          },
          "P17252_319": {
            "shape_x": 500.8,
            "shape_y": 244.5,
            "label_x": 505.8,
            "label_y": 239.5,
            "label_centering": "left",
            "symbol_x": 500.8,
            "symbol_y": 244.5,
            "ptm_position": "N3"
          }
        }
      }
    },
    {
      "protbox_id": "45",
      "proteins": [
        "P61224"
      ],
      "backup_label": "RAP1A",
      "x": 505.0,
      "y": 210.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function. {ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21840392}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: GTP-binding protein that possesses intrinsic GTPase activity. Contributes to the polarizing activity of KRIT1 and CDH5 in the establishment and maintenance of correct endothelial cell polarity and vascular lumen. Required for the localization of phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays a role in the establishment of basal endothelial barrier function. {ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21840392}.",
      "ptm_overrides": {
        "P61224": {
          "P61224_39": {
            "shape_x": 514.2,
            "shape_y": 206.5,
            "label_x": 509.20000000000005,
            "label_y": 201.5,
            "label_centering": "right",
            "symbol_x": 514.2,
            "symbol_y": 206.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "46",
      "proteins": [
        "P17612",
        "P22694"
      ],
      "backup_label": "PRKACA",
      "x": 505.0,
      "y": 161.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Required for phosphorylation of GLI transcription factors which inhibits them and prevents transcriptional activation of Hedgehog signaling pathway target genes (By similarity). GLI transcription factor phosphorylation is inhibited by interaction of PRKACA with SMO which sequesters PRKACA at the cell membrane (By similarity). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis most probably through the regulation of OFD1 in ciliogenesis (PubMed:33934390). Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984, ECO:0000269|PubMed:31112131, ECO:0000269|PubMed:33934390}.; FUNCTION: [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.\nT: Active site: ACT_SITE 167; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984, PubMed:31112131). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Required for phosphorylation of GLI transcription factors which inhibits them and prevents transcriptional activation of Hedgehog signaling pathway target genes (By similarity). GLI transcription factor phosphorylation is inhibited by interaction of PRKACA with SMO which sequesters PRKACA at the cell membrane (By similarity). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis most probably through the regulation of OFD1 in ciliogenesis (PubMed:33934390). Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed:31112131). {ECO:0000250|UniProtKB:P05132, ECO:0000250|UniProtKB:P27791, ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176, ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334, ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412, ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275, ECO:0000269|PubMed:21812984, ECO:0000269|PubMed:31112131, ECO:0000269|PubMed:33934390}.; FUNCTION: [Isoform 2]: Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.<br/><strong>T: Active site:</strong> ACT_SITE 167; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "P17612": {
          "P17612_339": {
            "shape_x": 514.2,
            "shape_y": 157.5,
            "label_x": 509.20000000000005,
            "label_y": 152.5,
            "label_centering": "right",
            "symbol_x": 514.1,
            "symbol_y": 157.0,
            "ptm_position": "N1"
          }
        },
        "P22694": {
          "P22694_339": {
            "shape_x": 514.2,
            "shape_y": 157.5,
            "label_x": 509.20000000000005,
            "label_y": 152.5,
            "label_centering": "right",
            "symbol_x": 514.2,
            "symbol_y": 157.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "47",
      "proteins": [
        "Q9Y4G8"
      ],
      "backup_label": "RAPGEF2",
      "x": 424.0,
      "y": 220.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Functions as a guanine nucleotide exchange factor (GEF), which activates Rap and Ras family of small GTPases by exchanging bound GDP for free GTP in a cAMP-dependent manner. Serves as a link between cell surface receptors and Rap/Ras GTPases in intracellular signaling cascades. Also acts as an effector for Rap1 by direct association with Rap1-GTP thereby leading to the amplification of Rap1-mediated signaling. Shows weak activity on HRAS. It is controversial whether RAPGEF2 binds cAMP and cGMP (PubMed:23800469, PubMed:10801446) or not (PubMed:10548487, PubMed:10608844, PubMed:11359771). Its binding to ligand-activated beta-1 adrenergic receptor ADRB1 leads to the Ras activation through the G(s)-alpha signaling pathway. Involved in the cAMP-induced Ras and Erk1/2 signaling pathway that leads to sustained inhibition of long term melanogenesis by reducing dendrite extension and melanin synthesis. Also provides inhibitory signals for cell proliferation of melanoma cells and promotes their apoptosis in a cAMP-independent nanner. Regulates cAMP-induced neuritogenesis by mediating the Rap1/B-Raf/ERK signaling through a pathway that is independent on both PKA and RAPGEF3/RAPGEF4. Involved in neuron migration and in the formation of the major forebrain fiber connections forming the corpus callosum, the anterior commissure and the hippocampal commissure during brain development. Involved in neuronal growth factor (NGF)-induced sustained activation of Rap1 at late endosomes and in brain-derived neurotrophic factor (BDNF)-induced axon outgrowth of hippocampal neurons. Plays a role in the regulation of embryonic blood vessel formation and in the establishment of basal junction integrity and endothelial barrier function. May be involved in the regulation of the vascular endothelial growth factor receptor KDR and cadherin CDH5 expression at allantois endothelial cell-cell junctions. {ECO:0000269|PubMed:10548487, ECO:0000269|PubMed:10608844, ECO:0000269|PubMed:10608883, ECO:0000269|PubMed:10801446, ECO:0000269|PubMed:10934204, ECO:0000269|PubMed:11359771, ECO:0000269|PubMed:12391161, ECO:0000269|PubMed:16272156, ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:21840392, ECO:0000269|PubMed:23800469}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Functions as a guanine nucleotide exchange factor (GEF), which activates Rap and Ras family of small GTPases by exchanging bound GDP for free GTP in a cAMP-dependent manner. Serves as a link between cell surface receptors and Rap/Ras GTPases in intracellular signaling cascades. Also acts as an effector for Rap1 by direct association with Rap1-GTP thereby leading to the amplification of Rap1-mediated signaling. Shows weak activity on HRAS. It is controversial whether RAPGEF2 binds cAMP and cGMP (PubMed:23800469, PubMed:10801446) or not (PubMed:10548487, PubMed:10608844, PubMed:11359771). Its binding to ligand-activated beta-1 adrenergic receptor ADRB1 leads to the Ras activation through the G(s)-alpha signaling pathway. Involved in the cAMP-induced Ras and Erk1/2 signaling pathway that leads to sustained inhibition of long term melanogenesis by reducing dendrite extension and melanin synthesis. Also provides inhibitory signals for cell proliferation of melanoma cells and promotes their apoptosis in a cAMP-independent nanner. Regulates cAMP-induced neuritogenesis by mediating the Rap1/B-Raf/ERK signaling through a pathway that is independent on both PKA and RAPGEF3/RAPGEF4. Involved in neuron migration and in the formation of the major forebrain fiber connections forming the corpus callosum, the anterior commissure and the hippocampal commissure during brain development. Involved in neuronal growth factor (NGF)-induced sustained activation of Rap1 at late endosomes and in brain-derived neurotrophic factor (BDNF)-induced axon outgrowth of hippocampal neurons. Plays a role in the regulation of embryonic blood vessel formation and in the establishment of basal junction integrity and endothelial barrier function. May be involved in the regulation of the vascular endothelial growth factor receptor KDR and cadherin CDH5 expression at allantois endothelial cell-cell junctions. {ECO:0000269|PubMed:10548487, ECO:0000269|PubMed:10608844, ECO:0000269|PubMed:10608883, ECO:0000269|PubMed:10801446, ECO:0000269|PubMed:10934204, ECO:0000269|PubMed:11359771, ECO:0000269|PubMed:12391161, ECO:0000269|PubMed:16272156, ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:21840392, ECO:0000269|PubMed:23800469}.",
      "ptm_overrides": {
        "Q9Y4G8": {
          "Q9Y4G8_1080": {
            "shape_x": 433.2,
            "shape_y": 216.5,
            "label_x": 428.2,
            "label_y": 211.5,
            "label_centering": "right",
            "symbol_x": 433.2,
            "symbol_y": 216.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "48",
      "proteins": [
        "Q15283"
      ],
      "backup_label": "RASA2",
      "x": 334.0,
      "y": 355.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4).",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4)."
    },
    {
      "protbox_id": "49",
      "proteins": [
        "O14807",
        "P62070",
        "P01112",
        "P01111",
        "P10301"
      ],
      "backup_label": "RRAS2",
      "x": 385.0,
      "y": 302.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Signal transducer in the Ras-MAPK signaling pathway that regulates cell proliferation and survival (PubMed:16630891, PubMed:28289718, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The formation of the SMP complex only occurs when MRAS is GTP-bound (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670, PubMed:39809765). MRAS has low intrinsic GTPase activity and may require additional factors for activation (PubMed:39809765). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). {ECO:0000269|PubMed:16630891, ECO:0000269|PubMed:28289718, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35830882, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:36175670, ECO:0000269|PubMed:39809765}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Signal transducer in the Ras-MAPK signaling pathway that regulates cell proliferation and survival (PubMed:16630891, PubMed:28289718, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The formation of the SMP complex only occurs when MRAS is GTP-bound (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670, PubMed:39809765). MRAS has low intrinsic GTPase activity and may require additional factors for activation (PubMed:39809765). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at &#x27;Ser-259&#x27; of RAF1 kinase, &#x27;Ser-365&#x27; of BRAF kinase and &#x27;Ser-214&#x27; of ARAF kinase, stimulating their kinase activities (PubMed:16630891, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). {ECO:0000269|PubMed:16630891, ECO:0000269|PubMed:28289718, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35830882, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:36175670, ECO:0000269|PubMed:39809765}.",
      "ptm_overrides": {
        "P62070": {
          "P62070_186": {
            "shape_x": 394.2,
            "shape_y": 298.5,
            "label_x": 389.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 394.09999999999997,
            "symbol_y": 298.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "50",
      "proteins": [],
      "backup_label": "RASGRP1",
      "x": 369.0,
      "y": 248.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "51",
      "proteins": [
        "Q07889"
      ],
      "backup_label": "SOS1",
      "x": 323.0,
      "y": 302.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Promotes the exchange of Ras-bound GDP by GTP (PubMed:8493579). Probably by promoting Ras activation, regulates phosphorylation of MAP kinase MAPK3/ERK1 in response to EGF (PubMed:17339331). Catalytic component of a trimeric complex that participates in transduction of signals from Ras to Rac by promoting the Rac-specific guanine nucleotide exchange factor (GEF) activity (By similarity). {ECO:0000250|UniProtKB:Q62245, ECO:0000269|PubMed:17339331, ECO:0000269|PubMed:8493579}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Promotes the exchange of Ras-bound GDP by GTP (PubMed:8493579). Probably by promoting Ras activation, regulates phosphorylation of MAP kinase MAPK3/ERK1 in response to EGF (PubMed:17339331). Catalytic component of a trimeric complex that participates in transduction of signals from Ras to Rac by promoting the Rac-specific guanine nucleotide exchange factor (GEF) activity (By similarity). {ECO:0000250|UniProtKB:Q62245, ECO:0000269|PubMed:17339331, ECO:0000269|PubMed:8493579}.",
      "ptm_overrides": {
        "Q07889": {
          "Q07889_1275": {
            "shape_x": 332.2,
            "shape_y": 298.5,
            "label_x": 327.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 332.2,
            "symbol_y": 298.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "52",
      "proteins": [
        "Q9UBI6",
        "Q03113"
      ],
      "backup_label": "GNA12",
      "x": 239.0,
      "y": 355.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction."
    },
    {
      "protbox_id": "53",
      "proteins": [
        "P62993"
      ],
      "backup_label": "GRB2",
      "x": 260.0,
      "y": 302.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Non-enzymatic adapter protein that plays a pivotal role in precisely regulated signaling cascades from cell surface receptors to cellular responses, including signaling transduction and gene expression (PubMed:11726515, PubMed:37626338). Thus, participates in many biological processes including regulation of innate and adaptive immunity, autophagy, DNA repair or necroptosis (PubMed:35831301, PubMed:37626338, PubMed:38182563). Controls signaling complexes at the T-cell antigen receptor to facilitate the activation, differentiation, and function of T-cells (PubMed:36864087, PubMed:9489702). Mechanistically, engagement of the TCR leads to phosphorylation of the adapter protein LAT, which serves as docking site for GRB2 (PubMed:9489702). In turn, GRB2 establishes a a connection with SOS1 that acts as a guanine nucleotide exchange factor and serves as a critical regulator of KRAS/RAF1 leading to MAPKs translocation to the nucleus and activation (PubMed:12171928, PubMed:25870599). Functions also a role in B-cell activation by amplifying Ca(2+) mobilization and activation of the ERK MAP kinase pathway upon recruitment to the phosphorylated B-cell antigen receptor (BCR) (PubMed:25413232, PubMed:29523808). Plays a role in switching between autophagy and programmed necrosis upstream of EGFR by interacting with components of necrosomes including RIPK1 and with autophagy regulators SQSTM1 and BECN1 (PubMed:35831301, PubMed:38182563). Regulates miRNA biogenesis by forming a functional ternary complex with AGO2 and DICER1 (PubMed:37328606). Functions in the replication stress response by protecting DNA at stalled replication forks from MRE11-mediated degradation. Mechanistically, inhibits RAD51 ATPase activity to stabilize RAD51 on stalled replication forks (PubMed:38459011). Additionally, directly recruits and later releases MRE11 at DNA damage sites during the homology-directed repair (HDR) process (PubMed:34348893). {ECO:0000269|PubMed:11726515, ECO:0000269|PubMed:12171928, ECO:0000269|PubMed:1322798, ECO:0000269|PubMed:19815557, ECO:0000269|PubMed:25413232, ECO:0000269|PubMed:25870599, ECO:0000269|PubMed:29523808, ECO:0000269|PubMed:34348893, ECO:0000269|PubMed:35831301, ECO:0000269|PubMed:36864087, ECO:0000269|PubMed:37328606, ECO:0000269|PubMed:37626338, ECO:0000269|PubMed:38182563, ECO:0000269|PubMed:38459011, ECO:0000269|PubMed:9489702}.; FUNCTION: [Isoform 2]: Does not bind to phosphorylated epidermal growth factor receptor (EGFR) but inhibits EGF-induced transactivation of a RAS-responsive element. Acts as a dominant negative protein over GRB2 and by suppressing proliferative signals, may trigger active programmed cell death. Mechanistically, inhibits RAS-ERK signaling and downstream cell proliferation by competing with GRB2 for SOS1 binding and thus by regulating SOS1 membrane recruitment (PubMed:36171279). {ECO:0000269|PubMed:36171279, ECO:0000269|PubMed:8178156}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Non-enzymatic adapter protein that plays a pivotal role in precisely regulated signaling cascades from cell surface receptors to cellular responses, including signaling transduction and gene expression (PubMed:11726515, PubMed:37626338). Thus, participates in many biological processes including regulation of innate and adaptive immunity, autophagy, DNA repair or necroptosis (PubMed:35831301, PubMed:37626338, PubMed:38182563). Controls signaling complexes at the T-cell antigen receptor to facilitate the activation, differentiation, and function of T-cells (PubMed:36864087, PubMed:9489702). Mechanistically, engagement of the TCR leads to phosphorylation of the adapter protein LAT, which serves as docking site for GRB2 (PubMed:9489702). In turn, GRB2 establishes a a connection with SOS1 that acts as a guanine nucleotide exchange factor and serves as a critical regulator of KRAS/RAF1 leading to MAPKs translocation to the nucleus and activation (PubMed:12171928, PubMed:25870599). Functions also a role in B-cell activation by amplifying Ca(2+) mobilization and activation of the ERK MAP kinase pathway upon recruitment to the phosphorylated B-cell antigen receptor (BCR) (PubMed:25413232, PubMed:29523808). Plays a role in switching between autophagy and programmed necrosis upstream of EGFR by interacting with components of necrosomes including RIPK1 and with autophagy regulators SQSTM1 and BECN1 (PubMed:35831301, PubMed:38182563). Regulates miRNA biogenesis by forming a functional ternary complex with AGO2 and DICER1 (PubMed:37328606). Functions in the replication stress response by protecting DNA at stalled replication forks from MRE11-mediated degradation. Mechanistically, inhibits RAD51 ATPase activity to stabilize RAD51 on stalled replication forks (PubMed:38459011). Additionally, directly recruits and later releases MRE11 at DNA damage sites during the homology-directed repair (HDR) process (PubMed:34348893). {ECO:0000269|PubMed:11726515, ECO:0000269|PubMed:12171928, ECO:0000269|PubMed:1322798, ECO:0000269|PubMed:19815557, ECO:0000269|PubMed:25413232, ECO:0000269|PubMed:25870599, ECO:0000269|PubMed:29523808, ECO:0000269|PubMed:34348893, ECO:0000269|PubMed:35831301, ECO:0000269|PubMed:36864087, ECO:0000269|PubMed:37328606, ECO:0000269|PubMed:37626338, ECO:0000269|PubMed:38182563, ECO:0000269|PubMed:38459011, ECO:0000269|PubMed:9489702}.; FUNCTION: [Isoform 2]: Does not bind to phosphorylated epidermal growth factor receptor (EGFR) but inhibits EGF-induced transactivation of a RAS-responsive element. Acts as a dominant negative protein over GRB2 and by suppressing proliferative signals, may trigger active programmed cell death. Mechanistically, inhibits RAS-ERK signaling and downstream cell proliferation by competing with GRB2 for SOS1 binding and thus by regulating SOS1 membrane recruitment (PubMed:36171279). {ECO:0000269|PubMed:36171279, ECO:0000269|PubMed:8178156}."
    },
    {
      "protbox_id": "54",
      "proteins": [
        "P04626",
        "P00533",
        "P29317",
        "P11362",
        "P22455",
        "P08069",
        "P06213"
      ],
      "backup_label": "CSF1R",
      "x": 197.0,
      "y": 302.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. {ECO:0000305}.; FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. {ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:15380516, ECO:0000269|PubMed:21555369}.\nT: Active site: ACT_SITE 845; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. {ECO:0000305}.; FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5&#x27;-TCAAATTC-3&#x27; sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. {ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:15380516, ECO:0000269|PubMed:21555369}.<br/><strong>T: Active site:</strong> ACT_SITE 845; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10028&quot;",
      "ptm_overrides": {
        "P00533": {
          "P00533_693": {
            "shape_x": 206.2,
            "shape_y": 298.5,
            "label_x": 201.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 205.89999999999998,
            "symbol_y": 298.5,
            "ptm_position": "N1"
          },
          "P00533_1026": {
            "shape_x": 220.0,
            "shape_y": 298.5,
            "label_x": 220.0,
            "label_y": 290.5,
            "label_centering": "center",
            "symbol_x": 219.7,
            "symbol_y": 298.5,
            "ptm_position": "N2"
          },
          "P00533_1166": {
            "shape_x": 233.8,
            "shape_y": 298.5,
            "label_x": 238.8,
            "label_y": 293.5,
            "label_centering": "left",
            "symbol_x": 233.8,
            "symbol_y": 298.5,
            "ptm_position": "N3"
          }
        },
        "P29317": {
          "P29317_892": {
            "shape_x": 206.2,
            "shape_y": 298.5,
            "label_x": 201.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 206.1,
            "symbol_y": 298.5,
            "ptm_position": "N1"
          },
          "P29317_570": {
            "shape_x": 220.0,
            "shape_y": 298.5,
            "label_x": 220.0,
            "label_y": 290.5,
            "label_centering": "center",
            "symbol_x": 220.0,
            "symbol_y": 298.5,
            "ptm_position": "N2"
          },
          "P29317_901": {
            "shape_x": 233.8,
            "shape_y": 298.5,
            "label_x": 238.8,
            "label_y": 293.5,
            "label_centering": "left",
            "symbol_x": 233.8,
            "symbol_y": 298.5,
            "ptm_position": "N3"
          }
        },
        "P04626": {
          "P04626_760": {
            "shape_x": 206.2,
            "shape_y": 298.5,
            "label_x": 201.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 206.2,
            "symbol_y": 298.5,
            "ptm_position": "N1"
          }
        },
        "P22455": {
          "P22455_419": {
            "shape_x": 206.2,
            "shape_y": 298.5,
            "label_x": 201.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 206.2,
            "symbol_y": 298.5,
            "ptm_position": "N1"
          },
          "P22455_573": {
            "shape_x": 220.0,
            "shape_y": 298.5,
            "label_x": 220.0,
            "label_y": 290.5,
            "label_centering": "center",
            "symbol_x": 220.0,
            "symbol_y": 298.5,
            "ptm_position": "N2"
          }
        },
        "P08069": {
          "P08069_1339": {
            "shape_x": 206.2,
            "shape_y": 298.5,
            "label_x": 201.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 206.2,
            "symbol_y": 298.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "55",
      "proteins": [
        "P54289",
        "Q9BXT2"
      ],
      "backup_label": "CACNG3...",
      "x": 197.0,
      "y": 167.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity). {ECO:0000250, ECO:0000269|PubMed:35293990}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity). {ECO:0000250, ECO:0000269|PubMed:35293990}."
    },
    {
      "protbox_id": "62",
      "proteins": [],
      "backup_label": "NR4A1",
      "x": 891.0,
      "y": 906.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "63",
      "proteins": [
        "Q13164"
      ],
      "backup_label": "MAPK7",
      "x": 740.0,
      "y": 906.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of STUB1-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction. {ECO:0000250|UniProtKB:P0C865, ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:11278431, ECO:0000269|PubMed:22869143, ECO:0000269|PubMed:9384584, ECO:0000269|PubMed:9790194}.\nT: Active site: ACT_SITE 182; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of STUB1-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction. {ECO:0000250|UniProtKB:P0C865, ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:11278431, ECO:0000269|PubMed:22869143, ECO:0000269|PubMed:9384584, ECO:0000269|PubMed:9790194}.<br/><strong>T: Active site:</strong> ACT_SITE 182; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "64",
      "proteins": [
        "Q13163"
      ],
      "backup_label": "MAP2K5",
      "x": 653.0,
      "y": 906.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). {ECO:0000250|UniProtKB:Q62862, ECO:0000269|PubMed:7759517, ECO:0000269|PubMed:9384584}.\nT: Active site: ACT_SITE 283; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). {ECO:0000250|UniProtKB:Q62862, ECO:0000269|PubMed:7759517, ECO:0000269|PubMed:9384584}.<br/><strong>T: Active site:</strong> ACT_SITE 283; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "65",
      "proteins": [],
      "backup_label": "NLK",
      "x": 763.0,
      "y": 843.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "66",
      "proteins": [],
      "backup_label": "CDC25B",
      "x": 828.0,
      "y": 813.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "67",
      "proteins": [
        "O75582",
        "O75676"
      ],
      "backup_label": "RPS6KA4",
      "x": 828.0,
      "y": 791.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes (PubMed:11909979, PubMed:12569367, PubMed:12763138, PubMed:18511904, PubMed:9687510, PubMed:9873047). Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin (PubMed:11909979, PubMed:9873047). Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression (PubMed:12628924, PubMed:18511904). In skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276' during oxidative stress (PubMed:12628924). In erythropoietin-stimulated cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and regulation of its transcriptional potential (PubMed:12763138). Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation (PubMed:12569367). Directly represses transcription via phosphorylation of 'Ser-1' of histone H2A (PubMed:15010469). Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:12773393). May also phosphorylate 'Ser-28' of histone H3 (PubMed:12773393). Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14) (PubMed:12773393). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines (By similarity). Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors (By similarity). Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury (By similarity). Phosphorylates TRIM7 at 'Ser-107' in response to growth factor signaling via the MEK/ERK pathway, thereby stimulating its ubiquitin ligase activity (PubMed:25851810). {ECO:0000250|UniProtKB:Q8C050, ECO:0000269|PubMed:11909979, ECO:0000269|PubMed:12569367, ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:18511904, ECO:0000269|PubMed:25851810, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047}.\nT: Active site: ACT_SITE 177; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 544; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factors RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes (PubMed:11909979, PubMed:12569367, PubMed:12763138, PubMed:18511904, PubMed:9687510, PubMed:9873047). Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin (PubMed:11909979, PubMed:9873047). Plays an essential role in the control of RELA transcriptional activity in response to TNF and upon glucocorticoid, associates in the cytoplasm with the glucocorticoid receptor NR3C1 and contributes to RELA inhibition and repression of inflammatory gene expression (PubMed:12628924, PubMed:18511904). In skeletal myoblasts is required for phosphorylation of RELA at &#x27;Ser-276&#x27; during oxidative stress (PubMed:12628924). In erythropoietin-stimulated cells, is necessary for the &#x27;Ser-727&#x27; phosphorylation of STAT3 and regulation of its transcriptional potential (PubMed:12763138). Phosphorylates ETV1/ER81 at &#x27;Ser-191&#x27; and &#x27;Ser-216&#x27;, and thereby regulates its ability to stimulate transcription, which may be important during development and breast tumor formation (PubMed:12569367). Directly represses transcription via phosphorylation of &#x27;Ser-1&#x27; of histone H2A (PubMed:15010469). Phosphorylates &#x27;Ser-10&#x27; of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN (PubMed:12773393). May also phosphorylate &#x27;Ser-28&#x27; of histone H3 (PubMed:12773393). Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14) (PubMed:12773393). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines (By similarity). Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors (By similarity). Plays a role in neuronal cell death by mediating the downstream effects of excitotoxic injury (By similarity). Phosphorylates TRIM7 at &#x27;Ser-107&#x27; in response to growth factor signaling via the MEK/ERK pathway, thereby stimulating its ubiquitin ligase activity (PubMed:25851810). {ECO:0000250|UniProtKB:Q8C050, ECO:0000269|PubMed:11909979, ECO:0000269|PubMed:12569367, ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:18511904, ECO:0000269|PubMed:25851810, ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047}.<br/><strong>T: Active site:</strong> ACT_SITE 177; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;; ACT_SITE 544; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;"
    },
    {
      "protbox_id": "68",
      "proteins": [
        "P49137"
      ],
      "backup_label": "MAPKAPK3",
      "x": 828.0,
      "y": 770.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Stress-activated serine/threonine-protein kinase involved in cytokine production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the interaction with HSP90 proteins and inhibiting HSF1 homotrimerization, DNA-binding and transactivation activities (PubMed:16278218). Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to the dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impairment of their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to the regulation of the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity, leading to inhibition of dependent degradation of ARE-containing transcripts. Phosphorylates CEP131 in response to cellular stress induced by ultraviolet irradiation which promotes binding of CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar satellites (PubMed:26616734). Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilization of GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:11844797, ECO:0000269|PubMed:12456657, ECO:0000269|PubMed:12565831, ECO:0000269|PubMed:14499342, ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:15629715, ECO:0000269|PubMed:16278218, ECO:0000269|PubMed:16456544, ECO:0000269|PubMed:17481585, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:26616734, ECO:0000269|PubMed:8093612, ECO:0000269|PubMed:8280084, ECO:0000269|PubMed:8774846}.\nT: Active site: ACT_SITE 186; /note=\"Proton acceptor\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Stress-activated serine/threonine-protein kinase involved in cytokine production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the interaction with HSP90 proteins and inhibiting HSF1 homotrimerization, DNA-binding and transactivation activities (PubMed:16278218). Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to the dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impairment of their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to the regulation of the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity, leading to inhibition of dependent degradation of ARE-containing transcripts. Phosphorylates CEP131 in response to cellular stress induced by ultraviolet irradiation which promotes binding of CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar satellites (PubMed:26616734). Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilization of GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:11844797, ECO:0000269|PubMed:12456657, ECO:0000269|PubMed:12565831, ECO:0000269|PubMed:14499342, ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:15014438, ECO:0000269|PubMed:15629715, ECO:0000269|PubMed:16278218, ECO:0000269|PubMed:16456544, ECO:0000269|PubMed:17481585, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:20932473, ECO:0000269|PubMed:26616734, ECO:0000269|PubMed:8093612, ECO:0000269|PubMed:8280084, ECO:0000269|PubMed:8774846}.<br/><strong>T: Active site:</strong> ACT_SITE 186; /note=&quot;Proton acceptor&quot;"
    },
    {
      "protbox_id": "69",
      "proteins": [],
      "backup_label": "ATF4",
      "x": 891.0,
      "y": 792.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "70",
      "proteins": [],
      "backup_label": "MEF2C",
      "x": 891.0,
      "y": 727.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "71",
      "proteins": [
        "P61244"
      ],
      "backup_label": "MAX",
      "x": 891.0,
      "y": 705.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5'-CAC[GA]TG-3'. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 'Lys-9' histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements. {ECO:0000269|PubMed:26070438}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5&#x27;-CAC[GA]TG-3&#x27;. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 &#x27;Lys-9&#x27; histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements. {ECO:0000269|PubMed:26070438}."
    },
    {
      "protbox_id": "72",
      "proteins": [
        "P35638"
      ],
      "backup_label": "DDIT3",
      "x": 891.0,
      "y": 683.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Multifunctional transcription factor in endoplasmic reticulum (ER) stress response (PubMed:15322075, PubMed:15775988, PubMed:19672300). Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress (PubMed:15322075, PubMed:15775988). Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes (By similarity). Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes (By similarity). Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L (PubMed:15775988, PubMed:17709599, PubMed:20876114, PubMed:22761832). Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:18940792, PubMed:19672300, PubMed:20829347). Together with ATF4, mediates ER-mediated cell death by promoting expression of genes involved in cellular amino acid metabolic processes, mRNA translation and the unfolded protein response (UPR) in response to ER stress (By similarity). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity (PubMed:16434966). Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response (By similarity). Acts as a major regulator of postnatal neovascularization through regulation of endothelial nitric oxide synthase (NOS3)-related signaling (By similarity). {ECO:0000250|UniProtKB:P35639, ECO:0000269|PubMed:15322075, ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:16434966, ECO:0000269|PubMed:17709599, ECO:0000269|PubMed:18940792, ECO:0000269|PubMed:19672300, ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:20876114, ECO:0000269|PubMed:22761832}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Multifunctional transcription factor in endoplasmic reticulum (ER) stress response (PubMed:15322075, PubMed:15775988, PubMed:19672300). Plays an essential role in the response to a wide variety of cell stresses and induces cell cycle arrest and apoptosis in response to ER stress (PubMed:15322075, PubMed:15775988). Plays a dual role both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes (By similarity). Acts as a dominant-negative regulator of C/EBP-induced transcription: dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in the promoter regions, and inhibits the expression of C/EBP regulated genes (By similarity). Positively regulates the transcription of TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM and ERO1L (PubMed:15775988, PubMed:17709599, PubMed:20876114, PubMed:22761832). Negatively regulates; expression of BCL2 and MYOD1, ATF4-dependent transcriptional activation of asparagine synthetase (ASNS), CEBPA-dependent transcriptional activation of hepcidin (HAMP) and CEBPB-mediated expression of peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:18940792, PubMed:19672300, PubMed:20829347). Together with ATF4, mediates ER-mediated cell death by promoting expression of genes involved in cellular amino acid metabolic processes, mRNA translation and the unfolded protein response (UPR) in response to ER stress (By similarity). Inhibits the canonical Wnt signaling pathway by binding to TCF7L2/TCF4, impairing its DNA-binding properties and repressing its transcriptional activity (PubMed:16434966). Plays a regulatory role in the inflammatory response through the induction of caspase-11 (CASP4/CASP11) which induces the activation of caspase-1 (CASP1) and both these caspases increase the activation of pro-IL1B to mature IL1B which is involved in the inflammatory response (By similarity). Acts as a major regulator of postnatal neovascularization through regulation of endothelial nitric oxide synthase (NOS3)-related signaling (By similarity). {ECO:0000250|UniProtKB:P35639, ECO:0000269|PubMed:15322075, ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:16434966, ECO:0000269|PubMed:17709599, ECO:0000269|PubMed:18940792, ECO:0000269|PubMed:19672300, ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:20876114, ECO:0000269|PubMed:22761832}."
    },
    {
      "protbox_id": "73",
      "proteins": [],
      "backup_label": "ELK4",
      "x": 891.0,
      "y": 661.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "74",
      "proteins": [
        "P04637"
      ],
      "backup_label": "TP53",
      "x": 891.0,
      "y": 605.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17189187, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:38653238, PubMed:9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed:12524540, PubMed:17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). {ECO:0000269|PubMed:11025664, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:15186775, ECO:0000269|PubMed:15340061, ECO:0000269|PubMed:17189187, ECO:0000269|PubMed:17317671, ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:20673990, ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:22726440, ECO:0000269|PubMed:24051492, ECO:0000269|PubMed:24652652, ECO:0000269|PubMed:35618207, ECO:0000269|PubMed:36634798, ECO:0000269|PubMed:38653238, ECO:0000269|PubMed:9840937}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17189187, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:38653238, PubMed:9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed:12524540, PubMed:17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). {ECO:0000269|PubMed:11025664, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:15186775, ECO:0000269|PubMed:15340061, ECO:0000269|PubMed:17189187, ECO:0000269|PubMed:17317671, ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:20673990, ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:22726440, ECO:0000269|PubMed:24051492, ECO:0000269|PubMed:24652652, ECO:0000269|PubMed:35618207, ECO:0000269|PubMed:36634798, ECO:0000269|PubMed:38653238, ECO:0000269|PubMed:9840937}.",
      "ptm_overrides": {
        "P04637": {
          "P04637_315": {
            "shape_x": 900.2,
            "shape_y": 626.5,
            "label_x": 895.2,
            "label_y": 631.5,
            "label_centering": "right",
            "symbol_x": 900.1,
            "symbol_y": 626.5,
            "ptm_position": "S1"
          }
        }
      }
    },
    {
      "protbox_id": "75",
      "proteins": [],
      "backup_label": "ELK1",
      "x": 891.0,
      "y": 584.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "76",
      "proteins": [
        "P15336"
      ],
      "backup_label": "ATF2",
      "x": 891.0,
      "y": 562.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro (PubMed:10821277). In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type. {ECO:0000269|PubMed:10821277, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:22304920}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5&#x27;-TGACGTCA-3&#x27;) or to AP-1 (activator protein 1) consensus sequences (5&#x27;-TGACTCA-3&#x27;). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro (PubMed:10821277). In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type. {ECO:0000269|PubMed:10821277, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:22304920}.",
      "ptm_overrides": {
        "P15336": {
          "P15336_136": {
            "shape_x": 900.2,
            "shape_y": 558.5,
            "label_x": 895.2,
            "label_y": 553.5,
            "label_centering": "right",
            "symbol_x": 900.2,
            "symbol_y": 558.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "77",
      "proteins": [
        "Q15759",
        "Q16539",
        "P53778"
      ],
      "backup_label": "MAPK14",
      "x": 740.0,
      "y": 694.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors (PubMed:12452429, PubMed:20626350, PubMed:35857590). Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 functions are mostly redundant with those of MAPK14 (PubMed:12452429, PubMed:20626350, PubMed:35857590). Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets (PubMed:12452429, PubMed:20626350). RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Additional examples of p38 MAPK substrates are the FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:15356147, PubMed:9430721). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers (PubMed:10330143, PubMed:15356147, PubMed:9430721). The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). Phosphorylates methyltransferase DOT1L on 'Ser-834', 'Thr-900', 'Ser-902', 'Thr-984', 'Ser-1001', 'Ser-1009' and 'Ser-1104' (PubMed:38270553). {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:15356147, ECO:0000269|PubMed:35857590, ECO:0000269|PubMed:38270553, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:12452429, ECO:0000303|PubMed:20626350}.\nT: Active site: ACT_SITE 150; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors (PubMed:12452429, PubMed:20626350, PubMed:35857590). Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 functions are mostly redundant with those of MAPK14 (PubMed:12452429, PubMed:20626350, PubMed:35857590). Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets (PubMed:12452429, PubMed:20626350). RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Additional examples of p38 MAPK substrates are the FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:15356147, PubMed:9430721). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers (PubMed:10330143, PubMed:15356147, PubMed:9430721). The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on &#x27;Ser-10&#x27; (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). Phosphorylates methyltransferase DOT1L on &#x27;Ser-834&#x27;, &#x27;Thr-900&#x27;, &#x27;Ser-902&#x27;, &#x27;Thr-984&#x27;, &#x27;Ser-1001&#x27;, &#x27;Ser-1009&#x27; and &#x27;Ser-1104&#x27; (PubMed:38270553). {ECO:0000269|PubMed:10330143, ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:15356147, ECO:0000269|PubMed:35857590, ECO:0000269|PubMed:38270553, ECO:0000269|PubMed:9430721, ECO:0000269|PubMed:9687510, ECO:0000303|PubMed:12452429, ECO:0000303|PubMed:20626350}.<br/><strong>T: Active site:</strong> ACT_SITE 150; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "ptm_overrides": {
        "Q16539": {
          "Q16539_182": {
            "shape_x": 749.2,
            "shape_y": 690.5,
            "label_x": 744.2,
            "label_y": 685.5,
            "label_centering": "right",
            "symbol_x": 749.1,
            "symbol_y": 690.0,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "78",
      "proteins": [
        "P53041"
      ],
      "backup_label": "PPP5C",
      "x": 634.0,
      "y": 747.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein phosphatase that dephosphorylates a myriad of proteins involved in different signaling pathways including the kinases CSNK1E, ASK1/MAP3K5, PRKDC and RAF1, the nuclear receptors NR3C1, PPARG, ESR1 and ESR2, SMAD proteins and TAU/MAPT (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Implicated in wide ranging cellular processes, including apoptosis, differentiation, DNA damage response, cell survival, regulation of ion channels or circadian rhythms, in response to steroid and thyroid hormones, calcium, fatty acids, TGF-beta as well as oxidative and genotoxic stresses (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Participates in the control of DNA damage response mechanisms such as checkpoint activation and DNA damage repair through, for instance, the regulation ATM/ATR-signaling and dephosphorylation of PRKDC and TP53BP1 (PubMed:14871926, PubMed:16260606, PubMed:21144835). Inhibits ASK1/MAP3K5-mediated apoptosis induced by oxidative stress (PubMed:23102700). Plays a positive role in adipogenesis, mainly through the dephosphorylation and activation of PPARG transactivation function (By similarity). Also dephosphorylates and inhibits the anti-adipogenic effect of NR3C1 (By similarity). Regulates the circadian rhythms, through the dephosphorylation and activation of CSNK1E (PubMed:16790549). May modulate TGF-beta signaling pathway by the regulation of SMAD3 phosphorylation and protein expression levels (PubMed:22781750). Dephosphorylates and may play a role in the regulation of TAU/MAPT (PubMed:15546861). Through their dephosphorylation, may play a role in the regulation of ions channels such as KCNH2 (By similarity). Dephosphorylate FNIP1, disrupting interaction with HSP90AA1/Hsp90 (PubMed:30699359). {ECO:0000250|UniProtKB:P53042, ECO:0000250|UniProtKB:Q60676, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:14764652, ECO:0000269|PubMed:14871926, ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15546861, ECO:0000269|PubMed:16260606, ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:19176521, ECO:0000269|PubMed:19948726, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22399290, ECO:0000269|PubMed:22781750, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:30699359, ECO:0000269|PubMed:9000529}.\nT: Active site: ACT_SITE 304; /note=\"Proton donor/acceptor\"; /evidence=\"ECO:0000269|PubMed:15155720\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein phosphatase that dephosphorylates a myriad of proteins involved in different signaling pathways including the kinases CSNK1E, ASK1/MAP3K5, PRKDC and RAF1, the nuclear receptors NR3C1, PPARG, ESR1 and ESR2, SMAD proteins and TAU/MAPT (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Implicated in wide ranging cellular processes, including apoptosis, differentiation, DNA damage response, cell survival, regulation of ion channels or circadian rhythms, in response to steroid and thyroid hormones, calcium, fatty acids, TGF-beta as well as oxidative and genotoxic stresses (PubMed:14734805, PubMed:14764652, PubMed:14871926, PubMed:15383005, PubMed:15546861, PubMed:16260606, PubMed:16790549, PubMed:16892053, PubMed:19176521, PubMed:19948726, PubMed:21144835, PubMed:22399290, PubMed:22781750, PubMed:23102700, PubMed:30699359, PubMed:9000529). Participates in the control of DNA damage response mechanisms such as checkpoint activation and DNA damage repair through, for instance, the regulation ATM/ATR-signaling and dephosphorylation of PRKDC and TP53BP1 (PubMed:14871926, PubMed:16260606, PubMed:21144835). Inhibits ASK1/MAP3K5-mediated apoptosis induced by oxidative stress (PubMed:23102700). Plays a positive role in adipogenesis, mainly through the dephosphorylation and activation of PPARG transactivation function (By similarity). Also dephosphorylates and inhibits the anti-adipogenic effect of NR3C1 (By similarity). Regulates the circadian rhythms, through the dephosphorylation and activation of CSNK1E (PubMed:16790549). May modulate TGF-beta signaling pathway by the regulation of SMAD3 phosphorylation and protein expression levels (PubMed:22781750). Dephosphorylates and may play a role in the regulation of TAU/MAPT (PubMed:15546861). Through their dephosphorylation, may play a role in the regulation of ions channels such as KCNH2 (By similarity). Dephosphorylate FNIP1, disrupting interaction with HSP90AA1/Hsp90 (PubMed:30699359). {ECO:0000250|UniProtKB:P53042, ECO:0000250|UniProtKB:Q60676, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:14764652, ECO:0000269|PubMed:14871926, ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15546861, ECO:0000269|PubMed:16260606, ECO:0000269|PubMed:16790549, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:19176521, ECO:0000269|PubMed:19948726, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22399290, ECO:0000269|PubMed:22781750, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:30699359, ECO:0000269|PubMed:9000529}.<br/><strong>T: Active site:</strong> ACT_SITE 304; /note=&quot;Proton donor/acceptor&quot;; /evidence=&quot;ECO:0000269|PubMed:15155720&quot;"
    },
    {
      "protbox_id": "79",
      "proteins": [],
      "backup_label": "MAP2K6",
      "x": 653.0,
      "y": 710.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "80",
      "proteins": [
        "P46734"
      ],
      "backup_label": "MAP2K3",
      "x": 653.0,
      "y": 679.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. {ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:8622669}.\nT: Active site: ACT_SITE 190; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. {ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:8622669}.<br/><strong>T: Active site:</strong> ACT_SITE 190; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "81",
      "proteins": [],
      "backup_label": "DUSP10",
      "x": 764.0,
      "y": 583.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "82",
      "proteins": [
        "P51452"
      ],
      "backup_label": "DUSP3",
      "x": 720.0,
      "y": 605.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines (PubMed:10224087, PubMed:11863439). Specifically dephosphorylates and inactivates ERK1 and ERK2 (PubMed:10224087, PubMed:11863439). {ECO:0000269|PubMed:10224087, ECO:0000269|PubMed:11863439}.\nT: Active site: ACT_SITE 124; /note=\"Phosphocysteine intermediate\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00160\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines (PubMed:10224087, PubMed:11863439). Specifically dephosphorylates and inactivates ERK1 and ERK2 (PubMed:10224087, PubMed:11863439). {ECO:0000269|PubMed:10224087, ECO:0000269|PubMed:11863439}.<br/><strong>T: Active site:</strong> ACT_SITE 124; /note=&quot;Phosphocysteine intermediate&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00160&quot;"
    },
    {
      "protbox_id": "83",
      "proteins": [
        "P35813"
      ],
      "backup_label": "PPM1A",
      "x": 663.0,
      "y": 583.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Enzyme with a broad specificity. Negatively regulates TGF-beta signaling through dephosphorylating SMAD2 and SMAD3, resulting in their dissociation from SMAD4, nuclear export of the SMADs and termination of the TGF-beta-mediated signaling. Dephosphorylates PRKAA1 and PRKAA2. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:18930133}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Enzyme with a broad specificity. Negatively regulates TGF-beta signaling through dephosphorylating SMAD2 and SMAD3, resulting in their dissociation from SMAD4, nuclear export of the SMADs and termination of the TGF-beta-mediated signaling. Dephosphorylates PRKAA1 and PRKAA2. Plays an important role in the termination of TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB. {ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:18930133}."
    },
    {
      "protbox_id": "84",
      "proteins": [
        "P31749",
        "Q9Y243",
        "P31751"
      ],
      "backup_label": "AKT3",
      "x": 620.0,
      "y": 605.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.\nT: Active site: ACT_SITE 274; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMed:29343641, PubMed:31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at &#x27;Ser-50&#x27; negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at &#x27;Ser-21&#x27; and GSK3B at &#x27;Ser-9&#x27;, resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of &#x27;Ser-83&#x27; decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at &#x27;Ser-939&#x27; and &#x27;Thr-1462&#x27;, thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915, PubMed:12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed:31548394, PubMed:33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at &#x27;Thr-24&#x27;, &#x27;Ser-256&#x27; and &#x27;Ser-319&#x27; (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates &#x27;Ser-454&#x27; on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of &#x27;Ser-273&#x27;, resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on &#x27;Ser-318&#x27;, which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at &#x27;Thr-120&#x27; and &#x27;Thr-387&#x27; leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at &#x27;Thr-117&#x27; and &#x27;Thr-384&#x27; leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at &#x27;Ser-259&#x27; and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at &#x27;Thr-369&#x27; and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at &#x27;Thr-145&#x27; induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at &#x27;Ser-90&#x27;, reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed:30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed:15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed:31204173). {ECO:0000250|UniProtKB:P31750, ECO:0000250|UniProtKB:P47196, ECO:0000269|PubMed:10358075, ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:12150915, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12176338, ECO:0000269|PubMed:12964941, ECO:0000269|PubMed:15861136, ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:17726016, ECO:0000269|PubMed:18507042, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19934221, ECO:0000269|PubMed:20086174, ECO:0000269|PubMed:20471940, ECO:0000269|PubMed:20682768, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:30504268, ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:31548394, ECO:0000269|PubMed:32228865, ECO:0000269|PubMed:32322062, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:9829964, ECO:0000303|PubMed:11882383, ECO:0000303|PubMed:15526160, ECO:0000303|PubMed:21432781, ECO:0000303|PubMed:21620960}.<br/><strong>T: Active site:</strong> ACT_SITE 274; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "Q9Y243": {
          "Q9Y243_447": {
            "shape_x": 629.2,
            "shape_y": 601.5,
            "label_x": 624.2,
            "label_y": 596.5,
            "label_centering": "right",
            "symbol_x": 629.2,
            "symbol_y": 601.5,
            "ptm_position": "N1"
          }
        },
        "P31751": {
          "P31751_451": {
            "shape_x": 629.2,
            "shape_y": 601.5,
            "label_x": 624.2,
            "label_y": 596.5,
            "label_centering": "right",
            "symbol_x": 629.2,
            "symbol_y": 601.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "85",
      "proteins": [
        "Q7L7X3",
        "Q9H2K8",
        "Q9UL54"
      ],
      "backup_label": "TAOK3",
      "x": 557.0,
      "y": 818.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. Plays an essential role in the regulation of neuronal development in the central nervous system (PubMed:33565190). Also plays a role in the regulation of neuronal migration to the cortical plate (By similarity). {ECO:0000250|UniProtKB:Q5F2E8, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936, ECO:0000269|PubMed:33565190}.\nT: Active site: ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating &#x27;Thr-208&#x27; of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. Plays an essential role in the regulation of neuronal development in the central nervous system (PubMed:33565190). Also plays a role in the regulation of neuronal migration to the cortical plate (By similarity). {ECO:0000250|UniProtKB:Q5F2E8, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936, ECO:0000269|PubMed:33565190}.<br/><strong>T: Active site:</strong> ACT_SITE 151; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "Q7L7X3": {
          "Q7L7X3_445": {
            "shape_x": 566.2,
            "shape_y": 814.5,
            "label_x": 561.2,
            "label_y": 809.5,
            "label_centering": "right",
            "symbol_x": 566.2,
            "symbol_y": 814.5,
            "ptm_position": "N1"
          },
          "Q7L7X3_965": {
            "shape_x": 593.8,
            "shape_y": 814.5,
            "label_x": 598.8,
            "label_y": 809.5,
            "label_centering": "left",
            "symbol_x": 593.8,
            "symbol_y": 814.5,
            "ptm_position": "N3"
          },
          "Q7L7X3_421": {
            "shape_x": 566.2,
            "shape_y": 839.5,
            "label_x": 561.2,
            "label_y": 844.5,
            "label_centering": "right",
            "symbol_x": 566.2,
            "symbol_y": 839.5,
            "ptm_position": "S1"
          }
        }
      }
    },
    {
      "protbox_id": "86",
      "proteins": [
        "Q9Y6R4"
      ],
      "backup_label": "MAP3K4",
      "x": 557.0,
      "y": 791.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. {ECO:0000269|PubMed:12052864, ECO:0000269|PubMed:9305639}.\nT: Active site: ACT_SITE 1463; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. {ECO:0000269|PubMed:12052864, ECO:0000269|PubMed:9305639}.<br/><strong>T: Active site:</strong> ACT_SITE 1463; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "87",
      "proteins": [
        "P04792"
      ],
      "backup_label": "HSPB1",
      "x": 891.0,
      "y": 760.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975). Plays a role in stress resistance and actin organization (PubMed:19166925). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742). {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:20178975, ECO:0000269|PubMed:23728742}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state (PubMed:10383393, PubMed:20178975). Plays a role in stress resistance and actin organization (PubMed:19166925). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (PubMed:23728742). {ECO:0000269|PubMed:10383393, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:20178975, ECO:0000269|PubMed:23728742}.",
      "ptm_overrides": {
        "P04792": {
          "P04792_15": {
            "shape_x": 900.2,
            "shape_y": 756.5,
            "label_x": 895.2,
            "label_y": 751.5,
            "label_centering": "right",
            "symbol_x": 900.1,
            "symbol_y": 756.5,
            "ptm_position": "N1"
          },
          "P04792_82": {
            "shape_x": 927.8,
            "shape_y": 756.5,
            "label_x": 932.8,
            "label_y": 751.5,
            "label_centering": "left",
            "symbol_x": 927.6999999999999,
            "symbol_y": 756.0,
            "ptm_position": "N3"
          },
          "P04792_176": {
            "shape_x": 900.2,
            "shape_y": 781.5,
            "label_x": 895.2,
            "label_y": 786.5,
            "label_centering": "right",
            "symbol_x": 900.2,
            "symbol_y": 781.5,
            "ptm_position": "S1"
          },
          "P04792_202": {
            "shape_x": 927.8,
            "shape_y": 781.5,
            "label_x": 932.8,
            "label_y": 786.5,
            "label_centering": "left",
            "symbol_x": 927.8,
            "symbol_y": 781.5,
            "ptm_position": "S3"
          }
        }
      }
    },
    {
      "protbox_id": "88",
      "proteins": [
        "O43318"
      ],
      "backup_label": "MAP3K7",
      "x": 557.0,
      "y": 724.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Plays an important role in the cascades of cellular responses evoked by changes in the environment (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR) (PubMed:16893890, PubMed:9079627). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7 (PubMed:11460167, PubMed:8663074). These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs); both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1) (PubMed:11460167, PubMed:12589052, PubMed:8663074). Independently of MAP2Ks and p38 MAPKs, acts as a key activator of NF-kappa-B by promoting activation of the I-kappa-B-kinase (IKK) core complex (PubMed:12589052, PubMed:8663074). Mechanistically, recruited to polyubiquitin chains of RIPK2 and IKBKG/NEMO via TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3, and catalyzes phosphorylation and activation of IKBKB/IKKB component of the IKK complex, leading to NF-kappa-B activation (PubMed:10094049, PubMed:11460167). In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B (PubMed:16893890). Promotes TRIM5 capsid-specific restriction activity (PubMed:21512573). Phosphorylates RIPK1 at 'Ser-321' which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). Phosphorylates STING1 in response to cGAMP-activation, promoting association between STEEP1 and STING1 and STING1 translocation to COPII vesicles (PubMed:37832545). {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:37832545, ECO:0000269|PubMed:8663074, ECO:0000269|PubMed:9079627}.\nT: Active site: ACT_SITE 156; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Plays an important role in the cascades of cellular responses evoked by changes in the environment (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR) (PubMed:16893890, PubMed:9079627). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7 (PubMed:11460167, PubMed:8663074). These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs); both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1) (PubMed:11460167, PubMed:12589052, PubMed:8663074). Independently of MAP2Ks and p38 MAPKs, acts as a key activator of NF-kappa-B by promoting activation of the I-kappa-B-kinase (IKK) core complex (PubMed:12589052, PubMed:8663074). Mechanistically, recruited to polyubiquitin chains of RIPK2 and IKBKG/NEMO via TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3, and catalyzes phosphorylation and activation of IKBKB/IKKB component of the IKK complex, leading to NF-kappa-B activation (PubMed:10094049, PubMed:11460167). In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B (PubMed:16893890). Promotes TRIM5 capsid-specific restriction activity (PubMed:21512573). Phosphorylates RIPK1 at &#x27;Ser-321&#x27; which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). Phosphorylates STING1 in response to cGAMP-activation, promoting association between STEEP1 and STING1 and STING1 translocation to COPII vesicles (PubMed:37832545). {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:37832545, ECO:0000269|PubMed:8663074, ECO:0000269|PubMed:9079627}.<br/><strong>T: Active site:</strong> ACT_SITE 156; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "O43318": {
          "O43318_439": {
            "shape_x": 566.2,
            "shape_y": 720.5,
            "label_x": 561.2,
            "label_y": 715.5,
            "label_centering": "right",
            "symbol_x": 566.1,
            "symbol_y": 720.5,
            "ptm_position": "N1"
          },
          "O43318_389": {
            "shape_x": 593.8,
            "shape_y": 720.5,
            "label_x": 598.8,
            "label_y": 715.5,
            "label_centering": "left",
            "symbol_x": 593.8,
            "symbol_y": 720.5,
            "ptm_position": "N3"
          }
        }
      }
    },
    {
      "protbox_id": "89",
      "proteins": [
        "Q99683"
      ],
      "backup_label": "MAP3K5",
      "x": 557.0,
      "y": 694.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). {ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:10849426, ECO:0000269|PubMed:11029458, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685, ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544, ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:17220297, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:26095851, ECO:0000269|PubMed:8940179, ECO:0000269|PubMed:8974401, ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}.\nT: Active site: ACT_SITE 803; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). {ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:10849426, ECO:0000269|PubMed:11029458, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685, ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544, ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:17220297, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:26095851, ECO:0000269|PubMed:8940179, ECO:0000269|PubMed:8974401, ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}.<br/><strong>T: Active site:</strong> ACT_SITE 803; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "90",
      "proteins": [
        "O95382"
      ],
      "backup_label": "MAP3K6",
      "x": 557.0,
      "y": 664.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. {ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:9875215}.\nT: Active site: ACT_SITE 771; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. {ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:9875215}.<br/><strong>T: Active site:</strong> ACT_SITE 771; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "91",
      "proteins": [],
      "backup_label": "MAP3K20",
      "x": 557.0,
      "y": 620.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "92",
      "proteins": [],
      "backup_label": "MAP3K12",
      "x": 557.0,
      "y": 600.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "93",
      "proteins": [],
      "backup_label": "MAP3K9",
      "x": 557.0,
      "y": 580.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "94",
      "proteins": [
        "Q12851"
      ],
      "backup_label": "MAP4K2",
      "x": 471.0,
      "y": 644.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidine (poly(IC)), lipopolysaccharides (LPS), lipid A, peptidoglycan (PGN), or bacterial flagellin. To a lesser degree, IL-1 and engagement of CD40 also stimulate MAP4K2-mediated JNKs activation. The requirement for MAP4K2/GCK is most pronounced for LPS signaling, and extends to LPS stimulation of c-Jun phosphorylation and induction of IL-8. Enhances MAP3K1 oligomerization, which may relieve N-terminal mediated MAP3K1 autoinhibition and lead to activation following autophosphorylation. Also mediates the SAP/JNK signaling pathway and the p38 MAPKs signaling pathway through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3. May play a role in the regulation of vesicle targeting or fusion. regulation of vesicle targeting or fusion. Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:15456887, ECO:0000269|PubMed:17584736, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:7477268, ECO:0000269|PubMed:7515885, ECO:0000269|PubMed:9712898}.\nT: Active site: ACT_SITE 136; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidine (poly(IC)), lipopolysaccharides (LPS), lipid A, peptidoglycan (PGN), or bacterial flagellin. To a lesser degree, IL-1 and engagement of CD40 also stimulate MAP4K2-mediated JNKs activation. The requirement for MAP4K2/GCK is most pronounced for LPS signaling, and extends to LPS stimulation of c-Jun phosphorylation and induction of IL-8. Enhances MAP3K1 oligomerization, which may relieve N-terminal mediated MAP3K1 autoinhibition and lead to activation following autophosphorylation. Also mediates the SAP/JNK signaling pathway and the p38 MAPKs signaling pathway through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3. May play a role in the regulation of vesicle targeting or fusion. regulation of vesicle targeting or fusion. Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:15456887, ECO:0000269|PubMed:17584736, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:7477268, ECO:0000269|PubMed:7515885, ECO:0000269|PubMed:9712898}.<br/><strong>T: Active site:</strong> ACT_SITE 136; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "ptm_overrides": {
        "Q12851": {
          "Q12851_328": {
            "shape_x": 480.2,
            "shape_y": 640.5,
            "label_x": 475.2,
            "label_y": 635.5,
            "label_centering": "right",
            "symbol_x": 480.2,
            "symbol_y": 640.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "95",
      "proteins": [
        "Q13188",
        "Q13043"
      ],
      "backup_label": "STK3",
      "x": 471.0,
      "y": 604.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation (PubMed:11278283, PubMed:8566796, PubMed:8816758). Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714, PubMed:29063833, PubMed:30622739). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714). STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By similarity). Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosome, and its ability to phosphorylate CROCC and CEP250 (PubMed:21076410, PubMed:21723128). In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation (PubMed:21104395). Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on 'Ser-259' (PubMed:20212043). Phosphorylates MOBKL1A and RASSF2 (PubMed:19525978). Phosphorylates MOBKL1B on 'Thr-74'. Acts cooperatively with MOBKL1B to activate STK38 (PubMed:18328708, PubMed:18362890). {ECO:0000250|UniProtKB:Q9JI10, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18362890, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:20212043, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:21723128, ECO:0000269|PubMed:23972470, ECO:0000269|PubMed:28087714, ECO:0000269|PubMed:29063833, ECO:0000269|PubMed:30622739, ECO:0000269|PubMed:8566796, ECO:0000269|PubMed:8816758}.\nT: Active site: ACT_SITE 146; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation (PubMed:11278283, PubMed:8566796, PubMed:8816758). Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714, PubMed:29063833, PubMed:30622739). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:15688006, PubMed:16930133, PubMed:23972470, PubMed:28087714). STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By similarity). Phosphorylates NEK2 and plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosome, and its ability to phosphorylate CROCC and CEP250 (PubMed:21076410, PubMed:21723128). In conjunction with SAV1, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation (PubMed:21104395). Positively regulates RAF1 activation via suppression of the inhibitory phosphorylation of RAF1 on &#x27;Ser-259&#x27; (PubMed:20212043). Phosphorylates MOBKL1A and RASSF2 (PubMed:19525978). Phosphorylates MOBKL1B on &#x27;Thr-74&#x27;. Acts cooperatively with MOBKL1B to activate STK38 (PubMed:18328708, PubMed:18362890). {ECO:0000250|UniProtKB:Q9JI10, ECO:0000269|PubMed:11278283, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:18328708, ECO:0000269|PubMed:18362890, ECO:0000269|PubMed:19525978, ECO:0000269|PubMed:20212043, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395, ECO:0000269|PubMed:21723128, ECO:0000269|PubMed:23972470, ECO:0000269|PubMed:28087714, ECO:0000269|PubMed:29063833, ECO:0000269|PubMed:30622739, ECO:0000269|PubMed:8566796, ECO:0000269|PubMed:8816758}.<br/><strong>T: Active site:</strong> ACT_SITE 146; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "ptm_overrides": {
        "Q13188": {
          "Q13188_384": {
            "shape_x": 480.2,
            "shape_y": 600.5,
            "label_x": 475.2,
            "label_y": 595.5,
            "label_centering": "right",
            "symbol_x": 479.9,
            "symbol_y": 600.5,
            "ptm_position": "N1"
          },
          "Q13188_316": {
            "shape_x": 507.8,
            "shape_y": 600.5,
            "label_x": 512.8,
            "label_y": 595.5,
            "label_centering": "left",
            "symbol_x": 507.7,
            "symbol_y": 600.5,
            "ptm_position": "N3"
          }
        },
        "Q13043": {
          "Q13043_414": {
            "shape_x": 480.2,
            "shape_y": 600.5,
            "label_x": 475.2,
            "label_y": 595.5,
            "label_centering": "right",
            "symbol_x": 480.2,
            "symbol_y": 600.5,
            "ptm_position": "N1"
          },
          "Q13043_410": {
            "shape_x": 507.8,
            "shape_y": 600.5,
            "label_x": 512.8,
            "label_y": 595.5,
            "label_centering": "left",
            "symbol_x": 507.8,
            "symbol_y": 600.5,
            "ptm_position": "N3"
          }
        }
      }
    },
    {
      "protbox_id": "96",
      "proteins": [
        "Q9BQ95"
      ],
      "backup_label": "ECSIT",
      "x": 404.0,
      "y": 770.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Adapter protein that plays a role in different signaling pathways including TLRs and IL-1 pathways or innate antiviral induction signaling. Plays a role in the activation of NF-kappa-B by forming a signal complex with TRAF6 and TAK1/MAP3K7 to activate TAK1/MAP3K7 leading to activation of IKKs (PubMed:25355951, PubMed:31281713). Once ubiquitinated, interacts with the dissociated RELA and NFKB1 proteins and translocates to the nucleus where it induces NF-kappa-B-dependent gene expression (PubMed:25355951). Plays a role in innate antiviral immune response by bridging the pattern recognition receptors RIGI and MDA5/IFIT1 to the MAVS complex at the mitochondrion (PubMed:25228397). Promotes proteolytic activation of MAP3K1. Involved in the BMP signaling pathway. Required for normal embryonic development (By similarity). {ECO:0000250, ECO:0000269|PubMed:25228397, ECO:0000269|PubMed:25355951, ECO:0000269|PubMed:31281713}.; FUNCTION: As part of the MCIA complex, involved in the assembly of the mitochondrial complex I. {ECO:0000269|PubMed:32320651}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Adapter protein that plays a role in different signaling pathways including TLRs and IL-1 pathways or innate antiviral induction signaling. Plays a role in the activation of NF-kappa-B by forming a signal complex with TRAF6 and TAK1/MAP3K7 to activate TAK1/MAP3K7 leading to activation of IKKs (PubMed:25355951, PubMed:31281713). Once ubiquitinated, interacts with the dissociated RELA and NFKB1 proteins and translocates to the nucleus where it induces NF-kappa-B-dependent gene expression (PubMed:25355951). Plays a role in innate antiviral immune response by bridging the pattern recognition receptors RIGI and MDA5/IFIT1 to the MAVS complex at the mitochondrion (PubMed:25228397). Promotes proteolytic activation of MAP3K1. Involved in the BMP signaling pathway. Required for normal embryonic development (By similarity). {ECO:0000250, ECO:0000269|PubMed:25228397, ECO:0000269|PubMed:25355951, ECO:0000269|PubMed:31281713}.; FUNCTION: As part of the MCIA complex, involved in the assembly of the mitochondrial complex I. {ECO:0000269|PubMed:32320651}."
    },
    {
      "protbox_id": "97",
      "proteins": [
        "Q9NYJ8"
      ],
      "backup_label": "TAB2",
      "x": 404.0,
      "y": 746.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020, PubMed:33184450, PubMed:36681779). Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to 'Lys-63'-linked polyubiquitin chains (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020). The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63'-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 (PubMed:15327770, PubMed:18079694, PubMed:22158122). Also recognizes and binds Lys-63'-linked polyubiquitin chains of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains (PubMed:27746020). Regulates the IL1-mediated translocation of NCOR1 out of the nucleus (By similarity). Involved in heart development (PubMed:20493459). {ECO:0000250|UniProtKB:Q99K90, ECO:0000269|PubMed:10882101, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:15327770, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:20493459, ECO:0000269|PubMed:22158122, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:33184450, ECO:0000269|PubMed:36681779}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of &#x27;Lys-63&#x27;-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020, PubMed:33184450, PubMed:36681779). Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to &#x27;Lys-63&#x27;-linked polyubiquitin chains (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020). The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63&#x27;-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 (PubMed:15327770, PubMed:18079694, PubMed:22158122). Also recognizes and binds Lys-63&#x27;-linked polyubiquitin chains of heterotypic &#x27;Lys-63&#x27;-/&#x27;Lys-48&#x27;-linked branched ubiquitin chains (PubMed:27746020). Regulates the IL1-mediated translocation of NCOR1 out of the nucleus (By similarity). Involved in heart development (PubMed:20493459). {ECO:0000250|UniProtKB:Q99K90, ECO:0000269|PubMed:10882101, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:15327770, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:20493459, ECO:0000269|PubMed:22158122, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:33184450, ECO:0000269|PubMed:36681779}.",
      "ptm_overrides": {
        "Q9NYJ8": {
          "Q9NYJ8_524": {
            "shape_x": 400.0,
            "shape_y": 749.11,
            "label_x": 395.0,
            "label_y": 747.11,
            "label_centering": "right",
            "symbol_x": 400.0,
            "symbol_y": 749.11,
            "ptm_position": "W1"
          },
          "Q9NYJ8_580": {
            "shape_x": 454.0,
            "shape_y": 749.11,
            "label_x": 459.0,
            "label_y": 747.11,
            "label_centering": "left",
            "symbol_x": 454.0,
            "symbol_y": 749.11,
            "ptm_position": "E1"
          }
        }
      }
    },
    {
      "protbox_id": "98",
      "proteins": [
        "Q15750"
      ],
      "backup_label": "TAB1",
      "x": 404.0,
      "y": 724.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Key adapter protein that plays an essential role in JNK and NF-kappa-B activation and proinflammatory cytokines production in response to stimulation with TLRs and cytokines (PubMed:22307082, PubMed:24403530). Mechanistically, associates with the catalytic domain of MAP3K7/TAK1 to trigger MAP3K7/TAK1 autophosphorylation leading to its full activation (PubMed:10838074, PubMed:25260751, PubMed:37832545). Similarly, associates with MAPK14 and triggers its autophosphorylation and subsequent activation (PubMed:11847341, PubMed:29229647). In turn, MAPK14 phosphorylates TAB1 and inhibits MAP3K7/TAK1 activation in a feedback control mechanism (PubMed:14592977). Also plays a role in recruiting MAPK14 to the TAK1 complex for the phosphorylation of the TAB2 and TAB3 regulatory subunits (PubMed:18021073). {ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:11847341, ECO:0000269|PubMed:14592977, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:22307082, ECO:0000269|PubMed:24403530, ECO:0000269|PubMed:25260751, ECO:0000269|PubMed:29229647, ECO:0000269|PubMed:37832545}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Key adapter protein that plays an essential role in JNK and NF-kappa-B activation and proinflammatory cytokines production in response to stimulation with TLRs and cytokines (PubMed:22307082, PubMed:24403530). Mechanistically, associates with the catalytic domain of MAP3K7/TAK1 to trigger MAP3K7/TAK1 autophosphorylation leading to its full activation (PubMed:10838074, PubMed:25260751, PubMed:37832545). Similarly, associates with MAPK14 and triggers its autophosphorylation and subsequent activation (PubMed:11847341, PubMed:29229647). In turn, MAPK14 phosphorylates TAB1 and inhibits MAP3K7/TAK1 activation in a feedback control mechanism (PubMed:14592977). Also plays a role in recruiting MAPK14 to the TAK1 complex for the phosphorylation of the TAB2 and TAB3 regulatory subunits (PubMed:18021073). {ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:11847341, ECO:0000269|PubMed:14592977, ECO:0000269|PubMed:18021073, ECO:0000269|PubMed:22307082, ECO:0000269|PubMed:24403530, ECO:0000269|PubMed:25260751, ECO:0000269|PubMed:29229647, ECO:0000269|PubMed:37832545}."
    },
    {
      "protbox_id": "99",
      "proteins": [],
      "backup_label": "GADD45G",
      "x": 338.0,
      "y": 791.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "100",
      "proteins": [],
      "backup_label": "TRAF6",
      "x": 338.0,
      "y": 759.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "101",
      "proteins": [
        "Q9UER7"
      ],
      "backup_label": "DAXX",
      "x": 432.0,
      "y": 694.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Transcription corepressor known to repress transcriptional potential of several sumoylated transcription factors. Down-regulates basal and activated transcription. Its transcription repressor activity is modulated by recruiting it to subnuclear compartments like the nucleolus or PML/POD/ND10 nuclear bodies through interactions with MCSR1 and PML, respectively. Seems to regulate transcription in PML/POD/ND10 nuclear bodies together with PML and may influence TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional activation of PAX3 and ETS1 through direct protein-protein interactions. Modulates PAX5 activity; the function seems to involve CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by regulating the RING-finger E3 ligase MDM2 ubiquitination activity. Under non-stress condition, in association with the deubiquitinating USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3 ligase activity of MDM2 towards TP53, thereby promoting TP53 ubiquitination and subsequent proteasomal degradation. Upon DNA damage, its association with MDM2 and USP7 is disrupted, resulting in increased MDM2 autoubiquitination and consequently, MDM2 degradation, which leads to TP53 stabilization. Acts as a histone chaperone that facilitates deposition of histone H3.3. Acts as a targeting component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Does not affect the ATPase activity of ATRX but alleviates its transcription repression activity. Upon neuronal activation associates with regulatory elements of selected immediate early genes where it promotes deposition of histone H3.3 which may be linked to transcriptional induction of these genes. Required for the recruitment of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested to function as regulatory sites for the incorporation of newly synthesized histone H3.3 into chromatin. In case of overexpression of centromeric histone variant CENPA (as found in various tumors) is involved in its mislocalization to chromosomes; the ectopic localization involves a heterotypic tetramer containing CENPA, and histones H3.3 and H4 and decreases binding of CTCF to chromatin. Proposed to mediate activation of the JNK pathway and apoptosis via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may not involve DAXX. Shows restriction activity towards human cytomegalovirus (HCMV). Plays a role as a positive regulator of the heat shock transcription factor HSF1 activity during the stress protein response (PubMed:15016915). {ECO:0000269|PubMed:12140263, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:15016915, ECO:0000269|PubMed:15364927, ECO:0000269|PubMed:16845383, ECO:0000269|PubMed:17081986, ECO:0000269|PubMed:17942542, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:23222847, ECO:0000269|PubMed:24200965, ECO:0000269|PubMed:24530302}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription corepressor known to repress transcriptional potential of several sumoylated transcription factors. Down-regulates basal and activated transcription. Its transcription repressor activity is modulated by recruiting it to subnuclear compartments like the nucleolus or PML/POD/ND10 nuclear bodies through interactions with MCSR1 and PML, respectively. Seems to regulate transcription in PML/POD/ND10 nuclear bodies together with PML and may influence TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional activation of PAX3 and ETS1 through direct protein-protein interactions. Modulates PAX5 activity; the function seems to involve CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by regulating the RING-finger E3 ligase MDM2 ubiquitination activity. Under non-stress condition, in association with the deubiquitinating USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3 ligase activity of MDM2 towards TP53, thereby promoting TP53 ubiquitination and subsequent proteasomal degradation. Upon DNA damage, its association with MDM2 and USP7 is disrupted, resulting in increased MDM2 autoubiquitination and consequently, MDM2 degradation, which leads to TP53 stabilization. Acts as a histone chaperone that facilitates deposition of histone H3.3. Acts as a targeting component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Does not affect the ATPase activity of ATRX but alleviates its transcription repression activity. Upon neuronal activation associates with regulatory elements of selected immediate early genes where it promotes deposition of histone H3.3 which may be linked to transcriptional induction of these genes. Required for the recruitment of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested to function as regulatory sites for the incorporation of newly synthesized histone H3.3 into chromatin. In case of overexpression of centromeric histone variant CENPA (as found in various tumors) is involved in its mislocalization to chromosomes; the ectopic localization involves a heterotypic tetramer containing CENPA, and histones H3.3 and H4 and decreases binding of CTCF to chromatin. Proposed to mediate activation of the JNK pathway and apoptosis via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may not involve DAXX. Shows restriction activity towards human cytomegalovirus (HCMV). Plays a role as a positive regulator of the heat shock transcription factor HSF1 activity during the stress protein response (PubMed:15016915). {ECO:0000269|PubMed:12140263, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:15016915, ECO:0000269|PubMed:15364927, ECO:0000269|PubMed:16845383, ECO:0000269|PubMed:17081986, ECO:0000269|PubMed:17942542, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:23222847, ECO:0000269|PubMed:24200965, ECO:0000269|PubMed:24530302}.",
      "ptm_overrides": {
        "Q9UER7": {
          "Q9UER7_671": {
            "shape_x": 441.2,
            "shape_y": 690.5,
            "label_x": 436.2,
            "label_y": 685.5,
            "label_centering": "right",
            "symbol_x": 441.2,
            "symbol_y": 690.5,
            "ptm_position": "N1"
          },
          "Q9UER7_495": {
            "shape_x": 455.0,
            "shape_y": 690.5,
            "label_x": 455.0,
            "label_y": 682.5,
            "label_centering": "center",
            "symbol_x": 455.0,
            "symbol_y": 690.5,
            "ptm_position": "N2"
          },
          "Q9UER7_213": {
            "shape_x": 468.8,
            "shape_y": 690.5,
            "label_x": 473.8,
            "label_y": 685.5,
            "label_centering": "left",
            "symbol_x": 468.8,
            "symbol_y": 690.5,
            "ptm_position": "N3"
          },
          "Q9UER7_688": {
            "shape_x": 441.2,
            "shape_y": 715.5,
            "label_x": 436.2,
            "label_y": 720.5,
            "label_centering": "right",
            "symbol_x": 441.2,
            "symbol_y": 715.5,
            "ptm_position": "S1"
          }
        }
      }
    },
    {
      "protbox_id": "102",
      "proteins": [
        "Q12933"
      ],
      "backup_label": "TRAF2",
      "x": 369.0,
      "y": 644.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: E3 ubiquitin-protein ligase that regulates activation of NF-kappa-B and JNK and plays a central role in the regulation of cell survival and apoptosis (PubMed:10346818, PubMed:11784851, PubMed:12917689, PubMed:15383523, PubMed:18981220, PubMed:19150425, PubMed:19810754, PubMed:19918265, PubMed:19937093, PubMed:20047764, PubMed:20064526, PubMed:20385093, PubMed:20577214, PubMed:22212761). Catalyzes 'Lys-63'-linked ubiquitination of target proteins, such as BIRC3, IKBKE, MLST8, RIPK1 and TICAM1 (PubMed:23453969, PubMed:28489822). Is an essential constituent of several E3 ubiquitin-protein ligase complexes, where it promotes the ubiquitination of target proteins by bringing them into contact with other E3 ubiquitin ligases (PubMed:15383523, PubMed:18981220). Regulates BIRC2 and BIRC3 protein levels by inhibiting their autoubiquitination and subsequent degradation; this does not depend on the TRAF2 RING-type zinc finger domain (PubMed:11907583, PubMed:19506082). Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR (PubMed:15121867). In complex with BIRC2 or BIRC3, promotes ubiquitination of IKBKE (PubMed:23453969). Acts as a regulator of mTORC1 and mTORC2 assembly by mediating 'Lys-63'-linked ubiquitination of MLST8, thereby inhibiting formation of the mTORC2 complex, while facilitating assembly of the mTORC1 complex (PubMed:28489822). Required for normal antibody isotype switching from IgM to IgG (By similarity). {ECO:0000250|UniProtKB:P39429, ECO:0000269|PubMed:10346818, ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:11907583, ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:15121867, ECO:0000269|PubMed:15383523, ECO:0000269|PubMed:18981220, ECO:0000269|PubMed:19150425, ECO:0000269|PubMed:19506082, ECO:0000269|PubMed:19810754, ECO:0000269|PubMed:19918265, ECO:0000269|PubMed:19937093, ECO:0000269|PubMed:20047764, ECO:0000269|PubMed:20064526, ECO:0000269|PubMed:20385093, ECO:0000269|PubMed:20577214, ECO:0000269|PubMed:22212761, ECO:0000269|PubMed:23453969, ECO:0000269|PubMed:28489822}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: E3 ubiquitin-protein ligase that regulates activation of NF-kappa-B and JNK and plays a central role in the regulation of cell survival and apoptosis (PubMed:10346818, PubMed:11784851, PubMed:12917689, PubMed:15383523, PubMed:18981220, PubMed:19150425, PubMed:19810754, PubMed:19918265, PubMed:19937093, PubMed:20047764, PubMed:20064526, PubMed:20385093, PubMed:20577214, PubMed:22212761). Catalyzes &#x27;Lys-63&#x27;-linked ubiquitination of target proteins, such as BIRC3, IKBKE, MLST8, RIPK1 and TICAM1 (PubMed:23453969, PubMed:28489822). Is an essential constituent of several E3 ubiquitin-protein ligase complexes, where it promotes the ubiquitination of target proteins by bringing them into contact with other E3 ubiquitin ligases (PubMed:15383523, PubMed:18981220). Regulates BIRC2 and BIRC3 protein levels by inhibiting their autoubiquitination and subsequent degradation; this does not depend on the TRAF2 RING-type zinc finger domain (PubMed:11907583, PubMed:19506082). Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR (PubMed:15121867). In complex with BIRC2 or BIRC3, promotes ubiquitination of IKBKE (PubMed:23453969). Acts as a regulator of mTORC1 and mTORC2 assembly by mediating &#x27;Lys-63&#x27;-linked ubiquitination of MLST8, thereby inhibiting formation of the mTORC2 complex, while facilitating assembly of the mTORC1 complex (PubMed:28489822). Required for normal antibody isotype switching from IgM to IgG (By similarity). {ECO:0000250|UniProtKB:P39429, ECO:0000269|PubMed:10346818, ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:11907583, ECO:0000269|PubMed:12917689, ECO:0000269|PubMed:15121867, ECO:0000269|PubMed:15383523, ECO:0000269|PubMed:18981220, ECO:0000269|PubMed:19150425, ECO:0000269|PubMed:19506082, ECO:0000269|PubMed:19810754, ECO:0000269|PubMed:19918265, ECO:0000269|PubMed:19937093, ECO:0000269|PubMed:20047764, ECO:0000269|PubMed:20064526, ECO:0000269|PubMed:20385093, ECO:0000269|PubMed:20577214, ECO:0000269|PubMed:22212761, ECO:0000269|PubMed:23453969, ECO:0000269|PubMed:28489822}."
    },
    {
      "protbox_id": "103",
      "proteins": [
        "P42574"
      ],
      "backup_label": "CASP3",
      "x": 369.0,
      "y": 604.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:35338844, PubMed:35446120, PubMed:7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond (PubMed:10497198, PubMed:16374543, PubMed:7596430, PubMed:7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed:7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed:37993714, PubMed:9334240). Involved in the cleavage of huntingtin (PubMed:8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed:21357690). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed:23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed:30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed:35338844, PubMed:35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed:23845944, PubMed:33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed:36758104, PubMed:36758106). {ECO:0000250|UniProtKB:Q60431, ECO:0000269|PubMed:10497198, ECO:0000269|PubMed:16374543, ECO:0000269|PubMed:18723680, ECO:0000269|PubMed:20566630, ECO:0000269|PubMed:21357690, ECO:0000269|PubMed:23152800, ECO:0000269|PubMed:23650375, ECO:0000269|PubMed:23845944, ECO:0000269|PubMed:30878284, ECO:0000269|PubMed:33725486, ECO:0000269|PubMed:35338844, ECO:0000269|PubMed:35446120, ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758106, ECO:0000269|PubMed:37993714, ECO:0000269|PubMed:7596430, ECO:0000269|PubMed:7774019, ECO:0000269|PubMed:8696339, ECO:0000269|PubMed:9334240}.\nT: Active site: ACT_SITE 121; /evidence=\"ECO:0000250|UniProtKB:P29466\"; ACT_SITE 163; /evidence=\"ECO:0000250|UniProtKB:P29466\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:35338844, PubMed:35446120, PubMed:7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed:18723680, PubMed:20566630, PubMed:23650375, PubMed:7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a &#x27;216-Asp-|-Gly-217&#x27; bond (PubMed:10497198, PubMed:16374543, PubMed:7596430, PubMed:7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed:7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed:37993714, PubMed:9334240). Involved in the cleavage of huntingtin (PubMed:8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed:21357690). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed:23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed:30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed:35338844, PubMed:35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed:23845944, PubMed:33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed:36758104, PubMed:36758106). {ECO:0000250|UniProtKB:Q60431, ECO:0000269|PubMed:10497198, ECO:0000269|PubMed:16374543, ECO:0000269|PubMed:18723680, ECO:0000269|PubMed:20566630, ECO:0000269|PubMed:21357690, ECO:0000269|PubMed:23152800, ECO:0000269|PubMed:23650375, ECO:0000269|PubMed:23845944, ECO:0000269|PubMed:30878284, ECO:0000269|PubMed:33725486, ECO:0000269|PubMed:35338844, ECO:0000269|PubMed:35446120, ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758106, ECO:0000269|PubMed:37993714, ECO:0000269|PubMed:7596430, ECO:0000269|PubMed:7774019, ECO:0000269|PubMed:8696339, ECO:0000269|PubMed:9334240}.<br/><strong>T: Active site:</strong> ACT_SITE 121; /evidence=&quot;ECO:0000250|UniProtKB:P29466&quot;; ACT_SITE 163; /evidence=&quot;ECO:0000250|UniProtKB:P29466&quot;"
    },
    {
      "protbox_id": "104",
      "proteins": [],
      "backup_label": "CD14",
      "x": 197.0,
      "y": 734.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "105",
      "proteins": [
        "P36897",
        "P37173"
      ],
      "backup_label": "TGFBR1",
      "x": 197.0,
      "y": 705.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis (PubMed:33914044). The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation. {ECO:0000269|PubMed:15761148, ECO:0000269|PubMed:16754747, ECO:0000269|PubMed:18758450, ECO:0000269|PubMed:33914044, ECO:0000269|PubMed:7774578, ECO:0000269|PubMed:8752209, ECO:0000269|PubMed:8980228, ECO:0000269|PubMed:9346908}.\nT: Active site: ACT_SITE 333; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis (PubMed:33914044). The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation. {ECO:0000269|PubMed:15761148, ECO:0000269|PubMed:16754747, ECO:0000269|PubMed:18758450, ECO:0000269|PubMed:33914044, ECO:0000269|PubMed:7774578, ECO:0000269|PubMed:8752209, ECO:0000269|PubMed:8980228, ECO:0000269|PubMed:9346908}.<br/><strong>T: Active site:</strong> ACT_SITE 333; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "106",
      "proteins": [
        "P25445"
      ],
      "backup_label": "FAS",
      "x": 197.0,
      "y": 683.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase CASP8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs CASP8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). {ECO:0000269|PubMed:19118384, ECO:0000269|PubMed:7533181, ECO:0000269|PubMed:9184224}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase CASP8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs CASP8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). {ECO:0000269|PubMed:19118384, ECO:0000269|PubMed:7533181, ECO:0000269|PubMed:9184224}.",
      "ptm_overrides": {
        "P25445": {
          "P25445_293": {
            "shape_x": 193.0,
            "shape_y": 686.11,
            "label_x": 188.0,
            "label_y": 684.11,
            "label_centering": "right",
            "symbol_x": 193.0,
            "symbol_y": 686.11,
            "ptm_position": "W1"
          },
          "P25445_212": {
            "shape_x": 247.0,
            "shape_y": 686.11,
            "label_x": 252.0,
            "label_y": 684.11,
            "label_centering": "left",
            "symbol_x": 247.0,
            "symbol_y": 686.11,
            "ptm_position": "E1"
          },
          "P25445_305": {
            "shape_x": 193.0,
            "shape_y": 697.72,
            "label_x": 188.0,
            "label_y": 699.72,
            "label_centering": "right",
            "symbol_x": 193.0,
            "symbol_y": 697.72,
            "ptm_position": "W2"
          }
        }
      }
    },
    {
      "protbox_id": "107",
      "proteins": [
        "P14778",
        "Q9NPH3"
      ],
      "backup_label": "IL1R1",
      "x": 197.0,
      "y": 654.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Receptor for IL1A, IL1B and IL1RN (PubMed:2950091, PubMed:37315560). After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (PubMed:10653850). {ECO:0000269|PubMed:10653850, ECO:0000269|PubMed:10671496, ECO:0000269|PubMed:2950091, ECO:0000269|PubMed:37315560}.\nT: Active site: ACT_SITE 470; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00204\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Receptor for IL1A, IL1B and IL1RN (PubMed:2950091, PubMed:37315560). After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. Involved in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (PubMed:10653850). {ECO:0000269|PubMed:10653850, ECO:0000269|PubMed:10671496, ECO:0000269|PubMed:2950091, ECO:0000269|PubMed:37315560}.<br/><strong>T: Active site:</strong> ACT_SITE 470; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00204&quot;"
    },
    {
      "protbox_id": "108",
      "proteins": [],
      "backup_label": "TNFRSF1A",
      "x": 197.0,
      "y": 621.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "109",
      "proteins": [
        "P01137"
      ],
      "backup_label": "TGFB1",
      "x": 114.0,
      "y": 705.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively. {ECO:0000269|PubMed:29109152, ECO:0000303|PubMed:27252363}.; FUNCTION: [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-1 (TGF-beta-1) chain in a latent state during storage in extracellular matrix (PubMed:28117447). Associates non-covalently with TGF-beta-1 and regulates its activation via interaction with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS, that control activation of TGF-beta-1 (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). Interaction with LRRC33/NRROS regulates activation of TGF-beta-1 in macrophages and microglia (Probable). Interaction with LRRC32/GARP controls activation of TGF-beta-1 on the surface of activated regulatory T-cells (Tregs) (PubMed:19651619, PubMed:19750484, PubMed:22278742). Interaction with integrins (ITGAV:ITGB6 or ITGAV:ITGB8) results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). {ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931, ECO:0000305|PubMed:29909984}.; FUNCTION: [Transforming growth factor beta-1]: Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains remain non-covalently linked rendering TGF-beta-1 inactive during storage in extracellular matrix (PubMed:29109152). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1, LRRC32/GARP and LRRC33/NRROS that control activation of TGF-beta-1 and maintain it in a latent state during storage in extracellular milieus (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). TGF-beta-1 is released from LAP by integrins (ITGAV:ITGB6 or ITGAV:ITGB8): integrin-binding to LAP stabilizes an alternative conformation of the LAP bowtie tail and results in distortion of the LAP chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). Once activated following release of LAP, TGF-beta-1 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (PubMed:20207738). While expressed by many cells types, TGF-beta-1 only has a very localized range of action within cell environment thanks to fine regulation of its activation by Latency-associated peptide chain (LAP) and 'milieu molecules' (By similarity). Plays an important role in bone remodeling: acts as a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner (By similarity). At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development (By similarity). At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed:25310401). Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed:25893292, PubMed:29483653, PubMed:30696809). Positively regulates odontoblastic differentiation in dental papilla cells, via promotion of IPO7-mediated translocation of phosphorylated SMAD2 to the nucleus and subsequent transcription of target genes (By similarity). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed:25893292, PubMed:30696809). {ECO:0000250|UniProtKB:P04202, ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:20207738, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:25310401, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:29109152, ECO:0000269|PubMed:29483653, ECO:0000269|PubMed:30696809, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively. {ECO:0000269|PubMed:29109152, ECO:0000303|PubMed:27252363}.; FUNCTION: [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-1 (TGF-beta-1) chain in a latent state during storage in extracellular matrix (PubMed:28117447). Associates non-covalently with TGF-beta-1 and regulates its activation via interaction with &#x27;milieu molecules&#x27;, such as LTBP1, LRRC32/GARP and LRRC33/NRROS, that control activation of TGF-beta-1 (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). Interaction with LRRC33/NRROS regulates activation of TGF-beta-1 in macrophages and microglia (Probable). Interaction with LRRC32/GARP controls activation of TGF-beta-1 on the surface of activated regulatory T-cells (Tregs) (PubMed:19651619, PubMed:19750484, PubMed:22278742). Interaction with integrins (ITGAV:ITGB6 or ITGAV:ITGB8) results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). {ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931, ECO:0000305|PubMed:29909984}.; FUNCTION: [Transforming growth factor beta-1]: Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains remain non-covalently linked rendering TGF-beta-1 inactive during storage in extracellular matrix (PubMed:29109152). At the same time, LAP chain interacts with &#x27;milieu molecules&#x27;, such as LTBP1, LRRC32/GARP and LRRC33/NRROS that control activation of TGF-beta-1 and maintain it in a latent state during storage in extracellular milieus (PubMed:19651619, PubMed:19750484, PubMed:2022183, PubMed:22278742, PubMed:8617200, PubMed:8939931). TGF-beta-1 is released from LAP by integrins (ITGAV:ITGB6 or ITGAV:ITGB8): integrin-binding to LAP stabilizes an alternative conformation of the LAP bowtie tail and results in distortion of the LAP chain and subsequent release of the active TGF-beta-1 (PubMed:22278742, PubMed:28117447). Once activated following release of LAP, TGF-beta-1 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (PubMed:20207738). While expressed by many cells types, TGF-beta-1 only has a very localized range of action within cell environment thanks to fine regulation of its activation by Latency-associated peptide chain (LAP) and &#x27;milieu molecules&#x27; (By similarity). Plays an important role in bone remodeling: acts as a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts (By similarity). Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner (By similarity). At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development (By similarity). At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells (By similarity). Stimulates sustained production of collagen through the activation of CREB3L1 by regulated intramembrane proteolysis (RIP) (PubMed:25310401). Mediates SMAD2/3 activation by inducing its phosphorylation and subsequent translocation to the nucleus (PubMed:25893292, PubMed:29483653, PubMed:30696809). Positively regulates odontoblastic differentiation in dental papilla cells, via promotion of IPO7-mediated translocation of phosphorylated SMAD2 to the nucleus and subsequent transcription of target genes (By similarity). Can induce epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types (PubMed:25893292, PubMed:30696809). {ECO:0000250|UniProtKB:P04202, ECO:0000269|PubMed:19651619, ECO:0000269|PubMed:19750484, ECO:0000269|PubMed:20207738, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:25310401, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:28117447, ECO:0000269|PubMed:29109152, ECO:0000269|PubMed:29483653, ECO:0000269|PubMed:30696809, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}."
    },
    {
      "protbox_id": "110",
      "proteins": [],
      "backup_label": "IL1A",
      "x": 114.0,
      "y": 654.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "111",
      "proteins": [],
      "backup_label": "TNF",
      "x": 114.0,
      "y": 621.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "112",
      "proteins": [
        "Q8IW41"
      ],
      "backup_label": "MAPKAPK5",
      "x": 828.0,
      "y": 748.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Tumor suppressor serine/threonine-protein kinase involved in mTORC1 signaling and post-transcriptional regulation. Phosphorylates FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB. Acts as a tumor suppressor by mediating Ras-induced senescence and phosphorylating p53/TP53. Involved in post-transcriptional regulation of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3 leads to promote nuclear localization of FOXO3, enabling expression of miR-34b and miR-34c, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent MYC translation. Acts as a negative regulator of mTORC1 signaling by mediating phosphorylation and inhibition of RHEB. Part of the atypical MAPK signaling via its interaction with ERK3/MAPK6 or ERK4/MAPK4: the precise role of the complex formed with ERK3/MAPK6 or ERK4/MAPK4 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPK (ERK3/MAPK6 or ERK4/MAPK4), ERK3/MAPK6 (or ERK4/MAPK4) is phosphorylated and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6 (or ERK4/MAPK4). Mediates phosphorylation of HSP27/HSPB1 in response to PKA/PRKACA stimulation, inducing F-actin rearrangement. {ECO:0000269|PubMed:17254968, ECO:0000269|PubMed:17728103, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874}.\nT: Active site: ACT_SITE 148; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Tumor suppressor serine/threonine-protein kinase involved in mTORC1 signaling and post-transcriptional regulation. Phosphorylates FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB. Acts as a tumor suppressor by mediating Ras-induced senescence and phosphorylating p53/TP53. Involved in post-transcriptional regulation of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3 leads to promote nuclear localization of FOXO3, enabling expression of miR-34b and miR-34c, 2 post-transcriptional regulators of MYC that bind to the 3&#x27;UTR of MYC transcript and prevent MYC translation. Acts as a negative regulator of mTORC1 signaling by mediating phosphorylation and inhibition of RHEB. Part of the atypical MAPK signaling via its interaction with ERK3/MAPK6 or ERK4/MAPK4: the precise role of the complex formed with ERK3/MAPK6 or ERK4/MAPK4 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPK (ERK3/MAPK6 or ERK4/MAPK4), ERK3/MAPK6 (or ERK4/MAPK4) is phosphorylated and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6 (or ERK4/MAPK4). Mediates phosphorylation of HSP27/HSPB1 in response to PKA/PRKACA stimulation, inducing F-actin rearrangement. {ECO:0000269|PubMed:17254968, ECO:0000269|PubMed:17728103, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:9628874}.<br/><strong>T: Active site:</strong> ACT_SITE 148; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "113",
      "proteins": [
        "P63000",
        "P15153",
        "P60953"
      ],
      "backup_label": "RAC1",
      "x": 385.0,
      "y": 543.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization, neurons adhesion, migration and differentiation, and growth-factor induced formation of membrane ruffles (PubMed:1643658, PubMed:22843693, PubMed:23512198, PubMed:28886345). Rac1 p21/rho GDI heterodimer is the active component of the cytosolic factor sigma 1, which is involved in stimulation of the NADPH oxidase activity in macrophages. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. Stimulates PKN2 kinase activity (PubMed:9121475). In concert with RAB7A, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts (PubMed:1643658). In podocytes, promotes nuclear shuttling of NR3C2; this modulation is required for a proper kidney functioning. Required for atypical chemokine receptor ACKR2-induced LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. In neurons, is involved in dendritic spine formation and synaptic plasticity (By similarity). In hippocampal neurons, involved in spine morphogenesis and synapse formation, through local activation at synapses by guanine nucleotide exchange factors (GEFs), such as ARHGEF6/ARHGEF7/PIX (PubMed:12695502). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3. In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in PAK1 activation and eventually F-actin stabilization (By similarity). Required for DSG3 translocation to cell-cell junctions, DSG3-mediated organization of cortical F-actin bundles and anchoring of actin at cell junctions; via interaction with DSG3 (PubMed:22796473). Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:38355798). {ECO:0000250|UniProtKB:P63001, ECO:0000250|UniProtKB:Q6RUV5, ECO:0000269|PubMed:12695502, ECO:0000269|PubMed:1643658, ECO:0000269|PubMed:22796473, ECO:0000269|PubMed:22843693, ECO:0000269|PubMed:23512198, ECO:0000269|PubMed:28886345, ECO:0000269|PubMed:38355798, ECO:0000269|PubMed:9121475}.; FUNCTION: [Isoform B]: Isoform B has an accelerated GEF-independent GDP/GTP exchange and an impaired GTP hydrolysis, which is restored partially by GTPase-activating proteins (PubMed:14625275). It is able to bind to the GTPase-binding domain of PAK but not full-length PAK in a GTP-dependent manner, suggesting that the insertion does not completely abolish effector interaction (PubMed:14625275). {ECO:0000269|PubMed:14625275}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization, neurons adhesion, migration and differentiation, and growth-factor induced formation of membrane ruffles (PubMed:1643658, PubMed:22843693, PubMed:23512198, PubMed:28886345). Rac1 p21/rho GDI heterodimer is the active component of the cytosolic factor sigma 1, which is involved in stimulation of the NADPH oxidase activity in macrophages. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. Stimulates PKN2 kinase activity (PubMed:9121475). In concert with RAB7A, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts (PubMed:1643658). In podocytes, promotes nuclear shuttling of NR3C2; this modulation is required for a proper kidney functioning. Required for atypical chemokine receptor ACKR2-induced LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. In neurons, is involved in dendritic spine formation and synaptic plasticity (By similarity). In hippocampal neurons, involved in spine morphogenesis and synapse formation, through local activation at synapses by guanine nucleotide exchange factors (GEFs), such as ARHGEF6/ARHGEF7/PIX (PubMed:12695502). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3. In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in PAK1 activation and eventually F-actin stabilization (By similarity). Required for DSG3 translocation to cell-cell junctions, DSG3-mediated organization of cortical F-actin bundles and anchoring of actin at cell junctions; via interaction with DSG3 (PubMed:22796473). Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:38355798). {ECO:0000250|UniProtKB:P63001, ECO:0000250|UniProtKB:Q6RUV5, ECO:0000269|PubMed:12695502, ECO:0000269|PubMed:1643658, ECO:0000269|PubMed:22796473, ECO:0000269|PubMed:22843693, ECO:0000269|PubMed:23512198, ECO:0000269|PubMed:28886345, ECO:0000269|PubMed:38355798, ECO:0000269|PubMed:9121475}.; FUNCTION: [Isoform B]: Isoform B has an accelerated GEF-independent GDP/GTP exchange and an impaired GTP hydrolysis, which is restored partially by GTPase-activating proteins (PubMed:14625275). It is able to bind to the GTPase-binding domain of PAK but not full-length PAK in a GTP-dependent manner, suggesting that the insertion does not completely abolish effector interaction (PubMed:14625275). {ECO:0000269|PubMed:14625275}."
    },
    {
      "protbox_id": "114",
      "proteins": [
        "Q13177",
        "Q13153"
      ],
      "backup_label": "PAK1",
      "x": 471.0,
      "y": 543.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues (PubMed:7744004). Full-length PAK2 stimulates cell survival and cell growth (PubMed:7744004). Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration (PubMed:21317288). Phosphorylates JUN and plays an important role in EGF-induced cell proliferation (PubMed:21177766). Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP (PubMed:21724829). Phosphorylates CASP7, thereby preventing its activity (PubMed:21555521, PubMed:27889207). Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis (PubMed:19273597, PubMed:19923322). On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway (PubMed:12853446, PubMed:16617111, PubMed:9171063). Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation (PubMed:15234964). {ECO:0000269|PubMed:12853446, ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:16617111, ECO:0000269|PubMed:19273597, ECO:0000269|PubMed:19923322, ECO:0000269|PubMed:21177766, ECO:0000269|PubMed:21317288, ECO:0000269|PubMed:21555521, ECO:0000269|PubMed:21724829, ECO:0000269|PubMed:27889207, ECO:0000269|PubMed:33693784, ECO:0000269|PubMed:7744004, ECO:0000269|PubMed:9171063}.\nT: Active site: ACT_SITE 367; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation (PubMed:12853446, PubMed:16617111, PubMed:19273597, PubMed:19923322, PubMed:33693784, PubMed:7744004, PubMed:9171063). Acts as a downstream effector of the small GTPases CDC42 and RAC1 (PubMed:7744004). Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues (PubMed:7744004). Full-length PAK2 stimulates cell survival and cell growth (PubMed:7744004). Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration (PubMed:21317288). Phosphorylates JUN and plays an important role in EGF-induced cell proliferation (PubMed:21177766). Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP (PubMed:21724829). Phosphorylates CASP7, thereby preventing its activity (PubMed:21555521, PubMed:27889207). Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis (PubMed:19273597, PubMed:19923322). On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway (PubMed:12853446, PubMed:16617111, PubMed:9171063). Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation (PubMed:15234964). {ECO:0000269|PubMed:12853446, ECO:0000269|PubMed:15234964, ECO:0000269|PubMed:16617111, ECO:0000269|PubMed:19273597, ECO:0000269|PubMed:19923322, ECO:0000269|PubMed:21177766, ECO:0000269|PubMed:21317288, ECO:0000269|PubMed:21555521, ECO:0000269|PubMed:21724829, ECO:0000269|PubMed:27889207, ECO:0000269|PubMed:33693784, ECO:0000269|PubMed:7744004, ECO:0000269|PubMed:9171063}.<br/><strong>T: Active site:</strong> ACT_SITE 367; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "Q13153": {
          "Q13153_144": {
            "shape_x": 480.2,
            "shape_y": 539.5,
            "label_x": 475.2,
            "label_y": 534.5,
            "label_centering": "right",
            "symbol_x": 480.09999999999997,
            "symbol_y": 539.0,
            "ptm_position": "N1"
          },
          "Q13153_139": {
            "shape_x": 507.8,
            "shape_y": 539.5,
            "label_x": 512.8,
            "label_y": 534.5,
            "label_centering": "left",
            "symbol_x": 507.8,
            "symbol_y": 539.5,
            "ptm_position": "N3"
          },
          "Q13153_219": {
            "shape_x": 480.2,
            "shape_y": 564.5,
            "label_x": 475.2,
            "label_y": 569.5,
            "label_centering": "right",
            "symbol_x": 480.2,
            "symbol_y": 564.5,
            "ptm_position": "S1"
          },
          "Q13153_185": {
            "shape_x": 507.8,
            "shape_y": 564.5,
            "label_x": 512.8,
            "label_y": 569.5,
            "label_centering": "left",
            "symbol_x": 507.8,
            "symbol_y": 564.5,
            "ptm_position": "S3"
          }
        },
        "Q13177": {
          "Q13177_134": {
            "shape_x": 480.2,
            "shape_y": 539.5,
            "label_x": 475.2,
            "label_y": 534.5,
            "label_centering": "right",
            "symbol_x": 480.09999999999997,
            "symbol_y": 539.5,
            "ptm_position": "N1"
          },
          "Q13177_20": {
            "shape_x": 507.8,
            "shape_y": 539.5,
            "label_x": 512.8,
            "label_y": 534.5,
            "label_centering": "left",
            "symbol_x": 507.7,
            "symbol_y": 539.5,
            "ptm_position": "N3"
          },
          "Q13177_141": {
            "shape_x": 480.2,
            "shape_y": 564.5,
            "label_x": 475.2,
            "label_y": 569.5,
            "label_centering": "right",
            "symbol_x": 480.09999999999997,
            "symbol_y": 564.0,
            "ptm_position": "S1"
          },
          "Q13177_169": {
            "shape_x": 507.8,
            "shape_y": 564.5,
            "label_x": 512.8,
            "label_y": 569.5,
            "label_centering": "left",
            "symbol_x": 507.7,
            "symbol_y": 564.5,
            "ptm_position": "S3"
          },
          "Q13177_152": {
            "shape_x": null,
            "shape_y": null,
            "label_x": null,
            "label_y": null,
            "label_centering": null,
            "symbol_x": null,
            "symbol_y": null,
            "ptm_position": ""
          },
          "Q13177_132": {
            "shape_x": null,
            "shape_y": null,
            "label_x": null,
            "label_y": null,
            "label_centering": null,
            "symbol_x": null,
            "symbol_y": null,
            "ptm_position": ""
          },
          "Q13177_143": {
            "shape_x": null,
            "shape_y": null,
            "label_x": null,
            "label_y": null,
            "label_centering": null,
            "symbol_x": null,
            "symbol_y": null,
            "ptm_position": ""
          }
        }
      }
    },
    {
      "protbox_id": "115",
      "proteins": [
        "Q9Y2U5",
        "Q99759"
      ],
      "backup_label": "MAP3K2",
      "x": 557.0,
      "y": 543.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}.\nT: Active site: ACT_SITE 483; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}.<br/><strong>T: Active site:</strong> ACT_SITE 483; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "ptm_overrides": {
        "Q9Y2U5": {
          "Q9Y2U5_163": {
            "shape_x": 566.2,
            "shape_y": 539.5,
            "label_x": 561.2,
            "label_y": 534.5,
            "label_centering": "right",
            "symbol_x": 566.2,
            "symbol_y": 539.5,
            "ptm_position": "N1"
          },
          "Q9Y2U5_239": {
            "shape_x": 593.8,
            "shape_y": 539.5,
            "label_x": 598.8,
            "label_y": 534.5,
            "label_centering": "left",
            "symbol_x": 593.8,
            "symbol_y": 539.5,
            "ptm_position": "N3"
          }
        },
        "Q99759": {
          "Q99759_176": {
            "shape_x": 566.2,
            "shape_y": 539.5,
            "label_x": 561.2,
            "label_y": 534.5,
            "label_centering": "right",
            "symbol_x": 566.2,
            "symbol_y": 539.5,
            "ptm_position": "N1"
          },
          "Q99759_274": {
            "shape_x": 593.8,
            "shape_y": 539.5,
            "label_x": 598.8,
            "label_y": 534.5,
            "label_centering": "left",
            "symbol_x": 593.8,
            "symbol_y": 539.5,
            "ptm_position": "N3"
          },
          "Q99759_237": {
            "shape_x": 566.2,
            "shape_y": 564.5,
            "label_x": 561.2,
            "label_y": 569.5,
            "label_centering": "right",
            "symbol_x": 566.2,
            "symbol_y": 564.5,
            "ptm_position": "S1"
          }
        }
      }
    },
    {
      "protbox_id": "116",
      "proteins": [],
      "backup_label": "MAPK8IP2",
      "x": 701.0,
      "y": 522.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "117",
      "proteins": [
        "Q16584"
      ],
      "backup_label": "MAP3K11",
      "x": 557.0,
      "y": 511.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}.\nT: Active site: ACT_SITE 241; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250|UniProtKB:Q02779, ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}.<br/><strong>T: Active site:</strong> ACT_SITE 241; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250|UniProtKB:Q02779, ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "Q16584": {
          "Q16584_524": {
            "shape_x": 566.2,
            "shape_y": 507.5,
            "label_x": 561.2,
            "label_y": 502.5,
            "label_centering": "right",
            "symbol_x": 566.2,
            "symbol_y": 507.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "118",
      "proteins": [
        "O14733"
      ],
      "backup_label": "MAP2K7",
      "x": 653.0,
      "y": 511.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by pro-inflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Part of a non-canonical MAPK signaling pathway, composed of the upstream MAP3K12 kinase and downstream MAP kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated transcription of APP in response to APOE (PubMed:28111074). {ECO:0000269|PubMed:28111074, ECO:0000269|PubMed:9312068, ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930, ECO:0000269|Ref.5}.\nT: Active site: ACT_SITE 243; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by pro-inflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Part of a non-canonical MAPK signaling pathway, composed of the upstream MAP3K12 kinase and downstream MAP kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated transcription of APP in response to APOE (PubMed:28111074). {ECO:0000269|PubMed:28111074, ECO:0000269|PubMed:9312068, ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930, ECO:0000269|Ref.5}.<br/><strong>T: Active site:</strong> ACT_SITE 243; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "119",
      "proteins": [
        "P45984",
        "P45983"
      ],
      "backup_label": "MAPK8",
      "x": 740.0,
      "y": 494.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK9/JNK2 (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). In turn, MAPK9/JNK2 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:10376527). In response to oxidative or ribotoxic stresses, inhibits rRNA synthesis by phosphorylating and inactivating the RNA polymerase 1-specific transcription initiation factor RRN3 (PubMed:15805466). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including TP53 and YAP1 (PubMed:17525747, PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells (PubMed:19290929). Upon T-cell receptor (TCR) stimulation, is activated by CARMA1, BCL10, MAP2K7 and MAP3K7/TAK1 to regulate JUN protein levels (PubMed:19290929). Plays an important role in the osmotic stress-induced epithelial tight-junctions disruption (PubMed:20595622). When activated, promotes beta-catenin/CTNNB1 degradation and inhibits the canonical Wnt signaling pathway (PubMed:19675674). Also participates in neurite growth in spiral ganglion neurons (By similarity). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). {ECO:0000250|UniProtKB:Q9WTU6, ECO:0000269|PubMed:10376527, ECO:0000269|PubMed:15805466, ECO:0000269|PubMed:17525747, ECO:0000269|PubMed:19675674, ECO:0000269|PubMed:20595622, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:22441692, ECO:0000269|PubMed:34048572, ECO:0000303|PubMed:19290929}.; FUNCTION: MAPK9 isoforms display different binding patterns: alpha-1 and alpha-2 preferentially bind to JUN, whereas beta-1 and beta-2 bind to ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms. JUNB is not a substrate for JNK2 alpha-2, and JUND binds only weakly to it.\nT: Active site: ACT_SITE 151; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK9/JNK2 (PubMed:10376527, PubMed:15805466, PubMed:17525747, PubMed:19675674, PubMed:20595622, PubMed:21364637, PubMed:22441692, PubMed:34048572). In turn, MAPK9/JNK2 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:10376527). In response to oxidative or ribotoxic stresses, inhibits rRNA synthesis by phosphorylating and inactivating the RNA polymerase 1-specific transcription initiation factor RRN3 (PubMed:15805466). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including TP53 and YAP1 (PubMed:17525747, PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells (PubMed:19290929). Upon T-cell receptor (TCR) stimulation, is activated by CARMA1, BCL10, MAP2K7 and MAP3K7/TAK1 to regulate JUN protein levels (PubMed:19290929). Plays an important role in the osmotic stress-induced epithelial tight-junctions disruption (PubMed:20595622). When activated, promotes beta-catenin/CTNNB1 degradation and inhibits the canonical Wnt signaling pathway (PubMed:19675674). Also participates in neurite growth in spiral ganglion neurons (By similarity). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates POU5F1, which results in the inhibition of POU5F1&#x27;s transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). {ECO:0000250|UniProtKB:Q9WTU6, ECO:0000269|PubMed:10376527, ECO:0000269|PubMed:15805466, ECO:0000269|PubMed:17525747, ECO:0000269|PubMed:19675674, ECO:0000269|PubMed:20595622, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:22441692, ECO:0000269|PubMed:34048572, ECO:0000303|PubMed:19290929}.; FUNCTION: MAPK9 isoforms display different binding patterns: alpha-1 and alpha-2 preferentially bind to JUN, whereas beta-1 and beta-2 bind to ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms. JUNB is not a substrate for JNK2 alpha-2, and JUND binds only weakly to it.<br/><strong>T: Active site:</strong> ACT_SITE 151; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "120",
      "proteins": [
        "P45985"
      ],
      "backup_label": "MAP2K4",
      "x": 653.0,
      "y": 478.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to pro-inflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. {ECO:0000269|PubMed:7716521}.\nT: Active site: ACT_SITE 229; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to pro-inflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14. {ECO:0000269|PubMed:7716521}.<br/><strong>T: Active site:</strong> ACT_SITE 229; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;",
      "ptm_overrides": {
        "P45985": {
          "P45985_394": {
            "shape_x": 662.2,
            "shape_y": 474.5,
            "label_x": 657.2,
            "label_y": 469.5,
            "label_centering": "right",
            "symbol_x": 662.2,
            "symbol_y": 474.5,
            "ptm_position": "N1"
          },
          "P45985_90": {
            "shape_x": 689.8,
            "shape_y": 474.5,
            "label_x": 694.8,
            "label_y": 469.5,
            "label_centering": "left",
            "symbol_x": 689.8,
            "symbol_y": 474.5,
            "ptm_position": "N3"
          }
        }
      }
    },
    {
      "protbox_id": "121",
      "proteins": [
        "P46108",
        "P46109"
      ],
      "backup_label": "CRK",
      "x": 695.0,
      "y": 442.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Involved in cell branching and adhesion mediated by BCAR1-CRK-RAPGEF1 signaling and activation of RAP1. {ECO:0000269|PubMed:12432078}.; FUNCTION: [Isoform Crk-II]: Regulates cell adhesion, spreading and migration (PubMed:31311869). Mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4 (PubMed:19004829). May regulate the EFNA5-EPHA3 signaling (By similarity). {ECO:0000250|UniProtKB:Q64010, ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:1630456, ECO:0000269|PubMed:17515907, ECO:0000269|PubMed:19004829, ECO:0000269|PubMed:31311869}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Involved in cell branching and adhesion mediated by BCAR1-CRK-RAPGEF1 signaling and activation of RAP1. {ECO:0000269|PubMed:12432078}.; FUNCTION: [Isoform Crk-II]: Regulates cell adhesion, spreading and migration (PubMed:31311869). Mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4 (PubMed:19004829). May regulate the EFNA5-EPHA3 signaling (By similarity). {ECO:0000250|UniProtKB:Q64010, ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:1630456, ECO:0000269|PubMed:17515907, ECO:0000269|PubMed:19004829, ECO:0000269|PubMed:31311869}.",
      "ptm_overrides": {
        "P46109": {
          "P46109_107": {
            "shape_x": 704.2,
            "shape_y": 463.5,
            "label_x": 699.2,
            "label_y": 468.5,
            "label_centering": "right",
            "symbol_x": 704.2,
            "symbol_y": 463.5,
            "ptm_position": "S1"
          },
          "P46109_220": {
            "shape_x": 718.0,
            "shape_y": 463.5,
            "label_x": 718.0,
            "label_y": 473.5,
            "label_centering": "center",
            "symbol_x": 718.0,
            "symbol_y": 463.5,
            "ptm_position": "S2"
          },
          "P46109_185": {
            "shape_x": 731.8,
            "shape_y": 463.5,
            "label_x": 736.8,
            "label_y": 468.5,
            "label_centering": "left",
            "symbol_x": 731.8,
            "symbol_y": 463.5,
            "ptm_position": "S3"
          }
        }
      }
    },
    {
      "protbox_id": "122",
      "proteins": [
        "P32121"
      ],
      "backup_label": "ARRB1",
      "x": 642.0,
      "y": 442.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Involved in internalization of P2RY1, P2RY4, P2RY6 and P2RY11 and ATP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 and subsequent recycling or degradation. Involved in ubiquitination of IGF1R. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as a signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2) and MAPK10 (JNK3). ERK1/2 and JNK3 activated by the beta-arrestin scaffold are largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Acts as a signaling scaffold for the AKT1 pathway. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Increases ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Involved in CCR7-mediated ERK1/2 signaling involving ligand CCL19. Is involved in type-1A angiotensin II receptor/AGTR1-mediated ERK activity. Is involved in type-1A angiotensin II receptor/AGTR1-mediated MAPK10 activity. Is involved in dopamine-stimulated AKT1 activity in the striatum by disrupting the association of AKT1 with its negative regulator PP2A. Involved in AGTR1-mediated chemotaxis. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. Suppresses UV-induced NF-kappa-B-dependent activation by interacting with CHUK. The function is promoted by stimulation of ADRB2 and dephosphorylation of ARRB2. Involved in p53/TP53-mediated apoptosis by regulating MDM2 and reducing the MDM2-mediated degradation of p53/TP53. May serve as nuclear messenger for GPCRs. Upon stimulation of OR1D2, may be involved in regulation of gene expression during the early processes of fertilization. Also involved in regulation of receptors other than GPCRs. Involved in endocytosis of TGFBR2 and TGFBR3 and down-regulates TGF-beta signaling such as NF-kappa-B activation. Involved in endocytosis of low-density lipoprotein receptor/LDLR. Involved in endocytosis of smoothened homolog/Smo, which also requires GRK2. Involved in endocytosis of SLC9A5. Involved in endocytosis of ENG and subsequent TGF-beta-mediated ERK activation and migration of epithelial cells. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN (PubMed:26839314). Involved in insulin resistance by acting as insulin-induced signaling scaffold for SRC, AKT1 and INSR. Involved in regulation of inhibitory signaling of natural killer cells by recruiting PTPN6 and PTPN11 to KIR2DL1. Involved in IL8-mediated granule release in neutrophils. Involved in the internalization of the atypical chemokine receptor ACKR3. Acts as an adapter protein coupling FFAR4 receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis (PubMed:22282525, PubMed:23809162). During the activation step of NLRP3 inflammasome, directly associates with NLRP3 leading to inhibition of pro-inflammatory cytokine release and inhibition of inflammation (PubMed:23809162). {ECO:0000269|PubMed:10644702, ECO:0000269|PubMed:11877451, ECO:0000269|PubMed:12488444, ECO:0000269|PubMed:12582207, ECO:0000269|PubMed:12949261, ECO:0000269|PubMed:12958365, ECO:0000269|PubMed:14711824, ECO:0000269|PubMed:15054093, ECO:0000269|PubMed:15125834, ECO:0000269|PubMed:15205453, ECO:0000269|PubMed:15475570, ECO:0000269|PubMed:15618519, ECO:0000269|PubMed:15635042, ECO:0000269|PubMed:15671180, ECO:0000269|PubMed:15699339, ECO:0000269|PubMed:15878855, ECO:0000269|PubMed:16144840, ECO:0000269|PubMed:16280323, ECO:0000269|PubMed:16378096, ECO:0000269|PubMed:16492667, ECO:0000269|PubMed:16820410, ECO:0000269|PubMed:17540773, ECO:0000269|PubMed:18419762, ECO:0000269|PubMed:18604210, ECO:0000269|PubMed:19325136, ECO:0000269|PubMed:19620252, ECO:0000269|PubMed:19643177, ECO:0000269|PubMed:20048153, ECO:0000269|PubMed:22282525, ECO:0000269|PubMed:22457824, ECO:0000269|PubMed:23809162, ECO:0000269|PubMed:24817116, ECO:0000269|PubMed:26839314}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Functions in regulating agonist-mediated G-protein coupled receptor (GPCR) signaling by mediating both receptor desensitization and resensitization processes. During homologous desensitization, beta-arrestins bind to the GPRK-phosphorylated receptor and sterically preclude its coupling to the cognate G-protein; the binding appears to require additional receptor determinants exposed only in the active receptor conformation. The beta-arrestins target many receptors for internalization by acting as endocytic adapters (CLASPs, clathrin-associated sorting proteins) and recruiting the GPRCs to the adapter protein 2 complex 2 (AP-2) in clathrin-coated pits (CCPs). However, the extent of beta-arrestin involvement appears to vary significantly depending on the receptor, agonist and cell type. Internalized arrestin-receptor complexes traffic to intracellular endosomes, where they remain uncoupled from G-proteins. Two different modes of arrestin-mediated internalization occur. Class A receptors, like ADRB2, OPRM1, ENDRA, D1AR and ADRA1B dissociate from beta-arrestin at or near the plasma membrane and undergo rapid recycling. Class B receptors, like AVPR2, AGTR1, NTSR1, TRHR and TACR1 internalize as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptors, for extended periods of time. Receptor resensitization then requires that receptor-bound arrestin is removed so that the receptor can be dephosphorylated and returned to the plasma membrane. Mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. Involved in internalization of P2RY1, P2RY4, P2RY6 and P2RY11 and ATP-stimulated internalization of P2RY2. Involved in phosphorylation-dependent internalization of OPRD1 and subsequent recycling or degradation. Involved in ubiquitination of IGF1R. Beta-arrestins function as multivalent adapter proteins that can switch the GPCR from a G-protein signaling mode that transmits short-lived signals from the plasma membrane via small molecule second messengers and ion channels to a beta-arrestin signaling mode that transmits a distinct set of signals that are initiated as the receptor internalizes and transits the intracellular compartment. Acts as a signaling scaffold for MAPK pathways such as MAPK1/3 (ERK1/2) and MAPK10 (JNK3). ERK1/2 and JNK3 activated by the beta-arrestin scaffold are largely excluded from the nucleus and confined to cytoplasmic locations such as endocytic vesicles, also called beta-arrestin signalosomes. Acts as a signaling scaffold for the AKT1 pathway. GPCRs for which the beta-arrestin-mediated signaling relies on both ARRB1 and ARRB2 (codependent regulation) include ADRB2, F2RL1 and PTH1R. For some GPCRs the beta-arrestin-mediated signaling relies on either ARRB1 or ARRB2 and is inhibited by the other respective beta-arrestin form (reciprocal regulation). Increases ERK1/2 signaling in AGTR1- and AVPR2-mediated activation (reciprocal regulation). Involved in CCR7-mediated ERK1/2 signaling involving ligand CCL19. Is involved in type-1A angiotensin II receptor/AGTR1-mediated ERK activity. Is involved in type-1A angiotensin II receptor/AGTR1-mediated MAPK10 activity. Is involved in dopamine-stimulated AKT1 activity in the striatum by disrupting the association of AKT1 with its negative regulator PP2A. Involved in AGTR1-mediated chemotaxis. Appears to function as signaling scaffold involved in regulation of MIP-1-beta-stimulated CCR5-dependent chemotaxis. Involved in attenuation of NF-kappa-B-dependent transcription in response to GPCR or cytokine stimulation by interacting with and stabilizing CHUK. Suppresses UV-induced NF-kappa-B-dependent activation by interacting with CHUK. The function is promoted by stimulation of ADRB2 and dephosphorylation of ARRB2. Involved in p53/TP53-mediated apoptosis by regulating MDM2 and reducing the MDM2-mediated degradation of p53/TP53. May serve as nuclear messenger for GPCRs. Upon stimulation of OR1D2, may be involved in regulation of gene expression during the early processes of fertilization. Also involved in regulation of receptors other than GPCRs. Involved in endocytosis of TGFBR2 and TGFBR3 and down-regulates TGF-beta signaling such as NF-kappa-B activation. Involved in endocytosis of low-density lipoprotein receptor/LDLR. Involved in endocytosis of smoothened homolog/Smo, which also requires GRK2. Involved in endocytosis of SLC9A5. Involved in endocytosis of ENG and subsequent TGF-beta-mediated ERK activation and migration of epithelial cells. Involved in Toll-like receptor and IL-1 receptor signaling through the interaction with TRAF6 which prevents TRAF6 autoubiquitination and oligomerization required for activation of NF-kappa-B and JUN (PubMed:26839314). Involved in insulin resistance by acting as insulin-induced signaling scaffold for SRC, AKT1 and INSR. Involved in regulation of inhibitory signaling of natural killer cells by recruiting PTPN6 and PTPN11 to KIR2DL1. Involved in IL8-mediated granule release in neutrophils. Involved in the internalization of the atypical chemokine receptor ACKR3. Acts as an adapter protein coupling FFAR4 receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis (PubMed:22282525, PubMed:23809162). During the activation step of NLRP3 inflammasome, directly associates with NLRP3 leading to inhibition of pro-inflammatory cytokine release and inhibition of inflammation (PubMed:23809162). {ECO:0000269|PubMed:10644702, ECO:0000269|PubMed:11877451, ECO:0000269|PubMed:12488444, ECO:0000269|PubMed:12582207, ECO:0000269|PubMed:12949261, ECO:0000269|PubMed:12958365, ECO:0000269|PubMed:14711824, ECO:0000269|PubMed:15054093, ECO:0000269|PubMed:15125834, ECO:0000269|PubMed:15205453, ECO:0000269|PubMed:15475570, ECO:0000269|PubMed:15618519, ECO:0000269|PubMed:15635042, ECO:0000269|PubMed:15671180, ECO:0000269|PubMed:15699339, ECO:0000269|PubMed:15878855, ECO:0000269|PubMed:16144840, ECO:0000269|PubMed:16280323, ECO:0000269|PubMed:16378096, ECO:0000269|PubMed:16492667, ECO:0000269|PubMed:16820410, ECO:0000269|PubMed:17540773, ECO:0000269|PubMed:18419762, ECO:0000269|PubMed:18604210, ECO:0000269|PubMed:19325136, ECO:0000269|PubMed:19620252, ECO:0000269|PubMed:19643177, ECO:0000269|PubMed:20048153, ECO:0000269|PubMed:22282525, ECO:0000269|PubMed:22457824, ECO:0000269|PubMed:23809162, ECO:0000269|PubMed:24817116, ECO:0000269|PubMed:26839314}."
    },
    {
      "protbox_id": "123",
      "proteins": [],
      "backup_label": "MECOM",
      "x": 770.0,
      "y": 446.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "124",
      "proteins": [
        "P34931",
        "P0DMV9",
        "P17066",
        "P11142"
      ],
      "backup_label": "HSPA1A",
      "x": 770.0,
      "y": 425.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). Positive regulator of PRKN translocation to damaged mitochondria (PubMed:24270810). {ECO:0000269|PubMed:24270810, ECO:0000303|PubMed:26865365}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). Positive regulator of PRKN translocation to damaged mitochondria (PubMed:24270810). {ECO:0000269|PubMed:24270810, ECO:0000303|PubMed:26865365}.",
      "ptm_overrides": {
        "P0DMV9": {
          "P0DMV9_633": {
            "shape_x": 779.2,
            "shape_y": 421.5,
            "label_x": 774.2,
            "label_y": 416.5,
            "label_centering": "right",
            "symbol_x": 779.2,
            "symbol_y": 421.5,
            "ptm_position": "N1"
          },
          "P0DMV9_631": {
            "shape_x": 793.0,
            "shape_y": 421.5,
            "label_x": 793.0,
            "label_y": 413.5,
            "label_centering": "center",
            "symbol_x": 793.0,
            "symbol_y": 421.5,
            "ptm_position": "N2"
          }
        },
        "P11142": {
          "P11142_254": {
            "shape_x": 779.2,
            "shape_y": 421.5,
            "label_x": 774.2,
            "label_y": 416.5,
            "label_centering": "right",
            "symbol_x": 779.2,
            "symbol_y": 421.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "125",
      "proteins": [
        "P17535"
      ],
      "backup_label": "JUND",
      "x": 891.0,
      "y": 505.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Transcription factor binding AP-1 sites (PubMed:9989505). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription factor complex, thereby enhancing their DNA binding activity to an AP-1 consensus sequence 3'-TGA[GC]TCA-5' and enhancing their transcriptional activity (PubMed:28981703, PubMed:9989505). {ECO:0000269|PubMed:28981703, ECO:0000269|PubMed:9989505}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription factor binding AP-1 sites (PubMed:9989505). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription factor complex, thereby enhancing their DNA binding activity to an AP-1 consensus sequence 3&#x27;-TGA[GC]TCA-5&#x27; and enhancing their transcriptional activity (PubMed:28981703, PubMed:9989505). {ECO:0000269|PubMed:28981703, ECO:0000269|PubMed:9989505}.",
      "ptm_overrides": {
        "P17535": {
          "P17535_100": {
            "shape_x": 900.2,
            "shape_y": 526.5,
            "label_x": 895.2,
            "label_y": 531.5,
            "label_centering": "right",
            "symbol_x": 900.1,
            "symbol_y": 526.5,
            "ptm_position": "S1"
          },
          "P17535_90": {
            "shape_x": 927.8,
            "shape_y": 526.5,
            "label_x": 932.8,
            "label_y": 531.5,
            "label_centering": "left",
            "symbol_x": 927.8,
            "symbol_y": 526.5,
            "ptm_position": "S3"
          },
          "P17535_255": {
            "shape_x": 941.0,
            "shape_y": 516.72,
            "label_x": 946.0,
            "label_y": 518.72,
            "label_centering": "left",
            "symbol_x": 941.0,
            "symbol_y": 516.72,
            "ptm_position": "E2"
          }
        }
      }
    },
    {
      "protbox_id": "126",
      "proteins": [
        "P05412"
      ],
      "backup_label": "FOS",
      "x": 891.0,
      "y": 483.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Transcription factor that recognizes and binds to the AP-1 consensus motif 5'-TGA[GC]TCA-3' (PubMed:10995748, PubMed:22083952). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription complex, thereby enhancing its DNA binding activity to the AP-1 consensus sequence 5'-TGA[GC]TCA-3' and enhancing its transcriptional activity (By similarity). Together with FOSB, plays a role in activation-induced cell death of T cells by binding to the AP-1 promoter site of FASLG/CD95L, and inducing its transcription in response to activation of the TCR/CD3 signaling pathway (PubMed:12618758). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306). {ECO:0000250|UniProtKB:P05627, ECO:0000269|PubMed:10995748, ECO:0000269|PubMed:12618758, ECO:0000269|PubMed:17210646, ECO:0000269|PubMed:22083952, ECO:0000269|PubMed:24623306}.; FUNCTION: (Microbial infection) Upon Epstein-Barr virus (EBV) infection, binds to viral BZLF1 Z promoter and activates viral BZLF1 expression. {ECO:0000269|PubMed:31341047}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription factor that recognizes and binds to the AP-1 consensus motif 5&#x27;-TGA[GC]TCA-3&#x27; (PubMed:10995748, PubMed:22083952). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription complex, thereby enhancing its DNA binding activity to the AP-1 consensus sequence 5&#x27;-TGA[GC]TCA-3&#x27; and enhancing its transcriptional activity (By similarity). Together with FOSB, plays a role in activation-induced cell death of T cells by binding to the AP-1 promoter site of FASLG/CD95L, and inducing its transcription in response to activation of the TCR/CD3 signaling pathway (PubMed:12618758). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306). {ECO:0000250|UniProtKB:P05627, ECO:0000269|PubMed:10995748, ECO:0000269|PubMed:12618758, ECO:0000269|PubMed:17210646, ECO:0000269|PubMed:22083952, ECO:0000269|PubMed:24623306}.; FUNCTION: (Microbial infection) Upon Epstein-Barr virus (EBV) infection, binds to viral BZLF1 Z promoter and activates viral BZLF1 expression. {ECO:0000269|PubMed:31341047}.",
      "ptm_overrides": {
        "P05412": {
          "P05412_63": {
            "shape_x": 887.0,
            "shape_y": 486.11,
            "label_x": 882.0,
            "label_y": 484.11,
            "label_centering": "right",
            "symbol_x": 886.9,
            "symbol_y": 485.61,
            "ptm_position": "W1"
          },
          "P05412_243": {
            "shape_x": 941.0,
            "shape_y": 486.11,
            "label_x": 946.0,
            "label_y": 484.11,
            "label_centering": "left",
            "symbol_x": 940.7,
            "symbol_y": 486.11,
            "ptm_position": "E1"
          }
        }
      }
    },
    {
      "protbox_id": "127",
      "proteins": [],
      "backup_label": "NFATC3",
      "x": 891.0,
      "y": 458.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "128",
      "proteins": [
        "O95644"
      ],
      "backup_label": "NFATC1",
      "x": 891.0,
      "y": 437.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells (PubMed:10358178). Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function (By similarity). {ECO:0000250|UniProtKB:O88942, ECO:0000269|PubMed:10358178}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 or IL-4 gene transcription. Also controls gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of T-lymphocytes as well as lymphoid and non-lymphoid cells (PubMed:10358178). Required for osteoclastogenesis and regulates many genes important for osteoclast differentiation and function (By similarity). {ECO:0000250|UniProtKB:O88942, ECO:0000269|PubMed:10358178}."
    },
    {
      "protbox_id": "129",
      "proteins": [
        "P48454",
        "Q08209",
        "P16298",
        "P63098"
      ],
      "backup_label": "PPP3CA",
      "x": 826.0,
      "y": 382.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals. Dephosphorylates and activates transcription factor NFATC1. Dephosphorylates and inactivates transcription factor ELK1. Dephosphorylates DARPP32. {ECO:0000269|PubMed:19154138}.\nT: Active site: ACT_SITE 147; /note=\"Proton donor\"; /evidence=\"ECO:0000250|UniProtKB:Q08209\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals. Dephosphorylates and activates transcription factor NFATC1. Dephosphorylates and inactivates transcription factor ELK1. Dephosphorylates DARPP32. {ECO:0000269|PubMed:19154138}.<br/><strong>T: Active site:</strong> ACT_SITE 147; /note=&quot;Proton donor&quot;; /evidence=&quot;ECO:0000250|UniProtKB:Q08209&quot;"
    },
    {
      "protbox_id": "131",
      "proteins": [
        "Q9UPT6"
      ],
      "backup_label": "MAPK8IP3",
      "x": 714.0,
      "y": 421.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:12189133). May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins (By similarity). Promotes neuronal axon elongation in a kinesin- and JNK-dependent manner. Activates cofilin at axon tips via local activation of JNK, thereby regulating filopodial dynamics and enhancing axon elongation. Its binding to kinesin heavy chains (KHC), promotes kinesin-1 motility along microtubules and is essential for axon elongation and regeneration. Regulates cortical neuronal migration by mediating NTRK2/TRKB anterograde axonal transport during brain development (By similarity). Acts as an adapter that bridges the interaction between NTRK2/TRKB and KLC1 and drives NTRK2/TRKB axonal but not dendritic anterograde transport, which is essential for subsequent BDNF-triggered signaling and filopodia formation (PubMed:21775604). {ECO:0000250|UniProtKB:Q9ESN9, ECO:0000269|PubMed:12189133, ECO:0000269|PubMed:21775604}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:12189133). May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins (By similarity). Promotes neuronal axon elongation in a kinesin- and JNK-dependent manner. Activates cofilin at axon tips via local activation of JNK, thereby regulating filopodial dynamics and enhancing axon elongation. Its binding to kinesin heavy chains (KHC), promotes kinesin-1 motility along microtubules and is essential for axon elongation and regeneration. Regulates cortical neuronal migration by mediating NTRK2/TRKB anterograde axonal transport during brain development (By similarity). Acts as an adapter that bridges the interaction between NTRK2/TRKB and KLC1 and drives NTRK2/TRKB axonal but not dendritic anterograde transport, which is essential for subsequent BDNF-triggered signaling and filopodia formation (PubMed:21775604). {ECO:0000250|UniProtKB:Q9ESN9, ECO:0000269|PubMed:12189133, ECO:0000269|PubMed:21775604}.",
      "ptm_overrides": {
        "Q9UPT6": {
          "Q9UPT6_365": {
            "shape_x": 723.2,
            "shape_y": 417.5,
            "label_x": 718.2,
            "label_y": 412.5,
            "label_centering": "right",
            "symbol_x": 723.2,
            "symbol_y": 417.5,
            "ptm_position": "N1"
          },
          "Q9UPT6_585": {
            "shape_x": 750.8,
            "shape_y": 417.5,
            "label_x": 755.8,
            "label_y": 412.5,
            "label_centering": "left",
            "symbol_x": 750.8,
            "symbol_y": 417.5,
            "ptm_position": "N3"
          }
        }
      }
    },
    {
      "protbox_id": "132",
      "proteins": [],
      "backup_label": "FLNA",
      "x": 661.0,
      "y": 421.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "133",
      "proteins": [],
      "backup_label": "MAP3K1",
      "x": 557.0,
      "y": 467.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "134",
      "proteins": [],
      "backup_label": "MAP3K8",
      "x": 557.0,
      "y": 443.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "135",
      "proteins": [],
      "backup_label": "MAP4K1",
      "x": 471.0,
      "y": 511.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "136",
      "proteins": [
        "Q8IVH8"
      ],
      "backup_label": "MAP4K3",
      "x": 471.0,
      "y": 445.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine kinase that plays a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway (PubMed:9275185). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:9275185}.\nT: Active site: ACT_SITE 136; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine kinase that plays a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway (PubMed:9275185). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:9275185}.<br/><strong>T: Active site:</strong> ACT_SITE 136; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;"
    },
    {
      "protbox_id": "137",
      "proteins": [],
      "backup_label": "FOS",
      "x": 1057.0,
      "y": 302.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "138",
      "proteins": [],
      "backup_label": "SRF",
      "x": 955.0,
      "y": 302.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "139",
      "proteins": [],
      "backup_label": "MYC",
      "x": 891.0,
      "y": 335.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "140",
      "proteins": [],
      "backup_label": "ELK4",
      "x": 891.0,
      "y": 313.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "141",
      "proteins": [],
      "backup_label": "ELK1",
      "x": 891.0,
      "y": 291.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "142",
      "proteins": [],
      "backup_label": "ATF4",
      "x": 891.0,
      "y": 263.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "143",
      "proteins": [
        "P51812",
        "Q9UK32",
        "Q15418"
      ],
      "backup_label": "RPS6KA6",
      "x": 827.0,
      "y": 273.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:16213824, PubMed:16223362, PubMed:17360704, PubMed:9770464). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:10436156, PubMed:9770464). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:8250835). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:18508509, PubMed:18813292). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:18722121). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.\nT: Active site: ACT_SITE 193; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"; ACT_SITE 539; /note=\"Proton acceptor\"; /evidence=\"ECO:0000250\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:16213824, PubMed:16223362, PubMed:17360704, PubMed:9770464). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at &#x27;Ser-10&#x27;, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:10436156, PubMed:9770464). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at &#x27;Ser-9&#x27; and inhibiting its activity (PubMed:8250835). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:18508509, PubMed:18813292). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at &#x27;Ser-1798&#x27;, which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:18722121). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at &#x27;Ser-1134&#x27; and &#x27;Ser-1161&#x27; that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at &#x27;Ser-897&#x27;, the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.<br/><strong>T: Active site:</strong> ACT_SITE 193; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;; ACT_SITE 539; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000250&quot;",
      "ptm_overrides": {
        "Q15418": {
          "Q15418_380": {
            "shape_x": 836.2,
            "shape_y": 294.5,
            "label_x": 831.2,
            "label_y": 299.5,
            "label_centering": "right",
            "symbol_x": 836.1,
            "symbol_y": 294.5,
            "ptm_position": "S1"
          },
          "Q15418_732": {
            "shape_x": 850.0,
            "shape_y": 294.5,
            "label_x": 850.0,
            "label_y": 304.5,
            "label_centering": "center",
            "symbol_x": 850.0,
            "symbol_y": 294.5,
            "ptm_position": "S2"
          }
        },
        "P51812": {
          "P51812_369": {
            "shape_x": 836.2,
            "shape_y": 294.5,
            "label_x": 831.2,
            "label_y": 299.5,
            "label_centering": "right",
            "symbol_x": 836.1,
            "symbol_y": 294.0,
            "ptm_position": "S1"
          },
          "P51812_227": {
            "shape_x": 850.0,
            "shape_y": 294.5,
            "label_x": 850.0,
            "label_y": 304.5,
            "label_centering": "center",
            "symbol_x": 849.9,
            "symbol_y": 294.0,
            "ptm_position": "S2"
          },
          "P51812_386": {
            "shape_x": 863.8,
            "shape_y": 294.5,
            "label_x": 868.8,
            "label_y": 299.5,
            "label_centering": "left",
            "symbol_x": 863.8,
            "symbol_y": 294.5,
            "ptm_position": "S3"
          },
          "P51812_415": {
            "shape_x": 877.0,
            "shape_y": 284.72,
            "label_x": 882.0,
            "label_y": 286.72,
            "label_centering": "left",
            "symbol_x": 877.0,
            "symbol_y": 284.72,
            "ptm_position": "E2"
          }
        }
      }
    },
    {
      "protbox_id": "144",
      "proteins": [],
      "backup_label": "MKNK2",
      "x": 827.0,
      "y": 252.5,
      "width": 46,
      "height": 17
    },
    {
      "protbox_id": "274",
      "proteins": [
        "P14210",
        "P09603",
        "P05230",
        "P09038"
      ],
      "backup_label": "EFNA4-EFNA3...",
      "x": 114.0,
      "y": 302.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types (PubMed:20624990). Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization (PubMed:15167892, PubMed:20977675). Activates MAPK signaling following TMPRSS13 cleavage and activation (PubMed:20977675). {ECO:0000269|PubMed:15167892, ECO:0000269|PubMed:20624990, ECO:0000269|PubMed:20977675}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types (PubMed:20624990). Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization (PubMed:15167892, PubMed:20977675). Activates MAPK signaling following TMPRSS13 cleavage and activation (PubMed:20977675). {ECO:0000269|PubMed:15167892, ECO:0000269|PubMed:20624990, ECO:0000269|PubMed:20977675}.",
      "ptm_overrides": {
        "P09038": {
          "P09038_189": {
            "shape_x": 123.2,
            "shape_y": 298.5,
            "label_x": 118.2,
            "label_y": 293.5,
            "label_centering": "right",
            "symbol_x": 123.2,
            "symbol_y": 298.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "275",
      "proteins": [
        "Q15628"
      ],
      "backup_label": "TRADD",
      "x": 276.0,
      "y": 621.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Adapter molecule for TNFRSF1A/TNFR1 that specifically associates with the cytoplasmic domain of activated TNFRSF1A/TNFR1 mediating its interaction with FADD (PubMed:23955153, PubMed:7758105, PubMed:8612133). Overexpression of TRADD leads to two major TNF-induced responses, apoptosis and activation of NF-kappa-B (PubMed:7758105, PubMed:8612133). The nuclear form acts as a tumor suppressor by preventing ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A by TRIP12: acts by interacting with TRIP12, leading to disrupt interaction between TRIP12 and isoform p19ARF/ARF of CDKN2A (By similarity). {ECO:0000250|UniProtKB:Q3U0V2, ECO:0000269|PubMed:23955153, ECO:0000269|PubMed:7758105, ECO:0000269|PubMed:8612133}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Adapter molecule for TNFRSF1A/TNFR1 that specifically associates with the cytoplasmic domain of activated TNFRSF1A/TNFR1 mediating its interaction with FADD (PubMed:23955153, PubMed:7758105, PubMed:8612133). Overexpression of TRADD leads to two major TNF-induced responses, apoptosis and activation of NF-kappa-B (PubMed:7758105, PubMed:8612133). The nuclear form acts as a tumor suppressor by preventing ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A by TRIP12: acts by interacting with TRIP12, leading to disrupt interaction between TRIP12 and isoform p19ARF/ARF of CDKN2A (By similarity). {ECO:0000250|UniProtKB:Q3U0V2, ECO:0000269|PubMed:23955153, ECO:0000269|PubMed:7758105, ECO:0000269|PubMed:8612133}."
    },
    {
      "protbox_id": "278",
      "proteins": [
        "Q99836"
      ],
      "backup_label": "MYD88",
      "x": 276.0,
      "y": 654.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response (PubMed:15361868, PubMed:18292575, PubMed:33718825, PubMed:37971847). Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:15361868, PubMed:19506249, PubMed:24316379). Increases IL-8 transcription (PubMed:9013863). Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8 activation by GU-rich single-stranded RNA (GU-rich RNA) derived from viruses such as SARS-CoV-2, SARS-CoV and HIV-1, induces IL1B release through NLRP3 inflammasome activation (PubMed:33718825). MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity). {ECO:0000250|UniProtKB:P22366, ECO:0000269|PubMed:15361868, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:19506249, ECO:0000269|PubMed:20855887, ECO:0000269|PubMed:24316379, ECO:0000269|PubMed:33718825, ECO:0000269|PubMed:37971847, ECO:0000269|PubMed:9013863}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Adapter protein involved in the Toll-like receptor and IL-1 receptor signaling pathway in the innate immune response (PubMed:15361868, PubMed:18292575, PubMed:33718825, PubMed:37971847). Acts via IRAK1, IRAK2, IRF7 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:15361868, PubMed:19506249, PubMed:24316379). Increases IL-8 transcription (PubMed:9013863). Involved in IL-18-mediated signaling pathway. Activates IRF1 resulting in its rapid migration into the nucleus to mediate an efficient induction of IFN-beta, NOS2/INOS, and IL12A genes. Upon TLR8 activation by GU-rich single-stranded RNA (GU-rich RNA) derived from viruses such as SARS-CoV-2, SARS-CoV and HIV-1, induces IL1B release through NLRP3 inflammasome activation (PubMed:33718825). MyD88-mediated signaling in intestinal epithelial cells is crucial for maintenance of gut homeostasis and controls the expression of the antimicrobial lectin REG3G in the small intestine (By similarity). {ECO:0000250|UniProtKB:P22366, ECO:0000269|PubMed:15361868, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:19506249, ECO:0000269|PubMed:20855887, ECO:0000269|PubMed:24316379, ECO:0000269|PubMed:33718825, ECO:0000269|PubMed:37971847, ECO:0000269|PubMed:9013863}."
    },
    {
      "protbox_id": "279",
      "proteins": [
        "Q9NWZ3",
        "P51617"
      ],
      "backup_label": "IRAK1",
      "x": 306.0,
      "y": 707.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections. {ECO:0000269|PubMed:11960013, ECO:0000269|PubMed:12538665, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:17217339, ECO:0000269|PubMed:17337443, ECO:0000269|PubMed:17878374, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509, ECO:0000269|PubMed:24316379}.\nT: Active site: ACT_SITE 311; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections. {ECO:0000269|PubMed:11960013, ECO:0000269|PubMed:12538665, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:17217339, ECO:0000269|PubMed:17337443, ECO:0000269|PubMed:17878374, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509, ECO:0000269|PubMed:24316379}.<br/><strong>T: Active site:</strong> ACT_SITE 311; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159&quot;",
      "ptm_overrides": {
        "Q9NWZ3": {
          "Q9NWZ3_145": {
            "shape_x": 315.2,
            "shape_y": 703.5,
            "label_x": 310.2,
            "label_y": 698.5,
            "label_centering": "right",
            "symbol_x": 315.2,
            "symbol_y": 703.5,
            "ptm_position": "N1"
          }
        }
      }
    },
    {
      "protbox_id": "284",
      "proteins": [
        "P10398"
      ],
      "backup_label": "ARAF",
      "x": 558.0,
      "y": 279.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. Phosphorylates PFKFB2 (PubMed:36402789). {ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:36402789}.; FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. {ECO:0000269|PubMed:22609986}.\nT: Active site: ACT_SITE 429; /note=\"Proton acceptor\"; /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027\"",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May also regulate the TOR signaling cascade. Phosphorylates PFKFB2 (PubMed:36402789). {ECO:0000269|PubMed:22609986, ECO:0000269|PubMed:36402789}.; FUNCTION: [Isoform 2]: Serves as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. {ECO:0000269|PubMed:22609986}.<br/><strong>T: Active site:</strong> ACT_SITE 429; /note=&quot;Proton acceptor&quot;; /evidence=&quot;ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027&quot;"
    },
    {
      "protbox_id": "286",
      "proteins": [
        "P61244"
      ],
      "backup_label": "MAX",
      "x": 891.0,
      "y": 352.5,
      "width": 46,
      "height": 17,
      "tooltip": "T: Function [CC]: FUNCTION: Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5'-CAC[GA]TG-3'. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 'Lys-9' histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements. {ECO:0000269|PubMed:26070438}.",
      "tooltip_html": "<strong>T: Function [CC]:</strong> FUNCTION: Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5&#x27;-CAC[GA]TG-3&#x27;. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 &#x27;Lys-9&#x27; histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements. {ECO:0000269|PubMed:26070438}."
    }
  ],
  "groups": [
    {
      "group_id": "287",
      "members": [
        {
          "type": "prot-box",
          "id": "139"
        },
        {
          "type": "prot-box",
          "id": "286"
        }
      ],
      "protbox_ids": [
        "139",
        "286"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8
    },
    {
      "group_id": "288",
      "members": [
        {
          "type": "prot-box",
          "id": "138"
        },
        {
          "type": "prot-box",
          "id": "140"
        },
        {
          "type": "prot-box",
          "id": "141"
        }
      ],
      "protbox_ids": [
        "141",
        "140",
        "138"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8
    },
    {
      "group_id": "bind_assoc_53",
      "members": [
        {
          "type": "prot-box",
          "id": "53"
        },
        {
          "type": "prot-box",
          "id": "51"
        },
        {
          "type": "prot-box",
          "id": "54"
        }
      ],
      "protbox_ids": [
        "51",
        "53",
        "54"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "53"
    },
    {
      "group_id": "bind_assoc_100",
      "members": [
        {
          "type": "prot-box",
          "id": "100"
        },
        {
          "type": "prot-box",
          "id": "96"
        },
        {
          "type": "prot-box",
          "id": "97"
        },
        {
          "type": "prot-box",
          "id": "98"
        }
      ],
      "protbox_ids": [
        "96",
        "100",
        "97",
        "98"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "100"
    },
    {
      "group_id": "bind_assoc_138",
      "members": [
        {
          "type": "prot-box",
          "id": "138"
        },
        {
          "type": "prot-box",
          "id": "140"
        },
        {
          "type": "prot-box",
          "id": "141"
        }
      ],
      "protbox_ids": [
        "141",
        "140",
        "138"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "138"
    },
    {
      "group_id": "bind_assoc_37",
      "members": [
        {
          "type": "prot-box",
          "id": "37"
        },
        {
          "type": "prot-box",
          "id": "36"
        },
        {
          "type": "prot-box",
          "id": "38"
        },
        {
          "type": "prot-box",
          "id": "39"
        }
      ],
      "protbox_ids": [
        "38",
        "37",
        "36",
        "39"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "37"
    },
    {
      "group_id": "bind_assoc_116",
      "members": [
        {
          "type": "prot-box",
          "id": "116"
        },
        {
          "type": "prot-box",
          "id": "117"
        },
        {
          "type": "prot-box",
          "id": "118"
        },
        {
          "type": "prot-box",
          "id": "119"
        },
        {
          "type": "prot-box",
          "id": "135"
        }
      ],
      "protbox_ids": [
        "119",
        "116",
        "118",
        "117",
        "135"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "116"
    },
    {
      "group_id": "bind_assoc_119",
      "members": [
        {
          "type": "prot-box",
          "id": "119"
        },
        {
          "type": "prot-box",
          "id": "116"
        },
        {
          "type": "prot-box",
          "id": "121"
        },
        {
          "type": "prot-box",
          "id": "131"
        }
      ],
      "protbox_ids": [
        "131",
        "119",
        "121",
        "116"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "119"
    },
    {
      "group_id": "bind_assoc_118",
      "members": [
        {
          "type": "prot-box",
          "id": "118"
        },
        {
          "type": "prot-box",
          "id": "116"
        },
        {
          "type": "prot-box",
          "id": "131"
        }
      ],
      "protbox_ids": [
        "131",
        "118",
        "116"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "118"
    },
    {
      "group_id": "bind_assoc_117",
      "members": [
        {
          "type": "prot-box",
          "id": "117"
        },
        {
          "type": "prot-box",
          "id": "116"
        },
        {
          "type": "prot-box",
          "id": "131"
        }
      ],
      "protbox_ids": [
        "131",
        "116",
        "117"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "117"
    },
    {
      "group_id": "bind_assoc_131",
      "members": [
        {
          "type": "prot-box",
          "id": "131"
        },
        {
          "type": "prot-box",
          "id": "117"
        },
        {
          "type": "prot-box",
          "id": "118"
        },
        {
          "type": "prot-box",
          "id": "119"
        },
        {
          "type": "prot-box",
          "id": "120"
        },
        {
          "type": "prot-box",
          "id": "133"
        }
      ],
      "protbox_ids": [
        "119",
        "120",
        "118",
        "117",
        "131",
        "133"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "131"
    },
    {
      "group_id": "bind_assoc_120",
      "members": [
        {
          "type": "prot-box",
          "id": "120"
        },
        {
          "type": "prot-box",
          "id": "121"
        },
        {
          "type": "prot-box",
          "id": "122"
        },
        {
          "type": "prot-box",
          "id": "131"
        },
        {
          "type": "prot-box",
          "id": "132"
        }
      ],
      "protbox_ids": [
        "132",
        "120",
        "121",
        "122",
        "131"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "120"
    },
    {
      "group_id": "bind_assoc_121",
      "members": [
        {
          "type": "prot-box",
          "id": "121"
        },
        {
          "type": "prot-box",
          "id": "119"
        },
        {
          "type": "prot-box",
          "id": "120"
        }
      ],
      "protbox_ids": [
        "120",
        "119",
        "121"
      ],
      "show_box": true,
      "box_padding": 10,
      "box_radius": 8,
      "anchor_member": "121"
    }
  ],
  "arrows": [
    {
      "protbox_id_1": "52",
      "protbox_id_2": "48",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "47",
      "protbox_id_2": "49",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "20",
      "protbox_id_2": "49",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "50",
      "protbox_id_2": "49",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "45",
      "protbox_id_2": "41",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "111",
      "protbox_id_2": "108",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "110",
      "protbox_id_2": "107",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "24",
      "protbox_id_2": "106",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "109",
      "protbox_id_2": "105",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "106",
      "protbox_id_2": "101",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "105",
      "protbox_id_2": "101",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "46",
      "protbox_id_2": "45",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "44",
      "protbox_id_2": "49",
      "protbox_id_1_side": "West",
      "protbox_id_2_side": "East",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "44",
      "protbox_id_2": "40",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "51",
      "protbox_id_2": "49",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "49",
      "protbox_id_2": "41",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "49",
      "protbox_id_2": "40",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "41",
      "protbox_id_2": "39",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "41",
      "protbox_id_2": "38",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "40",
      "protbox_id_2": "39",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "40",
      "protbox_id_2": "38",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "39",
      "protbox_id_2": "36",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "38",
      "protbox_id_2": "36",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "36",
      "protbox_id_2": "32",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "36",
      "protbox_id_2": "31",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "36",
      "protbox_id_2": "30",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "36",
      "protbox_id_2": "144",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "36",
      "protbox_id_2": "143",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "36",
      "protbox_id_2": "141",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "36",
      "protbox_id_2": "140",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "144",
      "protbox_id_2": "142",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "143",
      "protbox_id_2": "142",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": "",
      "protbox_id_1": "36",
      "protbox_id_1_side": "East",
      "x2": 914.0,
      "y2": 352.0
    },
    {
      "protbox_id_1": "113",
      "protbox_id_2": "133",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "113",
      "protbox_id_2": "114",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "103",
      "protbox_id_2": "95",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "102",
      "protbox_id_2": "94",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "102",
      "protbox_id_2": "89",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "102",
      "protbox_id_2": "133",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "101",
      "protbox_id_2": "89",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "99",
      "protbox_id_2": "86",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "114",
      "protbox_id_2": "115",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "135",
      "protbox_id_2": "117",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "29",
      "protbox_id_2": "133",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "136",
      "protbox_id_2": "133",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "92",
      "protbox_id_2": "118",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "93",
      "protbox_id_2": "118",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "91",
      "protbox_id_2": "118",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "89",
      "protbox_id_2": "80",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "89",
      "protbox_id_2": "79",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "88",
      "protbox_id_2": "35",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "88",
      "protbox_id_2": "34",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "88",
      "protbox_id_2": "80",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "88",
      "protbox_id_2": "79",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "88",
      "protbox_id_2": "65",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "90",
      "protbox_id_2": "80",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "90",
      "protbox_id_2": "79",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "80",
      "protbox_id_2": "77",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "79",
      "protbox_id_2": "77",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "76",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "75",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "74",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "73",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "72",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "71",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "70",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "112",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "68",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "67",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "77",
      "protbox_id_2": "66",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "112",
      "protbox_id_2": "87",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "68",
      "protbox_id_2": "87",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "68",
      "protbox_id_2": "69",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "67",
      "protbox_id_2": "69",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "64",
      "protbox_id_2": "63",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "63",
      "protbox_id_2": "62",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "134",
      "protbox_id_2": "35",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "134",
      "protbox_id_2": "34",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "134",
      "protbox_id_2": "39",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "134",
      "protbox_id_2": "38",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "133",
      "protbox_id_2": "34",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "133",
      "protbox_id_2": "120",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "117",
      "protbox_id_2": "118",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "133",
      "protbox_id_2": "39",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "133",
      "protbox_id_2": "38",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "120",
      "protbox_id_2": "119",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "118",
      "protbox_id_2": "119",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "119",
      "protbox_id_2": "126",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "119",
      "protbox_id_2": "125",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "119",
      "protbox_id_2": "75",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "119",
      "protbox_id_2": "74",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "119",
      "protbox_id_2": "128",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "inhibition",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "119",
      "protbox_id_2": "127",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "inhibition",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "129",
      "protbox_id_2": "128",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "84",
      "protbox_id_2": "89",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "inhibition",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "84",
      "protbox_id_2": "120",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "129",
      "protbox_id_2": "127",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "48",
      "protbox_id_2": "49",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "43",
      "protbox_id_2": "49",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "42",
      "protbox_id_2": "49",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "22",
      "protbox_id_2": "36",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "21",
      "protbox_id_2": "36",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "81",
      "protbox_id_2": "119",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "81",
      "protbox_id_2": "77",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "82",
      "protbox_id_2": "119",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "82",
      "protbox_id_2": "77",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "83",
      "protbox_id_2": "80",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "83",
      "protbox_id_2": "79",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "83",
      "protbox_id_2": "118",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "83",
      "protbox_id_2": "120",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "78",
      "protbox_id_2": "89",
      "protbox_id_1_side": "West",
      "protbox_id_2_side": "East",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "23",
      "protbox_id_2": "88",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "inhibition",
      "type": "dephosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "123",
      "protbox_id_2": "119",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "inhibition",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "124",
      "protbox_id_2": "119",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "inhibition",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_2": "137",
      "protbox_id_2_side": "West",
      "x1": 946.0,
      "y1": 311.0
    },
    {
      "protbox_id_1": "104",
      "protbox_id_2": "98",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "35",
      "protbox_id_2": "33",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "34",
      "protbox_id_2": "33",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_1": "55",
      "protbox_id_1_side": "East",
      "x2": 304.00056581888185,
      "y2": 175.1063769593736
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_2": "20",
      "protbox_id_2_side": "West",
      "x1": 321.87718061890195,
      "y1": 181.1603592019618
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_1": "55",
      "protbox_id_1_side": "East",
      "x2": 304.00056581888185,
      "y2": 175.1063769593736
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_2": "50",
      "protbox_id_2_side": "North",
      "x1": 320.8921376599751,
      "y1": 182.24558061689694
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_2": "104",
      "protbox_id_2_side": "West",
      "x1": 148.0,
      "y1": 743.0
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_2": "47",
      "protbox_id_2_side": "North",
      "x1": 447.0,
      "y1": 133.0
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_2": "44",
      "protbox_id_2_side": "North",
      "x1": 487.0,
      "y1": 146.0
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_2": "46",
      "protbox_id_2_side": "West",
      "x1": 494.69757960393395,
      "y1": 142.38335869594525
    },
    {
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": "",
      "protbox_id_2": "46",
      "protbox_id_2_side": "West",
      "x1": 455.64938486881545,
      "y1": 128.01877887449785
    },
    {
      "protbox_id_1": "103",
      "protbox_id_2": "114",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "103",
      "protbox_id_2": "133",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "35",
      "protbox_id_2": "34",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "98",
      "protbox_id_2": "88",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "97",
      "protbox_id_2": "88",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "108",
      "protbox_id_2": "275",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "275",
      "protbox_id_2": "102",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "275",
      "protbox_id_2": "103",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "107",
      "protbox_id_2": "278",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "278",
      "protbox_id_2": "279",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "102",
      "protbox_id_2": "98",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "279",
      "protbox_id_2": "100",
      "protbox_id_1_side": "South",
      "protbox_id_2_side": "North",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "274",
      "protbox_id_2": "54",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "49",
      "protbox_id_2": "284",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "284",
      "protbox_id_2": "39",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "284",
      "protbox_id_2": "38",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "86",
      "protbox_id_2": "80",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "86",
      "protbox_id_2": "79",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "85",
      "protbox_id_2": "80",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "85",
      "protbox_id_2": "79",
      "protbox_id_1_side": "North",
      "protbox_id_2_side": "South",
      "line": "arrow",
      "type": "phosphorylation",
      "control_points": [],
      "connector_type": ""
    },
    {
      "protbox_id_1": "49",
      "protbox_id_2": "133",
      "protbox_id_1_side": "East",
      "protbox_id_2_side": "West",
      "line": "arrow",
      "type": "",
      "control_points": [],
      "connector_type": ""
    }
  ],
  "compound_data": [
    {
      "compound_id": "19",
      "kegg_compound": "cpd:C00338",
      "label": "C00338",
      "x": 138.0,
      "y": 743.0,
      "width": 8,
      "height": 8,
      "fgcolor": "#000000",
      "bgcolor": "#FFFFFF",
      "graphics_type": "circle",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?C00338"
    },
    {
      "compound_id": "25",
      "kegg_compound": "cpd:C00165",
      "label": "C00165",
      "x": 487.0,
      "y": 136.0,
      "width": 8,
      "height": 8,
      "fgcolor": "#000000",
      "bgcolor": "#FFFFFF",
      "graphics_type": "circle",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?C00165"
    },
    {
      "compound_id": "26",
      "kegg_compound": "cpd:C00575",
      "label": "C00575",
      "x": 447.0,
      "y": 123.0,
      "width": 8,
      "height": 8,
      "fgcolor": "#000000",
      "bgcolor": "#FFFFFF",
      "graphics_type": "circle",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?C00575"
    },
    {
      "compound_id": "27",
      "kegg_compound": "cpd:C01245",
      "label": "C01245",
      "x": 410.0,
      "y": 136.0,
      "width": 8,
      "height": 8,
      "fgcolor": "#000000",
      "bgcolor": "#FFFFFF",
      "graphics_type": "circle",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?C01245"
    },
    {
      "compound_id": "28",
      "kegg_compound": "cpd:C00076",
      "label": "C00076",
      "x": 314.0,
      "y": 175.0,
      "width": 8,
      "height": 8,
      "fgcolor": "#000000",
      "bgcolor": "#FFFFFF",
      "graphics_type": "circle",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?C00076"
    }
  ],
  "text_data": [
    {
      "text_id": "56",
      "label": "MAPK signaling pathway",
      "x": 40.0,
      "y": 45.5,
      "width": 228.0,
      "height": 25.0,
      "fgcolor": "#000000",
      "bgcolor": "transparent",
      "graphics_type": "roundrectangle",
      "text_style": {},
      "border_color": "transparent",
      "border_width": 0,
      "is_background": false,
      "shape_type": "",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?hsa04010"
    },
    {
      "text_id": "57",
      "label": "Phosphatidylinositol signaling system",
      "x": 569.5,
      "y": 67.0,
      "width": 121.0,
      "height": 38.0,
      "fgcolor": "#000000",
      "bgcolor": "transparent",
      "graphics_type": "roundrectangle",
      "text_style": {},
      "border_color": "transparent",
      "border_width": 0,
      "is_background": false,
      "shape_type": "",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?hsa04070"
    },
    {
      "text_id": "58",
      "label": "Cell cycle",
      "x": 1284.0,
      "y": 466.5,
      "width": 34.0,
      "height": 271.0,
      "fgcolor": "#000000",
      "bgcolor": "transparent",
      "graphics_type": "roundrectangle",
      "text_style": {},
      "border_color": "transparent",
      "border_width": 0,
      "is_background": false,
      "shape_type": "",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?hsa04110"
    },
    {
      "text_id": "59",
      "label": "Apoptosis",
      "x": 1176.0,
      "y": 610.0,
      "width": 94.0,
      "height": 26.0,
      "fgcolor": "#000000",
      "bgcolor": "transparent",
      "graphics_type": "roundrectangle",
      "text_style": {},
      "border_color": "transparent",
      "border_width": 0,
      "is_background": false,
      "shape_type": "",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?hsa04210"
    },
    {
      "text_id": "60",
      "label": "Wnt signaling pathway",
      "x": 992.0,
      "y": 833.0,
      "width": 94.0,
      "height": 38.0,
      "fgcolor": "#000000",
      "bgcolor": "transparent",
      "graphics_type": "roundrectangle",
      "text_style": {},
      "border_color": "transparent",
      "border_width": 0,
      "is_background": false,
      "shape_type": "",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?hsa04310"
    },
    {
      "text_id": "61",
      "label": "p53 signaling pathway",
      "x": 992.0,
      "y": 595.0,
      "width": 94.0,
      "height": 38.0,
      "fgcolor": "#000000",
      "bgcolor": "transparent",
      "graphics_type": "roundrectangle",
      "text_style": {},
      "border_color": "transparent",
      "border_width": 0,
      "is_background": false,
      "shape_type": "",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?hsa04115"
    },
    {
      "text_id": "283",
      "label": "TNF signaling pathway",
      "x": 245.0,
      "y": 576.0,
      "width": 94.0,
      "height": 38.0,
      "fgcolor": "#000000",
      "bgcolor": "transparent",
      "graphics_type": "roundrectangle",
      "text_style": {},
      "border_color": "transparent",
      "border_width": 0,
      "is_background": false,
      "shape_type": "",
      "link": "https://www.kegg.jp/dbget-bin/www_bget?hsa04668"
    }
  ],
  "kegg_bg_image": "data:image/png;base64,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",
  "kegg_bg_size": {
    "width": 1346,
    "height": 1046
  },
  "_bookmark_key": "simple",
  "_persist_token": 1769731572.739003,
  "_global_protein_catalog": {
    "path": "c:\\Users\\clayt\\Desktop\\MapKinase\\MapKinase_WebApp\\cache\\global_protein_catalog.json",
    "metadata": {
      "generated_at": "2026-01-03T19:45:44.092638Z",
      "protein_count": 7807,
      "protein_file": "c:\\Users\\clayt\\Desktop\\MapKinase\\sample_input_files\\853paz_Prot_mapk.csv",
      "ptm_files": [
        "c:\\Users\\clayt\\Desktop\\MapKinase\\sample_input_files\\853paz_Phos_mapk.csv"
      ]
    }
  },
  "_color_preview_override": {
    "negative_color": [
      2,
      81,
      150
    ],
    "positive_color": [
      253,
      179,
      56
    ],
    "max_negative": -2.0,
    "max_positive": 2.0
  }
}